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FAIG	 CONSTAR	 que	 aquest	 treball,	 titulat	 “Prenatal	 one	 carbon	metabolism‐gene	
interactions,	 placenta	 trace	 element	 content	 and	 their	 effect	 on	 pregnancy	












I	 STATE	 that	 the	 present	 study,	 entitled	 “Prenatal	 one	 carbon	metabolism‐gene	
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One	 carbon	 (1C)	 metabolism	 is	 highly	 important	 in	 foetal	 development,	 maternal‐
placental‐foetal	unit	development	and	 function,	 and	optimal	pregnancy	outcome.	The	
folate	 and	 methionine	 cycles,	 betaine‐homocysteine	 methyltransferase	 (BHMT)	
pathway	 and	 related	 reactions	 of	 1C	 unit	 transfer	 are	 key	 components	 of	 the	 1C	
metabolic	 network.	 These	 pathways	 interact	 and	 their	 activity	may	 be	modulated	 by	
status	 in	 the	 nutrients	 that	 regulate	 them.	 Nutrients	 involved	 in	 1C	 metabolism	
(including	 amino	 acids,	 osmolytes,	 B	 vitamins,	 nitrogenous	 bases,	 phospholipids	 and	
methyl	 donors)	 are	 essential	 for	 cell	 proliferation,	 metabolism,	 regulation	 and	
differentiation.	The	 trace	elements,	zinc,	 copper,	 selenium	and	 iron	are	also	essential.	
Enzymes	and	other	proteins	containing	these	trace	elements	are	involved	in	processes	
such	as	oxygen	transport,	respiratory	chain,	metal	detoxification	and	oxidative	stress.	
The	 effects	 of	 frequent	 1C	 metabolism	 genetic	 polymorphisms	 on	 1C	 metabolism	
components	 or	 whether	 they	 are	 modulated	 by	 folate	 are	 not	 clearly	 understood,	
especially	 during	 pregnancy.	 There	 is	 much	 interest	 in	 the	 effect	 of	 folate	 because	
mandatory	 fortification	 of	 flour	 with	 folic	 acid	 has	 been	 implemented	 in	 numerous	
countries	 but	 not	 European	 countries,	 among	 others.	 Placenta	 functions	 include	
nutrient	 and	 metabolite	 transport,	 defence	 against	 toxicity,	 as	 well	 as	 endocrine	
functions.	The	role	of	the	above	trace	elements	in	the	placenta	is	unclear	and	evidence	
on	 determining	 factors	 of	 their	 concentrations	 in	 the	 placenta	 is	 inconsistent.	 No	
previous	study	has	investigated	whether	1C	metabolism	affects	these.	
The	aims	of	the	thesis	are	to	investigate:		
1)	 the	 effects	 of	 frequent	 maternal	 1C	 metabolism	 polymorphisms	
(methylenetetrahydrofolate	 reductase	 MTHFR	 c.665C>T,	 betaine‐homocysteine	
methyltransferase	 BHMT	 c.716G>A,	 reduced	 folate	 carrier	 SLC19A1	 c.80G>A	 and	
methionine	synthase	reductase	MTRR	c.66A>G)	on	related	metabolite	concentrations	in	
blood	during	pregnancy	and	whether	these	effects	are	modulated	by	folate	status.	
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3)	 whether	 these	 polymorphisms	 or	 placenta	 trace	 element	 concentrations	 are	
associated	 with	 adverse	 pregnancy	 outcomes	 such	 as	 miscarriage	 and	 intrauterine	
growth	restriction	(IUGR),	or	preterm	delivery	and	IUGR.	
The	 study	 was	 based	 on	 617	 pregnancies	 from	 the	 Reus‐Tarragona	 Birth	 Cohort	
(RTBC),	 a	 longitudinal	 observational	 pregnancy	 study	 including	 a	 subset	 of	 212	
pregnancies	from	which	placentas	were	collected	plus	other	6	placentas	of	participants	
recruited	at	labour	with	focus	on	adverse	pregnancy	outcomes.	Lifestyle,	biological	and	
obstetrical	 data	 was	 collected	 from	 the	 first	 trimester	 throughout	 pregnancy	 by	
questionnaires	and	 from	prenatal	 check‐ups.	Fasting	blood	samples	were	collected	at	
≤12,	 15,	 24‐27	 and	 34	 gestational	weeks	 (GW).	 Blood	 samples	 from	 the	mother	 and	
cord	were	also	collected	at	labour.	Red	blood	cell	(RBC)	and	plasma	folate,	and	plasma	
cobalamin	 were	 determined	 by	 microbiological	 assays.	 Gas	 chromatography	 ‐	 mass	
spectrometry	was	used	for	plasma	total	homocysteine	(tHcy)	concentrations,	and	liquid	
chromatography	 ‐	 tandem	 mass	 spectrometry	 for	 plasma	 betaine,	 dimethylglycine	
(DMG),	 choline	 and	 cotinine.	 The	 genotypes	 of	 the	 four	 polymorphisms	 were	
determined	 in	 maternal	 and	 cord	 leukocyte	 DNA	 by	 matrix‐assisted	 laser	
desorption/ionization	mass	spectrometry.	Placenta	concentrations	of	zinc,	copper	and	
selenium	were	 determined	 by	 inductively	 coupled	 plasma	 ‐	 mass	 spectrometry,	 and	
those	of	iron	by	inductively	coupled	plasma	‐	optic	emission	spectrometry.	
The	tHcy	enhancing	effect	in	MTHFR	c.665	variant	homozygotes	was	modulated	by	RBC	
folate	 at	 ≤12	 GW	 and	 by	 plasma	 folate	 from	 15	 GW	 on	 and	 in	 the	 cord:	 the	MTHFR	
c.665TT	 genotype	 was	 not	 associated	 with	 elevated	 (tHcy)	 during	 pregnancy	 when	
folate	status	was	high.	We	suggest	the	modulation	by	RBC	or	plasma	folate	at	different	
stages	of	pregnancy	could	be	due	to	the	pattern	of	folic	acid	supplement	use.	The	BHMT	
c.716	 variant	 genotypes	 were	 associated	 with	 lower	 DMG	 concentration	 and	 ratio	
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at	 the	 extremes	 of	 the	 folate	 status	 distribution.	 Plasma	 folate	 was	 an	 independent	
negative	 predictor	 of	 plasma	 DMG,	 supporting	 the	 idea	 that	 the	 BHMT	 pathway	 is	
upregulated	 under	 low	 folate	 status	 conditions.	 Plasma/RBC	 folate	 and	 tHcy	 did	 not	
vary	 with	 SLC19A1	 c.80G>A	 genotype.	 Higher	 plasma	 tHcy	 was	 found	 in	MTRR	 c.66	
variant	 homozygotes	 only	 in	 early	 pregnancy.	 After	 stratification	 by	 folate	 status	 the	
effect	was	lost	in	the	lowest	and	highest	plasma	folate	tertiles.	We	suggest	the	absence	
of	effect	in	early	pregnancy	with	low	folate	status	and	in	mid‐late	pregnancy	might	be	
due	 to	 upregulation	 of	 the	 BHMT	 pathway.	We	 also	 suggest	 the	 absence	 of	 effect	 in	
early	 pregnancy	 with	 high	 folate	 status	 could	 be	 due	 to	 reduction	 of	 this	 effect	 by	
higher	S‐adenosyl	methionine	(SAM)	and	lower	S‐adenosyl	homocysteine	(SAH).	More	
IUGR	neonates	had	the	MTHFR	c.665	normal	homozygote	genotype	compared	to	other	
genotypes.	 A	 speculative	 explanation	 for	 this	 might	 be	 that	 embryos	 with	 variant	
genotypes	are	less	likely	to	survive	when	combined	with	factors	leading	to	IUGR.	
Lower	 zinc	 concentrations	 were	 found	 in	 placentas	 of	 male	 than	 female	 neonates.	
Although	the	reason	 is	not	clear	a	speculative	explanation	 is	 that	 it	may	be	the	NBDY	




from	 the	 placenta	 to	 the	 intestine	 to	 increase	 ferroxidase	 activity	 at	 that	 location.	
Smoking	 during	 pregnancy	 was	 associated	 with	 higher	 placenta	 concentrations	 of	
copper	and	selenium.	Birth	weight	was	negatively	correlated	with	placenta	zinc,	copper	
and	 selenium,	 however,	 after	 adjustment	 this	 was	 true	 only	 for	 copper.	 Unlike	
selenium,	copper	was	associated	with	higher	IUGR	risk	after	adjustment.	In	addition	to	
the	 associations	 with	 smoking	 and	 birth	 weight,	 placenta	 zinc,	 copper	 and	 selenium	
were	positively	correlated	and	not	associated	with	total,	food	or	supplement	intake.	All	
this	led	us	to	suggest	the	levels	of	these	3	trace	elements	in	the	placenta	depend	mostly	
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on	 overlapping	 functions,	 namely	 oxidative	 stress	 and	 metal	 toxicity	 defence.	 1C	
metabolism	 was	 only	 associated	 with	 placenta	 copper.	 Plasma	 cobalamin	 in	 early	
pregnancy	 was	 negatively	 associated	 with	 placenta	 copper	 and	 late	 pregnancy	 tHcy	
was	 positively	 associated	 with	 it.	 Both	 associations	 are	 unclear	 but	 we	 suggest	 the	
mediator	 of	 the	 positive	 association	 between	 tHcy	 and	 copper	 is	 the	 placental	
adenosylhomocysteinase	enzyme.	
As	 major	 conclusions,	 with	 the	 exception	 of	 SLC19A1	 c.80G>A,	 the	 addressed	
polymorphisms	affect	1C	metabolism	during	pregnancy	and	their	effects	are	modulated	
by	 folate	 status	 in	 different	 ways	 in	 each	 case.	 Some	 of	 the	 analysed	 factors	 were	
associated	with	the	4	trace	elements	in	the	placenta,	but	multivariate	models	explained	
very	little	variability	in	the	observed	concentrations.	Therefore,	other	unknown	factors,	
or	 factors	 not	 considered	 in	 these	 models	 must	 be	 involved.	 The	 normal	 allele	 for	
MTHFR	 c.665	 in	 the	 offspring	 and	 placenta	 copper	 concentration	 were	 positively	
associated	with	IUGR	risk.	
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The	one	 carbon	 (1C)	 network	 involves	 the	 intracellular	 transfer	 of	 1C	units	 between	
molecules	 (Figure	 1).	 These	 transferable	 1C	 units	 occur	 in	 the	 forms	 of	 formimino	
(CHNH),	 formyl	 (CHO),	 methylene	 (CH2)	 and	 especially	 methyl	 (CH3)	 groups.	 One	
carbon	donors	include	amino	acids,	folates,	S‐adenosyl	methionine	(SAM),	betaine	and	
dimethylglycine	 (DMG),	 among	 others.	 Formyl	 groups	 can	 be	 acquired	 directly	 from	
formate	 into	tetrahydrofolate	(THF)	 in	a	reaction	catalysed	by	formyltetrahydrofolate	
synthetases	 (MTHFDs).	 1C	metabolism	 includes	 the	 folate	 cycle,	methionine	 cycle	 as	
well	 as	 the	 choline	 oxidation	 pathway	 (terminating	 with	 the	 betaine‐homocysteine	
methyltransferase	pathway)	and	related	reactions	of	1C	transfer.	The	availability	of	1C	
units	is	necessary	for	cell	proliferation	and	metabolism	(Molloy	2012),	and	therefore	it	
is	 regarded	 as	 highly	 important	 in	 pregnancy	 for	 embryo/foetal	 development.	
Derangements	in	1C	metabolism	have	been	associated	with	impaired	foetal	growth	and	
developmental	 abnormalities	 such	 as	 neural	 tube	 defects.	 Purines	 and	 pyrimidines	
(from	deoxythymidine)	derived	 from	1C	metabolism	are	necessary	 for	DNA	and	RNA	
synthesis,	 and	hence	 for	DNA	 replication,	 repair	 and	 expression.	 In	 the	 1C	metabolic	
network	 and	 transulphuration	 pathway	 amino	 acids	 are	 interconverted	 for	 protein	
synthesis.	 The	universal	methyl	donor	 SAM	can	be	produced	 in	 the	methionine	 cycle	
subsequently	 to	 the	 homocysteine	 remethylation	 to	 methionine,	 or	 from	 dietary	
methionine.	 Homocysteine	 remethylation	 can	 occur	 by	 the	 cobalamin	 and	 folate	
dependent	reaction	catalysed	by	the	ubiquitous	methionine	synthase	(MTR);	or	by	the	
betaine	 dependent	 reaction	 catalysed	 by	 betaine‐homocysteine	 methyltransferase	
(BHMT),	 a	 minor	 pathway	 limited	 to	 the	 liver	 and	 kidney	 (Finkelstein	 1990).	 Three	
SAMs	 are	 necessary	 for	 the	 complete	 methylation	 of	 phosphatidylethanolamine	 to	
phosphatidylcholine	(a	glycerophospholipid	with	choline	in	the	headgroup)	(Vance	and	
Ridgway	1988),	which	accounts	for	more	than	50%	of	the	phospholipids	in	mammalian	
cell	 membranes	 (Zeisel	 2006).	 SAM	 is	 also	 involved	 in	 the	 postranslational	
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and	 non‐histone	 proteins.	 The	 methyl	 groups	 for	 de	 novo	 and	 maintenance	 DNA	
methylation,	as	well	as	for	structural	and	regulatory	methylation	of	RNA,	are	provided	
by	SAM.	Histone	and	DNA	methylation	 form	part	of	 the	epigenetic	 regulation	of	gene	
expression,	 hence	 determining	 embryo	 cell	 differentiation	 and	 specialisation.	
Epigenetic	marks	have	been	 shown	 to	be	 relatively	 stable	 and	 to	be	heritable	 and	 so	
have	been	proposed	as	a	foetal	programming	mechanism	,	i.e.	predisposition	to	specific	
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written	 in	 bold,	 substrates	 and	 products	 are	 not.	 Substrates	 and	 products	 involved	 in	 DNA,	 RNA	 and
protein	 synthesis,	 and	 methylation	 reactions	 are	 underlined.	 Enzymes	 [vitamin	 cofactor]:	 ALDH7A1,
betaine	 aldehyde	 dehydrogenase;	 AHCY,	 adenosylhomocysteinase;	 BHMT,	 betaine‐homocysteine
methyltransferase;	 CBS,	 cystathionine‐beta‐synthase	 [B6];	 CGL,	 cystathionine‐gamma‐lyase	 [B6];	 CHDH,
choline	 dehydrogenase	 [B2];	 DHFR,	 dihydrofolate	 reductase;	 MATs,	 methionine	 adenosyltransferases;
MTHFDs,	 formyltetrahydrofolate	 synthetases1,	 methenyltetrahydrofolate	 cyclohydrolases2,
methylenetetrahydrofolate	 dehydrogenases3;	 MTHFR,	 methylenetetrahydrofolate	 reductase	 [B2];	 MTR,
methionine	synthase	[B12];	MTRR,	methionine	synthase	reductase	[B2];	MTs,	methyltransferases;	SHMTs,
serine	 hydroxymethyltransferases	 [B6];	 TYMS,	 thymidylate	 synthetase.	 Metabolites:	 Cbl(I/II),	 cobalamin
(1+/2+	 oxidation	 state);	 CH3Cbl(III),	 methylcobalamin	 (3+	 oxidation	 state);	 DHF,	 dihydrofolate;	 DMG,
dimethylglycine;	 dTMP,	 deoxythymidine	 monophosphate;	 dUMP,	 deoxyuridine	 monophosphate;	 Gly,
glycine;	Hcy,	homocysteine;	SAH,	S‐adenosyl	homocysteine;	SAM,	S‐adenosyl	methionine;	Ser,	serine;	THF,
tetrahydrofolate;	 10FTHF,	 10‐formylTHF;	 5,10CHTHF,	 5,10‐methenylTHF;	 5,10CH2THF,	 5,10‐
methyleneTHF;	 5CH3THF,	 5‐methylTHF.	 Information	 adapted	 from	 (Finkelstein	 1990;	 Olteanu	 and
Banerjee	2001;	Stover	2010b;	Vazquez	et	al.	2013;	Institute	of	Medicine	2016b).	
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Homocysteine	 can	 be	 remethylated	 to	 methionine	 in	 the	 methionine	 cycle,	 which	
intersects	with	 the	 folate	 cycle	 and	with	 the	 BHMT	 pathway	 (Introduction	 section	1,	
Figure	1).	Homocysteine	is	also	metabolised	in	the	transulphuration	pathway	(Figure	
1,	 red	 arrows),	which	 is	 pyridoxine	 dependent	 and	 in	which	 the	 first	 enzyme	 of	 the	
pathway,	 cystathionine‐beta‐synthase	 (CBS),	 catalyses	 a	 reaction	 that	 is	 irreversible	
under	 most	 in	 vivo	 conditions	 (Finkelstein	 1990).	 Homocysteine	 and	 serine	 are	
converted	 to	 cystathionine	 by	 cystathionine‐beta‐synthase,	 and	 cystathionine	 to	
cysteine,	 alpha‐ketobutyrate	 and	 NH3	 in	 a	 reversible	 reaction	 catalysed	 by	
cystathionine‐gamma‐lyase	(CGL)	(Matsuo	and	Greenberg	1959).	
Several	 forms	of	homocysteine	are	 transported	 in	 the	blood	due	 to	 its	ability	 to	 form	
disulphides	 or	 bind	 to	 proteins	 (Table	 1).	 In	 human	 plasma,	 two	 homocysteine	
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molecules	 can	 be	 oxidised	 to	 form	 the	 disulphide	 homocystine,	 or	 one	 molecule	 of	
homocysteine	and	one	cysteine	form	a	mixed	disulphide	by	a	mechanism	that	involves	
albumin.	 It	 is	 estimated	 that	 20%	 of	 these	 albumin‐mediated	 oxidations	 are	 due	 to	
albumin‐bound	 copper	 and	 80%	 through	 albumin‐S‐S‐cysteine	 or	 albumin‐S‐S‐
homocysteine	 by	 thiol/disulphide	 exchange	 (Sengupta	 et	 al.	 2001).	 The	
posttranslational	 and	 covalent	 binding	 of	 homocysteine	 to	 proteins	 is	 called	
homocysteinylation.	 In	 S‐homocysteinylation	 a	 protein‐S‐S‐homocysteine	 adduct	 is	
formed	by	the	reaction	of	the	thiol	group	(‐SH)	of	one	protein	cysteine	residue	and	that	
of	homocysteine.	Hydrogen	peroxide	can	be	formed	in	S‐homocysteinylation	if	oxygen	
is	 the	 electron	 acceptor	 (Jacobsen	 2001).	 In	 N‐homocysteinylation,	 the	 side	 chain	
amino	group	(‐NH2)	of	lysine	residues	in	a	protein	react	with	the	activated	carboxyl	of	
the	 homocysteine	 derivative	 homocysteine	 thiolactone,	 resulting	 in	 the	 linkage	 of	
homocysteine	to	a	protein	via	an	amide	bond	(Jakubowski	1997).		
Some	reported	plasma	concentration	values	of	different	homocysteine	forms	are	shown	
in	 Table	 1.	 Most	 of	 it	 is	 transported	 as	 protein	 S‐linked	 homocysteine,	 especially	
albumin	(Refsum	et	al.	1985).	Less	as	cysteine‐homocysteine	mixed	disulphide	(Gupta	
and	Wilcken	1978),	 and	only	 trace	amounts	 as	 the	disulphide	homocystine	 (Murphy‐
Chutorian	 et	 al.	 1985),	 protein	 N‐linked	 homocysteine	 (Uji	 et	 al.	 2002;	 Perna	 et	 al.	
2006)	and	reduced	homocysteine	(Araki	and	Sako	1987).	Homocysteine	thiolactone	is	
either	absent	or	found	in	trace	amounts	(Chwatko	and	Jakubowski	2005).	According	to	
in	 vitro	 experiments	 (Jakubowski	 2001),	 from	 the	 total	 of	 protein	 N‐linked	
homocysteine	half	 is	 incorporated	 in	 the	backbone	of	 the	proteins	 and	 the	 rest	 as	N‐
homocysteinylation.
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after	 a	 reducing	 treatment	 aimed	 to	 break	 disulphide	 bonds	 (Refsum	 et	 al.	 2004);	
therefore	 tHcy	 includes	homocysteine	molecules	 that	are,	prior	 to	 the	 treatment,	 free	
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Hyperhomocysteinaemia	 has	 been	 defined	 as	 plasma	 tHcy	 between	 15‐30µmol/L	
(mild),	 30‐100µmol/L	 (intermediate)	 and	 ≥100µmol/L	 (severe)	 (Vollset	 et	 al.	 2001);	





has	 not	 yet	 been	 established	 whether	 homocysteine	 is	 a	 cause,	 consequence	 or	




Homocysteinylation	 has	 negative	 effects	 on	 protein	 on	 most	 of	 the	 tested	 proteins	
which	may	lead	to	pathologies,	but	this	has	only	be	assessed	in	in	vitro	experiments.	S‐
homocysteinylation	 alters	 the	 functions	 of	 proteins	 from	plasma	 (Harpel	 et	 al.	 1992;	
Majors	 et	 al.	 2002;	 Zinellu	 et	 al.	 2015),	 extracellular	 matrix	 (Bescond	 et	 al.	 1999;	
Hubmacher	et	al.	2005)	and	plasmatic	membrane	(Hajjar	et	al.	1998).	In	the	cytoplasm,	
S‐homocystenylated	 metallothioneins	 have	 impaired	 zinc‐binding	 function	 and	
inhibited	 ability	 to	 scavenge	 superoxide	 anion	 radicals	 (Barbato	 et	 al.	 2007).	 N‐
homocysteinylated	 proteins	 have	 altered	 function	 (Jakubowski	 1999;	 Zinellu	 et	 al.	
2015),	structure	(Paoli	et	al.	2010),	degradation	rate	(Jakubowski	2004)	and	antigenic	
properties	 (Undas	 et	 al.	 2004;	 Jakubowski	 2006).	 It	 has	 been	 proposed	 that	 N‐
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Nitric	 oxide	 regulates	 activity	 and	 function	 of	 proteins,	 e.g.	 activation	 of	 DNA	
methyltransferases	(DNMTs)	(Hmadcha	et	al.	1999)	and	thioredoxin	1	(Haendeler	et	al.	
2002),	 inactivation	 of	 MTR	 (Danishpajooh	 et	 al.	 2001)	 and	 methionine	
adenosyltransferases	(Ruiz	et	al.	1998;	Pérez‐Mato	et	al.	1999),	and	release	of	zinc	from	




Homocysteine	 can	 indirectly	 affect	 methylation	 reactions.	 Adenosylhomocysteinase	
(AHCY)	 catalyses	 the	 reversible	 reaction:	 adenosine	 +	 homocysteine	 ⇄	 S‐adenosyl	
homocysteine	(SAH)	(Prigge	and	Chiang	2001),	and	although	the	synthetic	direction	is	
favoured,	the	efficient	removal	of	homocysteine	and	adenosine	in	the	organism	makes	
the	 reaction	 proceed	 in	 the	 hydrolytic	 direction	 (Cantoni	 1985).	 This	 is	 especially	
important	because	most	methyltransferases	are	inhibited	by	SAH	(Clarke	and	Banfield	
2001).	Therefore,	impairment	in	the	homocysteine	removal	mechanisms	can	lead	to	an	
increase	 in	 SAH,	 and	 this	 to	 higher	 inhibition	 of	 methyltransferases.	 This	 idea	 is	









hydrogen	 peroxide	 (H2O2)	 during	 S‐homocystenylation,	 autooxidation	 and	 oxidation	
with	 cysteine	 or	 other	 thiols	 (Jacobsen	 2001).	 The	 binding	 of	 homocysteine	 to	 nitric	
oxide	can	also	produce	the	reactive	oxygen	species	superoxide	(Gow	et	al.	1997).	Some	
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undergoes	 similar	 oxidations	 while	 being	 less	 toxic;	 and	 2)	 the	 abundance	 of	
antioxidants	 and	antioxidant	 enzymes	might	be	 enough	 to	 compensate	homocysteine	
induced	 oxidative	 stress	 (Jacobsen	 2000).	 However,	 antioxidants	 can	 ameliorate	 the	
negative	 effects	 of	 homocysteine.	 Although	 one‐week	 supplementation	with	 ascorbic	
acid	 does	 not	 reduce	 post‐methionine	 load	 homocysteine,	 it	 does	 reduce	 the	
impairment	 of	 the	 arterial	 flow‐mediated	 dilatation	 (Chambers	 et	 al.	 1999).	 This	 is	
mediated	by	nitric	oxide	release	(Joannides	et	al.	1995)	and	its	impairment	is	related	to	
plasma	 homocysteine	 (Chambers	 et	 al.	 1999).	 In	 addition,	 homocysteine	 seems	 to	
dysregulate	antioxidant	enzymes.	The	plasma	concentration	of	extracellular	superoxide	
dismutase	(SOD3),	with	copper	and	possibly	zinc	cofactors	 to	catalyse	 the	removal	of	
O2·‐,	 is	 highly	 positively	 correlated	 with	 tHcy	 in	 treated	 homocysteinuric	 patients	
(Wilcken	et	al.	2000).	The	activity	of	extracellular	 superoxide	dismutase	 in	plasma	of	
homocysteine	 treated	rats	 to	mimic	a	homocysteinuric	 state	 is	higher	 than	 in	control	
animals	 (Matté	 et	 al.	 2009).	On	 the	 other	hand,	 in	vitro	 experiments	have	 shown	 the	
downregulation	of	mRNA	expression	 (Upchurch	 et	 al.	 1997)	 and	 activity	 (Nishio	 and	
Watanabe	 1997)	 of	 the	 selenoproteins	 glutathione	 peroxidases,	 which	 catalyse	 the	
removal	 of	 lipid	 and	 hydrogen	 peroxides	 with	 glutathione.	 Glutathione	 peroxidase	
activity	 is	 also	 lower	 in	 brain	 extracts	 of	 homocysteinuric	 rats	 (Matté	 et	 al.	 2009).	
Homocysteine	has	been	shown	 to	downregulate	catalase	activity,	 another	antioxidant	
enzyme	 and,	 a	 haemoprotein	 involved	 in	 the	 removal	 of	 H2O2,	 in	 neuronal	 (Milton	
2008)	 but	 not	 in	 aortic	 smooth	muscle	 cell	 cultures	 (Nishio	 and	Watanabe	 1997).	 In	
these	rat	models	of	a	homocysteinuric	state,	catalase	activity	was	lower	and	higher	in	
brain	 extracts	or	plasma,	 respectively,	 compared	with	 the	 control	 group	 (Matté	 et	 al.	
2009).	 Although	 with	 many	 unanswered	 questions,	 it	 seems	 that	 as	 previously	
proposed	 for	vascular	cells	 (Jacobsen	2000),	homocysteine	generates	oxidative	stress	
due	to	mechanisms	other	than	thiol	oxidation.	
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Other	 possible	 homocysteine	 toxicity	 mechanisms	 include	 the	 inhibition	 of	 DNA	
synthesis	(as	less	incorporation	of	marked	thymidine)	as	a	possible	growth	inhibitory	
effect	in	endothelial	cell	experiments	(Wang	et	al.	1997;	Yang	et	al.	2005).	However,	it	




can	 affect	 tHcy	 levels.	 Lower	 glomerular	 filtration	 rate	 (decreased	 renal	 function),	
higher	serum	creatinine	and	albumin	concentrations	are	associated	with	higher	plasma	
tHcy	concentrations	(Wu	et	al.	1994;	Brattström	et	al.	1994;	Lussier‐Cacan	et	al.	1996;	
Wollesen	 et	 al.	 1999).	 Male	 sex,	 increasing	 age,	 hypothyroidism,	 late	 diabetes,	
leukaemia	 and	 psoriasis	 are	 positive	 determinants,	 and	 hyperthyroidism	 and	 early	
diabetes	are	negative	determinants	of	tHcy	(Refsum	et	al.	2004).	
Total	 homocysteine	 increase	 have	 been	 associated	 with	 various	 diseases	 and	
pathological	 conditions	 such	 as	 Alzheimer	 disease	 (Shen	 and	 Ji	 2015),	 schizophrenia	
(Nishi	et	al.	2014),	multiple	sclerosis	(Zhu	et	al.	2011),	obstructive	sleep	apnoea	(Niu	et	
al.	 2014),	 type	 2	 diabetes	 (Huang	 et	 al.	 2013),	 type	 1	 diabetic	 retinopathy	 (Xu	 et	 al.	
2014),	 type	 2	 diabetic	 nephropathy	 (Mao	 et	 al.	 2014),	 postmenopausal	 osteoporosis	
(Zhang	 et	 al.	 2014),	 hip	 fracture	 (Yang	 et	 al.	 2012b)	 and	 polycystic	 ovary	 syndrome	
(Murri	 et	 al.	 2013).	 Homocysteine	 is	 considered	 an	 independent	 risk	 factor	 of	
cardiovascular	 disease	 (CVD)	 due	 to	 its	 associations	 with	 pathologies	 encompassed	
under	 the	CVD	 threshold	 (World	Health	Organization	2011),	 such	 as	 coronary	 artery	
disease	 and	 stroke	 (Homocysteine	 Studies	 Collaboration	 2002;	 Wald	 et	 al.	 2002).	
Furthermore,	 the	 variant	 allele	 of	 the	 polymorphism	 methylenetetrahydrofolate	
reductase	 (MTHFR)	c.665C>T	has	been	associated	with	some	of	 the	 these	pathologies	
and	higher	homocysteine	concentrations	(see	Introduction	section	3.1).	However,	there	
is	 some	 controversy	 as	 clinical	 trials	 with	 treatments	 lowering	 homocysteine	 have	
usually	failed	in	preventing	the	recurrence	of	CVD	events.	In	adults	with	CVD	or	at	risk	
of	CVD,	B	vitamin	(including	 folic	acid)	based	homocysteine	 lowering	treatments	 lack	
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2012;	 Martí‐Carvajal	 et	 al.	 2013).	 On	 the	 contrary,	 a	 protective	 effect	 of	 these	
treatments	has	been	reported	in	stroke	when	the	participants	have	no	history	of	stroke	
(primary	 prevention),	 as	 reviewed	 (McNulty	 et	 al.	 2012).	 Folic	 acid	 based	
homocysteine	 lowering	 treatment	 does	 not	 reduce	 myocardial	 infarction	 and	
cardiovascular	mortality	in	patients	with	kidney	disease	(Jardine	et	al.	2012),	although	
for	 the	general	 category	CVD,	 a	protective	 effect	 has	been	 reported	 in	 these	patients,	
especially	evident	in	the	absence	of	exposure	to	folic	acid	fortification	(Qin	et	al.	2013).		
Homocysteine	in	pregnancy	
Previously	 our	 group	 described	 the	 pattern	 of	 changes	 in	 tHcy	 during	 normal	
pregnancy	 in	a	 longitudinal	study	of	women	followed	from	preconception	throughout	




use	 folic	 acid	 supplements	 (Murphy	 et	 al.	 2004).	 Transversal	 studies	 have	 reported	
lower	tHcy	concentrations	at	all	the	analysed	time	points	of	pregnancy	(from	12	to	42	
GW)	than	in	non	pregnant	women	(Kang	et	al.	1986;	Holmes	et	al.	2005;	Friesen	et	al.	
2007;	 Wu	 et	 al.	 2013).	 It	 has	 been	 suggested	 that	 pregnancy	 associated	 endocrine	
changes	may	underlie	 the	decrease	 in	 tHcy	 from	early	 to	mid	pregnancy	because	 it	 is	
not	completely	explained	by	folic	acid	supplementation,	haemodilution	or	the	decrease	
in	albumin	(Murphy	et	al.	2002).	This	may	also	be	true	for	the	late	pregnancy	increase	
in	 tHcy,	 independently	 of	 folic	 acid	 supplement	 use	 and	 in	 the	 face	 of	 continued	
haemodilution	 and	 increased	 renal	 function	 (Murphy	 et	 al,	 2004).	 A	 similar	 tHcy	
pregnancy	 pattern	 has	 been	 observed	 in	 the	 Reus‐Tarragona	 Birth	 Cohort	 (RTBC)	
(Fernàndez‐Roig	et	al.	2013)	and	in	other	studies	(Cikot	et	al.	2001;	Velzing‐Aarts	et	al.	
2005;	Ubeda	 et	 al.	 2011).	 In	 a	 Seychelles	 study	where	 those	women	 taking	 folic	 acid	
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supplements	did	 it	probably	 sporadically,	 serum	 tHcy	 increased	between	≈13	and	28	
GW	and	subsequently	until	delivery	(Wallace	et	al.	2008).	
Maternal	and	cord	tHcy	concentrations	are	positively	correlated	in	plasma	(Murphy	et	








women	 in	 the	 low‐mid	 tertile	 (Murphy	 et	 al.	 2004).	 The	 odds	 of	 having	 lower	 birth	
weight	offspring	in	high	versus	low‐normal	tHcy	at	these	same	points	of	pregnancy	was	






2007).	 No	 association	 between	 second	 trimester	 serum	 tHcy	 and	 conotruncal	 heart	
defects	 in	 the	 offspring	 was	 reported	 in	 a	 case	 control	 study	 carried	 out	
postfortification	with	folic	acid	in	the	USA	(Shaw	et	al.	2014).	Higher	concentrations	of	
amniotic	 fluid	 tHcy	were	 associated	with	 higher	 risk	 of	 congenital	 heart	 defects	 in	 a	
prefortification	 USA	 study	 (Wenstrom	 et	 al.	 2001).	 In	 a	 rat	 study,	 there	 was	 higher	
incidence	 of	 congenital	 heart	 defects	 in	 the	 offspring	 of	 dams	 receiving	 three	
intraperitoneal	injections	of	8µM	homocysteine	on	gestation	days	8,	9	and	10	compared	
to	saline	injected	dams	(He	et	al.	2009).	
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Chiari	 malformation	 and	 encephalocele	 (Renuka	 et	 al.	 2009;	 National	 Institutes	 of	
Health	2016a;	National	Institutes	of	Health	2016b).	Higher	maternal	concentrations	of	
plasma/serum	 tHcy	 are	 associated	with	NTDs,	 in	 cohort	 and	 case	 control	 studies,	 as	




Omphalocele	 is	 a	 congenital	 abdominal	 wall	 defect	 in	 which	 the	 intestine	 or	 other	
abdominal	organs	are	outside	of	the	body	due	to	incomplete	closure	of	the	navel	area	





Hyperhomocysteinaemia	 is	 associated	 with	 increased	 risk	 of	 recurrent	 miscarriage	





The	 term	 “folic	 acid”	 is	 used	 to	 refer	 to	 the	 most	 oxidised	 form	 of	
pteroylmonoglutamate	 (used	 in	 supplements	 and	 fortified	 foods),	 whereas	 “folates”	
encompasses	a	wide	range	of	biological	molecules	derived	from	pteroylmonoglutamate.	
Folic	acid	is	a	2‐amino‐4‐oxo‐pteridine	moiety	bound	by	a	methylene	group	at	the	C‐6	
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linkage	 (3).	 B.	 Tetrahydrofolate	 monoglutamate.	 C.	 5‐methyltetrahydrofolate	 monoglutamate.	 From	
(Institute	of	Medicine	2016a).	
Natural	 dietary	 folates	 have	 a	 polyglutamate	 chain,	 and	 5‐methylTHF	 is	 the	




considered	 to	 be	 mainly	 responsible	 for	 removing	 glutamates	 from	 the	 human	
intestine.	There	is	low	expression	of	gamma	glutamyl	hydrolase	as	mRNA	in	the	human	
small	 intestine	 and	 pancreas,	 suggesting	 that	 it	 may	 have	 a	 role	 in	 intestinal	 folate	
absorption,	 although	 minor	 compared	 to	 folate	 hydrolase	 1	 (Yin	 et	 al.	 2003).	 A	
saturable	 transport	 system	acts	 at	 the	physiological	 concentrations	of	 folate	 found	 in	
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 









folate	 intestinal	 absorption,	 the	 reduced	 folate	 carrier	 (SLC19A1)	 (Qiu	 et	 al.	 2006).	
However,	the	upregulation	of	the	SLC19A1	and	folate	receptors	in	the	intestine	of	folate	
deficient	mice	suggests	they	might	have	a	role,	although	less	important	than	the	proton	
coupled	 folate	 transporter,	 in	 folate	 intestinal	 uptake	 (Liu	 et	 al.	 2005).	 At	
pharmacological	 concentrations	 of	 folate	 (>10µM)	 in	 the	 intestinal	 lumen,	 a	 non‐
saturable	 transport	 (diffusion)	 exists	 (Rosenberg	 et	 al.	 1985).	 The	 folate	 in	 the	
enterocyte	 can	 be	 exported	 to	 the	 blood	 stream	 mainly	 as	 monoglutamate,	 or	 be	
transformed	into	polyglutamate	forms	that	are	coenzymatically	active	and	retained	in	
the	enterocytes	(and	all	cells)	 (Shane	2010).	The	cytosolic	and	mitochondrial	enzyme	
folypolyglutamate	 synthetase	 (FPGS)	 catalyses	 the	 synthesis	 of	 folypoly‐gamma‐
glutamates,	i.e.	the	addition	of	glutamates	to	the	glutamate	chain	in	folates.	Mammalian	
folypolyglutamate	 synthetase	 has	 the	 following	 affinity	 pattern	 for	 monoglutamate	




The	 most	 abundant	 folate	 forms	 found	 in	 the	 blood	 plasma	 are	 monoglutamate	 5‐
CH3THF,	 in	 the	 cytosol	 polyglutamate	 5‐CH3THF,	 and	 in	 the	 mitochondria	
polyglutamate	10‐formylTHF	(Shane	2010).	Red	blood	cell	(RBC)	folate	concentrations	
are	 used	 as	 a	 measure	 of	 long‐term	 (120	 days)	 folate	 status	 because	 the	 RBC	 only	
accumulates	 folate	 during	 erythropoiesis	 and	 cannot	 release	 it	 when	 the	 RBCs	 are	
mature	(Shane	2010).		
Folic	acid	metabolism	 is	of	concern	because	although	 it	 is	not	 significantly	present	 in	
fresh	natural	foods,	it	is	the	form	used	in	most	vitamin	supplements	and	that	added	to	
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DHF	 to	 THF	 (Stover	 2010a),	 being	 DHF	 a	 product	 of	 pyrimidines	 synthesis	 (see	




to:	 1)	 homocysteine,	 in	 homocysteine	 remethylation;	 2)	 5‐Aminoimidazole‐4‐
carboxamide	 ribonucleotide	 (AICAR),	 in	 purine	 synthesis;	 and	 3)	 deoxyuridine	
monophosphate	 (dUMP),	 in	 pyrimidine	 synthesis	 (Stover	 2010a).	 Serine	 is	 a	 1C	 unit	
donor	 that	 serves	 to	 recycle	 folate	 by	 serine	 hydroxymethyltransferases	 (SHMTs)	 in	
cytosol	 and	mitochondria	 (Appling	 1991).	 Formate	 can	 also	 be	 incorporated	 directly	
into	folates	in	the	cytosol	as	described	in	Introduction	section	1.	Other	1C	unit	donors	
for	 folate	 recycling	 are	 dimethylglycine	 (DMG),	 sarcosine	 and	 glycine,	 which	 are	
demethylated	 in	 the	mitochondria	 (Yoshida	 and	 Kikuchi	 1970;	Wittwer	 and	Wagner	
1981).	
Physiological	and	clinical	relevance	
As	 explained	 in	 Introduction	 section	1,	 folate	 is	 involved	 in	methylation	 reactions	 (of	
DNA,	proteins,	 and	other	molecules	 and	 compounds),	 interconversion	of	 amino	 acids	
and	synthesis	of	nucleotides	and	nitrogenous	bases.	A	study	in	piglets	reported	that	the	
percentage	 of	 methyl	 groups	 destined	 for	 methyl	 acceptors	 in	 the	 liver	 is:	 49%	 for	
phosphatidylethanolamine	 (see	 Introduction	 point	 2.3),	 32%	 for	 proteins,	 18%	 for	
guanidinoacetate,	 0.1%	 for	 DNA,	 and	 the	 rest	 are	 destined	 for	 other	 acceptors	
(McBreairty	et	al.	2013).	The	enzyme	guanidinoacetate	methyltransferase	catalyses	the	
transfer	 of	 one	 methyl	 group	 from	 SAM	 to	 guanidinoacetate	 producing	 creatine	
(Joncquel‐Chevalier	 Curt	 et	 al.	 2015).	 Creatine	 is	 an	 osmolyte	 and,	 when	
phosphorylated,	a	form	of	energy	storage	in	muscle	and	brain	(Joncquel‐Chevalier	Curt	
et	 al.	 2015).	 Feeding	 piglets	 a	 diet	 deficient	 in	 folate,	 betaine	 and	 choline	 lead	 to	 an	
increase	in	methyl	groups	destined	for	phosphatidylethanolamine,	a	decrease	in	those	
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The	World	Health	Organization	 (WHO)	 has	 two	 criteria	 for	 assessing	 folate	 status	 in	
populations	 (World	 Health	 Organization	 2012).	 The	 first	 is	 based	 on	 the	 risk	 of	
megaloblastic	 anaemia,	 a	 disease	 known	 to	 be	 associated	with	 low	 folate	 status;	 and	
categorises	 folate	 status	 according	 to	 the	 following	 values	 for	 plasma/serum:	
<6.8nmol/L	 (deficiency),	 6.8‐13.4	 (possible	 deficiency),	 13.5‐45.3	 (normal	 range),	
>45.3nmol/L	(elevated).	The	second	criteria	is	based	on	the	folate	concentration	below	
which	homocysteine	concentration	is	not	optimal:	plasma/serum	folate	of	<10nmol/L	
(deficiency).	These	 two	criteria	are	also	used	 for	 the	cutoffs	of	RBC	 folate.	RBC	 folate	
concentrations	 of	 <226.5nmol/L	 (megaloblastic	 anaemia	 criteria)	 or	 <340nmol/L	
(homocysteine	 criteria)	 are	 considered	 deficiency.	 It	 is	 important	 to	 note	 that	 in	 the	
megaloblastic	anaemia	criteria	folate	determination	is	the	microbiological	assay	and	in	
the	 homocysteine	 criteria	 is	 the	 radioassay	 (differences	 between	 both	 assays	will	 be	
described	in	Introduction	section	3.1).	
Serum	 tHcy	was	 higher	 in	 patients	with	 folate	 deficiency	 compared	 to	 normal	 status	
(Allen	et	al.	1993b)	and	population	studies	from	different	geographic	regions	including	
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transfer	 of	 1C	units	 to	 form	purines	 and	pyrimidines	 (deoxythymidine)	 (Introduction	
section	 1,	 Figure	 1).	 Low	 folate	 status	 can	 limit	 growth	 at	 the	 two	 aforementioned	
biosynthetic	pathways	(Steegers‐Theunissen	et	al.	2013).	Uracil	can	be	incorporated	in	
DNA	 as	 the	 nucleotide	 deoxyuridine	 instead	 of	 deoxythymidine,	 then	 a	 repair	
mechanism	starts	with	 the	removal	of	 the	nitrogenous	base	and	breaking	of	 the	DNA	
strand.	 If	 the	 level	 of	 uracil	 in	DNA	 is	 high	DNA	breaks	 accumulate	 and	 this	 leads	 to	
genetic	 instability	 (Blount	 et	 al.	 1997;	 Ciappio	 and	 Mason	 2010).	 Healthy	
splenectomised	subjects	with	<317nmol/L	RBC	folate	had	higher	blood	cell	DNA	uracil	
concentration	than	those	with	RBC	folate	>317nmol/L,	and	DNA	uracil	decreased	after	
supplementation	5mg/d	 folic	 acid	 for	8wk	 in	both	groups	 (Blount	et	 al.	1997).	 It	has	
been	 hypothesized	 that	 the	 resulting	 genetic	 instability	 rather	 than	 aberrant	
methylation,	is	the	main	mechanism	for	tumour	occurrence	associated	with	low	folate	
status.	 Increased	 intestinal	 uracil/thymine	 ratio	 and	 tumourigenesis,	 as	well	 as	 DNA	
breaks	and	damage	was	observed	in	mice	fed	folate	deficient	diets	(Knock	et	al.	2006;	
Knock	et	al.	2008);	and	this	was	not	corrected	after	administration	of	betaine	(methyl	
donor)	 (Knock	et	 al.	2008).	 In	populations	at	 risk	of	CVD	or	with	CVD,	homocysteine	
lowering	 treatments	 with	 B	 vitamins	 supplementation	 is	 not	 associated	 with	 the	
incidence	of	any	types	of	cancer	(Clarke	et	al.	2010;	Zhou	et	al.	2011;	Martí‐Carvajal	et	
al.	 2013).	 Specifically	 in	 colorectal	 cancer,	 folate	 is	 considered	 to	 play	 a	 dual	 role.	
Before	the	establishment	of	neoplastic	foci,	folate	suppresses	tumour	development	and	
progression,	 and	 after	 the	 establishment	 folate	 enhances	 tumour	 growth	 and	
progression,	 as	 reviewed	 (Smith	 et	 al.	 2008).	 Plasma	 folate	 concentrations	 are	
positively	 associated	 with	 prostate	 cancer	 risk	 in	 cohort	 studies,	 and	 it	 has	 been	
suggested	 that	 this	 effect	 is	 in	 the	 rate	 of	 progression	 of	 localized	 prostate	 cancer	
(Collin	et	al.	2010).		
As	 for	 CVD,	 lower	 concentrations	 of	 plasma/serum	 folate	 have	 been	 associated	with	
venous	 thrombosis	 in	 a	 meta	 analysis	 (Zhou	 et	 al.	 2012).	 Most	 prospective	 cohort	
studies	 have	 found	 an	 association	 between	 low	 baseline	 plasma/serum	 folate	
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and	 Rimm	 2010).	 Higher	 intakes	 of	 folate	were	 protective	 against	 hypertension	 in	 a	
cohort	 of	 women	 in	 prefortification	 USA	 (Forman	 et	 al.	 2005).	 Meta	 analyses	 of	
randomised	 controlled	 trials	 have	 found	 a	 protective	 effect	 of	 folic	 acid	
supplementation	 against	 stroke	 in	 populations	 unexposed	 to	 mandatory	 folic	 acid	
fortification	but	not	in	fortified	populations	(Yang	et	al.	2012a;	Zeng	et	al.	2015).	
Severe	 folate	 deficiency	 causes	 megaloblastic	 anaemia,	 and	 there	 is	 more	 evidence	
supporting	impaired	DNA	synthesis	than	impaired	methylation,	as	the	main	mechanism	










A	 postfortification	 Canadian	 study	 reported	 higher	 plasma	 folate	 concentration	 in	
pregnant	women	at	36	GW	than	in	non	pregnant	controls	(mothers	of	young	children)	
(Wu	 et	 al.	 2013).	 In	 addition	 to	 the	 use	 of	 prenatal	multivitamin	 supplements	 in	 the	
pregnant	women,	 the	non	pregnant	controls	of	 this	study	might	not	have	recover	 the	
normal	folate	pools	(Wu	et	al.	2013),	as	it	has	been	reported	that	serum	folate	pool	is	
not	replete	at	6	month	postpartum	(Bruinse	et	al.	1985).	Studies	without	the	use	of	folic	
acid	 supplements	 in	 pregnancy	 have	 found	 lower	 folate	 concentrations	 in	 pregnant	
than	in	non	pregnant	women	(Ball	and	Giles	1964;	Ek	and	Magnus	1981).	In	the	RTBC,	
plasma	folate	concentrations	decrease	when	folic	acid	supplementation	is	stopped	and	
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RBC	 folate	 concentrations	 decrease	 in	 late	 pregnancy	 (Fernàndez‐Roig	 et	 al.	 2013).	
Similar	decreases	have	been	found	in	most	studies	for	plasma/serum	(Ek	and	Magnus	
1981;	 Bruinse	 et	 al.	 1985;	 Qvist	 et	 al.	 1986;	 Bartels	 et	 al.	 1989;	 Cikot	 et	 al.	 2001;	
Wallace	et	al.	2008;	Ubeda	et	al.	2011)	and	RBC	folate	(Ek	and	Magnus	1981;	Qvist	et	al.	
1986);	 but	 there	 are	 also	 reports	 of	 no	 change	 (Velzing‐Aarts	 et	 al.	 2005;	Wu	 et	 al.	
2013)	or	an	 increase	(Cikot	et	al.	2001;	Takimoto	et	al.	2007).	Processes	occurring	 in	
pregnancy	has	been	proposed	as	 the	causes	 for	 the	usual	 folate	decline	 in	pregnancy,	
e.g.	increased	folate	demand	for	the	growth	of	the	foetus	and	uteroplacental	structures,	







folate	 status,	 folic	 acid	 supplementation	 has	 been	 associated	 with	 lower	 tHcy	 than	
without	 supplementation	 from	 20	 GW	 on	 (Murphy	 et	 al.	 2002;	Murphy	 et	 al.	 2004).	
Higher	plasma	tHcy	throughout	pregnancy	was	 found	 in	 the	RTBC	with	 low	maternal	
plasma	 folate	 status	 compared	 to	 high	 (Fernàndez‐Roig	 et	 al.	 2013).	Maternal	 serum	
folate	 is	 a	 negative	 predictor	 of	 tHcy	 (Wallace	 et	 al.	 2008).	 In	 the	 RTBC,	 maternal	
plasma	 folate	 concentration	 was	 a	 negative	 predictor	 of	 plasma	 tHcy	 throughout	
pregnancy	 when	 folate	 status	 was	 low,	 and	 only	 at	 mid‐late	 pregnancy	 when	 folate	
status	was	high	(Fernàndez‐Roig	et	al.	2013).	Maternal	plasma/serum	folate	and	tHcy	
are	negatively	correlated	(Kim	et	al.	2004;	Molloy	et	al.	2005;	Velzing‐Aarts	et	al.	2005;	
Wallace	 et	 al.	 2008),	 and	 a	 similar	 tHcy‐folate	 correlation	 has	 been	 found	 in	 cord	
plasma	(Molloy	et	al.	2005).	
According	 to	 the	 Institute	 of	 Medicine,	 the	 RDA	 for	 folate	 in	 pregnant	 women	 is	
600µg/d	 of	 dietary	 folate	 equivalents	 (Institute	 of	 Medicine	 2000).	 In	 Spain	 the	
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A	 meta‐analysis	 reported	 that	 folic	 acid	 supplementation	 during	 pregnancy	 was	
associated	with	higher	birth	weight	in	humans	(Lassi	et	al.	2013).	Deficient	or	excessive	
folic	 acid	 intake,	 i.e.	 3‐fold	 lower	 or	 20‐fold	 higher	 than	 the	 recommended	 intake,	
respectively,	 in	 pregnant	mice	 was	 associated	with	 growth	 retardation	 in	 the	 foetus	
(Pickell	et	al.	2009;	Pickell	et	al.	2011).	
In	 a	 postfortification	 USA	 case	 control	 study,	 low	 second	 trimester	 maternal	 serum	
folate	 was	 protective	 against	 conotruncal	 heart	 defects	 in	 the	 offspring	 (Shaw	 et	 al.	
2014).	Excessive	folic	acid	intake	in	pregnant	mice	was	associated	with	less	thickness	
of	ventricular	walls	in	the	hearts	of	embryos	(Pickell	et	al.	2011).	




countries	 adopted	 the	 same	 policy	 (Figure	 4).	 The	 policy	 in	 the	 USA	 has	 led	 to	 an	
increase	 in	 total	 folate	 intake	 by	 a	 mean	 of	 323µg/d	 of	 dietary	 folate	 equivalents	
(Choumenkovitch	 et	 al.	 2002),	 as	 well	 as	 increases	 in	 serum	 and	 RBC	 folate	
concentrations	 (Ganji	 and	Kafai	 2006);	 and	 a	 decrease	 in	 plasma	 tHcy	 (Pfeiffer	 et	 al.	
2008).
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A	 meta	 analysis	 reported	 that	 low	 maternal	 concentrations	 of	 plasma/serum	 folate	
were	 associated	 with	 NTDs	 affected	 pregnancies	 (Tang	 et	 al.	 2015).	 Given	 the	
association	between	maternal	folate	status	and	NTDs,	RBC	folate	concentrations	above	
906nmol/L	 have	 been	 recommended	 for	 the	 prevention	 of	 NTDs	 (World	 Health	
Organization	2015).	
A	 Swedish	 case	 control	 study	 found	 an	 association	 between	 low	 plasma	 folate	
concentrations	in	pregnant	women	at	6‐12	GW	and	the	risk	of	miscarriage	(George	et	
al.	 2002).	 Deficient	 folic	 acid	 intake	 (3‐fold	 lower	 than	 the	 recommended	 intake)	 in	
pregnant	mice	was	associated	with	higher	embryonic	loss	(Pickell	et	al.	2009).	
A	 meta	 analysis	 of	 four	 clinical	 trials	 reported	 lower	 incidence	 of	 megaloblastic	
anaemia	 in	 pregnant	women	 taking	 folic	 acid	 supplements	 during	 pregnancy	 than	 in	
non‐supplement	user	pregnant	women	(Lassi	et	al.	2013).	
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pancreatic	 secretions	 remove	 lipid	moieties	 from	phosphatidylcholine	 (Shapiro	1953;	
van	den	Bosch	 et	 al.	 1965),	 resulting	 in	 liposoluble	 and	hydrosoluble	 derivatives	 (Le	
Kim	and	Betzing	1976).	The	 liposoluble	derivatives	are	considered	to	be	absorbed	by	
passive	 diffusion	 (Jiang	 et	 al.	 2013),	 and	 the	 hydrosoluble	 derivatives	 can	 be	 further	
hydrolysed	rendering	free	choline	(Parthasarathy	et	al.	1974).	Three	families	of	choline	
transporters	 exist:	 high	 affinity	 choline	 transporter	 1	 (SLC5A7),	 choline	 transporter‐




Intestinal	 absorption	 of	 betaine	 is	 mediated	 by	 the	 IMINO	 transporter,	 which	 also	
absorbs	proline	(Stevens	and	Wright	1985).	This	transporter	is	coded	by	the	SLC6A20	
gene	 (Kowalczuk	 et	 al.	 2005;	 Takanaga	 et	 al.	 2005).	 The	 expression	 pattern	 of	 the	
IMINO	 transporter,	 with	 high	 expression	 in	 the	 distal	 small	 intestine	 and	 low	
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expression	 in	 other	 organs	 and	 regions	 of	 the	 digestive	 system,	 supports	 a	 role	 in	
intestinal	absorption	(Takanaga	et	al.	2005).	As	for	systemic	betaine	uptake,	the	GABA	
(gamma‐aminobutyric	 acid)	 /	 betaine	 transporter	 (SLC6A12)	 is	 considered	 the	main	
mediator	(Kempson	et	al.	2014).	This	transporter	has	higher	affinity	for	GABA	than	for	
betaine	 (Borden	 et	 al.	 1995),	 and	 has	 been	 detected	 in	 many	 organs	 including	 the	




Choline	 is	 oxidised	 in	 two	 consecutive	 reactions	 to	 form	 betaine	 (Figure	 6).	 First	
choline	 is	 converted	 into	 betaine	 aldehyde	 in	 a	 reaction	 catalysed	 by	 choline	
dehydrogenase	 (CHDH),	 a	 mitochondrial	 enzyme;	 then	 betaine	 aldehyde	 is	 further	
oxidised	to	betaine	by	the	betaine	aldehyde	dehydrogenase	(ALDH7A1)	(Ueland	2011).	
Betaine	aldehyde	dehydrogenase	has	cytosolic	and	mitochondrial	isoforms	(Chern	and	
Pietruszko	 1995;	 Chern	 and	 Pietruszko	 1999),	 being	 both	 coded	 by	 the	 same	 gene	
(Pietruszko	 and	 Chern	 2001)	 and	 the	 activity	 higher	 in	 the	 cytosol	 (Chern	 and	
Pietruszko	1999).	
In	 the	 betaine‐dependent	 homocysteine	 remethylation,	 which	 is	 less	 important	 than	
the	 folate‐dependent	 pathway,	 one	 methyl	 group	 is	 transferred	 from	 betaine	 to	
homocysteine	to	 form	DMG	and	methionine	 in	a	reaction	catalysed	by	BHMT	(Figure	
6).		
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Scheme	 of	 the	 choline	 oxidation	 pathway	 and	 further	 demethylation	 of	 DMG	 to	 glycine.	 Enzymes	 are	
written	 in	 bold,	 substrates	 and	 products	 are	 not;	 methyl	 and	methylene	 groups	 are	 illustrated	 in	 blue	
circles.	 Enzymes	 [vitamin	 cofactor]:	 ALDH7A1,	 betaine	 aldehyde	 dehydrogenase;	 BHMT,	 betaine‐
homocysteine	methyltransferase;	CHDH,	choline	dehydrogenase;	DMGDH,	dimethylglycine	dehydrogenase	
[B2];	 SARDH,	 sarcosine	 dehydrogenase	 [B2].	 Metabolites:	 DMG,	 dimethylglycine;	 THF,	 tetrahydrofolate;	
5,10‐CH2THF,	5,10‐methylenetetrahydrofolate.	Adapted	from	(Ueland	et	al.	2005).	
DMG	 can	 donate	 up	 to	 three	 more	 methyl	 groups	 through	 three	 mitochondrial	
reactions	which	are	irreversible	in	vivo	(Figure	6).	First,	in	a	reaction	catalysed	by	the	
covalent	 flavoenzyme	DMG	dehydrogenase	 (DMGDH),	DMG	 is	 converted	 to	 sarcosine	
donating	one	methyl	group	to	THF	which	is	converted	to	5,10methyleneTHF.	Sarcosine	




is	a	 cytosolic	enzyme	 that	 catalyses	 the	reverse	reaction	of	 sarcosine	dehydrogenase;	
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high	due	to	dietary	 intake	of	 labile	methyl	groups	exceeding	the	amount	required	 for	
obligatory	methylation	reactions	(Mudd	et	al.	2001;	Mudd	et	al.	2007).	
Phosphatidylcholine	 can	 be	 synthesised	 by	 two	 pathways:	 the	
phosphatidylethanolamine	 methyltransferase	 (PEMT)	 pathway,	 and	 the	 cytidine	
diphosphate―choline	 (CDP‐choline)	 pathway,	 (Figure	 7)	 (Caudill	 2010).	 The	 PEMT	
pathway	 involves	 three	 methylation	 reactions	 of	 phosphatidylethanolamine	 where	
SAM	is	the	methyl	donor	(Ridgway	and	Vance	1987).	Choline	can	be	synthesised	from	





choline	 pathway	 (brown	 arrows),	 choline	 synthesis	 reactions	 (black	 arrows).	 Enzymes:	 ALPL,	 alkaline	
phosphatase;	 CHKs,	 choline	 kinases;	 CHPT1,	 choline	 phosphotransferase;	 PCYT1s,	 choline‐phosphate	
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Betaine,	 as	 other	 methylamines,	 acts	 physiologically	 as	 an	 organic	 osmolyte	 against	
osmotic	 stress	 (Yancey	 et	 al.	 1982),	 especially	 in	 medullary	 kidney	 cells	 and	
chondrocytes	 (Wehner	 et	 al.	 2003).	 In	 line	 with	 this,	 the	 expression	 of	 the	
GABA/betaine	 transporter	 and	 the	 betaine	 uptake	 have	 been	 reported	 to	 increase	
under	 hypertonic	 conditions	 (Sheikh‐Hamad	 et	 al.	 1994;	 Peters‐Regehr	 et	 al.	 1999;	
Nishimura	 et	 al.	 2010).	 Betaine	 is	 also	 an	 stabiliser	 of	macromolecular	 structure	 and	
function	(Yancey	et	al.	1982;	Sheikh‐Hamad	et	al.	1994).	In	canine	kidney	cell	cultures,	
betaine	 inhibits	 the	heat‐shock	protein	70	(HSP70)	response	 to	elevated	temperature	
and	 this	 is	 attributed	 to	 HSP70	 and	 betaine	 being	 both	 protein	 stabilisers	 (Sheikh‐
Hamad	et	al.	1994).		
Betaine	can	act	as	a	methyl	donor.	According	to	rat	experiments,	 in	the	liver,	betaine‐
dependent	 homocysteine	 remethylation	 is	 as	 important	 as	 folate‐dependent	
homocysteine	 remethylation	 (Finkelstein	 and	 Martin	 1984a).	 However,	 the	 latter	 is	
thought	to	prevail	globally	in	mammals	based	on	the	fact	that	BHMT	activity	has	only	
been	 detected	 in	 some	 organs	 whereas	 MTR	 is	 ubiquitous	 (see	 Introduction	 section	
3.2).	 The	 contribution	 of	 each	 pathway	 to	 homocysteine	 remethylation	 in	 the	whole	
organism	has	not	been	assessed,	but	a	study	of	healthy	Dutch	adults	reported	that	the	
inverse	 association	between	 serum	 folate	 and	 fasting	plasma	 tHcy	was	 stronger	 than	
that	between	betaine	and	tHcy,	suggesting	that	the	MTR	reaction	prevails	under	normal	
circumstances	 (Melse‐Boonstra	 et	 al.	 2005).	 Complementary	 treatment	 with	 large	
doses	 of	 oral	 betaine	 is	 useful	 against	 very	 high	 tHcy	 due	 to	 inborn	 errors	 of	
metabolism	 (Wilcken	 et	 al.	 1983;	 Wilcken	 et	 al.	 1985;	 Bartholomew	 et	 al.	 1988).	
Supplementation	with	 3‐6g/d	 of	 betaine	 also	 reduces	 plasma/serum	 tHcy	 in	 healthy	
(Brouwer	et	al.	2000;	Olthof	et	al.	2003;	Steenge	et	al.	2003;	Alfthan	et	al.	2004)	and	
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obese	 individuals	 (Schwab	 et	 al.	 2002).	 Lower	 doses	 of	 betaine	 seems	 to	 require	
treatments	 longer	 than	at	 least	one	week	 to	have	a	 tHcy‐lowering	effect	 (Olthof	et	al.	
2003;	 Alfthan	 et	 al.	 2004).	 Plasma/serum	 betaine	 was	 a	 negative	 predictor	 of	 post‐
methionine	 load	 plasma	 homocysteine	 in	 Dutch	 (Holm	 et	 al.	 2005)	 and	 Norwegian	
populations	(Holm	et	al.	2004)	and	also	of	tHcy	(Lever	et	al.	2005;	Melse‐Boonstra	et	al.	
2005;	Imbard	et	al.	2013).	
In	 spite	 of	 the	 endogenous	 synthesis	 of	 choline,	 choline	 is	 considered	 an	 essential	
nutrient,	 based	 on	 choline	 deficient	 individuals	 showing	 signs	 of	 liver	 dysfunction	
(Zeisel	 et	 al.	 1991).	 Choline	 adequate	 intake	 is	 550mg/d	 for	 men	 and	 425mg/d	 for	
women	 according	 to	 the	 Institute	 of	 Medicine	 (Institute	 of	 Medicine	 2000),	 and	
400mg/d	for	both	sexes	according	to	the	European	Food	Safety	Authority	(EFSA	‐	NDA	
Panel	2016).	
High	 plasma	 DMG	 concentrations	 were	 associated	 with	 risk	 of	 acute	 myocardial	
infarction	 in	 a	 study	 of	 a	 Norwegian	 angina	 pectoris	 patients	 cohort	 (Svingen	 et	 al.	
2013).	In	another	Norwegian	cohort,	low	plasma	DMG	concentrations	were	associated	
with	 low	bone	mineral	density,	and	among	elder	 individuals	with	risk	of	hip	 fracture	
(Oyen	et	al.	2015).	
Betaine,	dimethylglycine	and	choline	in	pregnancy	
Higher	 plasma	 choline	 and	 lower	 betaine	 and	 DMG	 concentrations	were	 reported	 in	
postfortification	Canadian	pregnant	women	at	36	GW	(Wu	et	al.	2013)	or	at	delivery	
(Friesen	 et	 al.	 2007)	 than	 in	 non	 pregnant	 women.	 Some	 authors	 consider	 that	 the	




with	 diets	 containing	 labelled	 choline	 suggested	 a	 greater	 use	 of	 choline	 for	 the	
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2013).	 Maternal	 plasma	 DMG	 also	 decreases	 toward	 mid	 pregnancy	 and	 increases	
afterwards	reaching	higher	concentrations	at	or	close	to	labour	than	at	early	pregnancy	
(Velzing‐Aarts	 et	 al.	 2005;	Fernàndez‐Roig	 et	 al.	 2013;	Wu	et	 al.	 2013;	Visentin	et	 al.	
2015).	 Maternal	 plasma	 choline	 increases	 from	 early	 pregnancy	 to	 late	 pregnancy	
(Velzing‐Aarts	 et	 al.	 2005;	Fernàndez‐Roig	 et	 al.	 2013;	Wu	et	 al.	 2013;	Visentin	et	 al.	
2015).	
There	is	a	positive	correlation	between	maternal	and	cord	plasma	betaine	at	34GW	in	
Dutch	 (Hogeveen	 et	 al.	 2013),	 at	 37‐41GW	 in	 Canadian	 (Friesen	 et	 al.	 2007)	 and	 at	
labour	 in	 Irish	 women	 (Molloy	 et	 al.	 2005).	 Similar	 positive	 correlations	 have	 been	
found	for	DMG	(Molloy	et	al.	2005;	Friesen	et	al.	2007;	Hogeveen	et	al.	2013);	and	for	
choline	(Friesen	et	al.	2007;	Hogeveen	et	al.	2013),	except	in	an	Irish	study	(Molloy	et	






Fernàndez‐Roig	 et	 al.	 2013;	 Hogeveen	 et	 al.	 2013;	 Visentin	 et	 al.	 2015),	 and	 choline	
(Molloy	 et	 al.	 2005;	 Friesen	 et	 al.	 2007;	 Fernàndez‐Roig	 et	 al.	 2013;	 Hogeveen	 et	 al.	
2013;	 Visentin	 et	 al.	 2015)	 are	 higher	 than	 maternal	 concentrations	 of	 these	
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compounds.	 This	 suggests	 a	 flux	 of	 these	 to	 the	 foetus	 and/or:	 1)	 increased	 choline	
oxidation	 for	 the	 synthesis	 of	 betaine	 that	 can	 subsequently	 be	 used	 in	 the	 BHMT	
pathway	 producing	 DMG	 in	 the	 foetus;	 2)	 increased	 synthesis	 of	 choline	 from	 the	
phosphatidylcholine	 produced	 in	 the	 PEMT	 pathway	 or	 transported	 to	 the	 foetus.	
Results	 from	 a	 pregnancy	 study	 with	 labelled	 choline	 suggest	 phosphatidylcholine	
derived	 from	 the	 PEMT	 pathway	 and	 not	 from	 the	 CDP‐choline	 pathway	 is	
preferentially	produced/taken	up	by	the	foetus	(Yan	et	al.	2013).	




observed	 at	 an	 earlier	 stage	 of	 pregnancy	 in	mothers	 with	 low	 folate	 status	 than	 in	
those	with	high	folate	status	(Fernàndez‐Roig	et	al.	2013).	This	suggests	that	the	BHMT	
pathway	 may	 be	 upregulated	 in	 response	 to	 worsening	 folate	 status	 as	 pregnancy	
progresses.	Other	 interactions	among	1C	metabolism	compounds	will	be	explained	 in	
Introduction	point	2.5.	







al.	 1993;	 Dawson	 and	 Baltz	 1997).	 Such	 experiments	 also	 revealed	 that	 betaine	
transport	 exists	 in	 1‐cell	 stage	 embryos	 and	 is	 increased	with	 increasing	 osmolarity	
(Anas	 et	 al.	 2007).	The	 transport	 is	 by	 the	 IMINO	 transporter	 and	 stops	 at	 the	 2‐cell	
stage	 (last	 analysed	 time	 point	 is	 blastocyst	 stage)	 (Anas	 et	 al.	 2008).	 In	 addition,	
betaine	is	present	in	mouse	oviduct	in	vivo,	and	its	concentration	in	dams	with	embryos	
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studies	 betaine	 in	 its	 roles	 as	 methyl	 donor	 and	 as	 osmolyte,	 is	 important	 during	
pregnancy.	 Higher	 serum	methionine	 concentration	was	 detected	 in	 the	 offspring	 of	





risk	of	 low	birth	weight	 (LBW,	≤2.5Kg	birth	weight)	 and	 cord	 choline	or	betaine	and	
DMG	were	 negative	 and	 positive	 predictors,	 respectively,	 of	 birth	 weight	 in	 a	 Dutch	
study	 (Hogeveen	 et	 al.	 2013).	 In	 a	 Singapore	 pregnancy	 cohort,	 maternal	 plasma	
betaine	 at	 26‐28	 GW	 was	 a	 negative	 predictor	 of	 birth	 weight	 and	 other	 neonatal	
anthropometric	 values;	 and	 higher	 maternal	 plasma	 betaine	 was	 associated	 with	 a	
greater	risk	of	an	small	for	gestational	age	(SGA,	<P10	birth	weight)	neonate	(van	Lee	et	
al.	 2016).	The	 causes	 for	 these	 associations	 are	 unclear	 and	 several	 hypotheses	have	
been	 proposed,	 e.g.	 increased	 choline	 oxidation	 pathway	 is	 able	 to	 generate	 more	
glycine	 through	 the	demethylation	of	DMG,	being	glycine	necessary	 for	 foetal	 growth	
(Hogeveen	et	al.	2013).	
In	a	postfortification	USA	case	control	study,	second	trimester	maternal	serum	betaine,	
DMG	 and	 total	 choline	 were	 not	 associated	 with	 conotruncal	 heart	 defects	 in	 the	
offspring	(Shaw	et	al.	2014).	The	incidence	of	ventricular	septal	defects	was	higher	in	
the	 offspring	 born	 to	 mouse	 dams	 fed	 a	 choline	 deficient	 compared	 to	 control	 diet	
(Chan	et	al.	2010).	
An	 Irish	pregnancy	case‐control	 study	 reported	no	differences	 in	plasma	betaine	and	
choline	 at	 ≈14‐15	 GW	 in	 pregnant	 women	 not	 taking	 supplements	 and	 with	 NTD‐
affected	pregnancies	or	with	previous	NTD‐affected	pregnancies,	and	 their	 respective	
controls	(Mills	et	al.	2014).	However	in	this	study	there	was	more	proportion	of	variant	
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homozygotes	 for	 the	 PEMT	 +5465G>A	 polymorphism	 in	 cases	 compared	 to	 controls	
suggesting	a	role	for	the	synthesis	of	phosphatidylcholine	by	PEMT	in	NTDs;	although	
no	 differences	 in	 plasma	 betaine,	 choline	 and	 tHcy	were	 observed	 among	 the	 alleles	
(Mills	 et	 al.	 2014).	 In	 an	 American	 case	 control	 study	 higher	 betaine	 intakes	 were	
associated	 with	 lower	 risk	 of	 NTD‐affected	 pregnancy	 in	 a	 subsample	 of	 Hispanic	
ethnicity	 with	 mixed	 exposure	 to	 folic	 acid	 fortification	 (Chandler	 et	 al.	 2012).	 An	
American	prefortification	 study	 reported	 that	high	 intakes	of	 choline	were	protective	
against	 having	 a	 NTD‐affected	 pregnancy	 (Shaw	 et	 al.	 2004).	 In	 a	 postfortification	
pregnancy	 study	 with	 maternal	 blood	 samples	 collected	 at	 ≈15‐18	 GW,	 lower	 and	
higher	serum	choline	concentrations	increased	and	decreased,	respectively,	the	risk	of	
a	NTD‐affected	pregnancy	(Shaw	et	al.	2009a).	Neurulating	mouse	embryos	exposed	to	
inhibitory	 analogues	 of	 choline	 or	 of	 phosphatidylcholine	 synthesis	 derivatives	
developed	 NTD	 (Fisher	 et	 al.	 2001).	 Although	 little	 is	 known,	 the	 choline	 oxidation	





two	of	 the	 four	pyrrole	 rings	are	directly	bound	 to	a	central	 cobalt	atom	(Institute	of	
Medicine	 2016a).	 The	 cobalt	 atom	 is	 coordinated	 by	 four	 pyrrole	 nitrogens	 and	 a	
nitrogen	of	a	dimethylbenzimidazole	group.	A	sixth	coordinating	ligand	can	be	present,	
such	 as	 in	 methylcobalamin	 (methyl	 group	 carbon	 atom)	 and	 adenosylcobalamin	
(deoxyribose	 C5');	 or	 absent	 such	 as	 in	 cobalamin.	 The	 term	 “cobalamin”	 refers	 to	
cofactor	 forms,	 such	 as	 methylcobalamin	 and	 deoxyadenosylcobalamin	 (also	
abbreviated	 as	 adenosylcobalamin);	 and	 “vitamin	 B12”	 refers	 to	 non‐metabolically	
active	 forms,	such	as	aquacobalamin,	cyanocobalamin	and	hydroxycobalamin	(IUPAC‐
IUB	1975).	Cyano	and	hydroxycobalamin	are	synthetically	produced	stable	compounds	
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that	 are	 added	 to	 fortified	 foods,	 vitamin	 supplements	 and	 injections;	 but	
hydroxycobalamin	 can	 also	 be	 formed	 spontaneously	 from	 methyl	 and	
adenosylcobalamin	 in	 the	 organism	 (Obeid	 et	 al.	 2015).	 The	 oxidation	 state	 of	 the	
cobalt	atom	can	be	written	as	roman	numerals	 in	parenthesis	(IUPAC‐IUB	1975).	The	





Throughout	 this	 thesis,	 blood	 and	 tissue	 cobalamin	 concentrations	 will	 refer	 to	 the	
combination	of	metabolically	and	non‐metabolically	active	cobalamin	forms.		
The	 digestion	 of	 cobalamin	 is	 a	 complex	 process.	 A	 protein	 present	 in	 saliva,	
haptocorrin	 (TCN1),	 binds	 free	 cobalamin	 forms.	 In	 the	 upper	 small	 intestine,	
haptocorrin	 is	degraded	and	cobalamin	binds	 to	 the	 intrinsic	 factor	(GIF)	(Allen	et	al.	
1978).	The	intrinsic	factor‐cobalamin	complex	is	absorbed	in	the	distal	small	intestine	
(Nexo	 1998),	mainly	 by	 cubilin	 (Seetharam	 et	 al.	 1997;	 Christensen	 and	 Birn	 2002).	
Uptaken	cobalamin	 is	modified	and	whether	retained	 in	 the	enterocyte	as	cofactor	or	
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transported	 to	 the	 basolateral	 membrane	 where	 it	 is	 released	 to	 the	 plasma,	 in	
complexes	with	haptocorrin	or	with	 transcobalamin	2	 (TCN2)	 (Nexo	1998;	Moestrup	
and	 Verroust	 2001).	 Haptocorrin	 and	 transcobalamin	 2,	 bind	 mostly	 the	 forms	
methylcobalamin	 and	 adenosylcobalamin,	 respectively	 (Nexo	 1977).	 Transcobalamin	
2―cobalamin	 complexes	 are	 delivered	 to	 cells	 by	 the	 ubiquitous	 transcobalamin	 2	
receptor	 (CD320)	 (Nexo	 and	Hollenberg	 1980;	Moestrup	 et	 al.	 1996)	 and	 to	 a	 lesser	
extent	by	megalin	in	some	specific	tissues	(Moestrup	et	al.	1996).	Plasma	cobalamin	is	
found	 mostly	 as	 methylcobalamin,	 less	 as	 adenosylcobalamin,	 and	 the	 lowest	
concentrations	as	other	forms	such	as	cyanocobalamin	and	hydroxycobalamin	(Linnell	
et	 al.	 1974;	 Gimsing	 et	 al.	 1983).	 In	 tissues	 the	 major	 form	 is	 adenosylcobalamin	
(Linnell	et	al.	1974).	
Cobalamin	 acts	 as	 transient	 methyl	 group	 receptacle	 in	 the	 folate‐dependent	





reductive	 methylation	 catalysed	 by	 the	 methionine	 synthase	 reductase	 (MTRR)	 is	
necessary	(see	Introduction	section	3.4).	
Adenosylcobalamin	 participates	 in	 the	 molecular	 rearrangement	 of	 methylmalonyl‐
coenzyme	A	 (methylmalonyl‐CoA)	 to	 form	 succinyl‐coenzyme	A;	 a	 reaction	 catalysed	
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Crosstalk	 between	 both	 cobalamin	 dependent	 reactions	 has	 been	 suggested.	
Experiments	 with	 murine	 leukaemia	 cells	 showed	 intracellular	 protein‐bound	
cobalamin	 is	 associated	 to	 MTR	 and	 methylmalonyl‐CoA	 mutase,	 and	 when	 5‐




MTR	 and	 the	 methylmalonyl‐CoA	 mutase	 reactions,	 that	 is,	 folate	 dependent	
homocysteine	 remethylation	 and	 providing	 metabolites	 for	 the	 Krebs	 cycle.	 Several	
facts,	such	as	an	alternative	and	more	efficient	pathway	for	the	targeting	of	branched‐
chain	amino	acids	and	odd	chain	fatty	acids	to	the	Krebs	cycle;	has	led	some	authors	to	
suggest	 the	methylmalonyl‐CoA	 and	 its	 pathway	may	have	unknown	non‐anaplerotic	
functions	(Allen	et	al.	1993b).	
Cobalamin	plays	an	intimate	role	with	folate	in	homocysteine	remethylation,	but	it	may	
also	affect	 folate‐related	DNA	synthesis	 in	 situations	of	 cobalamin	deficiency	 that	 can	
lead	 to	 the	 accumulation	 of	 the	 5‐methylTHF	 form	because	 the	MTHFR	 reaction	 that	
leads	 to	 its	 synthesis	 is	 irreversible	 and	 the	 impaired	 MTR	 reaction	 prevents	 its	
conversion	to	THF	("methylfolate	trap").	As	a	result,	other	 forms	of	 folate	 involved	 in	








were	 no	 differences	 in	 plasma	 folate	 and	 colonic	 mucosa	 total	 folate	 concentrations	
between	the	groups	(Choi	et	al.	2004).	Therefore,	the	"methylfolate	trap"	is	considered	
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the	 mechanism	 by	 which	 cobalamin	 deficiency	 results	 in	 secondary	 intracellular	
deficiency	 of	 all	 forms	 of	 folate	 except	 5‐methylTHF,	 leading	 to	 haematological	
abnormalities	indistinguishable	from	those	caused	by	folate	deficiency	(Allen	2000).	In	
untreated	 megaloblastic	 anaemia,	 the	 concentrations	 of	 the	 different	 forms	 of	
cobalamin	 are	 equally	 reduced	 in	 cells,	 but	 in	 blood	 plasma	 the	 methylcobalamin	
concentration	is	disproportionately	reduced	(Linnell	et	al.	1974).		
Cobalamin	 is	 an	 essential	 nutrient,	 and	 the	 RDA	 for	 cobalamin	 in	 adults	 is	 2.4µg/d	




150pmol/L	 (de	 Benoist	 2008).	 Plasma	 cobalamin	 >150pmol/L	 and	 <221pmol/L	 has	
been	categorised	as	marginal	cobalamin	deficiency	(Allen	2009).	




impairment	 in	 this	 reaction	where	 adenosylcobalamin	 is	 the	 cofactor.	Both,	 tHcy	and	
methylmalonic	acid	can	be	considered	biomarkers	of	cobalamin	status,	although	tHcy	is	
not	 specific.	 There	 is	 a	 negative	 association	 between	 plasma/serum	 cobalamin	 and	
tHcy	 in	 cohort	 studies	 (Selhub	 et	 al.	 2000;	 Selhub	 et	 al.	 2008).	 According	 to	 a	 meta	
analysis,	vitamin	B12	supplementation	 in	addition	to	 folic	acid	supplementation,	has	a	
higher	 plasma	 homocysteine	 lowering	 effect	 than	 folic	 acid	 alone	 (Homocysteine	
Lowering	Trialists’	Collaboration.	2005).	
As	 previously	 commented	 for	 plasma	 folate,	 prostate	 cancer	 risk	 is	 higher	 per	
100pmol/L	increase	in	plasma/serum	cobalamin	(Collin	et	al.	2010).	It	is	unknown	if	in	
this	association	cobalamin	could	be	a	cause	such	as	the	MTR	c.2756A>G	variant	allele;	
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GW	 (Wu	 et	 al.	 2013),	 than	 in	 non	 pregnant	women.	 In	 the	 RTBC,	 plasma	 cobalamin	
decreases	 throughout	pregnancy	 (Fernàndez‐Roig	et	 al.	2013)	as	previously	 reported	
in	other	 studies	 (Bartels	 et	 al.	 1989;	Cikot	 et	 al.	 2001;	Koebnick	 et	 al.	 2002;	Velzing‐
Aarts	et	al.	2005;	Murphy	et	al.	2007;	Wallace	et	al.	2008;	Ubeda	et	al.	2011;	Wu	et	al.	
2013;	McNulty	et	al.	2013).		
Cord	 and	 maternal	 plasma/serum	 cobalamin	 are	 positively	 correlated	 (Molloy	 et	 al.	
2005;	Obeid	et	al.	2005),	but	higher	 concentrations	are	 found	 in	 the	cord	 than	 in	 the	
maternal	 compartment	 (Obeid	 et	 al.	 2005;	Wallace	 et	 al.	 2008;	 Fernàndez‐Roig	 et	 al.	
2013).	
Plasma	cobalamin	and	tHcy	are	negatively	correlated,	in	pregnant	women	(Molloy	et	al.	





No	differences	 in	second	trimester	maternal	serum	cobalamin	were	 found	 in	cases	of	
conotruncal	heart	defects	in	the	offspring	and	controls	in	a	postfortification	USA	study	
(Shaw	et	al.	2014).	In	this	study	no	data	about	cobalamin	deficiency	is	provided	being	
the	 low	 serum	 cobalamin	 quartile	 <282pmol/L	 (Shaw	 et	 al.	 2014).	 Lower	 maternal	
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concentrations	 of	 plasma/serum	 cobalamin	 are	 associated	 with	 neural	 tube	 defects	
(NTD),	in	cohorts	and	case	control	studies	(Tang	et	al.	2015).	
One	 link	 between	 cobalamin	 and	 omphalocele	 comes	 from	 a	 case	 control	 study	 of	 a	
sample	 of	multiple	 ethnicities	 from	 USA	 and	 exposed	 to	 folic	 acid	 fortification.	 After	
adjusting	 for	 confounders	 and	 correcting	 for	 multiple	 comparisons,	 only	 the	
transcobalamin	 2	 receptor	 c.23A>G	 polymorphism	 out	 of	 23	 single	 nucleotide	
polymorphisms	 (SNPs)	 in	 13	 one‐carbon	 metabolism	 genes,	 was	 associated	 with	 a	






The	 necessity	 to	 investigate	 interactions	 between	 the	 different	 micronutrients	 is	
increasingly	recognised.	Traditionally	they	have	often	been	studied	individually	but	the	
importance	 of	 nutrient‐nutrient	 and	 gene‐nutrient	 interactions	 on	 metabolic	 and	
clinical	outcomes	is	increasingly	clear.	
The	 negative	 association	 between	 serum	 betaine	 concentration	 and	 post‐methionine	
load	plasma	homocysteine	is	stronger	in	individuals	with	low	folate	status	(Holm	et	al.	
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low	 in	 pregnancy	 for	 the	 RTBC;	 and	 betaine	 becomes	 a	 negative	 predictor	 of	 tHcy	
earlier	in	pregnancy	in	women	with	low	folate	status	than	with	high	(Fernàndez‐Roig	et	
al.	2013).		





not	 (Liaugaudas	 et	 al.	 2001).	 These	 results	 suggest	 the	 effect	 of	 cobalamin	 on	 tHcy	
depends	on	folate	status.	
Genetic	variations	in	enzymes	and	transporters	involved	in	1C	metabolism	and	related	
pathways	 can	modulate	 the	 relationships	 between	 the	metabolites	 addressed	 in	 this	
thesis,	and	the	metabolites	themselves	can	modify	the	effect	of	a	given	polymorphism.	
A	 12wk	 postfortification	 USA	 clinical	 trial	 of	 diets	 containing	 600μg/d	 of	 folic	 acid,	
200mg/d	 of	 docosahexanoic	 acid	 and	 480	 or	 930mg/d	 of	 choline	 during	 the	 third	
trimester	of	pregnancy,	revealed	a	greater	betaine	to	DMG	flux	in	carriers	of	the	variant	
allele	 for	 the	MTHFR	c.665C>T	polymorphism	 in	both	diet	 groups	 (Ganz	et	 al.	 2016).	
Betaine	 dependent	 homocysteine	 remethylation	 did	 not	 differ	 between	 genotypes	 of	
the	MTR	 c.2756A>G	 polymorphism	 in	 the	 480mg/d	 choline	 group,	 but	was	 lower	 in	
variant	allele	carriers	compared	to	normal	homozygotes	in	the	930mg/d	choline	group	
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3.1. Methylenetetrahydrofolate	 reductase	 and	 the	 c.665C>T	 polymorphism	
(rs1801133)	
Methylenetetrahydrofolate	reductase		




introns	 and	 is	 coded	 in	 the	 minus	 strand	 (Goyette	 et	 al.	 1994;	 Goyette	 et	 al.	 1998;	
GeneCards	 2016).	 Additional	 exons	 with	 alternative	 splicing	 have	 been	 identified	
(Rozen	 2001).	 Mammalian	 MTHFR	 is	 a	 flavoenzyme,	 specifically	 flavin	 adenine	
dinucleotide	 (FAD)	 as	 cofactor;	 and	 the	 electron	 donor	 is	 nicotinamide	 adenine	
dinucleotide	phosphate	(NADPH).	MTHFR	is	strongly	inhibited	by	SAM,	but	this	can	be	
partially	 reversed	 by	 SAH,	 that	 can	 compete	 with	 SAM	 in	 a	 non‐catalytic	 site	 of	 the	
enzyme	 (Kutzbach	 and	 Stokstad	 1971).	Mammalian	MTHFR	 is	mainly	 in	 the	 form	 of	
homodimers	(Matthews	et	al.	1984).		
Phosphorylated	 and	 non‐phosphorylated	 forms	 of	 MTHFR	 have	 been	 detected	 in	 in	
vitro	experiments	with	human	recombinant	MTHFR	(Yamada	et	al.	2005;	Marini	et	al.	
2008),	 and	 in	 vivo	 in	 mouse	 liver	 (Christensen	 et	 al.	 2015).	 The	 degree	 of	
phosphorylation	 state	 and	 differences	 in	 the	 designs	 of	 the	 in	 vitro	 studies	 could	
underlie	 the	 controversial	 results:	 phosphorylation	 downregulating	 (Yamada	 et	 al.	
2005)	or	upregulating	 (Marini	 et	 al.	 2008)	enzyme	activity.	 There	 is	 evidence	 in	vivo	
(male	 mice	 fed	 a	 diet	 with	 excessive	 folic	 acid)	 supporting	 the	 phosphorylation	 is	
inhibitory	(Christensen	et	al.	2015).	
Like	 folate	 dependent	 remethylation,	 MTHFR	 activity	 is	 ubiquitous	 as	 it	 has	 been	
detected	 in	 all	 the	 analysed	 organs	 in	 rat,	 with	 the	 highest	 abundance	 in	 kidney	
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(Finkelstein	 et	 al.	 1978).	 As	 for	 the	 cellular	 location,	 it	 has	 been	 found	mainly	 in	 the	
cytoplasm	(Finkelstein	et	al.	1978).	
Diet	might	modulate	the	activity	and	expression	of	MTHFR.	The	protein	expression	of	











Human	 lymphocyte	 (Frosst	 et	 al.	 1995)	 and	 placenta	 (Daly	 et	 al.	 1999)	 studies	 have	
shown	that	MTHFR	activity	is	lower	in	the	heterozygote	than	in	the	homozygote	normal	
genotype	 and	 lowest	 in	 the	 homozygote	 variant	 genotype.	 This	 was	 also	 true	 for	
residual	 activity	 after	heat	 inactivation.	Thus	 the	 variant	 enzyme	 is	 thermolabile	 and	
has	 lower	 activity	 (Frosst	 et	 al.	 1995;	 Daly	 et	 al.	 1999).	 Lower	 concentrations	 of	 5‐
methylTHF	and	higher	concentrations	of	other	folate	derivatives	such	as	those	involved	
in	DNA	synthesis	would	be	expected	 if	MTHFR	activity	 is	reduced.	Supporting	this,	 in	
TT	compared	to	CC	USA	Caucasian	women	(Davis	et	al.	2005;	Huang	et	al.	2008)	and	
adults	 (Summers	 et	 al.	 2010)	 there	 were	 higher	 RBC	 THF,	 5,10‐methyleneTHF,	
formylTHF,	and	lower	RBC	5‐methylTHF	concentrations.	Also	there	were	 lower	blood	
DNA	 uracil	 concentrations	 in	 TT	 than	 CC	 adults	 of	 Puerto	 Rican	 origin	 (DeVos	 et	 al.	
2008).	 In	 vitro	 experiments	 suggest	 the	 lower	 activity	 of	 the	 variant	 compared	 to	
normal	 MTHFR	 is	 due	 to	 a	 higher	 dissociation	 rate	 of	 the	 homodimer	 with	 the	
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subsequent	 release	 of	 the	 FAD	 cofactor	 (Yamada	 et	 al.	 2001).	 The	 affinity	 for	 FAD	 is	
reduced	 by	 SAH,	 and	 increased	 (and	 to	 a	 higher	 extent	 in	 the	 variant	 than	 normal	
MTHFR)	by	SAM	and	5‐methylTHF	(Yamada	et	al.	2001).	
Folate	may	improve	the	SNP	defect	in	the	enzyme.	Growth	in	methionine‐absent	media	





Shahzad	 et	 al.	 2013).	 Given	 the	 controversy	 about	 the	 phosphorylation	 effect,	 it	 is	
possible	 that	 the	 phosphorylated	 states	 are	 different	 in	 both	 enzymes,	 and	 that	 the	
phosphorylation	 inhibits	 the	 normal	 enzyme	 but	 activates	 or	 has	 no	 effect	 on	 the	
variant	enzyme.	
A	 meta	 analysis	 of	 10	 genome	 wide	 association	 studies	 (GWAS's)	 of	 cohorts	 of	
European	descent	people,	reported	MTHFR	c.665C>T	polymorphism	as	a	genome	wide	
significant	positive	predictor	of	tHcy,	and	the	most	important	predictor	out	of	≈40000	
analysed	 SNPs	 (van	 Meurs	 et	 al.	 2013).	 Another	 meta	 analysis	 based	 on	 67	
observational	 studies	showed	higher	homocysteine	concentrations	with	variant	allele	
increase	(Holmes	et	al.	2011).	However,	when	stratifying	by	folate	status	world	regions	
in	 this	meta	analysis,	 the	 increases	 in	homocysteine	with	 the	SNP	were	higher	 in	 low	
folate	status	regions,	intermediate	in	mid	folate	status	regions	and	lower	in	high	folate	
status	 regions,	 such	 as	 postfortification	 USA	 (Holmes	 et	 al.	 2011).	 This	 can	 be	
considered	 as	 evidence	 for	 folate	 relief	 of	 the	 SNP	 defect.	 Another	 study	 comparing	
exposure	 to	 folic	 acid	 fortification	 versus	 non‐exposure	 in	 two	 patient	 cohorts,	
reported	that,	despite	being	a	strong	positive	predictor	of	tHcy,	the	effect	of	the	MTHFR	
c.665	 variant	 allele	 was	 less	 important	 in	 the	 fortified	 cohort	 (Nagele	 et	 al.	 2011).	
Regarding	the	MTHFR	FAD	cofactor,	the	effect	of	the	MTHFR	c.665C>T	polymorphism	
on	homocysteine	is	increased	in	the	presence	of	suboptimal	riboflavin	status	in	an	adult	
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population	 unexposed	 to	 folic	 acid	 fortification	 (García‐Minguillán	 et	 al.	 2014).	 An	 in	
vitro	 study	 showed	 that	 the	 variant	 enzyme	was	 less	 susceptible	 to	 heat‐inactivation	
when	the	medium	contained	riboflavin	as	well	as	5‐methylTHF	(Yamada	et	al.	2001).	In	
addition	to	folate	and	riboflavin	status,	the	effect	of	MTHFR	c.665C>T	polymorphism	on	
homocysteine	 seems	 to	 be	 affected	 by	 genetic	 interactions.	 In	 a	 prefortification	
American	 study	 the	 combination	 of	MTHFR	 c.665TT	 /	MTRR	 c.66GG	 was	 associated	
with	lower	serum	tHcy	compared	to	MTHFR	c.665TT	/	MTRR	c.66AA;	while	the	MTRR	
c.66A>G	polymorphism	alone	had	no	 effect	 on	homocysteine	 (Yang	et	 al.	 2008).	This	
gene‐gene	interaction	was	not	observed	in	the	Spanish	adult	population	though	(Bueno	
et	 al.	2016).	Unlike	 the	Spanish	 study,	 in	Yang	et	al.	 the	ethnicity	was	heterogeneous	
and	folic	acid	supplement	users	(≈24%	of	the	sample)	were	included	(Yang	et	al.	2008).	
A	 meta	 analysis	 of	 4763	 adults	 from	 two	 prefortification	 USA	 populations	 reported	
higher	plasma	tHcy	and	lower	plasma	folate	concentrations	with	increasing	number	of	
MTHFR	 c.665	 variant	 alleles,	 respectively;	 although	 the	 folate	 result	 did	 not	 reach	
genome	 wide	 significance	 (Hazra	 et	 al.	 2009).	 In	 this	 meta	 analysis	 no	 association	




was	 done	 in	 each	 GWAS,	 and	 the	 authors	 proposed	 that	 this	 was	 due	 to	 folic	 acid	
fortification.	
The	 polymorphism	 has	 been	 associated	 with	 lower	 plasma	 or	 serum	 folate	
concentrations	in	many	studies	(Harmon	et	al.	1996;	Molloy	et	al.	1997;	van	der	Put	et	





et	 al.	 2016).	 However,	 others	 have	 not	 confirmed	 these	 findings	 (Molloy	 et	 al.	 1997;	
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conducted	 in	 healthy	 population	 some	 have	 small	 sample	 size.	 In	 a	 study	 with	 also	
small	 sample	 size,	 higher	 concentrations	 of	 serum	 folate	 was	 associated	 with	 the	
variant	 homozygote	 genotype	 in	 "senior"	 (65‐75	 years,	 y)	 and	 "elder"	 (85‐102y)	
individuals	(Geisel	et	al.	2001).		
There	 is	 some	 controversy	 about	 the	 effect	 of	MTHFR	 c.665C>T	on	RBC	 folate.	Many	
studies	 have	 found	 lower	 RBC	 folate	 concentrations	 with	 the	 variant	 alleles	 or	
genotypes	(Molloy	et	al.	1997;	Chango	et	al.	2000c;	Lucock	et	al.	2001;	Kluijtmans	et	al.	
2003;	Parle‐McDermott	et	al.	2006;	Lucock	et	al.	2013;	Bueno	et	al.	2016).	There	are	







Hardy‐Weinberg	 equilibrium,	 and	 radioassay	 for	 the	RBC	 folate	 determination	which	
may	 overestimate	 the	 values	 in	MTHFR	 c.665TT	 individuals	 (Molloy	 et	 al.	 1998);	 as	
discussed	 (Parle‐McDermott	 et	 al.	 2006).	 A	 meta‐analysis	 including	 only	 women	 of	




with	 increasing	 number	 of	 variant	 T	 alleles	 (Fredriksen	 et	 al.	 2007),	 whereas	 in	 a	
Brazilian	prefortification	study	no	differences	were	reported	in	women	of	childbearing	
age	 (Barbosa	et	 al.	 2008b).	Unlike	 the	Norwegian	 study,	 in	Barbosa	et	al.	 the	 sample	
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size	 is	 small,	 younger,	 of	 only	 female	 sex,	 of	 heterogeneous	 ethnicity	 and	 blood	
collection	 is	 in	 fasting	 conditions.	 Thus,	 it	 is	 unclear	 if	 the	 MTHFR	 c.665C>T	
polymorphism	 can	disrupt	 1C	metabolism	 to	 an	 extent	 that	 affect	 the	 regulation	 and	
activity	of	the	choline	oxidation	pathway.	









Folate	 has	 been	 reported	 to	 modulate	 the	 effect	 of	 the	 polymorphism	 on	 tHcy.	
Numerous	 studies	 have	 observed	 loss	 of	 the	 tHcy‐increasing	 effect	 of	 the	 variant	





was	 higher	 in	 the	 first	 compared	 to	 the	 fifth	 serum	 folate	 quintile	 in	 healthy	 elderly	
English	 adults	 with	 the	 MTHFR	 c.665TT	 genotype	 only	 (Devlin	 et	 al.	 2006).	 In	
Australian	 gastroenterology	 patients,	 with	 RBC	 folate	 below	 the	median,	 the	MTHFR	
c.665C>T	polymorphism	was	no	longer	a	negative	predictor	of	RBC	folate	(Lucock	et	al.	
2013).		
Most	 pregnancy	 studies	 of	 the	 effect	 of	 the	 SNP	 on	 folate	 mediated	 one	 carbon	
metabolism	are	cross‐sectional	and	at	varying	times	of	pregnancy	ranging	from	the	first	
trimester	 (Molloy	 et	 al.	 1997;	 Relton	 et	 al.	 2005;	 Parle‐McDermott	 et	 al.	 2006),	 11‐
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25GW	 (Liang	 et	 al.	 2014),	 24‐28GW	 (Kim	 et	 al.	 2004),	 labour	 (Molloy	 et	 al.	 2002;	
Lopreato	 et	 al.	 2008;	 Barbosa	 et	 al.	 2008a;	 Visentin	 et	 al.	 2015)	 or	 at	 any	 time	 of	
pregnancy	(Barnabé	et	al.	2015).	One	study	does	have	longitudinal	data	on	serum	tHcy,	
folate	and	cobalamin	(Ubeda	et	al.	2011).	The	results	of	these	studies	confirm	that	the	
MTHFR	c.665C>T	polymorphism	 is	associated	with	higher	 tHcy,	 lower	plasma,	 serum	
and	RBC	 folate,	 and	not	with	 serum	 cobalamin.	A	UK	 study	using	 a	 (non	 radioassay)	
protein‐binding	assay	reported	higher	first	trimester	RBC	folate	in	the	MTHFR	c.665TT	
compared	to	CC	genotype	(Relton	et	al.	2005).	This	study	is	contrary	to	the	lower	RBC	
folate	 concentration	 found	 in	 another	 first	 trimester	 pregnancy	 study	 in	 Ireland	 that	
uses	the	microbiological	assay	(Molloy	et	al.	1997;	Parle‐McDermott	et	al.	2006).	Relton	
et	al.	study	does	not	have	the	aforementioned	features	that	may	confound	the	results	in	
studies	 finding	 higher	 RBC	 folate	 in	 non	 pregnant	 variant	 homozygotes	 (Parle‐
McDermott	 et	 al.	 2006).	 The	 protein‐binding	 assays	 are	 considered	 to	 have	 low	
accuracy	when	mixtures	of	 folates	 are	present,	which	 is	 the	 situation	 in	 the	different	
genotypes	 of	 the	 polymorphism;	 and	 overall	 protein‐binding	 assays	 are	 less	
recommended	 than	 the	microbiological	assay	 (Pfeiffer	et	 al.	2010).	Overestimation	of	
RBC	 folate	 in	MTHFR	 c.665TT	 individuals	 might	 also	 apply	 in	 the	 (non	 radioassay)	
protein‐binding	assays.		
To	 the	 best	 of	 our	 knowledge	 the	 studies	 assessing	 cord	 blood	 have	 investigated	
offspring	 but	 not	 the	 maternal	MTHFR	 c.665C>T	 genotype,	 except	 in	 an	 Irish	 study	
finding	a	non	significant	trend	toward	higher	cord	plasma	tHcy	in	TT	mothers	(Molloy	
et	al.	2002).	MTHFR	c.665	variant	genotypes	or	allele	in	the	offspring	is	associated	with	
lower	 serum	 folate	 (Lopreato	 et	 al.	 2008;	 Plumptre	 et	 al.	 2015),	 higher	 RBC	 folate	
(Relton	et	al.	2005;	Plumptre	et	al.	2015);	but	not	tHcy	(Molloy	et	al.	2002;	Lopreato	et	
al.	 2008;	Plumptre	et	 al.	 2015),	 betaine	and	DMG	 (Visentin	 et	 al.	 2015)	or	 cobalamin	
(Lopreato	et	al.	2008)	in	the	cord.	In	Molloy	et	al.	a	non‐significant	trend	toward	lower	
RBC	 folate	 in	 the	MTHFR	 c.665TT	 than	CC	 and	CT	offspring	 genotypes	was	 observed	
(Molloy	et	al.	2002).	Again,	RBC	folate	determinations	by	protein‐binding	(Relton	et	al.	
2005;	 Plumptre	 et	 al.	 2015)	 or	 microbiological	 assays	 (Molloy	 et	 al.	 2002)	 might	
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explain	 the	 differences.	 Another	 study	 reported	 no	 differences	 between	 offspring	
genotypes	in	cord	tHcy,	serum	folate	or	cobalamin	(Lopreato	et	al.	2008).	









studies	 included	 were	 from	 non	 fortified	 countries,	 while	 in	 the	 rest	 not	 all	 their	
participants	 were	 exposed	 to	 mandatory	 fortification	 (Facco	 et	 al.	 2009).	 Increasing	
number	of	variant	alleles	in	the	offspring	was	associated	with	a	lower	risk	of	SGA	in	a	
postfortification	big	Canadian	study	(Infante‐Rivard	et	al.	2002).	But	a	UK	study	found	






The	MTHFR	 c.665	 variant	 genotype	 and	 allele	 in	 the	 mother	 or	 offspring	 has	 been	
associated	with	risk	of	congenital	heart	defects	in	the	offspring,	as	reported	in	a	meta	
analysis	(Xuan	et	al.	2014).	The	risk	of	NTDs	in	the	offspring	is	also	associated	with	the	
variant	 genotype	 or	 allele	 in	 the	 mother	 (Yadav	 et	 al.	 2015;	 Yang	 et	 al.	 2015)	 or	
offspring	(Zhang	et	al.	2013;	Yang	et	al.	2015).	To	the	best	of	our	knowledge	no	study	
has	assessed	maternal	MTHFR	c.665	genotypes	and	omphalocele	risk	 in	the	offspring.	
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MTHFR	 c.665	 variant	 homozygote	 or	 heterozygote	 genotype	 in	 live	 born	 infants	was	
not	associated	with	omphalocele	risk	in	a	postfortification	USA	study	(Mills	et	al.	2012).	
Recurrent	 miscarriage	 is	 usually	 defined	 as	 ≥2	 or	 ≥3	 consecutive	 pregnancy	
spontaneous	 losses,	 as	 reviewed	 (Rai	and	Regan	2006).	There	were	no	differences	 in	
the	 MTHFR	 c.665C>T	 genotype	 frequencies	 between	 women	 with	 recurrent	
miscarriage	and	mothers	with	no	previous	miscarriage	 in	a	Spanish	study,	even	after	
stratifying	 by	 RBC	 folate	 status	 (Creus	 et	 al.	 2013).	 But	 more	 proportion	 of	 variant	
homozygote	was	observed	in	women	with	recurrent	miscarriage	compared	to	women	
with	normal	pregnancies	 in	a	Chinese	 study	 (Zhu	2015).	According	 to	meta	analyses,	
the	 maternal	 variant	 genotype	 and	 allele	 is	 associated	 with	 risk	 of	 recurrent	





a	 smaller	 study	 of	 a	 postfortification	 Mexican	 population	 found	 a	 higher	 risk	 in	 TT	
mothers	 compared	 to	 CC	 and	 CT	 (Rodríguez‐Guillén	 et	 al.	 2009).	 The	 foetal	 variant	
genotype	or	allele	has	been	associated	with	lower	(Isotalo	et	al.	2000;	Bae	et	al.	2007),	
higher	 risk	 of	 miscarriage	 (Callejón	 et	 al.	 2007)	 or	 not	 associated	 (Zetterberg	 et	 al.	
2002).	
The	MTHFR	 c.665	 variant	 genotype	 or	 allele	 has	 been	 associated	 with	 risk	 of	 male	
infertility	(Gupta	et	al.	2011),	hypertension	and	pregnancy	induced	hypertension	(Qian	
et	al.	2007),	coronary	artery	disease	(Wald	et	al.	2002;	Clarke	et	al.	2003),	peripheral	
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methyl	 group	 from	 betaine	 to	 homocysteine,	 producing	 DMG	 and	 methionine	
(Introduction	 section	 1,	 Figure	 1).	 The	 BHMT	 gene	 is	 located	 at	 chromosome	 5	
(cytogenetic	 band	 5q14.1),	 contains	 8	 exons	 and	 7	 introns	 and	 is	 coded	 in	 the	 plus	
strand	(Park	and	Garrow	1999;	GeneCards	2016;	Institute	of	Medicine	2016b).	Despite	
an	 initial	 controversy	 and	 based	 on	 the	 high	 homology	 with	 the	 rat	 enzyme,	 it	 is	
nowadays	 accepted	 that	 human	 hepatic	 BHMT	 has	 the	 general	 structure	 of	 an	
homotetramer	(González	et	al.	2002).	Oligomerisation	is	required	for	catalytic	function	
in	 human	 recombinant	 BHMT	 (Szegedi	 and	 Garrow	 2004).	 BHMT	 is	 a	 zinc	
metalloenzyme	whose	metal	atom	is	essential	for	catalytic	activity	(Millian	and	Garrow	
1998),	and	each	BMHT	protein	unit	contains	one	atom	of	zinc	(Szegedi	et	al.	2008).		
Human	BHMT	is	contained	 in	 liver	hepatocytes	(no	gradient	across	 the	organ)	and	 in	
the	kidney	cortex	(mostly	in	proximal	tubules),	in	both	located	in	the	cytosol	(Delgado‐
Reyes	 et	 al.	 2001).	 Mouse	 experiments	 have	 shown	 that	 BHMT	 activity	 is	 orders	 of	
magnitude	 lower	 in	 the	 kidney	 than	 in	 the	 liver	 (Szegedi	 et	 al.	 2008),	 although	 a	
previous	 study	 in	 humans	 implied	 they	 might	 be	 similar	 (Gaull	 et	 al.	 1973).	 Minor	
BHMT	 activity	 has	 also	 been	 reported	 in	 human	 foetal	 and	 adult	 brain	 (Gaull	 et	 al.	
1973)	 although	 this	 has	 not	 been	 confirmed	 in	 another	 study	 of	 human	 brain	 of	
unspecified	age	 (McKeever	et	al.	1991).	Moreover,	 the	mRNA	transcript	has	not	been	
detected	 in	human	brain	 (Sunden	et	al.	1997).	BHMT	activity	was	detected	 in	human	
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BHMT	 has	 been	 identified	 at	 different	 stages	 throughout	 the	 development	 of	 the	
embryo	and	 foetus.	 In	a	mouse	study	covering	gestational	days	(GD)	9	and	10,	BHMT	
mRNA	 was	 observed	 in	 the	 embryo	 and	 yolk	 sac	 only	 on	 gestational	 day	 (GD)	 10	
(Fisher	et	al.	2002).	Therefore,	since	neural	tube	closure	is	considered	complete	in	mice	
on	10	(Greene	and	Copp	2009)	or	10.5	GD	(Zhon	and	Sarkar	2008),	BHMT	should	not	
be	 completely	 excluded	 as	 having	 a	 role	 in	 neural	 tube	 closure	 in	 mice.	 Moreover,	
BHMT	mRNA	and	protein	expression	do	not	exactly	overlap	in	the	early	days	of	mouse	









in	 human	 first	 term	 and	 term	 (Solanky	 et	 al.	 2010)	 and	 unspecified	 gestational	 age	
placentas	(Sunden	et	al.	1997).	In	human	placentas	BHMT	protein	is	not	detectable	by	
immunohistochemistry	(The	human	protein	atlas	2016)	and,	 to	our	knowledge,	 there	
are	no	published	studies	 investigating	 the	protein	 in	placenta.	 In	human	 foetus	 livers	
ranging	 in	 age	 from	 approximately	 11‐32	 GW,	 BHMT	 protein	 and	 activity	 have	 been	
detected.	Both	 are	 lower	 than	 in	 adults,	 and	 the	 activity	 is	 positively	 correlated	with	
gestational	 age	 (Feng	 et	 al.	 2011).	 Detection	 of	 BHMT	 human	 foetal	 liver	 activity	 at	
lower	 levels	 than	 in	 adults	 but	 higher	 with	 increasing	 gestational	 age	 confirms	 the	
results	 of	 an	 earlier	 study	 and	 in	 fact	 that	 study	 also	 confirmed	 the	 same	 for	 foetal	
kidney	BHMT	activity	(Gaull	et	al.	1973).	However,	there	was	no	reference	to	statistical	
analysis	 in	 that	 study.	 Foetal	 BHMT	 may	 play	 a	 role	 in	 development	 but	 the	 lower	
BHMT	activity	plus	the	higher	MTR	activity	in	foetal	compared	to	adult	liver	(Gaull	et	al.	
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Early	 gestation	 mouse	 experiments	 show	 that	 inhibition	 of	 BHMT	 transcription	 and	
activity	is	associated	with	impaired	embryo	development	to	the	blastocyst	stage	both	in	
terms	 of	 reaching	 it	 and	 reduced	 cell	 number	 in	 the	 embryoblast	 (Lee	 et	 al.	 2012).	
Inhibition	of	BHMT	 transcription	before	 transferring	 the	 embryos	 to	pseudopregnant	




been	 found	 in	 rat	 hepatocytes	 autofagosomal	 membranes,	 and	 this	 has	 led	 some	
authors	to	suggest	a	role	 in	binding	proteins	 for	degradation	(Overbye	et	al.	2007).	 It	
has	been	reported	 in	human	cell	 cultures	 that	BHMT	 interacts	and	stabilises	betaine‐
homocysteine	 methyltransferase	 2	 (BHMT2)	 (Li	 et	 al.	 2008),	 which	 is	 a	 zinc	
metalloenzyme	 that	 can	 remethylate	homocysteine	with	S‐methylmethionine,	but	not	
with	betaine	(Szegedi	et	al.	2008).	BHMT	is	considered	a	structural	protein	(crystallin)	
in	the	human	lens,	especially	in	the	foetus,	as	reviewed	(Wistow	2012).	




endogenous	 BHMT	 mRNA	 levels	 (Ou	 et	 al.	 2007).	 Dietary	 methionine	 may	 regulate	
hepatic	 BHMT	 activity	 in	 a	 U‐shape	 fashion.	 Animals	 fed	 methionine‐supplemented	
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and	 Garrow	 1999).	 In	 cattle,	 hepatic	 BHMT	 activity	 also	 responds	 quadratically	 to	
dietary	methionine	(Lambert	et	al.	2002).	Betaine	or	choline	supplementation	enhances	
the	 methionine‐deficiency	 mediated	 increase	 in	 hepatic	 BHMT	 activity	 in	 chickens	
(Emmert	et	al.	1996)	and	rats	 (Park	and	Garrow	1999).	These	hepatic	BHMT	activity	
increases	 due	 to	methionine	 deficiency	 (Park	 et	 al.	 1997;	 Park	 and	Garrow	1999)	 or	
supplementation	 (Ohuchi	 et	 al.	 2009)	 are	 mirrored	 by	 BHMT	 mRNA	 and	 protein	
contents,	 suggesting	 upregulated	 BHMT	 expression.	 Dietary	 betaine	 of	 preweaning	
mice,	 i.e.	 with	 dams	 fed	 a	 betaine‐supplemented	 diet,	 increases	 liver	 BHMT	 activity	
(Schwahn	et	al.	2004).	Deficient	folate	intake	increases	hepatic	BHMT	specific	activity	
in	micropigs	(Halsted	et	al.	2002),	but	excess	folic	acid	intake	does	not	change	hepatic	
BHMT	 mRNA	 expression	 in	 a	 study	 of	 male	 wild	 type	 mice	 or	 with	 mild	 MTHFR	
deficiency	(Christensen	et	al.	2015).	
Purified	human	hepatic	BHMT	activity	was	strongly	inhibited	by	DMG	and	not	inhibited	
by	 methionine	 (results	 not	 shown)	 in	 a	 study	 where	 most	 of	 the	 substrates	 and	
inhibitors	 were	 at	 pharmacological	 concentrations	 (2500µM	 betaine	 and	 106µM	
homocysteine;	 and	 500‐50000µM	 DMG	 or	 methionine)	 (Skiba	 et	 al.	 1982).	 A	
subsequent	study	with	purified	human	hepatic	BHMT	and	substrates	and	inhibitors	at	
concentrations	 more	 close	 to	 the	 physiological	 ones	 (200µM	 betaine	 and	 200µM	
homocysteine;	20‐200µM	DMG	or	methionine	or	SAM,	or	20µM	SAH),	reported	strong	
inhibition	by	DMG,	weak	by	methionine	and	no	inhibition	by	SAM	or	SAH	(Szegedi	et	al.	
2008).	 Indeed,	 purified	 human	 recombinant	 BHMT	 does	 not	 seem	 to	 bind	 SAM,	 as	
shown	 in	 one	 study	 by	microcalorimetry	 (Bose	 et	 al.	 2002).	 The	 inhibition	 by	 these	
compounds	 could	 vary	 between	 species.	 Methionine	 had	 an	 apparently	 stronger	
inhibitory	effect	in	purified	mouse	hepatic	BHMT	compared	to	the	human	enzyme;	but	
the	results	for	DMG	and	SAM	were	similar	in	both	enzymes	(Szegedi	et	al.	2008).	
Apart	 from	 DMG	 and	 methionine,	 Szegedi	 et	 al.	 results	 were	 contrary	 to	 previous	
observations	 from	 earlier	 rat	 liver	 extract	 (semi	 purified	 BHMT)	 experiments.	 The	
activity	was	reduced	by	SAM	by	15%	in	an	assay	with	substrates	and	inhibitors	at	near	
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physiological	 concentrations	 (350µM	 betaine	 and	 20µM	 homocysteine;	 50µM	 SAM)	
(Finkelstein	et	al.	1972);	and	by	32%	with	supraphysiological	concentrations	(2000µM	
betaine	 and	 7000µM	homocysteine;	 224µM	SAM)	 (Finkelstein	 and	Martin	 1984b).	 In	
another	study	with	semi	purified	BHMTs	from	rat	liver,	or	human	liver	or	kidney;	the	
activity	 was	 reduced	 by	 ≈17%	 by	 SAM	 (results	 not	 shown)	 in	 an	 assay	 with	
physiological	 concentrations	 of	 betaine	 and	 supraphysiological	 concentrations	 of	
homocysteine	 and	 SAM	 (200µM	 betaine	 and	 200µM	 homocysteine;	 1000µM	 SAM)	
(Allen	et	al.	1993a).	Thus,	according	to	Finkelstein	et	al.	(Finkelstein	et	al.	1972),	SAM	
inhibition	of	BHMT	may	be	biologically	plausible.	
Inhibitory	 effects	 of	 SAH	 on	 BHMT	 activity	 were	 reported	 in	 rat	 liver	 extract	
experiments	 containing	physiological	 concentrations	of	 SAH	 (Finkelstein	et	 al.	 1972),	
but	the	results	are	not	clear	for	supraphysiological	concentrations	of	SAH	(Finkelstein	
et	al.	1974;	Finkelstein	and	Martin	1984b).	The	activity	was	reduced	by	16%	by	50µM	
SAH	 in	 an	 assay	 with	 substrates	 and	 inhibitors	 at	 near	 physiological	 concentrations	
(Finkelstein	 et	 al.	 1972).	 A	 study	 testing	 a	 range	 of	 SAH	 doses	 with	 substrate	
concentration	ranges	at	or	close	to	physiological	concentrations	(120‐1030µM	betaine	
and	25‐800µM	homocysteine;	380‐3750µM	SAH),	shown	reduced	BHMT	activity	across	
the	 tested	 SAH	 range	 (Finkelstein	 et	 al.	 1974).	 But	 in	 a	 subsequent	 study	 with	
supraphysiological	 concentrations	 of	 substrates,	 440µM	 and	 880µM	 SAH	 led	 to	 15%	
lower	 and	 16%	higher	 BHMT	 activity,	 compared	 to	 the	 control	 assay	with	 no	 added	
SAH,	respectively	(Finkelstein	and	Martin	1984b).	Possible	reasons	for	the	controvert	
results	of	the	two	latter	studies	have	not	been	proposed.	Therefore,	it	appears	that,	SAH	
at	similar	concentrations	to	those	reported	for	rat	 liver,	 i.e.	10‐47µM	(assuming	rat	 is	
equal	 to	 human	 liver	 density	 1.051g/mL,	 and	 rounding	 to	 1g/mL)	 (Overmoyer	 et	 al.	
1987;	Fowler	2001)	could	inhibit	BHMT	activity	in	vivo.		
Liver	 extract	 studies	 have	 also	 found	 an	 inhibitory	 effect	 of	 methionine	 for	 BHMT	
activity.	 Rat	 liver	 semi	 purified	 BHMT	 activity	 was	 reduced	 by	 93%	 by	 50µM	
methionine	 in	 an	 assay	 with	 substrates	 and	 inhibitors	 at	 near	 physiological	
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concentrations	 (Finkelstein	 et	 al.	 1972).	 In	 the	 study	with	 extracts	 from	 rat	 liver,	 or	
human	liver	or	kidney;	the	activity	was	reduced	by	≈8%	by	300µM	methionine	(results	
not	 shown)	 in	 an	 assay	 with	 physiological	 concentrations	 of	 betaine	 and	
supraphysiological	concentrations	for	homocysteine	(Allen	et	al.	1993a).	The	reported	
concentrations	 of	 methionine	 in	 rat	 liver	 are	 45µM	 (assuming	 liver	 density	 1g/ml)	
(Finkelstein	and	Martin	1986).	Thus,	the	rat	liver	extract	assay	of	Finkelstein	et	al.	from	
1972	 has	 concentrations	 in	 the	 physiological	 range	 making	 the	 reported	 results	 of	
methionine‐mediated	inhibition	of	BHMT	the	closest	to	 in	vivo	conditions	(Finkelstein	
et	 al.	 1972).	 Purified/semi	 purified	 state	 of	 BHMT	 and	 different	 concentrations	 of	
substrates	may	be	some	of	the	causes	for	the	different	results	for	methionine	inhibition	
among	 the	 commented	 studies	 (Finkelstein	 et	 al.	 1972;	 Skiba	 et	 al.	 1982;	Allen	 et	 al.	
1993a;	Szegedi	et	al.	2008).	
There	 is	evidence	 in	support	of	 in	utero	programming	of	BHMT.	Less	BHMT	mRNA	 is	
expressed	in	the	liver	of	the	offspring	of	rat	dams	on	diets	supplemented	with	folic	acid	
(5mg/Kg	 diet)	 and/or	 protein	 restricted	 compared	 to	 control	 diets	 (folic	 acid	 as	
2mg/Kg	 diet	 and	 normal	 protein	 content)	 (Chmurzynska	 and	 Malinowska	 2011).	
Furthermore,	mRNA	and	protein	BHMT	expression	were	higher	in	the	hippocampus	of	
offspring	 of	 sows	 fed	 a	 diet	 supplemented	 with	 betaine	 compared	 to	 the	
unsupplemented	group	(Li	et	al.	2014a).	Indeed,	the	BHMT	promoter	contains	part	of	a	






nucleotide	position	 is	 in	 the	exon	6	(Park	and	Garrow	1999),	whereas	the	239	amino	
acid	position	is	between	α6	helix	and	β7	strand,	main	secondary	structure	elements	of	
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exons	 count.	 White	 segments	 indicate	 non‐coding	 RNA.	 B.	 BHMT	 protein	 sequence	 diagram	 with	
Arg239Gln	location.	Yellow	and	green	segments	indicate	main	β	strands	and	α	helixes,	respectively,	of	the	
(β/α)8	barrel	structure.	Black	segments	 indicate	protein	regions	outside	of	the	main	secondary	structure	
elements	of	 the	barrel.	Based	on	sequences	 from	(Park	and	Garrow	1999;	Evans	et	al.	2002;	 Institute	of	
Medicine	2016c).	
No	differences	in	betaine	affinity	have	been	observed	in	assays	(with	unspecified	range	
of	 betaine	 and	 500µM	 homocysteine)	 of	 crude	 extract	 of	E.	 coli	 transfected	with	 the	
normal	or	variant	human	BHMT	 allele	 (Weisberg	et	al.	2003).	However,	 the	assays	of	
cytosol	of	monkey	kidney	cell	 transfected	with	human	BHMT	showed	that	the	variant	
enzyme	 has	 a	 higher	 affinity	 for	 betaine	 (assay	 with	 2‐256µM	 betaine	 and	 400µM	
homocysteine)	 and	 homocysteine	 (assay	 with	 64µM	 betaine	 and	 3.1‐400µM	
homocysteine).	 However,	 basal	 enzyme	 activities	 were	 similar	 (assay	 with	 64µM	
betaine	 and	 400µM	 homocysteine)	 (Li	 et	 al.	 2008).	 A	 recent	 study	 of	 human	 liver	
extract	 (endogenous	 BHMT),	 did	 not	 specify	 kinetic	 parameters	 but	 reported	 no	
correlation	between	BHMT	c.716G>A	genotypes	and	enzyme	activity	(assay	with	64µM	
betaine	 an	 400µM	 homocysteine)	 (Feng	 et	 al.	 2011).	 Rat	 liver	 betaine	 and	
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Koc	 et	 al.	 2002).	 Thus,	 none	 of	 the	 aforementioned	 enzyme	 assays	 have	 used	 the	
betaine	 physiological	 concentrations;	 while	 for	 homocysteine	 100‐fold	 higher	
concentrations	 are	 used	 (except	 in	 the	 homocysteine	 affinity	 assays).	 Assays	 using	
physiological	 liver	 concentrations	 of	 betaine	 and	 homocysteine	 are	 needed,	 although	
these	 are	 unknown,	 to	 the	 best	 of	 our	 knowledge,	 in	 human	 liver.	 No	 differences	 in	
protein	BHMT	levels	were	observed	between	the	normal	and	variant	alleles	in	monkey	
kidney	 cells	 transfected	 with	 human	 BHMT	 (Li	 et	 al.	 2008),	 and	 no	 correlation	 was	
observed	between	BHMT	c.716G>A	genotype	and	protein	levels	in	human	liver	extracts	
(Feng	 et	 al.	 2011).	 Both	 enzymes	had	 similar	 thermostability	 (Weisberg	 et	 al.	 2003).	
Overall	it	appears	from	the	in	vitro	studies	that	the	only	difference	between	the	variant	
enzyme	 and	 the	 normal	 enzyme	 is	 that	 the	 former	 has	 a	 higher	 affinity	 for	
homocysteine,	and	maybe	for	betaine.	





postfortification	 studies	 from	 Brazil	 and	 USA	 have	 reported	 significant	 associations	
between	 variant	 genotype	 or	 allele	 and	 homocysteine,	 and	 in	 the	 opposite	 sense.	





2012;	 Zampieri	 et	 al.	 2012;	 Misiak	 et	 al.	 2016),	 RBC	 folate	 (Morin	 et	 al.	 2003b),	 or	
plasma	 or	 serum	 cobalamin	 (Morin	 et	 al.	 2003b;	 Ananth	 et	 al.	 2007;	 Terruzzi	 et	 al.	
2007;	Fredriksen	et	al.	2007;	Misiak	et	al.	2016).	 Increasing	number	of	variant	alleles	
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1Cohort	 specific	 features:	DS,	Down	Syndrome;	 SAP,	 Stable	Angina	Pectoris.	 2Metabolites	 in	plasma/serum	unless	otherwise	 specified.	 3Genome	
wide	association	study.	
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growth	 restriction	 (IUGR).	 It	 might	 be	 expected	 to	 affect	 foetal	 growth	 because,	 as	
commented	above,	the	BHMT	pathway	becomes	more	important	during	late	pregnancy	
and/or	when	folate	status	is	low	(Fernàndez‐Roig	et	al.	2013).	
There	 is	 sparse	 literature	 regarding	 the	 BHMT	 c.716G>A	 polymorphism	 and	 risk	 of	
congenital	 heart	 defects.	 In	 USA	 studies	 where	 whole	 (Hobbs	 et	 al.	 2010)	 or	 the	
majority	 of	 the	 sample	 (Mitchell	 et	 al.	 2010)	 was	 exposed	 to	 mandatory	 folic	 acid	
fortification,	 there	was	no	 independent	effect	of	 the	maternal	 genotype	on	congenital	
heart	 defect	 risk	 in	 the	 offspring.	 There	 have	 been	 no	 maternal	 SNP	 studies	 before	







According	 to	 the	 age	 range	 (1‐22y)	 and	mean	 age	 (10y)	 of	 the	 offspring	 and	 to	 the	
blood	 draws	 in	 the	 sample	 being	 before	 1999	 (Christensen	 et	 al.	 1999),	most	 of	 the	





family‐based	 study	 including	 mothers	 using	 vitamin	 supplements	 and	 with	 most	
pregnancies	 exposed	 to	 mandatory	 folic	 acid	 fortification	 (information	 provided	 by	
author),	reported	the	SNP	in	the	offspring	was	associated	with	NTDs	risk	(Boyles	et	al.	
2006).	 In	 a	 postfortification	USA	 study	with	unknown	prenatal	 folic	 acid	 supplement	
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offspring	 and	NTDs	 risk	 (results	 not	 shown)	 (Liu	 et	 al.	 2014).	 The	 results	 of	 studies	
assessing	 the	 polymorphism	 in	 the	 offspring	 and	 NTDs	 risk	 according	 to	 maternal	
prenatal	 vitamin	 supplement	 use	 are	 controvert.	 When	 stratifying	 by	 preconception	
vitamin	supplement	use	in	Boyles	et	al.	study,	higher	risk	with	the	offspring	SNP	is	only	
observed	 with	 supplementation	 (Boyles	 et	 al.	 2006).	 However,	 when	 stratifying	 by	
pre/postconception	 folic	 acid	 supplement	use	 in	Liu	et	al.	 study,	higher	 risk	with	 the	
offspring	 SNP	 is	 only	 observed	 with	 no	 supplementation	 (Liu	 et	 al.	 2014).	 Some	
differences	between	both	studies	apart	from	ethnicity	are	exposure	to	mandatory	folic	
acid	fortification	in	most	pregnancies	in	the	USA	study	and	the	different	categories	used	
to	define	 supplement	user;	 e.g.	 the	Chinese	 study	 includes	postconception	use.	These	
inconclusive	 results	highlight	 the	 importance	of	 further	 study	of	 the	BHMT	c.716G>A	
polymorphism	according	to	folate	status.		
To	 the	 best	 of	 our	 knowledge	 there	 are	 no	 reports	 about	 maternal	 BHMT	 c.716	
genotypes	 and	omphalocele	 risk	 in	 the	offspring.	BHMT	c.716	variant	homozygote	or	
heterozygote	genotype	in	live	born	infants	was	not	associated	with	omphalocele	risk	in	
a	postfortification	USA	study	(Mills	et	al.	2012).	




coronary	 artery	 disease	 (Singh	 and	 Lele	 2012).	 The	 SNP	 may	 be	 a	 risk	 factor	 for	
placental	 abruption	 (Ananth	 et	 al.	 2007),	 and	 a	 protective	 factor	 for	 uterine	 cervical	
carcinoma	(Mostowska	et	al.	2011)	and	Down	syndrome	in	the	offspring	(Zampieri	et	
al.	2012;	Amorim	et	al.	2013).	A	study	of	USA	women	reported	lower	risk	of	colorectal	
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homozygotes	only	 in	 the	stratum	with	high	dietary	methyl	status	 (Hazra	et	al.	2007).	
The	assessment	of	dietary	methyl	status	was	by	a	food	frequency	questionnaire	based	




The	 reduced	 folate	 carrier	 (SLC19A1,	 also	 known	 as	 RFC)	 is	 along	 with	 the	 proton	
coupled	 folate	 transporter	 and	 the	 folate	 receptors,	 a	protein	 involved	 in	 the	 cellular	
uptake	 of	 folate.	 The	 SLC19A1	 gene	 is	 located	 at	 chromosome	 21	 (cytogenetic	 band	
21q22.3),	 contains	17	exons	(due	 to	 the	existence	of	upstream	and	downstream	non‐
coding	exons)	and	is	coded	in	the	minus	strand	(GeneCards	2016;	Institute	of	Medicine	
2016b).	Five	exons	are	protein	coding.	Depending	on	the	earlier	discovered	upstream	
non‐coding	 exons	 number	 and	 given	 names,	 the	 first	 coding	 exon	 has	 been	 termed	
"exon	 3"	 (Zhang	 et	 al.	 1998;	Whetstine	 et	 al.	 2001)	 or	 "exon	 2"	 (Tolner	 et	 al.	 1998;	
Williams	and	Flintoff	1998),	though	the	latter	term	is	more	used.	SLC19A1	consists	of	
12	transmembrane	domains	(Ferguson	and	Flintoff	1999).	SLC19A1	has	higher	affinity	
for	 5‐methylTHF	 (Kt	 1.1‐2.0µM)	 and	 5‐formylTHF	 (Kt	 1.2‐4.2µM),	 i.e.	 reduced	 folate	
forms,	than	for	the	oxidised	folic	acid	(Kt	from	110‐220µM);	according	to	experiments	
in	 human	 cell	 lines	 (Sirotnak	 and	 Tolner	 1999).	 Experiments	 of	 inhibition	 of	
methotrexate	 (chemical	 drug	 analogue	 of	 folic	 acid)	 influx	 by	 extracellular	 organic	
anions	revealed	that	the	mechanism	for	SLC19A1	mediated	folate	transport	into	the	cell	
is	the	coupling	of	the	downhill	efflux	of	organic	phosphates	to	the	uphill	influx	of	folate	
forms	 (Henderson	 and	 Zevely	 1983).	 Although	 folate	 transport	 by	 SLC19A1	may	 be	
bidirectional,	 physiologically	 it	 is	 considered	 to	 take	 up	 folate	 from	 the	 extracellular	
media	due	to	the	high	intracellular	concentrations	of	organic	anions	(Shane	2010)	
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Since	 the	 discovery	 that	 proton	 coupled	 folate	 transporter	 is	mainly	 responsible	 for	
folate	intestinal	absorption	(Qiu	et	al.	2006),	it	is	now	considered	that	SLC19A1	plays	a	
minor	role	in	intestinal	absorption.	The	optimal	pH	for	SLC19A1	mediated	transport	is	
7.5,	 according	 to	 methotrexate	 influx	 experiments	 in	 mouse	 lymphocytic	 leukaemia	
cells	 (Sierra	 et	 al.	 1997).	 While	 the	 optimal	 pH	 for	 folate	 intestinal	 absorption	 is	 6	
(Selhub	and	Rosenberg	1981),	that	SLC19A1	transcript	and	protein	are	up‐regulated	in	
the	 small	 intestine	 of	 folate	 deficient	 mice	 (Liu	 et	 al.	 2005)	 suggests	 a	 role	 for	 it	 in	






trimester	 (Solanky	 et	 al.	 2010).	 Probably	 due	 to	 its	 role	 as	 a	 transmembrane	
transporter,	 SLC19A1	 has	 been	 found	 in	membranes	 of	 several	 types	 of	 cells.	 These	
included	the	epithelia:	apical	brush‐border	membrane	of	the	entire	intestine	(jejunum,	
ileum,	 duodenum	 and	 colon),	 basolateral	 membrane	 of	 renal	 tubular	 epithelium,	




Fifty	 five	 CpG	 sites	 are	 close	 to	 or	 within	 the	 SLC19A1	 gene,	 organised	 in	 two	 CpG	
islands.	Several	of	these	CpG	sites	are	reported	to	differ	in	methylation	state	according	
to	tHcy.	Most	of	the	sites	had	lower	methylation	in	leukocytes	from	individual	with	high	
(20‐113µmol/L)	 compared	 to	 low	 (5‐10µmol/L)	 plasma	 tHcy	 (Farkas	 et	 al.	 2013).	
Methylation	 states	 in	 analysed	CpG	 sites	 of	 the	proton	 coupled	 folate	 transporter	 and	
folate	receptor	1	are	similar	in	situations	of	high	or	low	tHcy.	The	methylation	of	many	
of	 the	 CpG	 sites	 in	 SLC19A1	 is	 negatively	 associated	 with	 its	 expression.	 Therefore	
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SLC19A1	 may	 be	 a	 folate	 transporter	 which	 can	 be	 epigenetically	 upregulated	 in	
response	 to	 high	 tHcy	 (Farkas	 et	 al.	 2013).	 The	 inverse	 association	 between	 plasma	
tHcy	and	methylation	state	of	a	CpG	island	in	the	promoter	of	SLC19A1,	as	well	as	the	
inverse	 association	between	 the	 latter	 and	SLC19A1	mRNA	expression,	 has	 also	been	







were	 erroneously	 termed	 as	 CGG	 and	 CAG	 (Chango	 et	 al.	 2000b).	 The	 80	 nucleotide	
position	is	in	"exon	2"	(Chango	et	al.	2000b),	which	is	the	first	coding	exon;	whereas	the	
27	 amino	 acid	 position	 is	 in	 the	 most	 N‐terminal	 part	 of	 the	 first	 transmembrane	
domain,	close	to	the	cytoplasm	(Ferguson	and	Flintoff	1999).	
Experiments	in	human	intestinal	cell	cultures	transfected	with	truncated	constructs	of	





deficient	 erythroleukaemia	 (myeloid)	 human	 cell	 line	 transfected	with	 the	normal	 or	




of	 the	methotrexate	 transport	 in	 the	 variant	 protein).	 On	 the	 other	 hand	 the	 variant	
transporter	 has	 similar	 uptake	 rates	 for	methotrexate	 and	 5‐formylTHF,	 and	 similar	
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differences	 in	 protein	 expression	 of	 endogenous	 SLC19A1	were	 detected	 among	 the	
three	SLC19A1	c.80G>A	genotypes,	but	decreased	methotrexate	transport	efficacy	was	
reported	in	the	variant	homozygote	stimulated	lymphocytes	(Baslund	et	al.	2008).	The	
authors	suggest	 that	 the	different	 findings	between	their	and	Whetstine	et	al.'s	might	
be	 cell	 line	 specific.	 It	 is	 possible	 that	 depending	 on	 the	 cell	 type,	 the	 variant	




states	of	 this	 island	has	not	been	associated	with	 tissue‐specific	differences	or	mRNA	
expression	(Farkas	et	al.	2013).	However,	the	SNP	affects	the	methylation	state	of	other	
CpG	 sites	 related	 to	SLC19A1	expression:	 in	most	 of	 these	CpG	 sites	 there	was	 lower	
methylation	in	SLC19A1	c.80AA	compared	to	GG	leukocytes.	Plasma	tHcy	modified	the	
effect	 of	 the	 SNP	 on	 these	 CpG	 sites:	 in	 SLC19A1	 c.80AA	 compared	 to	 GG	 leukocytes	
most	 of	 these	 CpG	 sites	 had	 higher	 methylation	 when	 tHcy	 was	 low,	 and	 lower	
methylation	 when	 tHcy	 was	 high	 (Farkas	 et	 al.	 2013).	 With	 these	 finding	 it	 can	 be	
speculated	that	in	variant	compared	to	normal	homozygotes	the	downregulation	with	
low	tHcy	and	upregulation	with	high	tHcy	of	the	transporter	are	greater.	
Some	 human	 studies	 have	 investigated	 the	 effect	 of	 the	 polymorphism	 in	 the	
metabolites	addressed	in	this	thesis	(Table	4	and	Table	5).	
Most	of	the	studied	investigating	the	effect	of	the	SLC19A1	c.80G>A	SNP	reported	that	it	
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2012;	Kumudini	 et	 al.	 2014;	 Liang	 et	 al.	 2014;	 Bueno	 et	 al.	 2016).	 A	 tHcy‐increasing	
effect	 have	 been	 suggested	 in	 two	 studies.	 In	 Estonian	 women	 undergoing	 in	 vitro	
fertilisation	 higher	 tHcy	 was	 observed	 in	 heterozygotes	 compared	 to	 normal	
homozygotes	 (Laanpere	 et	 al.	 2011).	 Elderly	 (≥60y)	 patients	 of	 a	 postfortification	
Brazilian	study	had	higher	tHcy	with	increasing	number	of	variant	alleles	(Barnabé	et	
al.	 2015).	 These	 results	 do	 not	 agree	with	 previous	 European	 studies	 that	 found	 no	
association	in	individuals	aged	≥60y	(Devlin	et	al.	2006;	de	Lau	et	al.	2010).	In	Barnabé	
et	 al.	 the	 ethnicity	 was	 heterogeneous	 and	 serum	 folate	 median	 was	 25.4nmol/L	
(Barnabé	 et	 al.	 2015).	 The	 sample	 in	 Devlin	 et	 al.	 were	 former	 patients	 with	 serum	
folate	 means	 ranging	 10.6‐12.0nmol/L	 among	 genotypes;	 and	 in	 de	 Lau	 et	 al.	 the	
sample	was	 representative	of	 the	Estonian	population	and	plasma	 folate	median	was	
12.1nmol/L	(Devlin	et	al.	2006;	de	Lau	et	al.	2010).	Lower	tHcy	was	observed	in	variant	
homozygotes	 compared	 to	 hetero	 and	 normal	 homozygotes	 in	 a	 healthy	 Indian	
population	 possibly	 deficient	 for	 folate	 (plasma	 folate	 median	 11.1nmol/L)	 and	
marginal	 deficient	 for	 cobalamin	 (plasma	 cobalamin	median	 163pmol/L)	 (Sukla	 and	
Raman	 2012).	 But	 no	 association	 between	 increasing	 number	 of	 variant	 alleles	 and	










al.	 2012).	 And	 in	 old	 adults	 with	 thromboembolic	 vascular	 problems	 from	 UK	 or	
Australia,	 variant	 homozygotes	 had	 higher	 plasma	 folate	 than	 hetero	 and	 normal	
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Numerous	 studies	 reported	 no	 effect	 of	 the	 SLC19A1	 c.80G>A	 SNP	 on	 RBC	 folate	
(Chango	et	al.	2000b;	Födinger	et	al.	2003;	Relton	et	al.	2005;	Vesela	et	al.	2005;	Yates	
and	 Lucock	 2005;	 Barbosa	 et	 al.	 2008b;	 Stamp	 et	 al.	 2010;	 Lucock	 et	 al.	 2013).	
However,	 it	 was	 associated	 with	 higher	 RBC	 folate	 concentrations	 in	 healthy	 young	
adults	from	Northern	Ireland	(Stanislawska‐Sachadyn	et	al.	2009)	and	with	lower	RBC	
folate	 concentrations	 in	 our	 study	 of	 a	 local	 Spanish	 adult	 population	 (Bueno	 et	 al.	
2016).	 A	 young	 sample	 (20‐26y)	 including	 multivitamin	 supplement	 users	 was	
analysed	 in	 the	 former	 study	 (Stanislawska‐Sachadyn	et	 al.	 2009).	Bueno	et	al.	 study	








have	 reported	 no	 effect	 (Morin	 et	 al.	 2003a;	 Fredriksen	 et	 al.	 2007;	 Lopreato	 et	 al.	
2008;	Barbosa	et	al.	2008b;	Summers	et	al.	2010;	Laanpere	et	al.	2011;	Bialecka	et	al.	
2012;	Barnabé	et	al.	2015).	In	old	adults	with	thromboembolic	event	vascular	problems	




tHcy	was	 tested	 in	 a	 study	of	healthy	elderly	English	adults	 (Devlin	 et	 al.	 2006).	The	
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Four	 cross‐sectional	 studies	 have	 assessed	 the	 effect	 of	 the	 polymorphism	 on	 1C	
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1Case	 outcomes:	 SB,	 Spina	 Bifida;	 IVF,	 In	 Vitro	 Fertilisation;	 PD,	 Parkinson's	 Disease;	 IRPL,	 Idiopathic	 Recurrent	 Pregnancy	 Loss;	 DS,	 Down	
Syndrome;	AD,	Alzheimer's	Disease;	VD,	Vascular	Dementia.	2Metabolites	in	plasma/serum	unless	otherwise	specified.	3ND,	No	Data.		
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1994‐96	 No	 1042	 68‐102 tHcy,	folate	 No	association	
1Cohort	 specific	 features:	 ESRD,	 End‐Stage	 Renal	 Disease;	 RT,	 Renal	 Transplant;	 TE,	 Thromboembolic	 Event;	 NTE,	 Non‐Thromboembolic	 Event	
vascular	problems.	2Metabolites	in	plasma/serum	unless	otherwise	specified.	3ND,	No	Data.	
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trimester	where	 the	 blood	 sample	 is	 drawn	 varies	 in	 the	 sample:	 25%,	 50%	 and	 25%	 of	 the	 participants	 in	 first,	 second	 and	 third	 trimester,	
respectively.		
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As	 far	 as	 we	 know	 only	 one	 study	 has	 assessed	 the	 effect	 of	 the	 SLC19A1	 c.80G>A	
polymorphism	on	birth	weight.	 In	a	UK	cohort,	there	was	no	effect	of	the	maternal	or	
foetal	 SNP	 on	 birth	 weight,	 even	 when	 comparing	 the	 most	 extreme	 categories	 of	
maternal	RBC	folate	status	at	first	trimester	(Relton	et	al.	2005).	




USA	 study	 reported	 a	 higher	 risk	 in	 foetal	 heterozygote	 compared	 to	 variant	
homozygote	genotypes	(but	not	to	normal	homozygotes).	However,	the	association	was	
lost	 in	 the	 offspring	 of	 maternal	 folic	 acid	 supplement	 users,	 suggesting	 a	 modest	
interaction	 between	 infant	 SLC19A1	 c.80	 genotype	 and	 periconceptional	 intake	 of	
vitamins	(Shaw	et	al.	2003).	A	Chinese	study	reported	no	association	between	offspring	
genotype	and	congenital	heart	defect	risk	but	further	analysis	of	the	subsample	born	to	
mothers	 that	 had	 not	 used	 folic	 acid	 supplements	 revealed	 a	 higher	 risk	 in	
heterozygotes	 or	 normal	 homozygotes	 versus	 variant	 homozygotes	 (Pei	 et	 al.	 2006).	
Another	Chinese	study	reported	a	higher	 risk	 for	 foetal	heterozygote,	but	not	variant	
homozygotes,	 compared	 to	 the	 normal	 homozygote	 genotype	 (Gong	 et	 al.	 2012).	
Another	 Chinese	 study	 found	 no	 association	 between	 the	 foetal	 SLC19A1	 c.80G>A	
polymorphism	alone	and	congenital	heart	defects.	It	only	conferred	greater	risk	when	
combined	with	 2	 other	 SNPs	 affecting	 1C	metabolism	 (MTHFD1	 c.1958G>A	 and	MTR	
c.2756A>G)	(Wang	et	al.	2013).	
Meta	analyses	have	concluded	that	neither	the	polymorphism	in	the	mother	(Wang	et	
al.	 2012)	 nor	 the	 offspring	 (Wang	 et	 al.,	 2012;	 Zhang	 et	 al.,	 2013)	 affects	 NTD	 risk.	
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the	 offspring	 had	 higher	 NTD	 risk	 only	 in	 the	 absence	 of	 periconceptional	 folic	 acid	
supplement	use	(Pei	et	al.	2009).	
The	 SLC19A1	 c.80G>A	 genotype	 in	 live	 born	 infants	 was	 not	 associated	 with	
omphalocele	risk	in	a	postfortification	USA	study	(Mills	et	al.	2012).	
To	the	best	of	our	knowledge	only	three	case	control	studies,	from	South	Korea,	China	





Methionine	 synthase	 reductase	 (MTRR,	 EC	 1.16.1.8)	 is	 the	 protein	 that	 catalyses	 the	
reductive	methylation	of	cob(II)alamin	to	methylcob(III)alamin,	which	can	be	used	by	
MTR	 for	 the	 folate‐dependent	 homocysteine	 remethylation	 (Olteanu	 and	 Banerjee	





experiments	with	purified	recombinant	cobalamin	dependent	MTR	 from	E.	coli	 in	 the	
absence	 of	 SAM,	 where	 a	 loss	 of	 enzymatic	 activity	 is	 detected	 towards	 ≈2000	
turnovers	 (Drummond	 et	 al.	 1993).	 MTRR	 has	 binding	 domains	 for	 FAD,	 flavin	
mononucleotide	(FMN)	and	NADPH	(Leclerc	et	al.	1998).	 In	 the	reaction	catalysed	by	
MTRR,	NADPH	 is	 the	 electron	 donor	 (Gulati	 et	 al.	 1997)	whereas	 SAM	 is	 the	methyl	
donor	(Foster	et	al.	1964;	Ludwig	and	Matthews	1997).	MTRR	is	a	monomeric	enzyme	
with	 one	 molecule	 of	 FAD	 and	 one	 of	 FMN	 (Olteanu	 and	 Banerjee	 2001).	 The	
similarities	of	mammal	MTRR	to	E.	coli	proteins	with	FAD	and	FMN	that	are	responsible	
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stimulation	 are	 two:	 reduction	 of	 free	 or	 MTR‐bound	 aquacob(III)alamin	 to	
cob(II)alamin,	 and	 the	 conversion	 of	 free	 cob(II)alamin	 to	 MTR‐bound	
methylcob(III)alamin.	 MTRR,	 independently	 of	 NADPH,	 also	 protects	 the	 apoenzyme	
MTR	 from	denaturalization	at	37ºC.	This	stabilisation	effect	adds	 to	 the	promotion	of	
holoenzyme	MTR	formation	(Yamada	et	al.	2006).	
MTRR	 mRNA	 has	 been	 detected	 in	 all	 the	 human	 organs	 analysed,	 including	 the	
placenta	 and	with	 the	 highest	 expression	 in	 skeletal	muscle	 (Leclerc	 et	 al.	 1998).	 In	
mice,	 the	protein	 and	 activity	has	been	detected	 in	 the	 liver,	 heart,	 kidney	 and	brain	
(Elmore	 et	 al.	 2007).	 Due	 to	 alternative	 transcription	 start	 sites	 and	 splicing,	 two	
isoforms	of	MTRR	are	proposed.	One	shorter	MTRR	starts	the	protein	coding	at	exon	2	
and	is	cytoplasmic,	while	the	larger	starts	at	exon	1	and	has	a	mitochondria	targeting	






0	 or	 50µg	 folic	 acid.	 This	 suggests	 that	 folic	 acid	 supplementation	 during	
embryogenesis	 could	modulate	 the	postnatal	 expression	of	MTRR	 (Li	 et	 al.	2016).	On	
the	contrary,	 there	are	no	differences	 in	hepatic	MTRR	mRNA	and	protein	expression	
between	mice	 fed	 a	 folate‐adequate	 diet	 or	 a	 folate‐deficient	 diet	 (Christensen	 et	 al.	
2010).	 This	 is	 also	 true	 for	 hepatic	 mRNA	 from	 lactating	 cows	 receiving	 weekly	
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injections	of	 160mg	of	 folic	 acid	with	or	without	10mg	vitamin	B12	 (for	19wk)	or	no	
supplement	injections	(Preynat	et	al.	2010).	
The	 natural	 genetic	 variations	 in	 a	 DNA	 locus	 including	 the	MTRR	 gene	 have	 been	
shown	 in	 a	 GWAS	 of	 mice	 strains	 to	 determine	 the	methylation	 state	 of	 the	 biggest	
number	of	CpG	sites	both	 in	cis	and	in	trans.	The	methylation	state	of	27%	of	the	CpG	
sites	affected	by	this	locus	has	been	reported	to	be	due	to	the	MTRR	gene	in	a	severely	
deficient	MTRR	mouse	 model	 (gene	 trapped)	 (Orozco	 et	 al.	 2015).	 Previous	 studies	
with	the	same	mouse	model	reported	higher	tHcy	(Elmore	et	al.	2007)	and	betaine,	and	
lower	DNA	global	methylation	in	the	hippocampus	than	in	the	wild	type	(Jadavji	et	al.	
2014).	 Offspring	 that	were	 homozygote	 for	 this	mutation,	 or	 born	 from	 homozygote	
dams,	had	lower	birth	and	placenta	weights,	and	higher	risk	of	congenital	heart	defects	
compared	 to	 heterozygote	 or	 wild	 type	 genotypes.	 In	 addition,	 the	 MTRR	 mutant	
homozygote	 dams	 had	 a	 higher	 proportion	 of	 embryo	 resorptions	 compared	 to	
heterozygote	 or	 wild	 type	 genotypes	 (Deng	 et	 al.	 2008).	 Higher	 plasma	 tHcy	 and	
transgenerational	defects	comprising	restricted	growth	 in	 the	second	generation,	and	






MTRR	 is	affected	by	 the	common	polymorphism	c.66A>G	 in	which	 the	substitution	of	
the	adenosine	at	an	ATA	codon	by	a	guanosine	results	in	a	ATG	codon,	and	substitution	
of	 isoleucine	 at	 position	 22	 by	methionine	 (Wilson	 et	 al.	 1999;	 Institute	 of	Medicine	
2016b).	The	66	nucleotide	position	is	in	the	exon	2	(Leclerc	et	al.	1999),	whereas	the	22	
amino	acid	position	is	in	the	FMN	binding	domain	(Olteanu	et	al.	2002).	
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velocity	 of	 the	 reaction	 of	 activation	 of	MTR	 between	 the	 variant	 and	 normal	MTRR	
(Olteanu	 et	 al.	 2002).	 The	 polymorphism	 has	 no	 relevant	 effects	 on	 the	 flavin	 redox	
potentials	 or	 electron	 transfer	 (Olteanu	 et	 al.	 2004).	 However,	 the	 higher	 ratio	 of	
MTRR/MTR	 required	 to	 reach	 the	 maximal	 velocity	 in	 the	 variant	 MTRR	 suggests	
defects	in	the	formation	of	the	MTRR‐MTR	complex	and/or	its	stability	(Olteanu	et	al.	
2002).	 In	experiments	with	the	 isolated	domains	of	MTRR	and	MTR	that	 interact,	 the	
dissociation	 constants	 of	 the	MTRR‐MTR	 complex	 did	 not	 differ	 between	 the	 variant	
and	 normal	 MTRR	 (Wolthers	 and	 Scrutton	 2007).	 Therefore,	 it	 appears	 that	 the	
reduced	 efficiency	 of	 the	 variant	 enzyme	 is	 due	 to	 impaired	 formation	 of	 the	MTRR‐
MTR	complex,	i.e.	variant	MTRR	with	less	affinity	for	MTR.	
Human	 studies	 assessing	 the	 possible	 metabolic	 effect	 of	 the	 MTRR	 c.66A>G	
polymorphism	 have	 focused	 on	 serum	 or	 plasma	 tHcy,	 folate	 and	 cobalamin	
concentrations	(Table	6	and	Table	7).		










Two	 studies	 from	 Morocco	 and	 India	 that	 include	 cases	 of	 coronary	 artery	 disease	
found	higher	tHcy	in	variant	homozygotes	compare	to	hetero	and	normal	homozygotes	
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previous	 one	 in	 Northern	 Ireland	 that	 reported	 no	 differences	 in	 tHcy	 among	MTRR	
c.66A>G	genotypes,	although	the	studied	population	was	younger	and	included	women	
(Kluijtmans	et	al.	2003).		
A	 UK	 study	 reported	 lower	 serum	 folate	 with	 increasing	 variant	 allele	 number	 in	
mothers	without	previous	NTD	affected	pregnancies	(Lucock	et	al.	2001).	However,	an	
Italian	 Down	 syndrome	 offspring	mothers	 case‐control	 study	 reported	 higher	 serum	
folate	 in:	 variant	 versus	 normal	 homozygotes	 (whole	 sample),	 variant	 homozygotes	
versus	heterozygotes	(cases),	hetero	versus	normal	homozygotes	(controls)	(Coppedè	
et	 al.	 2014).	 In	 both	 studies	 determination	 of	 serum	 folate	 was	 by	 protein‐binding	
assays.	These	assays	were	radioassay	(Lucock	et	al.	2001)	or	non	radioassay	(Coppedè	
et	 al.	 2014).	 As	 previously	 commented	 protein‐binding	 assays	 are	 considered	 less	
reliable	 for	 folate	 determination	 than	 the	microbiological	 assay	 (Introduction	 section	
3.1).	
In	 Lucock	 et	 al.	 lower	 RBC	 folate	 was	 also	 found	 in	 mothers	 without	 previous	 NTD	
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and	MTRR	 c.66A>G	 genotypes	 in	Norwegian	 cohort	 of	 older	 adults	 (Fredriksen	 et	 al.	
2007)	and	in	Brazilian	women	of	childbearing	age	(Barbosa	et	al.	2008b).	
Higher	plasma	cobalamin	in	participants	with	the	MTRR	c.66AG	genotype	compared	to	
the	 AA	 genotype	 were	 reported	 in	 one	 European	 study	 (Botto	 et	 al.	 2003)	 whereas	
lower	 plasma	 cobalamin	 in	 AG	 compared	 to	 AA	 or	 GG	 genotypes	 was	 reported	 in	
another	(García‐Minguillán	et	al.	2014).	Among	the	differences	between	the	studies,	the	
former	 was	 conducted	 in	 an	 Italian	 cohort	 of	 patients	 that	 underwent	 coronary	
angiography	(Botto	et	al.	2003),	while	the	latter	was	in	a	Spanish	population	of	healthy	
adults	 with	 a	 broader	 age	 range	 (García‐Minguillán	 et	 al.	 2014).	 The	 cobalamin	
determination	methods	were	 also	 different,	 with	 a	 (non	 radioassay)	 protein‐binding	
assay	 in	 the	 Italian	 study	 (Botto	 et	 al.	 2003),	 and	 the	 microbiological	 assay	 in	 the	
Spanish	study	(García‐Minguillán	et	al.	2014).	
Whether	folate	status	modulates	the	effect	of	the	MTRR	c.66A>G	polymorphism	on	tHcy	
has	been	 investigated	 in	pregnant	women	at	 labour	(Barbosa	et	al.	2008a)	and	 in	old	
adults	 (60‐90y)	 (de	 Lau	 et	 al.	 2010).	 Both	 studies	 reported	 no	 association	 between	
MTRR	 c.66A>G	 genotypes	 and	 tHcy,	 between	 individuals	 above	 or	 below	 the	
serum/plasma	folate	median.	
The	pregnancy	studies	to	date	that	have	investigated	the	association	between	the	MTRR	
c.66A>G	 polymorphism	 and	 tHcy,	 folate,	 cobalamin,	 betaine	 or	 DMG	 were	 based	 on	
maternal	 blood	 determinations	 at	 delivery	 (Barbosa	 et	 al.	 2008a)	 or	 postpartum	
(Ananth	 et	 al.	 2007),	 or	 on	 foetal	 genotype	 and	 amniotic	 fluid	 concentrations	 at	
amniocentesis	(Brouns	et	al.	2008),	or	in	cord	plasma	(Visentin	et	al.	2015).	The	former	
studies	 reported	 no	 association	 between	 the	maternal	MTRR	 c.66A>G	 genotypes	 and	
plasma/serum	 tHcy,	 folate	 and	 cobalamin	 (Ananth	et	 al.	 2007;	Barbosa	et	 al.	 2008a).	
This	was	also	true	for	foetal	genotype	and	amniotic	fluid	tHcy	(Brouns	et	al.	2008)	and	
for	cord	plasma	betaine	and	DMG	(Visentin	et	al.	2015).	Clearly	a	common	factor	in	all	
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of	 these	 studies	 is	 the	 inevitable	 variation	 in	 gestational	 age	 at	 the	 time	 of	 blood	 or	
amniotic	fluid	collection.	
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1Case	 outcomes:	 SB,	 Spina	 Bifida;	 NTD,	 Neural	 Tube	 Defect;	 HRCHD,	 High	 Risk	 of	 Coronary	 Heart	 Disease;	 DS,	 Down	 Syndrome;	 AP,	Abruptio	
Placentae;	CAD,	Coronary	Artery	Disease.	2Metabolites	in	plasma/serum	unless	otherwise	specified.	3ND,	No	Data.	4PML,	Post‐methionine	load	test.	
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 


























































































1Case	 outcomes:	 CBD,	 Complex	 Birth	 Defect	 (combination	 of	 NTD,	 orofacial	 cleft,	 congenital	 heart	 defect,	 omphalocele);	 CAD,	 Coronary	 Artery	
Disease;	OZP,	Oligozoospermia;	PD,	Parkinson's	Disease.	2Metabolites	in	plasma/serum	unless	otherwise	specified.	3ND,	No	Data.	
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[DS]	 0‐30	 tHcy,	folate	 No	association
	
1Cohort	 specific	 features:	 MTXR,	 Methotrexate	 treated	 Rheumatoid	 arthritis;	 NOP,	 Nitrous	 Oxide‐exposed	 Patients;	 DS,	 Down	 Syndrome.	
2Metabolites	in	plasma/serum	unless	otherwise	specified.	3ND,	No	Data.	
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1998‐02	 No	 789	 18‐75	
tHcy,	folate	
(plasma	and	RBC)	 No	association	
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in	 two	 Dutch	 studies	 (van	 Beynum	 et	 al.	 2006;	 Verkleij‐Hagoort	 et	 al.	 2008).	
Subsequently,	a	prefortification	Canadian	study	also	reported	no	effect	of	the	maternal	
polymorphism	on	congenital	heart	defect	risk	(Christensen	et	al.	2013).	However,	 the	






Caucasians	 (Yu	 et	 al.	 2014).	 This	was	 also	 true	 for	 the	 comparison	 of	 variant	 versus	
normal	homozygotes	(Yu	et	al.	2014).	The	analysed	studies	were	not	the	same	in	both	
meta	 analyses;	 e.g.	 Cai	 et	 al.	 included	 transmission	 disequilibrium	 test	 studies	 in	
addition	 to	 case	 control	 studies	 and	 also	 a	 USA	 Down	 Syndrome	 study	 (Locke	 et	 al.	
2010).	 These	 meta	 analyses	 did	 not	 include	 two	 previous	 case	 control	 studies	 that	
found	 no	 association	 between	 foetal	MTRR	 c.66A>G	 genotypes	 and	 congenital	 heart	
defect	 risk	 in	 Canada	 (Christensen	 et	 al.	 2013)	 and	 China	 (Wang	 et	 al.	 2013).	




our	 knowledge	 no	 study	 from	 India,	 where	 low	 cobalamin	 status	 is	 prevalent,	 has	
assessed	 this;	 and	 2)	 in	 Verkleij‐Hagoort	 et	 al.	 cobalamin	 status	 was	 normal	 (241‐
284pmol/L	 serum	cobalamin	means	among	genotypes)	and	 the	 low	cobalamin	group	
(≤175pmol/L	serum	cobalamin)	was	not	deficient	but	marginally	deficient.	To	sum	up,	
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although	 this	 is	 based	 on	 only	 three	 studies.	 The	 variant	 allele	 in	 the	 offspring	may	
increase	the	risk	in	Asians	but	not	Caucasians.	
Several	 studies	 have	 investigated	 the	 association	 between	 the	 MTRR	 c.66A>G	
polymorphism	and	NTD	risk.	In	a	big	Irish	case	control	study	there	were	not	differences	
in	 the	 MTRR	 c.66A>G	 genotype	 frequencies	 of	 mothers	 of	 children	 with	 NTDs	 or	
children	with	NTDs,	 and	 controls	 (O’Leary	 et	 al.	 2005).	A	meta	 analysis	 assessing	11	





Omphalocele	 risk	 did	 not	 differ	 between	 foetal	MTRR	 c.66A>G	 genotypes,	 in	 a	 case	
control	 study	 of	 a	 sample	 of	multiple	 ethnicities	 from	USA	 and	 exposed	 to	 folic	 acid	
fortification	(Mills	et	al.	2012).	
Few	studies	have	investigated	the	effect	of	the	MTRR	c.66A>G	polymorphism	on	risk	of	
miscarriage.	 In	 regard	 to	 the	 SNP	 in	 mothers,	 a	 South	 Korean	 study	 of	 sporadic	
miscarriage	reported	no	differences	in	allelic	and	genotypic	frequencies	between	cases	
and	 controls	 (Kim	 et	 al.	 2011).	 A	 Chinese	 study	 of	 the	 risk	 of	 recurrent	miscarriage,	
including	 stillbirths,	 reported	 similar	 findings	 (Luo	 et	 al.	 2015).	 However,	 another	
Chinese	 study	 of	 recurrent	 miscarriages	 (of	 unspecified	 gestational	 age)	 reported	
higher	proportion	of	 variant	homozygotes	 and	variant	 allele	 in	 the	 case	 compared	 to	
the	control	group	(Zhu	2015).	The	sample	sizes	of	these	three	studies	were:	188,	260	
and	292.	Insufficient	sample	size	for	the	detection	of	an	effect	in	the	two	former	studies	
cannot	be	ruled	out.	Thus,	 the	evidence	 for	an	association	between	 the	maternal	SNP	
and	miscarriage	occurrence	is	scarce	to	date.	To	the	best	of	our	knowledge,	there	have	
been	 no	 epidemiological	 reports,	 so	 far,	 on	 the	 effect	 of	 the	 polymorphism	 in	 the	
embryo.	
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with	 the	 placenta	 (Huxley	 1869).	 The	 placenta	 anatomy	 is	 complex	 and	 only	 main	
features	 will	 be	 explained	 briefly	 (Kraus	 et	 al.	 2004).	 A	 scheme	 of	 the	 placenta	
circulation	 and	 anatomy	 is	 shown	 in	 Figure	 10.	 A	 high	 proportion	 of	 the	 placenta	
volume	 consist	 of	 a	 space	where	 the	 uterine	 arteries	 discharge	maternal	 blood.	 This	
space	 is	 called	 the	 intervillous	 space	 and	 the	 chorium	 frondosum	 forms	 tree‐like	
structures	(chorionic	villi)	in	this	space.	These	structures	protrude	from	the	mesoderm	
of	 the	 chorionic	plate	 (the	part	of	 the	placenta	 closest	 to	 the	 foetus)	and	branch	 into	
villi	of	decreasing	diameter,	to	enhance	the	surface	in	contact	with	the	maternal	blood	
(Figure	11).	 Inside	 the	 chorionic	 villi,	 vessels	 transport	 foetal	 blood.	 Some	 chorionic	
villi	 grow	 up	 to	 the	 decidua	 basalis,	 forming	 specialised	 structures	 to	 anchor	 the	
placenta	 to	 the	 endometrium.	 Nutrients,	 gases	 and	 other	 molecules	 are	 transported	
from	the	maternal	 to	 the	 foetal	blood	and	vice	versa	penetrating	 through	several	 cell	
layers	in	the	chorionic	villi.	One	of	these	layers	is	the	syncytiotrophoblast,	a	continuous	
space	with	multiple	nuclei	which	 is	 in	direct	 contact	with	 the	maternal	 blood.	Under	
syncytiotrophoblast	is	the	cytotrophoblast,	a	 layer	of	unfused	cells.	The	surface	of	the	
chorionic	 plate	 is	 covered	with	 an	 epithelium	 called	 amnion	 and	 the	 cord	 protrudes	
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Radial	 growth	of	 the	placenta	 and	 continuous	 sealing	of	 the	placental	 edges	with	 the	
decidua	(which	also	anchors	the	placenta	to	the	uterus),	leads	to	the	formation	of	septa	
that	protrude	into	the	intervillous	space	marking	compartment	like	sections	within	this	
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Optic	microscope	photographs	of	 formalin	 fixed	placentas	 from	participants	(standard	haematoxylin	and	
eosin	 stain).	 A.	 Chorionic	 plate	 and	 chorion	 frondosum.	 1,	 amnion;	 2,	mesoderm;	 3,	 intervillous	 space;	 4	
major	chorionic	stem	villi	(greater	diameter).	B.	Chorion	frondosum	and	basal	plate.	1,	terminal	chorionic	
villi	(lesser	diameter);	2,	intervillous	space;	3,	decidua	basalis.	
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growth	hormone,	 thyrotropin,	 gonadotropin	and	 their	 respective	 releasing	hormones	
(Imperatore	et	al.	2006;	Tal	et	al.	2015).	
During	human	placental	development,	 the	 foetal	blood	begins	 to	 flow	 in	 the	placenta	
vessels	 at	 ≈3GW	 (Enders	 and	 Blankenship	 1999),	 while	 maternal	 blood	 flow	 to	 the	
intervillous	space	 is	not	achieved	until	 the	end	of	 the	 first	 trimester	 (Wang	and	Zhao	
2010).	 Initially,	 during	 the	 first	 trimester	 foetal	 nutrition	 is	 histiotrophic,	 i.e.	 from	
endometrium	and	uterine	 glandular	 secretions	 (Burton	 et	 al.	 2002).	 From	 the	 end	of	
the	first	trimester	on,	 is	mainly	haemotrophic,	 i.e.	 from	the	nutrients	contained	in	the	
maternal	 blood.	 The	 advantages	 of	 histiotrophic	 nutrition	 in	 early	 gestation	 are	
considered	 to	 be	 the	 hypoxia	 (the	 foetus	 at	 early	 stages	 of	 development	 is	 highly	
susceptible	 to	 reactive	 oxygen	 species),	 and	 the	 more	 efficient	 uptake	 of	 maternal	
cytokines	 (compared	 to	 haemotrophic	 nutrition)	 (Burton	 et	 al.	 2001).	 It	 can	 be	
considered	 that	 the	 placenta	 is	 fully	 developed	 once	 the	 final	 transport	 way	
(haemotrophic	nutrition)	is	achieved,	that	is,	at	the	end	of	the	first	trimester.	
The	placenta	can	act	as	a	barrier	 to	 several	 toxins,	 in	some	cases	accumulating	 them.	
The	 foeto	 toxic	 heavy	 metal	 cadmium	 is	 an	 example	 (Goyer	 and	 Cherian	 1992).	
Placental	 tissue	 cadmium	 concentration	 (median	 68.6ng/g	 dw,	 dry	 weight)	 is	 much	
higher	than	in	umbilical	cord	tissue	(median	1.16ng/g	dw)	(Sakamoto	et	al.	2013).	This	
effect	 is	 thought	 to	be	mediated	by	metallothioneins.	Human	placentas	perfused	with	
pharmacological	 cadmium	 concentrations	 (20µM)	 up‐regulate	 metallothionein	 2A	
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MTHFR	 and	MTR	 mRNAs	 are	 highly	 expressed	 so	 it	 has	 been	 suggested	 that	 human	
placenta	 (in	 the	 first	 trimester	 and	 at	 term)	homocysteine	 is	mainly	 remethylated	 to	
methionine	 and	 by	 the	 cobalamin	 dependent	 reaction	 (Solanky	 et	 al.	 2010).	 By	
experiments	of	competitive	inhibition	of	the	transport	of	substrates	or	homocysteine	in	
syncytiotrophoblast	apical	membrane	vesicles,	three	amino	acid	transport	systems	(L,	
y+L	 and	 A)	 have	 been	 shown	 to	 be	 involved	 homocysteine	 transport	 (Tsitsiou	 et	 al.	
2011).	 Several	 amino	 acids	 are	 transported	 by	 each	 system,	 and	 methionine	 is	 the	
common	 amino	 acid	 to	 all	 of	 these	 (Tsitsiou	 et	 al.	 2011).	 The	 system	 L	 is	 the	major	
mediator	 of	 homocysteine	 transport	 from	 the	 intervillous	 space	 to	 the	





a	homocysteine	 foetal‐maternal	 transport	mechanism;	 although	other	 factors	 such	as	
the	relationship	between	maternal	and	foetal	methyl	donor	status	cannot	be	excluded	
as	 the	 main	 reason.	 Apart	 from	 possible	 toxic	 effects,	 homocysteine	 may	 induce	
apoptosis	 and	 lower	 chorionic	 gonadotropin	production	 in	 the	placenta;	 as	 shown	 in	
trophoblast	cultures	with	physiologically	plausible	levels	of	homocysteine	in	the	media	
(20µM)	 (Di	 Simone	 et	 al.	 2003).	 Also,	 potential	 importing	 of	 homocysteine	 to	 the	
placenta	would	 result	 in	 a	 lower	 flux	 of	 amino	 acid	 to	 the	 foetus,	 and	 the	 supply	 of	
amino	acids	such	as	leucine	and	phenylalanine	(transported	by	system	L)	is	reported	to	
not	be	limiting	just	by	a	small	margin	(Chien	et	al.	1993).	
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Serum	 folate	 in	 the	 maternal	 vein,	 placenta	 intervillous	 space	 and	 umbilical	 cord	
(neonate	 blood)	 is	 positively	 correlated	 in	 humans	 (Giugliani	 et	 al.	 1985).	 In	 vitro	
experiments	 show	 the	 membrane‐bound	 form	 of	 folate	 receptor	 alpha,	 the	 proton	
coupled	 folate	 transporter	 and	 the	 reduced	 folate	 carrier	 (SLC19A1)	 are	 involved	 in	
human	 placental	 folate	 transport	 (Yasuda	 et	 al.	 2008).	 The	 mRNA	 levels	 of	 these	
proteins	increase	throughout	pregnancy	in	rat	placenta	suggesting	an	increased	need	of	
folate	 for	 the	 foetus	 and	 placenta	 as	 pregnancy	 progresses	 (Yasuda	 et	 al.	 2008).	
Experiments	 with	 isolated	 human	 placental	 cotyledons	 perfused	 with	 labelled	 5‐
methylTHF	suggest	that	folate	receptor	binding	and	the	release	of	folate	on	the	surface	
of	 the	 syncytiotrophoblast	 in	 contact	with	 the	maternal	 blood,	 is	 the	 first	 step	 in	 the	
maternal‐to‐foetal	folate	transport	(Henderson	et	al.	1995).	The	different	localisations	
of	 the	 membrane‐bound	 form	 of	 folate	 receptor	 alpha,	 the	 proton	 coupled	 folate	
transporter	 and	 SLC19A1	 in	 the	 human	 syncytiotrophoblast	 (Yasuda	 et	 al.	 2008;	
Solanky	 et	 al.	 2010),	 has	 led	 to	 the	proposal	 of	 the	 current	model	 for	placenta	 folate	





coupled	 folate	 transporter,	 and	 afterwards	 folate	 receptors	 and	 transporters	 in	 the	
vesicle	 are	 recycled	 back	 to	 the	 maternal	 blood	 exposed	 syncytiotrophoblast	
membrane.	 SLC19A1	 in	 this	membrane	 are	 an	 alternative	 pathway	 for	 the	 import	 of	
folates	 from	maternal	blood.	The	export	of	 folate	 from	the	syncytiotrophoblast	 to	 the	
foetal	blood	(vessels	in	the	chorionic	villi)	 is	achieved	by	SLC19A1	and	possibly	other	
exporters,	 but	 not	 folate	 receptor	 alpha	 or	 the	 proton	 coupled	 folate	 transporter	
(Solanky	 et	 al.	 2010).	 In	 cultured	 human	 cytotrophoblasts,	 folate	 receptor	 alpha,	 the	
proton	coupled	folate	transporter	and	SLC19A1	are	involved	in	folate	uptake	(Keating	
et	al.	2009).		
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intravenous	 injections	 (Landon	 et	 al.	 1975).	 It	 is	 found	 as	 folate	 derivatives	 though,	
indicating	rapid	and	extensive	metabolism	by	the	mother	and/or	placenta	(Landon	et	
al.	1975).	Supporting	a	possible	role	of	 the	placenta	 in	 the	metabolism	of	 folic	acid	 is	
the	finding	of	dihydrofolate	reductase	activity	in	human	placenta	(Jarabak	and	Bachur	
1971).	 Human	 placental	 folate	 mainly	 occurs	 in	 the	 polyglutamated	 forms	 (Landon	
1975)	 and	 gamma	 glutamyl	 hydrolase	 activity	 has	 been	 found	 in	 human	 placental	
extracts	 (Landon	 1972).	 The	 optimal	 pH	 for	 this	 enzymatic	 activity	 is	 acid	 (Landon	
1972).	 Two	 enzymes	 can	 remove	 glutamates	 from	 the	 glutamates	 chain	 of	 folates:	
soluble	 gamma	 glutamyl	 hydrolase	 and	 membrane	 folate	 hydrolase	 1;	 but	 only	 the	
former	has	acid	pH	as	optimal	(Galivan	et	al.	2000).	 In	Landon	et	al’s	experiment,	the	
placenta	 extract	 is	 the	 supernatant	 from	 homogenising	 and	 centrifuging	 placental	
tissue	in	water.	Therefore,	it	is	improbable	that	the	placental	enzyme	is	folate	hydrolase	
1,	a	transmembrane	enzyme	(Landon	1972).	Another	study	detected	abundant	gamma	
glutamyl	 hydrolase	 mRNA	 in	 human	 placenta	 (Yin	 et	 al.	 2003).	 Moreover,	
immunohistochemically	 gamma	 glutamyl	 hydrolase	 is	 detectable	 in	 human	 placenta	
whereas	folate	hydrolase	is	not	(The	human	protein	atlas	2016).	Therefore,	the	enzyme	
involved	in	placenta	folate	mobilisation	is	gamma	glutamyl	hydrolase.		
In	 human	 placentas	 at	 term	 from	 a	 sample	 containing	 preeclampsia	 cases	 (40%),	
placental	folate	concentration	measured	by	microbiological	assay	ranged	2‐32µg/g	wet	
weight	(ww)	(Mislanova	et	al.	2011).	Human	placenta	density	have	been	reported	to	be	
0.995	 or	 1.020g/ml	 (Younoszai	 and	 Haworth	 1969;	 Del	 Nero	 et	 al.	 2002),	 therefore	
rounding	to	1g/ml	the	concentration	in	Mislanova	et	al.	is	4.5‐72.5µmol/L.	In	this	study	
the	highest	folate	concentrations	occurred	in	preeclampsia	cases	with	MTHFR	c.665TT	
maternal	 genotype,	 and	 the	 lowest	 in	 cases	 with	 CT	 genotype.	 Without	 genotype	
stratification	 cases	 and	 uncomplicated	 pregnancies	 did	 not	 differ	 in	 placental	 folate	
concentration	(Mislanova	et	al.	2011).	A	previous	study	had	reported	about	1µg/g	ww	
(2.3µmol/L)	in	human	placentas	of	≈16	GW	(Landon	1975).	
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low	 affinity	 transports	 are	 mediated	 by	 SLC44A1	 (CTL1)	 and	 SLC44A2	 (CTL2),	
respectively	(Yara	et	al.	2015).	These	two	transporter	mRNAs	are	highly	expressed	 in	





1975).	 Experiments	 with	 fragments	 of	 human	 placentas	 at	 term	 shown	 choline	 is	
mainly	 metabolised	 to	 acetylcholine,	 with	 a	 small	 proportion	 to	 phosphocholine	 (a	
precursor	of	phosphatidylcholine)	and	none	to	betaine	(Welsch	1976).	





involved	 in	 the	 placental	 betaine	 transport.	 A	 study	with	 rat	 syncytiotrophoblast	 cell	
line	 revealed	 higher	 betaine	 uptake	 and	 up‐regulation	 of	 GABA/betaine	 transporter	
and	 one	 of	 the	 amino	 acid	 transport	 system	 A	 members	 in	 hypertonic	 conditions	
compared	to	normal	conditions	(Nishimura	et	al.	2010).	The	addition	of	a	ligand	of	the	
amino	 acid	 transport	 system	A,	 but	 not	 of	 a	 ligand	of	 the	GABA/betaine	 transporter;	




stress	 (Yancey	 et	 al.	 1982)	 may	 be	 relevant	 in	 the	 placenta.	 The	 IMINO	 transport	
system,	 responsible	 for	 the	 betaine	 intestinal	 absorption,	 can	 be	 excluded	 from	
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that	 this	 binding	 is	 mediated	 by	 a	 membrane	 protein	 that	 needs	 divalent	 cations	
(Friedman	et	al.	1977).	 It	has	also	been	reported	 that	 the	 intrinsic	 factor	 ‐	 cobalamin	
complex	 does	 not	 bind	 to	 this	 preparation	 (Friedman	 et	 al.	 1977),	 adding	 more	
evidence	for	the	exclusion	of	the	intestinal	cobalamin	uptake	pathway	in	the	placental	
transport.	 The	 membrane	 protein	 has	 been	 subsequently	 purified	 and	 is	 the	
transcobalamin	2	receptor,	although	additionally	two	different	proteins	or	isoforms	of	
transcobalamin	 2	 receptor	 that	 bind	 holotranscobalamin	 have	 also	 been	 detected	
(Seligman	 and	 Allen	 1978).	 In	 line	 with	 the	 possibility	 of	 other	 holotranscobalamin	
receptors	is	the	fact	that	transcobalamin	2	receptor	knockout	mouse	is	not	embryonic	
lethal	 (Lai	 et	 al.	 2013).	 As	 the	 receptor	 megalin	 can	 bind	 and	 internalise	
holotranscobalamin	in	the	rat	renal	proximal	tubule	and	is	expressed	in	placenta,	it	has	
been	proposed	as	an	alternative	pathway	for	transcobalamin	2	receptor	(Moestrup	et	
al.	 1996).	 Although	 haptocorrin	 and	 intrinsic	 factor	 do	 not	 seem	 to	 participate	 in	
cobalamin	placental	transport,	a	study	with	perfused	human	placenta	suggests	19%	of	
the	 cobalamin	 internalised	 in	 the	 placenta	 is	 bound	 to	 haptocorrin	 and/or	 intrinsic	
factor	 (Perez‐D’Gregorio	 and	 Miller	 1998).	 The	 transport	 of	 cobalamin	 toward	 the	
foetus	 is	 thought	 to	 involve	a	concentrating	step	as	proposed	 for	 folate,	based	on	 the	
higher	 concentration	 of	 serum	 cobalamin	 found	 in	 the	 maternal	 blood	 of	 the	
intervillous	space	than	in	the	maternal	veins	(Giugliani	et	al.	1985).	It	is	considered	that	
holotranscobalamin	 in	 the	placenta	 follows	 the	 same	pathway	discovered	 in	 cultured	
human	skin	fibroblast.	Holotranscobalamin	binds	to	its	receptor	and	is	internalised	by	
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endocytosis,	 then	 cobalamin	 is	 released	 by	 the	 lysosomal	 degradation	 of	
transcobalamin	2	(Youngdahl‐Turner	et	al.	1979).	In	human	placentas,	methylmalonyl‐
CoA	mutase	has	been	isolated,	with	cobalamin	bound	to	 it	(Kolhouse	et	al.	1980)	and	
















finger	 domains	 involved	 in	 DNA	 recognition	 (Miller	 et	 al.	 1985),	 and	 of	 superoxide	
dismutase	 1	 (SOD1)	 (Banci	 et	 al.	 2009).	 Transcription	 of	 genes	 containing	 metal	
responsive	 elements	 can	 be	 regulated	 by	 zinc	 levels;	 e.g.	 via	 the	 metal‐binding	
transcription	 factor	 1	 that	 acts	 as	 an	 intracellular	 zinc	 sensor	 (Giedroc	 et	 al.	 2001;	
Zhang	et	al.	2003).	Among	these	genes	are	the	genes	coding	for	metallothioneins,	metal	
binding	 proteins	 involved	 in	 heavy	metal	 detoxification,	 redox	 and	 zinc	 homeostasis	
(Lazo	 et	 al.	 1995;	 King	 2011;	 Kimura	 and	 Kambe	 2016),	 whose	 synthesis	 is	 also	
induced	by	copper	and	cadmium	(Hamer	1986).	
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intestinal	 absorption	 is	 an	 active	 process	 facilitated	 by	 the	 zinc	 transporter	 ZIP4	
(SLC39A4)	in	the	enterocyte	apical	membrane	(Cousins	2010).	
An	 accepted	 biomarker	 of	 zinc	 status	 has	 not	 yet	 been	 established.	 Plasma	 zinc	
concentrations	 are	 subject	 to	 high	 physiological	 variability	 (King	 2011),	 and	 other	
potential	biomarkers	such	as	RBC	metallothioneins	are	being	investigated	(Caulfield	et	
al.	 2008).	 Zinc	 is	 transported	 in	blood	plasma	 as	70%	bound	 to	 albumin,	 18%	 to	α2‐
macroglobulin	 and	 the	 rest	 to	 other	 proteins	 and	 amino	 acids	 (Gibson	 et	 al.	 2008).	
Within	 the	 cells	most	 zinc	 is	 bound	 to	proteins	 and	 free	 zinc	 concentration	 is	 tightly	
controlled	(Outten	and	O’Halloran	2001).	






The	RDA	 for	 zinc	 in	 non‐pregnant	women	 is	 based	 on	quantities	 of	 absorbed	 zinc	 to	
exceed	 endogenous	 zinc	 losses.	 Foetus	 zinc	 content	 in	 late	 pregnancy	 is	 taking	 into	
account	for	the	RDA	in	pregnancy.	The	zinc	RDA	in	pregnancy	is	12mg/d	or	11mg/d	for	
women	of	18y	or	under,	or	over	19y,	respectively.	The	zinc	tolerable	upper	intake	level	
(UL)	 is	 based	 on	 the	 appearance	 of	 adverse	 effects	 (low	 copper	 status	 as	 low	 RBC	
superoxide	 dismutase	 1	 activity).	 The	 zinc	 UL	 in	 pregnant	 women	 is	 considered	 the	
same	 as	 in	 non‐pregnant	 women,	 i.e.	 34mg/day	 or	 40mg/day	 for	 women	 of	 18y	 or	
under,	or	over	19y,	respectively	(Institute	of	Medicine	‐	Panel	on	Micronutrients	2001).	
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Variables	 that	may	 affect	 or	 be	 affected	 by	 the	 concentrations	 of	 the	 trace	 elements	
addressed	in	this	thesis	will	be	commented	throughout	this	and	the	following	sections:	




2000).	 There	 is	 controversy	 about	 whether	 maternal	 smoking	 reduces	 the	 zinc	
concentration	in	RBC	of	the	foetus	(Kuhnert	et	al.	1987b;	Kuhnert	et	al.	1988a)	or	not	
(Aydogan	et	al.	2013).	
In	 the	placenta,	higher	zinc	concentrations	are	 found	 in	pregnant	smokers	 from	Chile	
(Ronco	et	 al.	 2005)	and	Croatia	 (Stasenko	et	 al.	 2010);	but	not	Turkey	 (Sorkun	et	 al.	
2007),	Ukraine	(Zadorozhnaja	et	al.	2000),	and	Finland,	Estonia	and	Russia	(Kantola	et	
al.	 2000).	 In	 USA,	 the	 association	 between	 smoking	 and	 higher	 placenta	 zinc	
concentration	is	found	in	some	studies	(Kuhnert	et	al.	1987b),	but	not	others	(Punshon	
et	al.	2016).	As	smoking	is	an	important	source	of	cadmium	exposure	(EFSA	‐	CONTAM	
Panel	 2009),	 the	 controversial	 finding	 of	 higher	 zinc	 concentration	 in	 placentas	 of	
smokers	 in	 some	 studies	 has	 been	 attributed	 to	 a	 protective	 mechanism	 where	
cadmium	 induces	 higher	 metallothionein	 levels	 in	 placenta,	 with	 a	 subsequent	 side	
effect	of	zinc	retention	in	the	organ	(Ronco	et	al.	2005;	Ronco	et	al.	2006).	The	ratio	of	
placenta	zinc/cadmium	concentration	is	lower	in	pregnant	smokers	from	USA	(Kuhnert	




al.	 1984),	 with	 some	 studies	 reporting	 similar	 results	 at	 delivery	 only	 in	 smokers	
(Kuhnert	 et	 al.	 1988a).	 Other	 studies	 reported	 no	 association	 between	 maternal	
plasma,	serum	or	whole	blood	at	delivery	and	birth	weight	(Díaz	et	al.	2002;	Al‐Saleh	et	
al.	 2004;	 Ozdemir	 et	 al.	 2007)	 or	 found	 a	 positive	 association	with	maternal	 plasma	
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collected	 in	 the	 first	 half	 of	 pregnancy	 (Crosby	 et	 al.	 1977).	 Cord	 plasma,	 serum	 and	
whole	 blood	 zinc	 have	 not	 been	 associated	with	 birth	weight	 either,	 in	most	 studies	
(Osman	 et	 al.	 2000;	 Díaz	 et	 al.	 2002;	 Al‐Saleh	 et	 al.	 2004;	 Ozdemir	 et	 al.	 2007).	
However,	 cord	 RBC	 zinc	 is	 positively	 associated	 with	 birth	 weight	 (Kuhnert	 et	 al.	
1988a;	Kippler	et	al.	2010).	 In	a	USA	study,	cord	plasma	zinc	 is	negatively	correlated	
with	birth	weight	only	in	smokers	(Kuhnert	et	al.	1988a).	In	a	big	Chinese	observational	
study,	 maternal	 zinc	 deficiency	 (as	 serum	 zinc	 <56µg/dL)	 in	 the	 first	 trimester	 is	
associated	with	SGA,	and	in	the	second	and	third	trimester	with	SGA	and	LBW	(Wang	et	
al.	2015a).	The	serum	zinc	deficiency	cutoff	of	Wang	et	al.	 is	based	on	the	P2.5	of	 first	
trimester	 pregnant	women	 in	 the	National	Health	 and	Nutrition	 Examination	 Survey	
(NHANES)	II	study	(Hess	et	al.	2007),	and	in	another	big	study	from	USA	using	a	higher	
cutoff	 (P25)	no	differences	 in	 SGA	 risk	are	 found	 (Tamura	et	 al.	 2000).	 In	 general	 the	
association,	if	any,	between	maternal	plasma/serum	and	LBW	and	SGA	is	controversial	









well	 drinkers	 cohort	 (Punshon	 et	 al.	 2016),	 but	 not	 in	 other	 studies	 (Dawson	 et	 al.	
1969;	Llanos	and	Ronco	2009).	Also	no	differences	were	observed	between	placentas	
of	SGA	and	control	neonates	 (Malhotra	et	al.	1990;	Osada	et	 al.	2002;	Zadrozna	et	 al.	
2009).	 It	 is	 currently	 unknown	 whether	 higher	 placenta	 zinc	 concentrations	 reflect	
more	 zinc	 available	 for	 foetal	 development	 or	 retention	 of	 zinc	 to	 compensate	 toxics	
such	 as	 cadmium.	 The	 ratio	 of	 placenta	 zinc/cadmium	 concentration	 is	 positively	
correlated	with	birth	weight	in	pregnant	smokers	from	USA	(Kuhnert	et	al.	1987a),	but	
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In	 longitudinal	 studies,	 the	 maternal	 concentrations	 of	 zinc	 decrease	 in	 plasma	 and	
increase	 in	 whole	 blood	 and	 RBC	 (Vir	 et	 al.	 1981;	 Qvist	 et	 al.	 1986;	 Caulfield	 et	 al.	
2008);	 although	 the	 RBC	 increase	 in	 a	 clinical	 trial	 of	 zinc	 supplementation	 is	 only	
found	 in	 the	zinc	supplemented	group	(Caulfield	et	al.	2008).	At	delivery,	 cord	whole	
blood	zinc	 is	positively	associated	with	gestational	age	(Kippler	et	al.	2010),	but	cord	
serum	 is	 not	 associated	 (Reddy	 et	 al.	 2014).	 There	 is	 controversy	 about	 the	 possible	
association	between	maternal	plasma/serum	zinc	and	preterm	risk.	Results	range	from	
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Income	 is	 not	 associated	 with	 maternal	 serum	 zinc	 in	 pregnant	 women	 from	 China	
(Wang	et	 al.	2015a),	 and	 to	 the	best	of	our	knowledge	no	 study	has	assessed	 this	on	
placenta	concentrations.	
There	 is	higher	placenta	zinc	 in	placentas	of	male	newborns	 in	 the	USA	well	drinkers	
cohort	(Punshon	et	al.	2016),	but	other	studies	has	found	no	association	(Osman	et	al.	
2000;	Phuapradit	et	al.	2000).	




al.	2012)	and	 Japan	 (Tsuchiya	et	 al.	1984).	Placenta	zinc	 is	positively	 correlated	with	
placenta	concentrations	of	selenium	in	several	studies	(Osman	et	al.	2000),	including	a	
USA	well	drinkers	study	(Punshon	et	al.	2016);	but	not	 in	other	studies	(Odland	et	al.	
2001).	 Placenta	 zinc	 and	 iron	 concentrations	 are	 negatively	 correlated	 in	 Northern	
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1984),	 and	not	associated	 in	Turkey	 (Ozdemir	 et	 al.	2009).	 Supporting	an	absence	of	
interaction	 between	 zinc	 and	 iron,	 no	 differences	 in	 placenta	 zinc	 concentration	 are	
found	between	iron	supplement	users	and	non‐users	from	England	(Ward	et	al.	1987).	
Lower	 placenta	 zinc	 compared	 to	 control	 diets	 is	 observed	 in	 animals	 fed	 a	 zinc	
deficient	 diet	 (McKenzie	 et	 al.	 1975;	 Fosmire	 et	 al.	 1977;	 Masters	 et	 al.	 1983a).	




(Masters	 et	 al.	 1983b),	 or	not	 (McKenzie	 et	 al.	 1975).	 Zinc	 intake	 seems	not	 to	 affect	











Zn65	 absorption	 from	 bread	 made	 with	 flour	 fortified	 with	 folic	 acid	 (Hansen	 et	 al.	
2001).	 The	 former	 was	 also	 true	 in	 ZTT	 with	 200mg	 folic	 acid	 compared	 to	 5‐
formylTHF	(Arnaud	et	al.	1992).	Two	other	studies	reported	that	zinc	absorption	was	
lower	 in	 the	 presence	 of	 folic	 acid	 (Milne	 1989;	 O’Brien	 et	 al.	 2000).	 Lower	 Zn65	
absorption	 from	meals	 with	 800µg	 of	 folic	 acid	 compared	 to	 without	 folic	 acid	 was	
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found	 in	5/13	healthy	adults	 that	had	a	 tendency	 to	 low	zinc	 intake	and	plasma	zinc	
(Milne	 1989).	 This	 was	 also	 true	 for	 zinc	 isotopes	 absorption	 from	 intravenous	
injections	 and	 oral	 doses	 combined	with	 250µg	 folic	 acid,	 60mg	 iron	 and	 15mg	 zinc	







et	 al.	1985),	or	with	perfusates	with	460µM	 folic	 acid	 compared	 to	without	 folic	 acid	
(Ghishan	et	al.	1986),	or	fed	6mg	folic	acid,	308mg	iron	and	11.6g	calcium	compared	to	
2.8mg	 folic	 acid,	 37.7mg	 iron	 and	 5.8g	 calcium	 (/Kg	 diet)	 (Southon	 et	 al.	 1989).	 The	
latter	finding	was	also	true	for	pregnant	rats	(Southon	et	al.	1989).	But	no	differences	
in	zinc	absorption	were	observed	among	groups	of	rats	administered	1ml	of	aqueous	
solution	or	milk	 formula,	 containing	13µg	zinc	plus	Zn65	and	4.4µg,	176µg	or	no	 folic	
acid	intragastrically	(Keating	et	al.	1987).	Folic	acid	and	zinc	were	shown	to	bind	and	to	
form	complexes	in	vitro,	but	this	mechanism	for	the	possible	effect	of	folic	acid	on	zinc	
absorption	 seems	 unlikely	 because	 the	 complexes	 only	 occurred	 at	 pH	 2	 and	 were	
dissolved	at	pH	6	(Ghishan	et	al.	1986).	The	pH	is	changed	to	≈6	towards	the	jejunum	in	
individuals	 without	 gastrointestinal	 pathologies	 (Evans	 et	 al.	 1988).	 Endocytosis	 of	
folate	 bound	 to	 membrane	 folate	 receptors	 alpha	 plus	 proton	 coupled	 folate	
transporters	 has	 been	 proposed	 as	 a	 folate	 uptake	 a	 mechanism	 in	 the	 placenta,	
together	with	 a	necessary	 acidification	of	 the	 endocytic	 vesicle	 lumen	 for	 the	 release	
and	transport	of	folate	to	the	cytoplasm	(Solanky	et	al.	2010).	This	mechanism	has	been	
verified	 in	 cervical	 cancer	 cells	 and	proposed	as	 the	mechanism	by	which	 the	proton	
coupled	folate	transporter	takes	up	folate	when	the	extracellular	milieu	is	at	neutral	pH	
(Zhao	et	al.	2009).	The	pH	of	 these	vesicles	 is	as	 low	as	6‐6.5,	but	this	 is	 in	reclycling	
vesicles	for	5‐methylTHF	uptake,	and	a	non	recycling	pathway	with	lower	pH	for	folic	
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folate.	 In	 in	 vitro	 studies,	 zinc	 uptake	 did	 not	 differ	 in	 pig	 purified	 brush	 border	
membrane	 vesicles	 for	 a	 folic	 acid	 concentration	 range	 (0.05‐50µM)	 (Turnbull	 et	 al.	
1990),	 or	 in	 human	 intestinal	 cells	 after	 the	 addition	 of	 beverages	 digestates	 with	
1.75µg/g	folic	acid	or	without	folic	acid	(Pullakhandam	et	al.	2011).	But	zinc	uptake	in	





1989).	There	was	 lower	zinc	absorption	 in	healthy	volunteers	 following	a	ZTT	or	 the	
intake	 of	 a	 meal	 with	 Zn65	 after	 2wk	 treatments	 with	 folic	 acid	 as	 550µg/d	 (plus	
100mg/d	 iron)	 (Meadows	et	 al.	1983),	or	350µg/d	 (Simmer	et	 al.	1987),	or	800µg/d	
(Milne	 1989),	 compared	 to	 before	 the	 interventions.	 This	 was	 also	 true	 for	 a	 2wk	
treatment	with	350µg/d	folic	acid	plus	100mg	iron	in	pregnant	women	(Simmer	et	al.	
1987).	 The	 finding	 in	 Milne	 study	 only	 occurred	 in	 the	 5/14	 healthy	 adults	 with	 a	
tendency	 to	 low	 zinc	 intake	 and	 plasma	 zinc	 (Milne	 1989).	 But	 there	 were	 no	
differences	 in	Zn65	absorption	 from	meals	after	a	3wk	400µg/d	or	800µg/d	 folic	acid	
treatment,	 compared	 to	 before	 the	 interventions	 in	 healthy	 volunteers	 (Milne	 et	 al.	
1990).	Higher	zinc	absorption	was	reported	in	the	pups	of	rat	dams	fed	an	ethanol	diet	
plus	 folic	 acid,	 compared	 to	 the	 ethanol/no	 folic	 acid	 group,	 from	 8	 weeks	 before	
pregnancy	throughout	21	days	of	 lactation.	Rats	 in	the	 folic	acid	group	had	about	80‐
100µg/d	more	folic	acid	than	the	no	folic	acid	group	(Tavares	et	al.	2000).	
Most	clinical	trials	of	folic	acid	supplementation	assessing	zinc	status	did	not	specify	if	
folic	 acid	was	 simultaneous	 to	 zinc	 intake,	 and	 have	 found	 no	 differences	 in	 plasma,	
serum,	RBC	and	urinary	zinc	concentrations	in	treated	(400‐10000µg/d	of	folic	acid	for	
24d	up	to	4	months)	compared	to	untreated	patients	(Butterworth	et	al.	1988;	Reid	et	
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al.	 1992)	 or	 untreated	 healthy	 volunteers	 (Milne	 et	 al.	 1990;	 Hambidge	 et	 al.	 1993;	
Kauwell	et	al.	1995;	Green	et	al.	2003).	However,	lower	maternal	but	not	cord	plasma	
zinc	was	found	in	pregnant	women	taking	250µg	folic	acid	plus	60mg	iron	compared	to	
the	 unsupplemented	 group	 (O’Brien	 et	 al.	 2000).	 Animal	 studies	 have	 assessed	 the	
effect	 of	 folic	 acid	 on	 zinc	 status	 in	 tissues.	 No	 differences	 in	 liver	 or	 femur	 zinc	
concentrations	 were	 observed	 in	 rat	 fed	 diets	 supplemented	 with	 folic	 acid	 as	
100mg/Kg	 diet	 compared	 to	 unsupplemented	 diets	 (Fuller	 et	 al.	 1988),	 or	with	 folic	
acid	 as	 6mg/Kg	 diet	 compared	 to	 2.8mg/Kg	 diet	 (Southon	 et	 al.	 1989).	 However,	 in	
Fuller	et	al.	study	higher	kidney	zinc	concentration	was	found	in	pregnant	or	lactating	
rat	 dams	 fed	 the	 folic	 acid	 supplemented	 diet	 compared	 to	 the	 unsupplemented	 diet	
(Fuller	et	al.	1988).	
In	 observational	 studies	 folate	 and	 zinc	 concentrations	 are	 positively	 correlated	 in	
amniotic	 fluid	 (Weekes	 et	 al.	 1992)	 and	 negatively	 correlated	 in	 plasma/serum	 of	




Rats	 fed	 a	 choline	 deficient	 diet	 have	 lower	 hepatic	 zinc	 concentrations	 than	 fed	 a	
control	 diet	 (Keefer	 et	 al.	 1973).	 The	 author	 of	 this	 experiment	 did	 not	 test	 zinc	
intestinal	 uptake	 in	 perfused	 rat	 intestine	 but	 proposed	 impaired	 zinc	 absorption	
(Keefer	 et	 al.	 1973).	 In	 vitro	 experiments	 with	 human	 neuroblastoma	 cell	 line	 in	
medium	 with	 1µM	 zinc,	 show	 higher	 intracellular	 zinc	 levels	 when	 M1	 muscarinic	
acetylcholine	receptor	or	its	downstream	effector	are	stimulated	(Zuchner	et	al.	2006).	
Because	 this	 receptor	 is	 localised	 in	 the	 intervillous	 space	 membrane	 of	 the	
syncytiotrophoblast	according	to	pharmacological	experiments	(Pavía	et	al.	1997)	and	
there	 is	 high	 acetylcholine	 synthesis	 in	 the	 placenta	 (Welsch	 1976),	 a	 link	 between	
placenta	zinc	status	and	choline	might	exist.	
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on	 copper	 homeostasis	 (Meyer	 et	 al.	 2001).	 However,	 liver	 copper	 and	 iron	
concentration	are	higher	 in	 aceruloplasminemic	mice	and	 this	has	been	 attributed	 to	
loss	of	ferroxidase	activity	(Meyer	et	al.	2001).	




In	 the	placenta,	 copper	uptake	 from	the	 intervillous	space	 is	 through	passive	carrier‐
mediated	transport	(Tong	and	McArdle	1995;	Nandakumaran	et	al.	2003).	 In	addition	
two	copper	transporting	ATPases	have	been	identified	in	human	placenta	(Hardman	et	
al.	2004),	 and	according	 to	human	placenta	 cells	 and	mouse	experiments,	 the	ATP7A	
pump	 delivers	 copper	 to	 the	 foetus,	 and	 the	 ATP7B	 pump	 returns	 excess	 copper	 to	
maternal	 blood	 (Hardman	 et	 al.	 2007;	Wadwa	 et	 al.	 2014).	 Copper	 concentrations	 in	
cord	plasma,	serum	or	whole	blood	are	lower	than	in	the	mother	(Goel	and	Misra	1982;	
Hyvonen‐Dabek	et	al.	1984;	Tsuchiya	et	al.	1984;	Schramel	et	al.	1988;	Ong	et	al.	1993;	
Krachler	 et	 al.	 1999;	 Al‐Saleh	 et	 al.	 2004).	 This	 has	 been	 attributed	 to	 lower	
ceruloplasmin	 levels	 in	 foetal	 than	maternal	blood,	but	an	endocytic	pathway	against	
the	copper	gradient	may	also	be	involved	(Hardman	et	al.	2006).	
The	 calculation	 of	 RDA	 for	 copper	 in	 pregnancy	 is	 based	 on	 the	 reported	 content	 of	
copper	 in	 term	 foetus,	 placenta,	 amniotic	 fluid	 and	 maternal	 tissues	 developed	 in	
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(Aydogan	 et	 al.	 2013).	 There	 are	 no	 differences	 between	 placenta	 copper	










Placenta	 copper	 concentrations	 have	 been	 reported	 to	 be	 negatively	 associated	with	
birth	 weight	 (Kantola	 et	 al.	 2000),	 but	 other	 studies	 reported	 a	 positive	 association	
(Ozdemir	et	al.	2009)	or	none	(Ward	et	al.	1987;	Odland	et	al.	2004;	Ronco	et	al.	2005).	






for	 plasma	 and	whole	 blood	 at	 delivery	 (Ghneim	 et	 al.	 2016).	 In	 two	 cross‐sectional	
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studies,	 maternal	 serum	 copper	 concentrations	 are	 higher	 in	 more	 advanced	
pregnancies	(Hyvonen‐Dabek	et	al.	1984;	Kantola	et	al.	2000),	with	one	study	 finding	
no	differences	at	deliveries	before,	at,	or	after	37	GW	(Reddy	et	al.	2014).	A	longitudinal	
study	 reported	 that	 maternal	 serum	 copper	 increases	 between	 28	 to	 37	 GW,	
maintaining	 a	 plateau	 thereafter	 (Mochizuki	 et	 al.	 1984).	 Cord	 serum	 copper	 though	









pregnant	 smokers	but	not	 in	 non	 smokers	 (Kantola	 et	 al.	 2000),	 nor	 in	 a	 study	 from	
Turkey	 with	 unknown	 smoking	 status	 of	 the	 participants	 (Ozdemir	 et	 al.	 2009).	 In	










al.	 2001).	 Placenta	 copper	 and	 iron	 concentrations	 were	 negatively	 correlated	 in	
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studies	 from	Northern	Norway	and	Russia	 (Odland	et	al.	2001),	but	not	associated	 in	
Turkey	 (Ozdemir	 et	 al.	 2009)	 and	 Japan	 (Tsuchiya	 et	 al.	 1984).	 Placenta	 copper	 and	
iron	are	negatively	correlated	in	a	rat	study	of	low	iron	or	deficiency,	and	this	is	not	due	
to	 changes	 in	 the	 transcription	 of	 copper	 transport	 proteins	 in	 liver	 (including	
ceruloplasmin)	 or	 placenta	 (Gambling	 et	 al.	 2004).	 In	 addition	 to	 the	 possible	
postranslational	 regulation	 of	 these	 proteins,	 the	 placental	 copper	 containing	













day	 for	 5‐6	 months),	 and	 in	 the	 unsupplemented	 group	 (Milne	 et	 al.	 1984).	 In	 a	
pregnant	 rat	 study	 where	 methotrexate	 was	 added	 in	 intraperitoneal	 injections	
chronically	 and	 also	 concomitantly	 to	 copper	 intake,	 no	 differences	 in	 serum	 copper	
concentration	 were	 detected	 between	 the	 methotrexate	 treated	 and	 the	 untreated	
group	(Al‐Saleh	et	al.	2009).	
Higher	serum	copper	concentrations	was	reported	in	mice	two	hours	after	receiving	a	
single	oral	dose	of	 folic	 acid	as	100mg/Kg	body	weight	 than	 in	animals	not	 receiving	
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In	 observational	 studies,	 no	 differences	 in	 copper	 concentrations	 at	 ≈17	 GW	 were	
observed	between	users	and	non‐users	of	prenatal	supplements	(800‐1000µg	folic	acid	




In	 rats	 a	 foetal	 programming	 effect	 of	 folic	 acid	 on	 copper	 status	was	 reported.	 The	










acid	 selenocysteine.	 Enzymes	 such	 as	 glutathione	 peroxidases,	 which	 catalyse	 the	
conversion	 of	 lipid	 or	 hydrogen	 peroxide	 and	 reduced	 glutathiones	 to	 water	 and	
oxidised	 glutathione,	 have	 selenocysteine	 in	 their	 sequence	 (Diamond	 2015).	 Other	
selenocysteine‐containing	 enzymes	 are	 the	 thioredoxin	 reductases,	which	 reduce	 the	
thioredoxin	proteins	that	can	then	reduce	other	proteins	to	avoid	oxidative	stress	(Lu	
and	 Holmgren	 2014).	 Non‐selenocysteine	 selenoproteins	 includes	 selenium	 binding	
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in	 the	 intestine	by	 two	amino	acid	 transport	 systems	 (B0	and	b0+	 rBAT)	 (Nickel	 et	 al.	
2009).	Inorganic	selenium	as	selenate	(SeO42‐)	is	possibly	absorbed	in	the	intestine	by	
the	 anion	 exchangers	 SLC26s	 (Fairweather‐Tait	 et	 al.	 2011).	 Selenate	 uptake	 in	 the	
placenta	 is	 possibly	 mediated	 by	 SLC26s	 (Shennan	 1988)	 and	 SLC13A4,	 which	 also	
transport	 chromium	 (Miyauchi	 et	 al.	 2006).	 Cord	 blood	 selenium	 concentrations	 are	
lower	than	in	the	mother	(Hyvonen‐Dabek	et	al.	1984;	Wasowicz	et	al.	1993;	Al‐Saleh	et	




correspond	with	 tissue	selenoenzyme	activity	 level.	The	RDA	 in	pregnancy	 takes	 into	
account	 the	 selenium	content	of	 a	4kg	 foetus.	 Selenium	RDA	 in	pregnancy	 is	60µg/d.	
The	pregnancy	 selenium	UL	 is	based	on	hair	 and	nail	 brittleness	 and	 loss	 as	 adverse	
effects	 in	 non‐pregnant	 women.	 In	 addition,	 uncertainty	 due	 to	 more	 sensitive	
individuals	 is	 taken	 into	 account.	 Selenium	UL	 in	 pregnancy	 is	 400µg/d	 (Institute	 of	
Medicine	‐	Panel	on	Dietary	Antioxidant	and	Related	Compounds	2000).	
Smoking	 has	 been	 reported	 not	 to	 affect	 maternal	 serum	 or	 whole	 blood	 selenium	
(Kantola	et	al.	2004)	although	it	had	been	negatively	associated	with	blood	selenium	in	
a	previous	 study	 (Kosanovic	et	 al.	2002).	A	 similar	 controversy	occurs	 in	 cord	whole	
blood	 selenium	 concentrations	 (Kosanovic	 et	 al.	 2002;	 Kantola	 et	 al.	 2004).	 Passive	
smoking	 was	 recently	 reported	 not	 to	 be	 associated	 with	 cord	 serum	 selenium	 (Al‐
Saleh	et	al.	2015).	
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women	 (Kantola	 et	 al.	 2004).	 Passive	 smoking	 was	 not	 associated	 with	 placenta	
selenium	(Al‐Saleh	et	al.	2015).	
Maternal	 serum	 selenium	 is	 negatively	 associated	 with	 birth	 weight	 only	 in	 non	
smokers	 (Kantola	 et	 al.	 2004),	 but	 no	 association	 is	 found	 in	 maternal	 whole	 blood	
selenium	(Kantola	et	al.	2004).	Cord	whole	blood	selenium	is	positively	associated	with	
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2004).	 No	 differences	 in	 placenta	 selenium	 were	 observed	 in	 rats	 at	 different	
gestational	ages	(Bou‐Resli	et	al.	2001).	
Maternal	blood	 selenium	 in	 term	and	preterm	deliveries	were	 reported	 to	be	 similar	
(Wilson	et	al.	1991;	Mask	and	Lane	1993;	Wasowicz	et	al.	1993;	Lorenzo	Alonso	et	al.	
2005),	except	in	a	study	in	which	plasma	selenium	was	lower	in	preterm	pregnancies	
(Dobrzynski	 et	 al.	 1998).	 Reports	 on	 cord	 blood	 selenium	 and	 preterm	delivery	 also	
have	inconsistent	findings	with	some	studies	showing	lower	concentrations	in	plasma	
of	 preterm	 neonates	 (Mask	 and	 Lane	 1993;	 Dobrzynski	 et	 al.	 1998)	 and	 others	 no	
differences	 in	 plasma	 (Wilson	 et	 al.	 1991;	 Wasowicz	 et	 al.	 1993)	 or	 whole	 blood	
(Lorenzo	Alonso	et	al.	2005)	compared	to	control	neonates.	Higher	placenta	selenium	
in	 preterm	 deliveries	 was	 reported	 in	 one	 study	 (Zadrozna	 et	 al.	 2009)	 but	 not	 in	
others	(Dobrzynski	et	al.	1998;	Lorenzo	Alonso	et	al.	2005).	
No	 association	 was	 observed	 between	 maternal	 age	 and	 maternal	 serum	 or	 whole	
blood	selenium	(Kantola	et	al.	2004;	Lorenzo	Alonso	et	al.	2005).	There	is	controversy	
regarding	the	association	between	maternal	age	and	cord	blood	selenium,	with	studies	





2015;	 Punshon	 et	 al.	 2016).	 Socioeconomic	 level	 was	 not	 associated	 with	 placenta	
selenium	(Al‐Saleh	et	al.	2015),	and	that	is	true	also	for	neonate	sex	(Osman	et	al.	2000;	
Al‐Saleh	et	al.	2015;	Punshon	et	al.	2016).	
Placenta	 selenium	 and	 iron	 are	 negatively	 associated	 (Odland	 et	 al.	 2001).	 As	 for	
selenium	 intake,	 higher	 serum	 selenium	 concentration	 was	 found	 in	 cattle	 fed	 diets	
supplemented	with	 1mg/d	 or	 2mg/d	 inorganic	 selenium,	 than	 fed	 a	 control	 diet	 (de	
Toledo	and	Perry	1985).	In	a	clinical	trial	of	organic	selenium	supplementation,	plasma	
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Selenium	 is	 usually	 considered	 a	 nutrient,	 but	 as	 a	 trace	 element	 is	 toxic	 at	 high	
concentrations.	One	carbon	metabolism	can	have	an	effect	on	selenium	status	because,	
as	in	arsenic,	methylation	of	selenium	is	required	for	its	detoxification.	The	methylated	
intermediaries,	 i.e.	 mainly	 the	 pulmonary‐excreted	 dimethylselenide	 and	 the	 urine‐
excreted	 trimethylselenonium,	 are	 less	 toxic	 than	 selenite	 ion	 (SeO32‐)	 (Olson	 1986).	
SAM	is	required	for	its	methylation	(Tandon	et	al.	1986;	Hoffman	and	McConnell	1987).	
Effect	of	folate	on	selenium	uptake	and	status	














In	 a	 pregnant	 rat	 study	where	methotrexate	was	 added	 in	 intraperitoneal	 injections	
chronically	 and	 also	 concomitantly	 to	 selenium,	 no	 differences	 in	 serum	 selenium	
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concentration	 were	 detected	 between	 the	 methotrexate	 treated	 and	 the	 untreated	
group	(Al‐Saleh	et	al.	2009).	
Effect	of	choline	on	selenium	uptake	and	status	
Methyl	 groups	derived	 from	choline	oxidation	 appear	not	 to	be	 involved	 in	 selenium	
detoxification	 by	 methylation.	 Rats	 fed	 a	 choline	 deficient	 diet	 had	 similar	 urinary	





Higher	 kidney	 selenium	 (but	 not	 liver)	 was	 reported	 in	 cobalt	 deficient	 sheep	
compared	with	 the	 cobalt	 supplemented	 group	 (Andrews	 et	 al.	 1963).	 This	was	 true	
both	 in	 the	 case	 of	 low	 natural	 selenium	 supply	 and	 for	 selenium	 supplementation	
(Andrews	 et	 al.	 1963).	 More	 susceptibility	 to	 selenium	 toxicity	 induced	 by	 oral	
supplements	was	suggested	in	cobalt	deficient	sheep	or	those	with	low	protein	intake	
in	an	Australian	study,	although	no	statistical	test	was	used	(Gardiner	1966).	In	a	study	
with	 rats	 injected	 intraperitoneally	 with	 1.5mg	 selenium	 and	 75Se,	 the	 cobalamin	
depleted	 group	 had	 reduced	 formation	 of	 dimethylselenide,	 reduced	 urine	
trimethylselenonium,	 higher	 retention	 of	 75Se	 in	 liver,	 kidney	 and	muscle,	 and	 lower	
retention	 of	 75Se	 in	 blood	 (Chen	 and	Whanger	 1993).	 In	 this	 study,	 liver	 extracts	 or	
hepatocytes	 from	 cobalamin	 deficient	 rats	 transformed	 less	 selenium	 to	
dimethylselenide,	 and	 the	 hepatocytes	were	 less	 resistant	 to	 selenium	 toxicity	 (Chen	
and	 Whanger	 1993).	 A	 subsequent	 study	 with	 perfused	 rat	 intestines	 and	 labelled	
selenium	 discarded	 a	 chronic	 effect	 of	 dietary	 cobalamin	 on	 selenium	 intestinal	
absorption	 (Chen	 et	 al.	 1993).	 Liver	 and	 kidney	 selenium	 were	 higher	 and	 blood	
selenium	 lower	 in	 rats	 after	 6	 weeks	 on	 a	 cobalamin	 deficient	 compared	 to	
supplemented	diet,	each	including	different	sub‐toxic	concentrations	of	selenium	(Chen	
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et	 al.	 1993).	 In	 other	 tissues	 (heart,	 spleen),	 lower	 selenium	 concentrations	 were	




Physiologically,	 iron	 exists	 in	 two	 stable	 oxidation	 states:	 ferric	 (Fe3+)	 and	 ferrous	
(Fe2+).	Body	iron	content	(about	4.0g	in	men	and	3.5g	in	women)	is	distributed	between	
RBC	haemoglobin	(60‐70%),	muscle	myoglobin	(10%),	and	storage	pools	(20‐30%)	as	
ferritin	 and	 haemosiderin	 in	 the	 liver	 and	 in	 the	monocytes	 and	macrophages	 of	 the	
reticular	 connective	 tissue	 (Geissler	 and	 Singh	 2011).	 The	 ferritin	 complex	 contains	
iron	 as	 Fe3+	 (up	 to	 4500	 atoms)	 which	 is	 easily	 released	 and	 reduced	 to	 Fe2+	 when	
ferritin	is	degraded	in	the	cytosol	(Koorts	and	Viljoen	2007).	If	ferritin	is	internalised	in	
lysosomes	for	degradation,	haemosiderin	can	be	formed	and	in	this	case	the	stored	iron	
is	 less	 mobilisable,	 thus	 protecting	 against	 iron	 toxicity	 (Koorts	 and	 Viljoen	 2007).	
About	 1%	 of	 total	 body	 iron	 is	 contained	 in	 enzymes:	 haem	 enzymes	 such	 as	
cytochromes,	catalase	and	haem‐dependent	peroxidases;	and	non‐haem	iron	enzymes.	
Less	than	0.2%	of	total	body	iron	is	transported	in	plasma	bound	to	soluble	transferrin	
proteins	 (Geissler	 and	 Singh	 2011).	 Each	 transferrin	 binds	 one	 Fe3+	 atom	 and	 this	
holotransferrin	can	interact	with	its	membrane	receptor,	undergoing	endocytosis,	and	
releasing	 the	 iron	 to	 the	 acidic	 lumen	 of	 the	 vesicle	 (Luck	 and	 Mason	 2012).	 The	
transferrin‐mediated	cellular	iron	delivery	process	ends	with	the	export	of	Fe3+	to	the	
cytosol	and	the	recycling	of	transferrin	and	its	receptor	back	to	the	blood	plasma	and	
cell	membrane,	 respectively	 (Luck	 and	Mason	2012).	 Extracellular	 iron	not	bound	 to	
transferrin,	 and	 in	 the	 Fe2+	 state	 can	 be	 transported	 into	 cells	 by	 ZIP14	 (SLC39A14)	
(Liuzzi	 et	 al.	 2006),	 which	 is	 one	 of	 the	 cellular	 importers	 of	 Zn2+	 (King	 2011).	 The	
export	of	Fe2+	 from	the	cells	 is	carried	out	only	by	the	 ferroportin	protein	(SLC40A1)	
(McKie	et	al.	2000;	Gulec	et	al.	2014).	
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transporter	 1	 (SLC11A2)	 (Gunshin	 et	 al.	 1997).	 The	 divalent	 state	 of	 iron	 in	 the	
intestinal	 lumen	 is	 achieved	 by	 ferrireductase	 activities	 of	 enzymes	 (such	 as	
cytochrome	 b	 reductase	 1)	 and	 certain	molecules	 (such	 as	 ascorbic	 acid)	 (Luck	 and	
Mason	 2012).	 The	 non‐haem	 iron	 absorbed	 by	 the	 enterocytes	 (in	 Fe2+	 state)	 is	
exported	by	the	ferroportin	transporter	(McKie	et	al.	2000).	The	exported	iron	needs	to	
be	 oxidised	 to	 Fe3+	 (by	 proteins	 with	 ferroxidase	 activity,	 which	 in	 the	 enterocyte	
basolateral	membrane	is	hephaestin,	a	copper‐containing	enzyme)	to	be	transported	by	
transferrin	 in	 blood	 (Chen	 et	 al.	 2004).	 Ceruloplasmin,	 another	 copper‐containing	




There	 is	 controversy	regarding	 the	pathways	 involved	 in	haem	 iron	 intestinal	uptake	
(Gulec	et	al.	2014).	The	later	termed	proton	coupled	folate	transporter	(Qiu	et	al.	2006),	
was	 firstly	 identified	 as	 a	 low	 affinity	 intestinal	 haem	 transporter	 (Shayeghi	 et	 al.	
2005).	An	in	vitro	experiment	with	colorectal	adenocarcinoma	human	cells	showed	that	
when	 the	 transcription	 of	 this	 transporter	 is	 inhibited,	 both	 haem	 iron	 and	 reduced	









authors	 have	 proposed	 that	 during	 pregnancy,	 iron	 absorbed	 in	 the	maternal	 gut	 is	
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In	 the	 placentas	 from	 rat	 dams	 on	 iron	 deficient	 diets,	 there	 is	 an	 up‐regulation	 of	
proteins	 involved	 in	 iron	 uptake	 from	 the	 maternal	 blood:	 transferrin	 receptor	
(responsible	 for	 transferrin‐bound	 iron	 uptake)	 and	 divalent	 metal	 transporter	 1	
(importer	of	 free	Fe2+),	suggesting	that	these	are	two	pathways	for	 iron	uptake	in	the	
placenta.	 Although	 ferroportin	 (Fe2+	 exporter)	 expression	 is	 not	 changed,	 these	
placentas	may	have	a	higher	efflux	of	iron	towards	foetal	blood,	given	that	the	activity	
of	placental	ferroxidase	(zyklopen)	is	higher	(Gambling	et	al.	2001).	In	the	same	study,	
human	 placenta	 cell	 growth	 in	 iron	 deficient	 medium	 have	 higher	 expression	 of	
transferrin	 receptors	 and	 there	 is	 a	 higher	 iron	 efflux	 from	 the	 basolateral	 side,	
corresponding	with	the	 foetal	circulation	(Gambling	et	al.	2001).	These	results	add	to	
the	 idea	 that	 in	 maternal	 iron	 deficiency	 conditions,	 the	 flux	 toward	 the	 foetus	 is	







The	 UL	 in	 pregnancy	 is	 based	 on	 the	 appearance	 of	 gastrointestinal	 distress	 in	 non‐
pregnant	 women,	 and	 it	 is	 45mg/day	 of	 iron	 (Institute	 of	 Medicine	 ‐	 Panel	 on	
Micronutrients	2001).	
Lower	placenta	iron	concentration	is	found	in	pregnant	smokers	from	Chile	(Ronco	et	
al.	 2005),	 but	 not	 Croatia	 (Stasenko	 et	 al.	 2010).	 Exposure	 to	 nicotine	 by	 smoking	
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AGA	neonates,	 suggesting	 impaired	 iron	 transport	 (Mando	et	 al.	 2011).	The	available	
evidence	 suggests	 that,	 mobilisable	 iron	 in	 placenta	 may	 be	 associated	 with	 foetal	
growth,	but	not	placenta	total	iron.	
In	cross‐sectional	studies,	maternal	(Hyvonen‐Dabek	et	al.	1984;	Reddy	et	al.	2014)	and	
cord	 (Reddy	 et	 al.	 2014)	 serum	 iron	 did	 not	 vary	with	 gestational	 age.	 Placenta	 iron	
concentration	 was	 not	 associated	 with	 gestational	 age	 in	 pregnant	 women	 from	
England	(Ward	et	al.	1987)	and	India	(Reddy	et	al.	2014).		
Placenta	iron	was	not	correlated	with	maternal	age	in	studies	from	Turkey	(Ozdemir	et	
al.	 2009)	 and	 Jamaica	 (Grant	 et	 al.	 2010).	However,	 Brazilian	 adult	 pregnant	women	
had	 higher	 placenta	 foetal	 side	 iron	 concentrations	 than	 the	 15‐19y	 group,	 although	
this	was	not	observed	in	the	maternal	side	specimens	(De	Moraes	et	al.	2011).	
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No	 studies	 assessing	 maternal	 BMI,	 socioeconomic	 status	 and	 neonate	 sex	 with	
placenta	iron	concentrations	has	been	identified.	Regarding	iron	intake,	no	differences	





according	 to	 some	 studies	 a	 low	 affinity	 haem	 iron	 importer.	 Proton	 coupled	 folate	
transporter	 can	mediate	 haem	 iron	 uptake	 according	 to	 studies	 using	 labelled	 haem	





Salojin	 et	 al.	 2011).	 In	 human	 cases	 of	 hereditary	 folate	 malabsorption,	 caused	 by	
mutations	in	the	proton	coupled	folate	transporter	gene,	large	doses	of	5‐formylTHF	are	
sufficient	 to	 apparently	 correct	 the	 associated	 haematological	 disorder	 (Geller	 et	 al.	
2002;	Qiu	et	al.	2006).	Mutant	mice	deficient	for	the	proton	coupled	folate	transporter	
have	survival	rates	improved	with	oral	doses	or	injections	of	various	folate	forms,	but	
not	with	 oral	 non‐haem	 iron	 or	 injections	 of	 haem	 iron	 (Salojin	 et	 al.	 2011).	 Oral	 5‐
methylTHF	completely	rescues	the	anaemia	in	these	mutant	mice	(Salojin	et	al.	2011).	
Serum	and	hepatic	iron	are	increased	in	these	mutant	mice,	which	the	authors	propose	
to	be	due	 to	diminished	 iron	use	when	haemoglobin	 synthesis	 is	 lower	 (Salojin	et	 al.	
2011).	 In	 the	 mouse	 duodenum,	 the	 mRNA	 transcripts	 of	 the	 proton	 coupled	 folate	
transporter	 are	 not	 modulated	 by	 iron	 (deficiency	 or	 loading	 conditions),	 but	 the	
cellular	 location	 is,	with	 it	 ranging	 from	predominantly	 apical	membrane	 under	 iron	
deficient	 diets	 to	 cytoplasmic	 location	 under	 iron‐loaded	 conditions	 (Shayeghi	 et	 al.	
2005).	 In	 a	 human	 intestinal	 cell	 line	 higher	 haem	 iron	 concentrations	 in	 the	media	
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down‐regulate	 proton	 coupled	 folate	 transporter	 mRNA	 (Le	 Blanc	 et	 al.	 2012),	 and	
inhibition	of	 the	 translation	of	 this	 transporter	 results	 in	 lower	haem	 iron	and	 folate	
uptakes	 (Laftah	 et	 al.	 2009;	 Le	 Blanc	 et	 al.	 2012).	 In	 the	 retina	 and	 retinal	 pigment	
epithelium	 cells	 there	 is	 higher	 expression	 of	 proton	 coupled	 folate	 transporter	
transcripts	in	mutant	mouse	models	of	haemochromatosis,	than	in	the	wild	type	strain	
(Gnana‐Prakasam	et	al.	2011).	Due	to	the	high	bioavailability	of	haem	iron,	in	Western	
societies	 haem	 iron	 intake	 makes	 up	 two‐thirds	 of	 the	 total	 iron	 stores	 in	 spite	 of	
constituting	only	one‐third	of	 the	 ingested	 iron	 (West	and	Oates	2008).	Although	 the	
role	of	the	proton	coupled	folate	transporter	in	intestinal	haem	iron	uptake	is	not	well	
defined,	 a	 competitive	 inhibition	 might	 exist	 between	 haem	 iron	 and	 folate	 at	 the	
intestinal	absorption	site.	
Iron	uptake	in	human	thyroid	slices	incubated	in	sera	with	59Fe	was	not	correlated	with	
serum	 folate	 (Buchanan	 1971).	Non‐haem	 iron	 and	 folic	 acid	 seem	not	 to	 interact	 in	




perfusion	 experiments	 using	 the	 equivalent	 dose	 of	 folic	 acid	 to	 1000µg	 and	 iron	
(ferrous	 sulphate)	 equivalent	 to	 6.4,	 64	 or	 300mg	 in	 humans	 (Campbell	 et	 al.	 1994).	
Iron	 uptake	 was	 higher	 in	 human	 intestinal	 cell	 cultures	 incubated	 with	 media	
(containing	iron,	zinc	and	vitamin	A)	with	added	folic	acid	and	ascorbic	acid	compared	
to	the	basic	media	alone.	This	effect	was	specific	to	an	experiment	using	a	high‐phytate	
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iron	 status.	 Higher	 iron	 (ferrous	 citrate)	 absorption	 and	 plasma	 iron	 concentrations	
were	observed	in	rabbits	 fed	a	 folate	deficient	compared	to	normal	diet	 for	10	weeks	
and	 both	 parameters	 returned	 to	 normal	 following	 intramuscular	 injection	 of	 15mg	
folic	acid	(Celada	et	al.	1979).	In	the	previously	mentioned	clinical	trial	of	zinc	depletion	
in	 8	 healthy	USA	men,	 there	were	 no	 differences	 in	 total	 iron	 absorption	 (haem	 and	
non‐haem),	 serum	 iron,	 total	 iron	 binding	 capacity,	 serum	 transferrin	 or	 ferritin	
between	the	group	supplemented	with	400µg	folic	acid	every	other	day	for	5‐6	months	
and	 the	 unsupplemented	 group	 (Milne	 et	 al.	 1984).	Higher	 serum	 iron	was	 reported	
two	 hours	 after	 receiving	 a	 single	 oral	 dose	 (100mg/Kg	 body	 weight)	 of	 folic	 acid	
compared	to	no	folic	acid	in	mice	(Hamed	et	al.	2009).	The	authors	proposed	folic	acid	
mobilises	tissue	iron	stores	towards	the	blood.	
In	 a	 USA	 observational	 study,	 no	 differences	 in	 total	 iron	 concentrations	 in	 amniotic	





dams	 suggesting	 a	 lack	 of	 foetal	 programming	 effect	 by	 folic	 acid	 on	 postnatal	 iron	
status	(Król	et	al.	2011).	
Effect	of	choline	on	iron	uptake	and	status	
Substituting	 sodium	 chloride	 by	 choline	 chloride	 in	 the	 medium	 in	 which	 mouse	
duodenal	 fragments	 were	 incubated	 led	 to	 no	 changes	 in	 intestinal	 iron	 absorption	
suggesting	 that	 choline	 probably	 does	 not	 interfere	 with	 the	 intestinal	 reduction	 of	
non‐haem	 iron	 in	 the	 ferric	 state	 and	 its	 subsequent	 absorption	 (Raja	 et	 al.	 1989).	
There	are	in	vitro	reports	based	on	spectrophotometry	showing	that	choline	and	non‐
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perfusate	 had	 been	 substituted	 with	 choline	 (Wright	 et	 al.	 1988).	 The	 choline	
concentration	 used	 in	 the	 perfusate	 in	 this	 experiment	 was	 much	 greater	 than	 the	
physiological	 (≈105µM)	 (Zeisel	 et	 al.	 1989).	 In	 the	 study	 of	 female	 rats	 fed	 a	 choline	
deficient	diet	to	induce	liver	steatosis	of	Batey	and	Johnson,	lower	hepatic	transferrin‐
bound	 iron	 (Fe3+)	 uptake	 was	 detected	 as	 59Fe	 signal	 in	 the	 liver	 6	 hours	 after	 an	
injection	in	the	tail	vein	of	400µg/mL	transferrin	(50%	saturation)	(Batey	and	Johnston	
1993).	This	 is	 a	physiological	dose	of	 transferrin	 (≈475µg/mL	 in	 rat	 serum)	 (Gentry‐
Nielsen	et	al.	2001).	Therefore,	the	study	with	the	best	replication	of	in	vivo	conditions	




1995).	 It	 was	 proposed	 that	 phosphatidylcholine	 lowers	 RBC	membrane	 cholesterol	
and	 that	 this	 affects	 expression	 and/or	 mobility	 of	 the	 ovotransferrin	 receptors	
(D’Andrea	et	al.	1995).	
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‐	 Polymorphisms	 in	 1C	 metabolism	 genes	 affect	 1C	 analyte	 concentrations	 during	
pregnancy	and	pregnancy	outcome.		
Subhypotheses	
‐	 The	 effects	 of	 the	 polymorphisms	 (MTHFR	 c.665C>T,	 BHMT	 c.716G>A,	 SLC19A1	
c.80G>A	and	MTRR	c.66A>G)	on	the	analytes	are	modulated	by	folate	status.		








‐	 To	 analyse	 the	 associations	 between	 1C	 metabolism	 polymorphisms	 and	 1C	
metabolism	analytes	during	pregnancy	and	pregnancy	outcome.	
Specific	objectives	
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‐	 To	 investigate	 whether	 folate	 status	 modulates	 the	 effect	 of	 the	MTHFR	 c.665C>T,	
BHMT	c.716G>A,	SLC19A1	c.80G>A,	and	MTRR	c.66A>G	maternal	polymorphisms	on	1C	
metabolism	analytes	other	than	plasma	and	RBC	folate,	in	the	RTBC.	
‐	 To	 assess	 whether	 the	MTHFR	 c.665C>T,	 BHMT	 c.716G>A,	 SLC19A1	 c.80G>A,	 and	
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is	 an	 ongoing	 observational	 longitudinal	 cohort	 study.	 It	 is	 being	 carried	 out	 by	 the	
Area	of	Preventive	Medicine	and	Public	Health	of	the	Universitat	Rovira	i	Virgili	(URV);	
and	 the	 Areas	 of	 Obstetrics	 and	 Gynaecology	 of	 the	 University	 Hospitals:	 Sant	 Joan,	
Reus	 and	 Joan	 XXIII,	 Tarragona	 (Spain).	 Ethics	 approval	 was	 granted	 by	 the	 Ethics	
Committees	 of	 both	 hospitals	 in	 accordance	 with	 the	 Helsinki	 Declaration	 (World	
Medical	Association	2013).	The	global	aim	of	the	study	is	to	investigate	the	associations	
between	maternal	and	paternal	nutritional,	genetic,	medical	and	other	environmental	
factors	 and	 placental	 function,	 pregnancy	 outcome	 and	 offspring	 health	 and	
development.	The	pregnancy	phase	of	the	study	is	considered	in	this	thesis.	
Participants	 are	women	whose	pregnancies	 are	monitored	 in	 the	 Sant	 Joan	 and	 Joan	
XIII	 hospitals.	 The	 population	 is	 not	 exposed	 to	mandatory	 folic	 acid	 fortification	 as	
such	 a	 policy	 is	 absent	 in	 Spain.	 From	 January	 2005	 to	 October	 2014,	 626	 women	
joined	the	study.	
Participant	 recruitment	 was	 carried	 out	 by	 the	 obstetricians	 at	 the	 first	 antenatal	
check‐up.	Eligible	participants	were	informed	about	the	study	and	required	to	provide	
signed	 consent	 on	 acceptance	 to	 participate.	 Participants	 with	 a	 viable	 singleton	
pregnancy	confirmed	by	ultrasonography	and	that	provided	 their	 first	prenatal	blood	
sample	 before	 or	 at	 12	 GW	 were	 eligible	 to	 participate.	 Exclusion	 criteria	 included 
chronic	 diseases,	 surgical	 interventions	 and	 medical	 treatment	 affecting	 nutritional	
status	or	1C	metabolism.	
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In	 line	with	 the	recommendations	of	 the	Spanish	Obstetrics	and	Gynaecology	Society,	
women	were	recommended	to	take	400µg	folic	acid	supplements	daily	until	the	end	of	
the	 first	 trimester	 (Dirección	 General	 de	 Salud	 Pública	 (Ministerio	 de	 Sanidad	 y	
Consumo	‐	Gobierno	de	España)	2001).	The	recommended	supplements	also	contained	
2µg	 cyanocobalamin.	 The	 regional	 pregnancy	 guidelines	 recommend	 folic	 acid	
supplements	to	be	taken	from	four	weeks	before	conception	(Direcció	General	de	Salut	









are	 the	 first	 and	 second	 food	 frequency	 questionnaires.	 Q1	 and	 Q2	 are	 the	 first	 and	 second	 lifestyle	
questionnaires.
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Maternal	 blood	 samples	 are	 collected	 from	 the	 antecubital	 vein.	 The	 umbilical	 cord	
blood	sample	 is	collected	 from	the	umbilical	vein	of	 the	cleaned	cord	before	placenta	
expulsion	following	the	protocol	 for	cord	blood	and	stem	cell	sample	collection	of	the	
participating	 hospitals.	 Dipotassium	 ethylenediaminetetraacetate	 (K2EDTA)	
Vacutainer®	 tubes	 (Becton	 Dickinson)	 are	 used	 for	 all	 blood	 samples.	 Fasting	 blood	
samples	are	collected	at	≤12,	24‐27	and	34	GW.	Initially	another	sample	was	collected	
at	 15	GW	but	 this	 has	 since	 been	 omitted	due	 to	 changes	 in	 prenatal	 care	 protocols.	
Blood	 samples	 collected	 on	 admission	 to	 hospital	 with	 confirmed	 labour	 (or	 labour	
induction,	or	planned	caesarean	section)	are	not	necessarily	fasting	(Figure	12).	




of	 collection	 to	 avoid	 artefacts	 in	 the	 concentrations	 of	 1C	 analytes.	 In	 the	 case	 of	
University	Hospital	Joan	XXIII,	blood	samples	are	processed	in	the	research	laboratory	
of	 the	 hospital.	 In	 the	 case	 of	 University	 Hospital	 Sant	 Joan,	 blood	 samples	 are	
processed	in	the	Institut	d’Investigació	Sanitària	Pere	Virgili	(IISPV)	Biobank.		
For	the	RBC	folate	determination	(≤12,	15,	24‐27	and	34	GW),	50µl	of	whole	blood	is	
removed	 from	 the	 K2EDTA	 tube	 before	 centrifugation	 and	 diluted	 in	 450µl	 freshly	
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lysate	 is	 stored	 at	 ‐80ºC	 in	 two	 separate	 aliquots.	 These	 aliquots	 and	 the	 plasma	





DNA	 is	 extracted	 from	 these.	 After	 the	 plasma	 has	 been	 removed,	 PBS	 [Phosphate	
Buffered	Saline:	8g	NaCl	(Panreac),	0.2g	KCl	(Panreac),	0.24g	KH4PO4	(Panreac),	1.44g	





2000g	 for	5	minutes	and	the	supernatant	 is	discarded.	The	removal	of	 lysated	RBC	 is	
also	aided	with	several	soft	washings	of	the	pellet	edges	with	haemolysis	solution.	The	
pellet	 is	 then	 resuspended	 to	 20ml	 haemolysis	 solution,	 and	 centrifuged	 and	
supernatant‐discarded	 as	 previously	 described.	 This	 process	 yields	 a	 buffy	 pellet	 of	
total	leukocytes,	which	is	resuspended	to	450µl	PBS	and	finally	placed	in	a	Falcon	tube	
with	 10ml	 of	 Cell	 Lysis	 Solution	 (Qiagen).	 The	 Falcon	 tube	 is	 stored	 in	 dark	 at	 room	
temperature	during	a	varying	time	ranging	from	one	month	to	18	months.	
DNA	is	extracted	 from	maternal	and	cord	 leukocytes	with	 the	Gentra	Puregene	Blood	
Kit	(Qiagen).	The	following	reagents	of	this	kit	are	used:	Protein	Precipitation	Solution	
and	DNA	Hydration	Solution.	First,	3.33ml	of	Protein	Precipitation	Solution	are	added	
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minutes	 incubation	 on	 ice,	 the	 mixture	 is	 centrifuged	 at	 4ºC	 and	 at	 2000g	 for	 15	
minutes.	The	supernatant	is	gently	mixed	with	10ml	100%	isopropyl	alcohol	(Fluka)	at	
4ºC	 in	 a	Falcon	 tube,	discarding	 the	pellet	 of	precipitated	proteins.	When	 the	DNA	 is	
visible,	 the	 tube	 is	 centrifuged	 at	 4ºC	 and	 2000g	 for	 5	 minutes.	 The	 supernatant	 is	
discarded	before	adding	10ml	70%	ethanol	(Merck)	at	4ºC	and	mixing	gently.	Then	the	
mixture	is	centrifuged	at	4ºC	and	2000g	for	5	minutes	discarding	the	supernatant,	and	
the	 tube	 is	 left	 face	 down	 on	 blotting	 paper	 for	 the	 precipitated	 DNA	 pellet	 to	 dry	
during	30‐40	minutes.	The	dried	DNA	pellet	is	rehydrated	by	incubation	with	1200µl	of	










was	 reported	 that	after	a	 standard	dinner	 (50g	protein	 content)	 the	 concentration	of	
plasma	 tHcy	 increases	 14.6%	 (Guttormsen	 et	 al.	 2004).	 In	 a	 small	 trial,	 women	 that	
took	a	 ready‐to‐eat	 cereal‐containing	breakfast	had	an	11%	 increase	 in	plasma	 folate	
concentrations	after	two	hours	(Noy	et	al.	2002);	RBC	folate	was	not	assessed,	although	
the	authors	deem	 its	 concentration	 could	not	 change	due	 to	RBC	 folate	being	 a	 long‐
term	 folate	 status	 indicator.	 A	Norwegian	 study	 reported	 higher	 plasma	 betaine	 in	 a	
group	of	 adult	 donors	who	 took	 an	unspecified	 light	 breakfast	 compared	 to	 a	 fasting	
group	(Holm	et	al.	2003).	However,	there	were	more	men	in	the	non	fasting	group	and	
this	 may	 have	 influenced	 the	 reported	 result.	 In	 a	 Northern	 Irish	 study	 only	 in	
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fasting	 individuals	 (Holm	 et	 al.	 2003;	 Svingen	 et	 al.	 2013).	 To	 the	 best	 of	 our	
knowledge,	 the	 only	 reports	 on	 plasma	 cobalamin	 changes	 after	 an	 unsupplemented	
meal	were	 from	an	animal	study.	 In	 this	pig	study,	plasma	cobalamin	decreased	after	
the	 meal,	 reaching	 at	 15h	 after	 the	 meal	 a	 minimum	 value	 of	 29.6%	 less	 than	 the	
premeal	 values	 (Matte	 et	 al.	 2010).	 Therefore,	 concentrations	 in	 the	 non	 fasting	
samples	at	labour,	may	be	so	affected.	
After	blood	sampling,	if	the	blood	fractions,	i.e.	blood	cells	and	plasma	or	serum,	are	not	
separated	 by	 centrifugation	 and	 removed,	 plasma/serum	 tHcy	 has	 been	 reported	 to	
increase	 a	 10%	 per	 hour	 at	 room	 temperature	 (Vester	 and	 Rasmussen	 1991),	 or	 a	
≈2.5%	per	hour	 in	a	cooler	 (Midttun	et	al.	2014).	Another	study	reported	 lower	 tHcy	
increases,	i.e.	1%	or	3%	after	one	hour	at	4ºC	or	at	20ºC,	respectively	(Fiskerstrand	et	
al.	1993).	The	possible	explanation	to	this	Hcy	increase	in	whole	blood	has	been	most	
commonly	homocysteine	 synthesis	and	 release	 from	blood	cells	 (Ubbink	et	 al.	1992).	
Indeed	blood	cells	adenosylhomocysteinase	activity	has	been	reported	to	be	necessary	
for	this	Hcy	increase	(Hill	et	al.	2002).	However,	several	facts	have	led	some	authors	to	





Willems	 et	 al.	 1998;	 Hübner	 et	 al.	 2007),	 in	 vitro	 non‐enzymatic	 synthesis	 of	
homocysteine	from	methionine,	SAM	and	cystathionine	in	EDTA	buffer	with	FeSO4,	and	
higher	 homocysteine	 in	 participants	 subjected	 to	 methionine	 load	 test	 with	 FeSO4	
compared	to	without	it	(Baggott	and	Tamura	2007).	Therefore,	the	increases	of	tHcy	in	
whole	blood	 could	be	due	 to	 two	non‐excluding	 causes:	 synthesis	 and	 exportation	 in	
blood	cells,	and	free	iron‐mediated	non‐enzymatic	synthesis.	In	addition,	tHcy	has	been	
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of	 coagulation	 before	 centrifugation	 (Rasmussen	 and	 Møller	 2000).	 The	 protocol	 of	
RTBC	blood	 samples	 collection	 emphasizes	 that	 the	blood	 sample	 is	 refrigerated	 and	
plasma	is	isolated	before	one	hour	of	the	extraction.	
1.2.2. Placenta	samples	
After	 expulsion,	 placentas	 are	weighed	 and	 stored	 in	 black	 polyethylene	 bags	 at	 4ºC	
until	collected	by	a	member	of	the	RTBC	team	and	transported	by	cooler	to	the	Faculty	
of	 Medicine	 and	 Health	 Sciences	 (URV).	 Due	 to	 space	 constraints	 placentas	 from	
suspected	 IUGR	 pregnancies	 were	 initially	 targeted	 (see	 also	Material	 and	methods	
point	 1.4),	 and	 periodically	 placentas	 from	 control	 pregnancies	 were	 collected	 to	
represent	collections	across	the	timeframe	of	the	field	work	of	the	RTBC	study.	
When	starting	the	processing,	the	placenta	is	positioned	in	a	plastic	tray	always	in	the	
same	manner,	as	described	next.	The	reason	 for	 this	systematic	positioning	 is	 to	 take	
triangular	 sections	 from	 the	 same	 region	 in	 all	 the	 analysed	 placentas.	 First	 the	
placenta	is	positioned	foetal	side	up	and	maternal	side	down	on	the	tray	using	stainless	
steel	Adson	and	dissection	forceps	(Figure	13).	
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A.	Top	view	photograph	with	 foetal	 surface	 shown.	Note	 the	 foetal	 surface	has	a	violet	 colour,	 is	 scored	
with	vessels	and	the	cord	protrudes	from	this	side.	B.	Side	view	scheme	with	the	positioning	of	the	placenta	
in	the	tray.	
From	 above,	 the	 placenta	 is	 positioned	 to	 include	 as	 the	 vertical	 axis	 the	 shortest	
distance	 from	 the	 protruding	 cord	 to	 the	 edge	 of	 the	 placenta.	 If	 the	 cord	 does	 not	
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from	 the	 cord	 insertion	 point	 to	 the	 edge	 of	 the	 placenta	 (Figure	 14.	 B).	 As	 the	
triangular	 section	 contains	 the	 complete	 thickness	 of	 the	 organ,	 the	 chorionic	 plate	
with	the	amnion	on	top	of	it	(foetal	surface)	is	included,	as	well	as	the	basal	plate	with	
the	decidua	basalis	 (maternal	 surface).	The	 thickness	of	 term	placentas	 in	 the	 central	
region	 is	 usually	 about	 2.5cm.	 The	 triangular	 section	 length	 from	 the	 cord	 insertion	
point	to	the	edge	of	the	placenta	varies	among	placentas.	The	width	varies	according	to	
the	thickness	and	length	of	the	triangular	section,	which	are	fixed	parameters	for	each	
placenta	placed	 in	the	reference	position,	and	this	width	 is	 the	maximum	possible	 for	
the	specimen	to	be	stored	appropriately	 in	a	20ml	screw‐capped	flask	(Deltalab).	The	
width	of	the	part	of	the	triangular	section	that	corresponds	with	the	edge	of	the	organ	






at	 20	GW	and	32	GW.	 In	 the	 first	 questionnaire	 information	 is	 collected	 to	 cover	 the	
period	 from	preconception	 to	20	GW.	The	second	questionnaire	at	32	GW	covers	 the	
time	 range	between	20	GW	to	32	GW.	 In	 these	questionnaires	 information	 related	 to	




names	of	 the	vitamin	supplement	products	which	are	sold	 in	Spain	 is	use	 to	help	 the	
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illegal	 drug	 use	 during	 the	 pregnancy	 and	 12	 months	 before	 it,	 is	 recorded.	 This	
information	 includes	 frequency	 categories	 (cigarettes	 per	 day,	 drinks	 per	 week,	 and	
illegal	 drug	 use	 habitually	 or	 occasionally),	 timing	 of	 cessation	 before	 or	 during	
pregnancy,	and	type	of	illegal	drug.		










Age,	height,	weight	at	 the	 first	antenatal	check‐up	and	parity	 (number	of	 term	births,	
preterm	births,	abortions	and	living	children)	data	from	the	participant	are	collected.		
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 







Systolic	 and	 diastolic	 blood	 pressure	measurements	 taken	 at	 the	 prenatal	 check‐ups	
are	recorded.		
The	recommendations	of	the	regional	pregnancy	guidelines	(Direcció	General	de	Salut	




gestational	 diabetes,	 previous	 obstetrical	 pathology,	 obesity),	 and	 are	 tested	 with	
glucose	challenge	tests	at	the	first	antenatal	check‐up,	at	24‐28	GW	and	at	30‐32	GW;	
unless	one	of	the	tests	give	a	positive	result.	Regardless	of	if	the	women	are	at	risk	or	
not,	 a	 confirmed	 suspicion	 of	 gestational	 diabetes	 is	 further	 checked	 to	 a	 confirmed	
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Plasma	 samples	 were	 sent	 frozen	 to	 BeVital	 A/S	 laboratories	 (Norway)	 as	 0.5mL	
aliquots	 on	 dry	 ice	 for	 tHcy,	 folate,	 betaine,	 DMG,	 cobalamin	 and	 cotinine	
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in	 the	present	determination.	Total	 homocysteine	 is	derivatised	and	extracted	 in	one	
step	 with	 methylchloroformate	 and	 toluene,	 respectively.	 Finally	 the	 derivatives	 are	
determined	 with	 GC‐MS	 (Windelberg	 et	 al.	 2005).	 The	 within‐day	 and	 between‐day	





Scott	 1997)	 in	 BeVital	 analytical	 platform	 F.	 This	 assay	 allows	 the	 use	 of	 disposable	
laboratory	 ware	 and	 removes	 the	 need	 for	 autoclaving	 due	 to	 the	 resistance	 of	 the	
strain.	The	principle	of	this	assay	is	the	increase	in	turbidity	 in	parallel	to	the	L.	casei	
growth,	 which	 depends	 on	 the	 concentration	 of	 folate	 forms	 in	 the	 media.	 As	 a	
clarification,	 for	 the	 case	 of	 RBC	 folate,	 the	 concentration	 obtained	 in	 this	 assay	 is	
indeed	the	ascorbic	acid	lysated	whole	blood	folate	concentration,	and	is	converted	to	
RBC	 folate	concentration	as	specified	 in	Material	and	methods	point	3.2.	This	assay	 is	
widespread	used	and	considered	superior	 than	protein‐binding	assays,	 and	 the	WHO	
has	recommended	 it	 for	RBC	 folate	determination	(World	Health	Organization	2015).	
The	plasma	folate	within‐day	and	between‐day	coefficient	of	variation	are	4%	and	5%,	
respectively,	and	the	lower	limit	of	detection	is	2nmol/L	(BeVital	A/S	2016).	
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Mass	 Spectrometry	 (LC‐MS/MS)	 in	 BeVital	 analytical	 platform	 C.	 Briefly,	 a	 protein	
precipitation	 step	 with	 acetonitrile	 is	 carried	 out.	 Then	 high	 performance	 liquid	
chromatography	 (HPLC)	 with	 a	 Fortis	 Phenyl	 column	 (Fortis	 Technologies)	 and	 a	
mobile	 phase	 of	 methanol	 and	 acetic	 acid	 is	 performed,	 prior	 to	 the	 tandem	 mass	
spectrometry	 (Midttun	 et	 al.	 2013).	 The	 betaine	 within‐day	 and	 between‐day	
coefficient	 of	 variation	 are	 6‐7%	 and	 8‐10%,	 respectively	 and	 the	 lower	 limit	 of	
detection	 is	0.5µmol/L.	The	DMG	within‐day	and	between‐day	coefficient	of	variation	
are	2.8‐3.4%	and	4.5‐5.6%,	respectively	and	the	lower	limit	of	detection	is	1.25µmol/L.	
The	 choline	 within‐day	 and	 between‐day	 coefficient	 of	 variation	 are	 3%	 and	 4%,	
respectively	and	the	lower	limit	of	detection	is	1µmol/L	(BeVital	A/S	2016).	
Plasma	cobalamin	determination	
Plasma	 cobalamin	 was	 determined	 by	 automated	 microbiological	 assay	 with	 the	
colistin	 sulphate‐resistant	 Lactobacillus	 leichmannii	 strain	 NCIB	 12519	 (Kelleher	 and	
Broin	1991)	 in	BeVital	analytical	platform	F.	 In	this	assay	aseptic	precautions	are	not	
necessary	 due	 to	 the	 resistance	 of	 the	 strain.	 The	 effect	 of	 antibiotic	 treated	 patient	
samples	 on	 the	 assay	 is	 removed	 by	 adding	 β‐lactamase	 enzyme	 to	 the	 media.	 The	
principle	 of	 this	 assay	 is	 the	 increase	 in	 turbidity	 in	 parallel	 to	 the	 L.	 leichmannii	
growth,	 which	 depends	 on	 the	 concentration	 of	 cobalamin	 forms	 in	 the	 media.	 The	
within‐day	and	between‐day	coefficient	of	variation	are	4%	and	5%,	respectively.	The	
lower	limit	of	detection	is	30pmol/L	(BeVital	A/S	2016).	
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Plasma	 cotinine	 was	 determined	 by	 Liquid	 Chromatography	 ‐	 tandem	 Mass	
Spectrometry	 (LC‐MS/MS)	 in	 BeVital	 analytical	 platform	 D.	 Cotinine	 is	 a	 marker	 of	
tobacco	 exposure	 after	 up	 to	 3‐4	 days	 ago	 (Benowitz	 1996).	 Briefly,	 after	 a	 protein	











Lyophilised	 aliquots	 of	 120ng	 of	 total	 leukocyte	 DNA	 were	 sent	 to	 BeVital	 for	
polymorphism	determinations.		
The	 SNPs	 determined	 for	 this	 thesis	 were	 MTHFR	 c.665C>T	 (rs1801133),	 BHMT	
c.716G>A	 (rs3733890),	 SLC19A1	 c.80G>A	 (rs1051266)	 and	 MTRR	 c.66A>G	
(rs1801394).	 The	 technique	 is	 a	 high‐level	 multiplex	 genotyping	 by	 Matrix‐Assisted	
Laser	Desorption/Ionization	Mass	Spectrometry	(MALDI‐TOF	MS),	as	described	(Meyer	
et	al.	2004).	Briefly,	the	DNA	regions	containing	the	SNPs	of	interest	are	amplified	using	
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multiplex	 PCR	 in	 the	 first	 step.	 Then	 primers	 of	 one	 sense	 anneal	 immediately	
downstream	from	the	polymorphic	position	to	the	amplicons	of	the	previous	step,	and	
to	 these	 primers	 one	 more	 nucleotide	 (a	 dideoxynucleotide)	 is	 added	 in	 a	 DNA	
polymerase	 reaction	 (primer	extension	 reaction	with	Pin‐Point	 format).	That	 is,	 for	 a	
specific	 SNP,	 a	 common	 homozygote	 participant	 will	 have	 one	 type	 of	 extended	
primers,	a	variant	homozygote	the	other	type	of	extended	primers,	and	a	heterozygote	
both	 types.	 These	 primers,	 which	 are	 purified	 prior	 to	 the	 MALDI‐TOF	 MS,	 are	 soft	
ionized	with	a	 laser	beam	(MALDI).	 In	 the	mass	analyser,	 the	 time	 that	 these	 ionized	
primers	 take	 to	 cross	 a	 drift	 tube	 is	 measured	 to	 calculate	 the	mass‐to‐charge	 ratio	
(TOF).	Finally,	the	signal	of	each	primer	(with	its	own	mass‐to‐charge	ratio)	is	recorded	
and	 amplified	 in	 the	 detector,	which	 sends	 this	 information	 to	 the	 data	 processor	 to	
calculate	the	abundance	of	each	primer	(Griffin	and	Smith	2000;	Meyer	et	al.	2004).	
2.3. Placenta	chemical	determinations	
Prior	 to	 the	 trace	 element	 determinations	 by	 Inductively	 Coupled	 Plasma	 ‐	 Mass	
Spectrometry	(ICP‐MS)	or	 Inductively	Coupled	Plasma	‐	Optic	Emission	Spectrometry	
(ICP‐OES),	 placenta	 samples	 were	 washed	 and	 dissected	 to	 obtain	 clean	 and	
representative	 tissue	 blocks,	 and	 digested	 with	 nitric	 acid	 (HNO3)	 and	 hydrogen	
peroxide	(H2O2).	
Washing	and	dissection	of	placenta	samples	
This	 step	was	 carried	out	 in	 the	 Faculty	 of	Medicine	 and	Health	 Sciences	 (URV).	The	
triangular	 sections	 described	 in	Material	 and	methods	 point	 1.2.2	 were	 defrosted	 at	
room	 temperature	 in	 their	 closed	 screw‐capped	 flask.	 The	 section	 was	 placed	 in	 a	
plastic	 tray	 and	washed	 thoroughly	 with	 deionised	water	 (H2O)	 from	 a	 wash	 bottle,	
using	stainless	steel	Adson	and	dissection	forceps	to	handle	the	tissue	(Figure	15.	A).	
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0.5cm	wide	 and	 a	 varying	 length	were	dissected	 from	 the	 foetal	 side	 (Figure	15.	B).	
The	longer	the	section,	the	bigger	the	possibilities	of	doing	more	representative	blocks	








On	 the	dry	plastic	 tray,	blocks	of	≈0.5cm3	volume	and	0.5cm2	 foetal	 surface	were	cut	
from	the	strips:	0.5x1x1	or	1x0.5x1cm	(long,	wide,	thick).	This	is	shown	in	Figure	15.	
D.	A	ruler	was	used	to	measure	the	dimensions	of	the	strips	and	blocks,	but	there	was	
no	 contact	 between	 the	 ruler	 and	 the	 sample	 or	 work	 surfaces	 (Figure	 15.	 E).	 The	
blocks	were	stored	at	‐20ºC	in	acid‐washed	polypropylene	tubes.	
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All	 placentas	 were	 processed	 in	 this	 way	 in	 several	 batches	 of	 placenta	 triangular	
sections	washing	 and	dissecting,	between	14/10/2015	and	19/01/2016.	On	average,	
10	 placenta	 triangular	 sections	 can	 be	 processed	 in	 one	 day	 in	 two	 batches	 of	 5	
placenta	 triangular	 sections.	 The	 forceps	 were	 washed	 with	 deionised	 H2O	 between	
each	placenta.	The	plastic	grid,	tray	and	other	material	is	washed	with	deionised	water	
between	 each	 batch,	 and	 acid‐washed	 weekly.	 The	 procedure	 of	 this	 acid‐washing,	
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the	 following	point	Acid	digestion.	 The	washing	 of	 the	material	with	 deionised	water	
and	 the	 positioning	 of	 the	 strips	 on	 the	 tray	 and	 grid	 ensure	 no	 contact	 between	
placentas	 from	 different	 participants	 occurs.	 Also,	 there	 was	 no	 use	 of	 paper	 in	 the	
procedure	because	paper	can	potentially	contaminate	the	samples	(Rankama	1941).	
We	consider	that	the	placenta	blocks	obtained	from	this	procedure	are	representative	
of	 the	 foetal	side	of	 the	placenta	and	similar	among	them.	They	contain	the	chorionic	
plate	with	the	amnion	on	top	of	it	(foetal	surface),	plus	the	chorionic	villi	closest	to	the	
foetal	side;	and	no	decidua	basalis	(maternal	surface).	They	have	a	similar	proportion	of	
foetal	 surface	 ‐	 volume	 of	 the	 inner	 part	 of	 the	 placenta;	 although	 the	 proportion	 of	
volume	of	the	chorionic	plate	chorion	‐	volume	of	chorionic	villi	could	vary	according	to	
the	 thickness	 and	development	of	 each	placenta.	Keeping	 surface‐volume	proportion,	
selecting	 apparently	healthy	placenta	 areas	 and/or	 areas	without	 features	 that	 could	
affect	trace	element	content,	excluding	hollows,	excluding	decidua	basalis	 in	placentas	
of	 small	 thickness,	 and	 obtaining	 blocks	 which	 do	 not	 separate	 into	 smaller	 pieces;	
make	this	step	hard,	with	usually	only	about	3	representative	blocks	obtained	out	of	a	
triangular	 section.	 All	 the	 blocks	 came	 from	 placenta	 strips	 that	 have	 undergone	 a	
similar	 procedure,	 i.e.	 washing	 and	 time	 on	 the	 grid;	 though	 depending	 on	 the	
dimensions	of	the	strip	(1	or	0.5cm	wide)	more	or	less	tissue	is	exposed	to	the	washing	





at	 room	 temperature	 and	 weighed	 in	 the	 base	 of	 polytetrafluoroethylene	 (PTFE	 or	
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Placenta	 ≈0.5cm3	 1.5	 2	 25‐27 90 24	 50	
Reference	
material	 1ml	 1.5	 2	 3	 90	 24	 50	
Blank	 ‐	 1.5	 2	 4 90 24	 50	
	
The	PTFE	vessels	were	placed	 in	 an	oven	24h	 at	 90ºC.	 In	 all	 the	batches	 a	 yellowish	
transparent	 digestate	was	 obtained	 from	 the	 placenta	 blocks	 and	 reference	material.	
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diluted	 placenta	 digestates.	 Behind	 the	 flasks	 there	 are	 the	 PTFE	 vessels.	 Behind	 the	 vessels	 there	 are	
several	plastic	containers	for	washing	the	material.	
The	surface	of	all	plastic	and	glassware	used	in	the	acid	digestion	is	acid	washed	by	the	
following	 process:	 2	 washes	 with	 distilled	 H2O	 >	 2	 washes	 with	 deionised	 H2O	 >	
overnight	 in	10%	diluted	 suprapure	HNO3	>	2	washes	with	distilled	H2O	>	2	washes	
with	deionised	H2O.	The	PTFE	vessels	cleaning	is	more	thorough:	hot	tap	water	wash	>	
15	 minutes	 sonication	 wash	 with	 distilled	 H2O	 and	 phosphate	 free	 detergent	 >	 tap	
water	wash	>	distilled	H2O	wash	>	8h	 room	 temperature	and	8h	90ºC	 acid	digestion	
with	10%	diluted	suprapure	HNO3	>	distilled	H2O	wash	>	deionised	H2O	wash.	
There	are	several	forms	of	acid	digestion	depending	on	the	acid	or	acids	used	with	or	
without	H2O2	 as	 another	 oxidation	 reagent,	 and	 on	 the	 time	 and	 source	 of	 heat	 plus	
temperature	 degree.	 The	 purpose	 of	 all	 types	 of	 acid	 digestion	 is	 to	 eliminate	 the	
organic	matter	or	convert	it	to	simpler	inorganic	forms	in	solution	(Bolann	et	al.	2007).	
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If	 this	 is	 achieved,	 interferences	 in	 the	 matrix	 (e.g.	 placenta)	 are	 expected	 to	 be	
minimised	 allowing	 the	 further	 trace	 element	 determination	 techniques	 to	 run	
properly,	 e.g.	 without	 differences	 in	 sample	 digestate	 and	 blank	 digestate	 transport	
through	the	inductively	coupled	plasma.	
In	 relation	 to	 the	 reagents	used	 (HNO3	 and	H2O2)	 a	 comment	 can	be	made.	Although	
analysing	 samples	 with	 a	 slightly	 different	 treatment	 (wet	 ashing,	 which	 uses	 open	
vessels),	 a	 study	 has	 reported	 better	 trace	 element	 recoveries	 from	 bovine	 liver	
analysed	by	inductively	coupled	plasma	‐	optic	emission	spectrometry	(ICP‐OES)	when	
using	 HNO3	 with	 perchloric	 acid	 (HClO4)	 than	 HNO3	 with	 H2O2	 (Ward	 et	 al.	 1980).	
However,	HClO4	requires	more	specialised	handling	due	to	its	higher	hazard	level;	and	
when	 analysing	 via	 inductively	 coupled	plasma	 ‐	mass	 spectrometry	 (ICP‐MS),	HClO4	
can	 form	 the	 polyatomic	 ion	 ClO+	 causing	 spectral	 interferences	 in	 the	 technique	
(Subramanian	1996).	
Regarding	 the	 used	 PTFE	 vessels,	 it	 is	 worth	 noting	 the	 closure	 is	 not	 completely	
hermetic,	 therefore	 a	 small	 loss	 of	 volatile	 elements	 such	 as	mercury	 can	 take	 place.	
Also,	 although	 vessels	 made	 of	 PTFE	 are	 of	 widespread	 use,	 some	 authors	 consider	
quartz	vessels	 can	achieve	better	digestions	due	 to	 its	 resistance	 to	 temperature	and	
pressure	 (Subramanian	 1996).	 However,	 quartz	 vessels	 were	 not	 available	 for	 the	
study.	
As	for	the	digestate	dilution	step,	two	main	reasons	account	for	it.	First,	a	concentration	
of	 ≤5%	 HNO3	 was	 requested	 to	 rise	 the	 pH	 to	 non‐detrimental	 levels	 for	 the	 ICP	
equipments.	And	second,	matrix	interferences	of	physical	nature	can	occur	in	the	trace	
element	 determination	 technique	 (especially	 in	 ICP‐MS)	 because	 of	 a	 high	
concentration	of	dissolved	solids	(Bolann	et	al.	2007).	
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This	 step	was	 carried	out	 in	 the	CCiT‐UB	using	a	NexION	350D	 ICP‐MS	 spectrometer	
(PerkinElmer)	(Figure	17.	A).	Placenta	zinc,	copper,	selenium,	iron,	cadmium,	mercury,	
arsenic,	 vanadium,	 chromium,	 lead,	 nickel,	 and	 manganese	 concentrations	 are	
determined	 in	 the	 diluted	 digestates	 with	 this	 technique.	 The	 instrument	 detection	
limits	and	the	method	detection	limits	for	each	element	are	shown	in	Table	9.	Material	
and	 methods	 point	 3.2	 includes	 the	 calculations	 to	 obtain:	 method	 detection	 limit,	
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	 Zn	 Cu	 Se	 Fe	 Cd Hg As V Cr Pb Ni	 Mn	
IDL1	 1	 1	 1	 0.01	 0.05 0.2 0.2 1 0.5 0.1 0.2	 0.5	




into	 ionic	 products;	 by	 hot	 argon‐plasma	 activated	 by	 a	 high‐voltage	 field	 (ICP).	 The	




each	 trace	 element.	 It	 is	 worth	 noting	 the	 NexION	 350D	 ICP‐MS	 spectrometer	 has	 a	
helium	 collision	 reaction	 cell	 to	 avoid	 spectral	 interferences;	 e.g.	 the	 polyatomic	
interferences	of	chlorine	with	arsenic	and	vanadium,	and	of	calcium	with	nickel.	ICP‐MS	





(PerkinElmer)	 (Figure	17.	B).	 Diluted	 digestates	 iron	 concentration	was	 determined	
with	this	technique.	The	Instrument	Detection	Limit	and	the	Method	Detection	Limit	for	
iron	is	shown	in	Table	9.	As	stated	for	ICP‐MS,	the	calculations	are	included	in	Material	
and	methods	 point	 3.2.	 The	 iron	 analysis	 by	 ICP‐OES	 was	 in	 two	 consecutive	 days	
(14/03/2016	and	15/03/2016).	
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 







The	 sample	 was	 hard	 ionized	 by	 hot	 argon‐plasma	 activated	 by	 a	 high‐voltage	 field	
(ICP).	 Then,	 each	 excited	 ion	 emits	 several	 wave	 length	 light	 signals	 depending	 on	
which	 element	 it	 is.	 This	 optic	 emission	was	measured	 and	with	 the	 intensity	 of	 the	
signal,	the	abundance	of	each	element	was	calculated	(OES)	(Klotz	et	al.	2013).	ICP‐OES	
(also	 called	 ICP‐AES,	 Inductively	Coupled	Plasma	 ‐	Atomic	Emission	Spectrometry)	 is	










Participants	 were	 categorised	 as	 first	 trimester	 smokers	 if	 plasma	 cotinine	 was	
>10ng/mL	 in	 the	 ≤12	 GW	 blood	 sample,	 if	 smoking	 during	 the	 first	 trimester	 was	
declared	 in	 the	 habits	 and	 lifestyle	 questionnaires	 or	 if	 it	 was	 recorded	 in	 their	
obstetrical	 history.	 Women	 that	 continued	 to	 smoke	 throughout	 pregnancy	 were	
identified	by	plasma	cotinine	>10ng/mL	in	the	≤24‐27	GW	blood	sample	or	in	the	cord.	
Declaration	of	 continued	smoking	 in	 the	second	 lifestyle	questionnaire	or	a	 record	of	
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continued	 smoking	 on	 the	 obstetrical	 history	 were	 also	 used	 to	 identify	 smokers	
throughout	pregnancy.		
Maternal	first	term	BMI	





pressure	greater	or	equal	 to	90mmHg	at	 least	 in	 two	check‐ups	(6	hours	apart)	after	
the	20th	GW.	
Gestational	diabetes	
Gestational	 diabetes	 participants	 was	 defined	 in	 the	 study	 as	 those	 with	 a	 positive	
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Miscarriage	 is	 the	 loss	 of	 pregnancy	 due	 to	 natural	 causes	 before	 the	 20th	 week	 of	




RBC	 folate	 concentrations	 are	 calculated	 as	 ascorbic	 acid	 lysated	whole	 blood	 folate	
concentration	multiplied	by	 the	dilution	 factor	 (10)	and	divided	by	haematocrit	 (as	a	
decimal)	(Molloy	and	Scott	1997).	
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the	 detection	 limit	 to	 the	 placenta	 samples,	 the	 aimed	 volume	 of	 one	 representative	
block	is	used	because	the	block	weight	was	more	variable.	
Placenta	trace	element	concentration	
First,	 in	 each	 acid	 digestion	 batch	 the	 arithmetic	 mean	 of	 each	 trace	 element	
concentration	in	the	diluted	blanks	digestates	is	calculated.	Whenever	this	blank	mean	





the	 value	 is	 imputed	 as	 half	 the	 detection	 limit	 (middle	 bound),	 and	 the	 placenta	 is	
categorised	as	below	the	detection	limit	for	a	specific	trace	element.		
To	 get	 the	 placenta	 trace	 element	 concentration	 in	 function	 of	 the	 tissue	wet	weight	
(ng/g	 ww,	 except	 for	 iron	 µg/g	 ww),	 the	 result	 of	 the	 background	 subtraction	 is	
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Certified	 reference	 material	 trace	 element	 concentration	 and	 percentage	
recovery		
To	get	 the	 reference	material	 trace	element	 concentration	 in	 function	of	 the	digested	
volume	(ng/ml,	except	for	iron	µg/ml),	the	calculation	is	done	as	in	the	placenta	trace	
element	 concentration,	 including	 the	 imputation	 as	 half	 the	 detection	 limit	 (middle	
bound)	 when	 the	 background	 subtraction	 result	 is	 below	 the	 detection	 limit;	 but	
dividing	 by	 the	 reference	 material	 digested	 volume	 (1ml)	 instead	 of	 the	 placenta	
weight:	




For	 each	 digestion	 batch,	 the	 mean	 of	 the	 three	 reference	 material	 trace	 element	
concentrations	is	calculated.	Then	the	recovery	percentage	of	each	batch	is	calculated	
as	 the	 obtained	 reference	material	 trace	 element	 concentration	mean	 divided	 by	 the	
expected	 reference	 material	 trace	 element	 concentration	 according	 to	 the	
manufacturer,	and	multiplied	for	100:	
	 % 	 100
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cadmium,	 mercury,	 arsenic,	 vanadium,	 chromium,	 lead,	 nickel	 and	 manganese,	 a	
screening	according	to	 two	methodological	criteria	was	used.	For	each	trace	element,	
these	 criteria	 were:	 percentage	 of	 placentas	 below	 limit	 of	 detection	 (LOD,	 as	MDL)	
lower	than	40%,	and	recovery	percentage	within	a	range	of	80‐110%.	RTBC	placenta	
zinc,	 copper,	 selenium,	 iron,	 cadmium,	 mercury,	 arsenic,	 vanadium,	 chromium,	 lead,	
nickel	and	manganese	concentrations,	the	percentage	of	placentas	below	LOD	for	each	
trace	 element,	 and	 the	percentage	 recoveries	 for	 each	 trace	 element;	 are	 reported	 in	
Table	10.	In	the	screening,	cadmium,	mercury,	arsenic,	vanadium,	chromium,	lead	and	
nickel	 concentrations	 were	 below	 the	 LOD	 in	 a	 percentage	 greater	 than	 40%	 of	 the	
placentas;	 while	 vanadium	 and	manganese	 had	 a	 percentage	 recovery	 too	 high.	 The	
selected	 trace	elements	 in	 the	 screening	were	 zinc,	 copper,	 selenium	and	 iron.	These	
four	 trace	 elements	 were	 present	 in	 high	 concentrations	 in	 placenta	 and	 might	 be	
modulated	by	one	carbon	metabolism	analytes	as	detailed	in	Introduction	point	5.	It	is	
worth	 noting	 that	 trace	 elements	 known	 to	 affect	 foetal	 development	 and/or	 to	 be	
affected	 by	 one	 carbon	 metabolism,	 such	 as	 arsenic,	 were	 also	 excluded	 from	 this	
selection.	 Arsenic	 can	 be	 harmful	 in	 the	 placenta	 and	 foetus	 because	 it	 is	 at	 higher	
concentrations	in	placentas	of	LBW	neonates	(Llanos	and	Ronco	2009),	associated	with	
lower	birth	weight	in	mice	studies	(Gutiérrez‐Torres	et	al.	2015),	and	known	to	lower	
SAM	 concentration	 and	 DNA	 methylation	 in	 vitro	 (Zhao	 et	 al.	 1997;	 Reichard	 et	 al.	
2007).	The	arsenic‐induced	1C	metabolism	 imbalances	can	be	due	 to	 the	necessity	of	
methylate	the	metal	for	a	faster	excretion	(Gebel	2002).	In	line	with	this,	homocysteine,	
folate	 and	 cobalamin	 are	 associated	 with	 arsenic	 and	 its	 methylated	 products,	
according	 to	human	 studies	 in	pregnancy	 (Hall	 et	 al.	 2007),	 adulthood	 (Gamble	et	 al.	
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1All	 placenta	 median	 (P25,	 P75)	 and	 arithmetic	 mean	 (95%	 confidence	 interval)	 trace	 element	
concentrations	are	reported	as	ng/g	of	placenta	wet	weight	 (ww);	except	 for	 iron:	µg/g	of	placenta	ww.	
2LOD,	Limit	Of	Detection,	as	lower	instrument	detection	limit.	3Trace	element	recovery	percentages	of	the	
certified	 reference	materials	 (arithmetic	mean	of	 the	9	 batches	where	 the	RTBC	placenta	 samples	were	
digested).	
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 


















the	 results	 section.	 This	 section	 describes	 the	 general	 statistical	 tests	 used	 and	
analytical	strategies.		
Variables	with	 skewed	distributions	were	natural	 log	 transformed	 for	 analyses	using	
parametric	 tests	 (ANOVA,	 ANCOVA,	 Student’s	 t‐test,	 the	 dependent	 variables	 in	




metabolism	 nutrients	 or	 metabolites	 were	 compared	 between	 different	 genotypes	
using	ANCOVA.	Covariables	included	in	the	models	were	gestational	age	at	the	time	of	
blood	 draw.	 Interactions	 between	 genotypes	 and	 plasma	 concentration	 of	 1C	
metabolism	 nutrients	 or	 metabolites	 were	 determined	 by	 including	 the	 product	
genotype*plasma	 concentration	 as	 a	 covariable	 in	 the	 model.	 When	 a	 significant	
interaction	was	observed,	a	stratified	analysis	was	carried	out	and	the	effect	reported	
for	individual	genotypes	or	concentration	level	(for	example	tertiles).	Plasma	nutrient	/	
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ANOVA	 for	 repeated	 measures	 (intersubject	 factor:	 gestational	 age	 at	 blood	 draw;	
intrasubject	 factor:	 genotype).	 Post‐hoc	Bonferoni	 correction	 of	P	 values	 for	multiple	
comparisons	was	applied.		
When	 examining	 the	BHMT	 c.716G>A	 polymorphism,	 the	 betaine‐DMG	 pathway	 and	
the	 SLC19A1	 c.80G>A	 polymorphism	 according	 to	 folate	 status,	 folate	 status	 was	
categorised	at	2	different	points	of	pregnancy	to	allow	for	changes	in	status	due	to	the	
cessation	 of	 folic	 acid	 supplement	 use.	When	 testing	 the	 effects	 of	 low	or	 high	 folate	
status	during	the	most	intense	phase	of	supplement	use	(at	≤12	GW	and	at	15	GW),	it	
was	classified	as	low	when	plasma	folate	was	in	the	lowest	tertile	at	either	of	these	time	
points	 and	was	 classified	as	high	when	 it	was	 in	 the	highest	 tertile	 at	 either	of	 these	
time	 points.	 Similar	 criteria	 were	 applied	 in	 mid‐late	 pregnancy	 to	 plasma	 folate	
determined	at	24‐27	or	34	GW.	





determined	using	multiple	 linear	 regression	analysis.	 In	 all	multiple	 lineal	 regression	
models	tested,	individual	effects	of	independent	variables	were	only	considered	valid	if	
the	global	model	was	significant.	
Correlations	 between	 2	 quantitative	 variables	 were	 determined	 using	 Spearman	
correlation	coefficients.		
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All	 analyses	 were	 performed	 using	 SPSS	 version	 23.0	 for	 windows	 and	 significance	
level	was	set	at	P<0.05.	
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Information	 regarding	 lifestyle,	 habits,	 supplement	 use	 and	 other	 basic	 participant	
characteristics	 is	 reported	 in	Table	11.	 The	 prevalence	 of	 low	 socioeconomic	 status	
was	7.2%	(95%	CI:	5.3,	9.5).	Although	80.8%	(95%	CI:	77.2,	83.9)	of	 the	pregnancies	
were	 declared	 as	 planned,	 only	 34.2%	 (95%	 CI:	 30.2,	 38.3)	 of	 the	 women	 reported	
taking	 preconception	 folic	 acid	 supplements.	 Folic	 acid	 supplement	 use	 in	 the	 first	
trimester	was	reported	by	92.4%	(95%	CI:	90.0,	94.2)	of	participants	but	only	53.1%	
(95%	CI:	48.9,	57.3)	continued	taking	folic	acid	supplements	throughout	pregnancy.	
The	 median	 plasma	 concentrations	 of	 1C	 metabolism	 nutrients	 and	 metabolites	
relevant	to	the	thesis	are	shown	in	Table	11.		
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RTBC	 flow	 chart	 of	 the	pregnancy	phase	 in women	 recruited	between	 January	2005	 and	October	2014.	
*Did	not	show	up	for	expected	prenatal	check‐ups	for	unknown	reasons.	
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Values	 are	 1arithmetic	means	 or	 2percentages	 (95%	 confidence	 interval)	 [sample	 size];	 3based	 on	 total	
income,	occupation	and	education	level	of	both	parents.	
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	 	 Mother	 Cord	
MTHFR	c.665C>T	 	 6031	 433	
	 CC	 34.0	(30.3,	37.9)2	 36.3	(31.9,	40.9)	
	 CT	 48.6	(44.6,	52.6)	 45.4	(40.9,	50.2)	
	 TT	 17.4	(14.6,	20.6)	 18.2	(14.9,	22.2)	
	 C	 58.3	(55.5,	61.0)	 59.0	(55.7,	62.2)	
	 T	 41.7	(39.0,	44.5)	 41.0	(37.8,	44.3)	
BHMT	c.716G>A	 	 603	 434	
	 GG	 48.9	(45.0,	52.9)	 43.1	(38.5,	47.8)	
	 GA	 40.5	(36.6,	44.4)	 48.6	(43.9,	53.3)	
	 AA	 10.6	(8.4,	13.3)	 8.3	(6.1,	11.3)	
	 G	 69.2	(66.5,	71.7)	 67.4	(64.2,	70.4)	
	 A	 30.8	(28.3,	33.5)	 32.6	(29.6,	35.8)	
SLC19A1	c.80G>A	 	 600	 429	
	 GG	 27.7	(24.2,	31.4)	 27.0	(23.1,	31.4)	
	 GA	 45.3	(41.4,	49.3)	 46.2	(41.5,	50.9)	
	 AA	 27.0	(23.6,	30.7)	 26.8	(22.8,	31.2)	
	 G	 50.3	(47.5,	53.2)	 50.1	(46.8,	53.5)	
	 A	 49.7	(46.8,	52.5)	 49.9	(46.5,	53.2)	
MTRR	c.66A>G	 	 599	 431	
	 AA	 28.9	(25.4,	32.6)	 27.8	(23.8,	32.3)	
	 AG	 44.9	(41.0,	48.9)	 45.5	(40.8,	50.2)	
	 GG	 26.2	(22.8,	29.9)	 26.7	(22.7,	31.1)	
	 A	 51.3	(48.5,	54.2)	 50.6	(47.2,	53.9)	
	 G	 48.7	(45.8,	51.5)	 49.4	(46.1,	52.8)	
Values	 are	 1sample	 size;	 2percentages	 (95%	 confidence	 interval).	 Variations	 in	 sample	 size	 for	 SNP	
determinations	in	some	cases	is	due	to	insufficient	DNA	for	the	genotyping	of	multiple	SNPs.	
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Plasma	 and	 RBC	 folate	 and	 tHcy	 throughout	 pregnancy	 and	 in	 cord	 blood	 were	
compared	among	the	maternal	MTHFR	c.665C>T	genotypes	(Table	13).	As	explained	in	
Material	and	Methods	point	1.2,	RBC	folate	was	not	determined	for	samples	collected	at	
labour.	 There	 were	 no	 differences	 in	 plasma	 folate	 among	 genotypes	 at	 any	 time	 of	
pregnancy.	 RBC	 folate	 was	 lower	 in	 participants	 with	 the	MTHFR	 c.665TT	 genotype	
throughout	pregnancy	with	the	exception	of	at	15	GW.	THcy	was	higher	in	the	MTHFR	
c.665TT	genotype	compared	to	the	other	genotypes	throughout	pregnancy	and	in	cord.	
It	was	 also	 higher	 in	 the	MTHFR	 c.665CT	 genotype	 compared	 to	 the	MTHFR	 c.665CC	
genotype	at	≤12GW.		
There	were	no	differences	 in	 the	 longitudinal	 changes	of	plasma	and	RBC	 folate,	 and	
tHcy	among	 the	MTHFR	c.665CT	genotypes.	Plasma	 folate	decreased	between	15	and	
24‐27,	and	between	24‐27	and	34	GW.	RBC	folate	increased	between	≤12	and	15	GW,	
and	 decreased	 between	 15	 to	 24‐27,	 and	 between	 24‐27	 and	 34	 GW.	 Plasma	 tHcy	





plasma	 folate	 at	 labour	 also	 modified	 the	 association	 between	 MTHFR	 c.665C>T	
genotype	and	cord	tHcy	(P	for	interaction:	0.043).		
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 
























































































ANCOVA2	models	 P=0.062	 NS	 P<0.05	 P=0.073	 	 	
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ANCOVA3	models	 P<0.01	 P<0.001	 P<0.001	 P<0.001	 P<0.001	 P<0.05	
Plasma	folate‐
genotype	interaction4	 NS	 P<0.001	 P<0.001
	 P=0.058	 NS	 P<0.05	
RBC	folate‐genotype	
interaction	
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or	 plasma	 folate	 tertiles	 is	 shown	 in	 those	 pregnancy	 time	 points	 where	 significant	
folate	interactions	on	genotype‐tHcy	were	observed	(Figure	19).	No	differences	in	tHcy	
among	 genotypes	 were	 found	 in	 the	 highest	 tertile	 of	 RBC	 folate	 for	 ≤12	 GW,	 or	 of	
plasma	 folate	 for	 15,	 24‐27	GW	 and	 cord	 tHcy.	 Higher	 tHcy	was	 observed	 in	 variant	
homozygotes	than	in	normal	homozygotes	in	the	lowest	plasma	folate	tertiles,	at	24‐27	
GW	and	 in	 the	 cord.	Higher	 tHcy	 in	 variant	homozygotes	 compared	 to	heterozygotes	
was	observed	in	the	lowest	tertile	of	RBC	folate	for	≤12	GW,	or	of	plasma	folate	for	15,	
24‐27	GW	and	cord.		




status:	 RBC	 folate	 tertiles	 at	 ≤12	 GW,	 and	 plasma	 folate	 tertiles	 at	 15,	 24‐27	 GW	 and	 labour.	 GW:	




(n=56),	 CT	 (n=83),	 TT	 (n=31).	With	 cord	 blood	 samples,	 1st:	 CC	 (n=47),	 CT	 (n=72),	 TT	 (n=27);	 2nd:	 CC	
(n=55),	CT	(n=76),	TT	(n=21);	3rd:	CC	(n=55),	CT	(n=70),	TT	(n=28).	Values	are	geometrical	means.	Error	
bars	 represent	 95%	 confidence	 interval.	 Comparison	 between	 genotypes	 were	 made	 using	 ANCOVA	
adjusting	 for	 gestational	 age	 at	 time	 of	 blood	 draw,	 and	 RBC	 folate	 at	 ≤12	 GW	 or	 plasma	 folate	
concentration	at	15,	24‐27	GW	and	labour;	with	posthoc	Bonferroni	correction	for	multiple	comparisons:	
*p<0.05,	**p<0.01,	#p=0.06.		
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4. BHMT	 c.716G>A	 polymorphism,	 plasma	 betaine,	 dimethylglycine,	
dimethylglycine/betaine	ratio	and	tHcy	
Plasma	 betaine,	 dimethylglycine	 (DMG),	 tHcy	 and	 DMG/betaine	 ratio	 according	 to	
maternal	 BHMT	 c.716G>A	 genotype	 throughout	 pregnancy	 and	 in	 cord	 blood	 are	
reported	in	Table	14.	Betaine	and	tHcy	did	not	differ	among	genotypes	at	any	time	of	
pregnancy.	 Lower	 plasma	DMG	was	 observed	 in	 the	BHMT	 c.716AA	 compared	 to	GG	
genotype	 in	 late	 pregnancy	 and	 in	 the	 cord.	 This	was	 also	 true	 for	 the	 heterozygote	
genotype	at	≤12,	15	GW	and	at	labour.	A	lower	DMG/betaine	ratio	was	also	observed	in	
the	 heterozygote	 compared	 to	 homozygote	 common	 genotype	 at	 15	 GW	 and	 in	 the	
homozygote	variant	compared	to	homozygote	common	genotype	at	34	GW.		
In	all	of	the	BHMT	c.716	genotypes,	plasma	betaine	decreased	between	≤12	and	24‐27	






Interactions	 between	 plasma	 folate	 tertile	 based	 category	 and	 the	 effect	 of	 BHMT	
c.716G>A	genotype	on	DMG	were	observed	at	≤12	and	15	GW	and	on	the	DMG/betaine	
ratio	 at	 ≤12	 GW.	 Plasma	 folate	 category	 also	 modified	 the	 association	 between	 the	
BHMT	c.716G>A	genotype	and	plasma	tHcy	at	≤12,	34	GW,	labour	and	in	the	cord	(P	for	
interactions:	0.037,	0.056,	0.057	and	0.019,	respectively).		
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ANCOVA2	models	 NS	 NS	 NS	 NS	 NS	 NS	
Plasma	folate‐genotype	
interaction4	











































ANCOVA3	models	 P<0.05	 P<0.05	 NS	 P<0.01	 P<0.001	 P<0.05	
Plasma	folate‐genotype	
interaction4	
P<0.05	 P<0.05	 NS	 NS	 NS	 NS	
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ANCOVA2	models	 P<0.05	 P<0.05	 NS	 P<0.01	 NS	 P=0.053	
Plasma	folate‐genotype	
interaction4	










































ANCOVA2	models	 NS	 NS	 NS	 NS	 NS	 NS	
Plasma	folate‐genotype	
interaction4	
P<0.05	 NS	 NS	 P=0.056	 P=0.057	 P<0.05	
GW:	gestational	weeks;	NS:	non‐significant.	Sample	size:	plasma	betaine	(n	=	603,	454,	517,	501,	480,	463;	for	≤12,	15,	24‐27,	34	GW,	labour	and	
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based	 categories	 at	 early	 and	 mid‐late	 pregnancy),	 plasma	 betaine	 and	 gestational	 age	 at	 time	 of	 blood	 draw.	 ANCOVA	 Bonferroni	 posthoc:	
***p<0.001,	 *p<0.05,	 versus	 GG;	 †p<0.05,	 §p=0.055,	 versus	 GA.	 4Maternal	 plasma	 folate	 tertile‐based	 categories	 at	mid‐late	 pregnancy	 for	 cord	
analyte‐genotype	 interactions.	 Two‐factor	 repeated	measures	 ANOVA	 (intrasubject	 factor:	 gestational	 age;	 intersubject	 factor:	BHMT	 c.716G>A	
genotype)	followed	by	post	hoc	Bonferroni	correction	for	multiple	comparisons:	ap<0.001,	bp<0.05,	cp<0.01	versus	previous	time	point.	
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A	 stratified	 analysis	 of	 plasma	 DMG,	 DMG/betaine	 ratio	 and	 tHcy	 for	 each	 BHMT	
c.716G>A	genotype	according	to	plasma	folate	status	(tertile	based	categories)	in	early	
or	mid‐late	pregnancy	was	conducted	in	those	pregnancy	time	points	where	significant	
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≤18.6	 or	 20.5nmol/L	 at	 ≤12	 or	 15	 GW	 respectively;	 high:	 ≥35.8	 or	 33.4nmol/L,	 at	 ≤12	 or	 15	 GW	
respectively;	mid)	or	in	the	cord	(low:	≤8.9	or	7.1nmol/L,	at	24‐27	or	34	GW	respectively;	high:	≥17.1	or	






GG	 (n=75),	 GA	 (n=76),	 AA	 (n=14).	 Values	 are	 geometrical	means.	 Error	 bars	 represent	 95%	 confidence	
interval.	Comparison	between	genotypes	were	made	using	ANCOVA	adjusting	for	gestational	age	at	time	of	
blood	 draw,	 plasma	 folate	 concentration	 at	 ≤12,	 15	 GW	 and	 labour,	 and	 in	 the	 case	 of	 dimethylglycine	
analysis	 also	 for	 plasma	 betaine	 at	 ≤12	 or	 15	 GW;	 with	 posthoc	 Bonferroni	 correction	 for	 multiple	
comparisons:	*p<0.05,	**p<0.01,	#p=0.08,	§p=0.07.	
How	 maternal	 plasma	 folate	 status	 (tertile‐based	 categories)	 and	 BHMT	 c.716G>A	
genotype	 are	 associated	with	 plasma	 DMG	 throughout	 pregnancy	 and	 in	 the	 cord	 is	
reported	in	Table	15.	Low	compared	to	mid	(reference	tertile	based	category)	plasma	
folate	was	associated	with	higher	plasma	DMG	throughout	pregnancy	and	in	the	cord.	
High	 compared	 to	mid	 plasma	 folate	 status	 was	 associated	 with	 lower	 plasma	 DMG	
from	mid	 pregnancy	 throughout	 the	 rest	 of	 pregnancy	 although	 the	 association	was	
only	significant	at	34	GW.	Compared	to	the	normal	homozygote	BHMT	c.716	genotype	
(GG),	 both	 variant	 GA	 and	 AA	 genotypes	 were	 associated	 with	 lower	 plasma	 DMG	
throughout	 pregnancy.	 The	 observed	 associations	 are	 stronger	 in	 the	 case	 of	 the	
variant	homozygote	genotype	(AA)	during	late	pregnancy	and	in	the	cord.	
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Table	15.	Change	 in	plasma	dimethylglycine	according	 to	plasma	 folate	category	and	
maternal	BHMT	c.716G>A	genotype.	
	 Model	 Plasma	folate	category1	 BHMT	c.716G>A	genotype	
	 R2	 F	[n]	 Low	vs	Mid	 High	vs	Mid	 GA	vs	GG	 AA	vs	GG	
≤12	GW	 18.3 12.3	[455]***	 0.08	(0.04)2	 ‐0.01	(0.04)	 ‐0.09	(0.03)**	 ‐0.07	(0.06)	
15	GW	 13.9 8.4	[420]***	 0.10	(0.05)*	 0.03	(0.05)	 ‐0.08	(0.03)*	 ‐0.10	(0.06)#	
24‐27	GW	 13.8 9.8	[494]***	 0.13	(0.04)**	 ‐0.03	(0.05)	 ‐0.06	(0.04)	 ‐0.09	(0.06)	
34	GW	 21.9 15.8	[476]***	 0.15	(0.05)**	 ‐0.09	(0.05)*	 ‐0.07	(0.04)	 ‐0.20	(0.06)***
Labour	 19.0 13.1	[463]***	 0.16	(0.05)**	 ‐0.04	(0.05)	 ‐0.10	(0.04)*	 ‐0.22	(0.07)**	
Cord	 10.6 6.7	[436]***	 0.16	(0.05)**	 0.06	(0.04)	 ‐0.06	(0.04)§	 ‐0.12	(0.06)*	
GW:	 Gestational	 weeks.	 Multiple	 linear	 regression	 analysis:	 dependent	 variable	 plasma	 dimethylglycine	
(µmol/L).	 Adjusted	 for	 plasma	 betaine	 and	 gestational	 age	 at	 time	 of	 blood	 draw.	 1Relating	 to	
corresponding	time	of	pregnancy:	≤12	and	15	GW	(low:	≤18.6	or	20.5nmol/L	at	≤12	or	15	GW	respectively;	
high:	≥35.8	or	33.4nmol/L,	at	≤12	or	15	GW	respectively)	or	24‐27	GW	throughout	the	rest	of	pregnancy	
and	 in	 the	 cord	 (low:	≤8.9	or	7.1nmol/L,	 at	24‐27	or	34	GW	respectively;	high:	≥17.1	or	13.4nmol/L,	 at	
24‐27	or	 34	GW	 respectively).	 2B	 coefficient	 (standard	 error).	 *p<0.05,	 **p<0.01,	 ***p<0.001,	#p=0.065,	
§p=0.071.	
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Plasma	 folate,	 RBC	 folate,	 and	 tHcy	 were	 compared	 between	 the	 different	 maternal	
SLC19A1	 c.80G>A	 genotypes	 throughout	 pregnancy	 and	 in	 the	 cord	 (Table	 16).	 No	
differences	were	observed.	
In	all	of	 the	SLC19A1	 c.80	genotypes,	plasma	folate	decreased	between	15	and	24‐27,	
and	 between	 24‐27	 and	 34	 GW.	 In	 all	 of	 the	 SLC19A1	 c.80	 genotypes,	 RBC	 folate	
increased	between	≤12	and	15	GW,	and	decreased	between	15	to	24‐27,	and	between	




between	 SLC19A1	 c.80G>A	 genotype	 and	 tHcy	 was	 tested	 and	 no	 folate‐genotype	
interaction	throughout	pregnancy	or	in	the	cord	was	observed.	
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ANCOVA2	models	 NS	 NS	 NS	 NS	 	 	
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ANCOVA3	models	 NS	 NS	 NS	 NS	 NS	 NS	
Plasma	folate‐genotype	
interaction4	







tHcy‐genotype	 interactions.	 Two‐factor	 repeated	 measures	 ANOVA	 (intrasubject	 factor:	 gestational	 age;	 intersubject	 factor:	 SLC19A1	 c.80G>A	
genotype)	followed	by	post	hoc	Bonferroni	correction	for	multiple	comparisons:	ap<0.001,	bp<0.01,	versus	previous	time	point.	
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 









Plasma	and	RBC	 folate,	plasma	cobalamin	and	 tHcy	 throughout	pregnancy	and	 in	 the	
cord	are	compared	between	the	different	maternal	MTRR	c.66A>G	genotypes	in	Table	
17.	 Plasma	 folate	 was	 lower	 in	 heterozygotes	 at	 ≤12	 GW	 compared	 to	 normal	
homozygotes,	but	no	other	differences	were	observed	between	the	different	MTRR	c.66	
genotypes	for	the	rest	of	pregnancy	or	in	the	cord.	RBC	folate	did	not	differ	between	the	
genotypes.	 Higher	 plasma	 tHcy	 and	 cobalamin	 were	 observed	 in	 the	MTRR	 c.66GG	
compared	to	AA	genotype	at	≤12	and	15	GW,	and	at	24‐27	GW,	respectively.	
In	the	three	MTRR	c.66A>G	genotypes,	plasma	folate	decreased	between	15	and	24‐27,	
and	 between	 24‐27	 and	 34	 GW.	 RBC	 folate	 decreased	 from	 15	 GW	 throughout	
pregnancy	 in	 the	 three	 MTRR	 c.66	 genotypes.	 Plasma	 tHcy	 decreased	 in	 the	 three	
genotypes	 at	 early	 pregnancy,	 started	 increasing	 after	 15	 GW	 for	 AA	 genotype,	 and	
after	 24‐27	 GW	 for	 AG	 and	 GG	 genotypes.	 Plasma	 cobalamin	 decreased	 throughout	
pregnancy	 in	 the	 three	genotypes,	but	 in	AG	 the	decrease	 from	34	GW	to	 labour	was	
borderline	significant	(P=0.062).		
The	 relationship	 between	MTRR	 c.66A>G	 and	 tHcy	was	modified	 by	 plasma	 folate	 at	
≤12,	 15	 and	 24‐27	 GW.	 Plasma	 folate	 also	 affected	 the	 genotype	 effect	 on	 plasma	
cobalamin	at	≤12,	15	and	24‐27	and	34	GW;	although	at	34	GW	the	interaction	did	not	
reach	significance	(P	for	interaction:	0.070).	
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ANCOVA2	models	 NS	 NS	 NS	 NS	 	 	
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ANCOVA3	models	 P<0.05	 P<0.05	 NS	 NS	 NS	 NS	
Plasma	folate‐genotype	
interaction5	











































ANCOVA4	models	 NS	 NS	 P<0.05	 NS	 NS	 NS	
Plasma	folate‐genotype	
interaction5	




cord,	 respectively).	 Sample	 size	 varies	between	 time	points	due	 to	participant	 loss	due	 to	 complications,	 non‐attendance	of	programmed	blood	
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 






age	 at	 time	of	 blood	draw.	 3Adjusting	 for	maternal	 folate	 status	 (plasma	 folate	 concentration	at	 each	 time	point),	 plasma	 cobalamin	 tertile	 and	
gestational	age	at	time	of	blood	draw.	4Adjusting	for	maternal	folate	status	(plasma	folate	concentration	at	each	time	point)	and	gestational	age	at	
time	of	blood	draw.	ANCOVA	Bonferroni	posthoc:	*p<0.05,	versus	AA.	5Based	on	maternal	plasma	folate	concentration	at	labour	for	cord	analyte‐
genotype	 interactions.	Two‐factor	 repeated	measures	ANOVA	(intrasubject	 factor:	 gestational	 age;	 intersubject	 factor:	MTRR	 c.66A>G	genotype)	
followed	by	post	hoc	Bonferroni	correction	for	multiple	comparisons:	ap<0.05,	bp<0.001,	cp<0.01,	versus	previous	time	point.	
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A	 stratified	 analysis	 of	 plasma	 tHcy	 and	 cobalamin	 for	 each	MTRR	 c.66A>G	 genotype	
according	 to	 plasma	 folate	 tertiles	 was	 conducted	 in	 those	 pregnancy	 time	 points	









≤12,	15	 and	24‐27	GW.	B.	Plasma	 cobalamin	at	≤12,	15	 and	24‐27	GW.	GW:	Gestational	weeks;	1st,	 first	
tertile;	 2nd,	 second	 tertile;	 3rd,	 third	 tertile.	 At	 ≤12	 GW,	 1st:	 AA	 (n=45),	 AG	 (n=96),	 GG	 (n=48);	 2nd:	 AA	
(n=54),	AG	(n=88),	GG	(n=56);	3rd:	AA	(n=69),	AG	(n=81),	GG	(n=52).	At	15	GW,	1st:	AA	(n=43),	AG	(n=64),	
GG	(n=38);	2nd:	AA	(n=37),	AG	(n=69),	GG	(n=40);	3rd:	AA	(n=51),	AG	(n=62),	GG	(n=35).	At	24‐27	GW,	1st:	
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genotypes	were	made	 using	ANCOVA	 adjusting	 for	 gestational	 age	 at	 time	 of	 blood	 draw,	 plasma	 folate	
concentration	at	≤12,	15	and	24‐27	GW,	and	in	the	case	of	tHcy	analysis	also	for	plasma	cobalamin	tertile	at	
≤12,	15	and	24‐27	GW;	with	posthoc	Bonferroni	correction	for	multiple	comparisons:	*p<0.05.	
Due	 to	 the	 known	 relationship	 between	 cobalamin	 and	 tHcy,	 and	 cobalamin	 being	 a	
substrate	 for	 MTRR,	 a	 stratified	 analysis	 of	 plasma	 tHcy	 for	 each	 MTRR	 c.66A>G	
genotype	according	to	plasma	cobalamin	tertiles	was	conducted	throughout	pregnancy	
and	 in	 the	 cord.	No	differences	 in	plasma	 tHcy	were	observed	among	MTRR	 c.66A>G	
genotypes	 throughout	 pregnancy	 and	 in	 the	 cord,	 in	 any	 of	 the	 maternal	 plasma	
cobalamin	tertiles	(Figure	22).	
Figure	22.	 Plasma	 tHcy	 according	 to	maternal	MTRR	 c.66A>G	 genotype	 and	 plasma	
cobalamin	tertiles.	
	
Plasma	 tHcy	 throughout	 pregnancy	 and	 in	 the	 cord	 according	 to	maternal	MTRR	 c.66A>G	 genotype	 and	




AG	 (n=77),	 GG	 (n=48);	 3rd:	 AA	 (n=51),	 AG	 (n=68),	 GG	 (n=51).	 At	 34	GW,	 1st:	 AA	 (n=53),	 AG	 (n=70),	 GG	
(n=41);	2nd:	AA	 (n=40),	AG	 (n=90),	GG	 (n=36);	3rd:	AA	 (n=47),	AG	 (n=62),	GG	 (n=54).	At	 labour,	 1st:	AA	
(n=52),	AG	(n=61),	GG	(n=45);	2nd:	AA	(n=42),	AG	(n=86),	GG	(n=31);	3rd:	AA	(n=46),	AG	(n=60),	GG	(n=52).	
In	the	cord,	1st:	AA	(n=48),	AG	(n=60),	GG	(n=42);	2nd:	AA	(n=38),	AG	(n=81),	GG	(n=29);	3rd:	AA	(n=46),	AG	
(n=59),	 GG	 (n=45).	 Values	 are	 geometrical	 means.	 Error	 bars	 represent	 95%	 confidence	 interval.	
Comparison	between	genotypes	were	made	using	ANCOVA	adjusting	for	gestational	age	at	time	of	blood	
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draw,	 plasma	 folate	 and	 cobalamin	 concentrations	 at	 ≤12,	 15,	 24‐27,	 34	 GW	 and	 labour;	 with	 posthoc	
Bonferroni	correction	for	multiple	comparisons.	
7. Maternal	 and	 neonate	 genotypes,	 miscarriage	 and	 intrauterine	 growth	
restriction	
There	were	36	cases	of	miscarriage	and	43	cases	of	IUGR.	Due	to	the	small	number	of	
cases	 of	 congenital	 malformations	 previously	 commented;	 further	 analyses	 of	 the	
associations	 between	 these	 pregnancy	 complications	 and	 MTHFR	 c.665C>T,	 BHMT	
c.716G>A,	SLC19A1	c.80G>A,	MTRR	c.66A>G	polymorphisms	were	not	carried	out.	The	
occurrence	 of	 miscarriage	 according	 to	 maternal	 genotype	 of	 the	 aforementioned	
polymorphisms	is	reported	in	Table	18.	The	prevalence	of	miscarriage	varied	between	
the	 maternal	 SLC19A1	 c.80G>A	 genotypes,	 although	 with	 borderline	 significance	
(p=0.055).	 More	 miscarriages	 were	 observed	 in	 mothers	 with	 the	 SLC19A1	 c.80AA	




c.665C>T	 polymorphism	 in	 the	 cord.	 It	 was	 highest	 in	 the	 presence	 of	 the	MTHFR	
c.665CC	genotype	(normal	homozygote).	
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CC	 5.4	(3.1,	9.4)1	 [203]2	 7.9	(4.9	12.7)	 [189]	 	CC	 10.8	(6.9,	16.7)*	 [157]	
CT	 5.2	(3.2,	8.4)	 [290]	 7.4	(4.8,	11.1)	 [272]	 	CT	 6.1	(3.5,	10.3)	 [197]	
TT	 7.6	(3.9,	14.3)	 [105]	 8.5	(4.4,	15.9)	 [94]	 	TT	 1.3	(0.2,	6.8)	 [79]	
BHMT	
c.716G>A	
GG	 5.8	(3.7,	9.1)	 [293]	 8.1	(5.4,	11.9)	 [272]	 	GG	 5.3	(2.9,	9.6)	 [187]	
GA	 5.0	(2.9,	8.5)	 [242]	 6.7	(4.1,	10.7)	 [225]	 	GA	 8.1	(5.1,	12.5)	 [211]	
AA	 7.9	(3.4,	17.3)	 [63]	 10.3	(4.8,	20.8)	 [58]	 	AA	 8.3	(2.9,	21.8)	 [36]	
SLC19A1	
c.80G>A	
GG	 5.5	(2.9,	10.1)#	 [164]	 7.8	(4.5,	13.2)	 [153]	 	GG	 7.8	(4.1,	14.1)	 [116]	
GA	 3.7	(2.0,	6.7)	 [269]	 7.8	(5.1,	11.8)	 [256]	 	GA	 6.6	(3.9,	10.9)	 [198]	
AA	 9.3	(5.7	14.7)	 [162]	 7.7	(4.3,	3.2)	 [143]	 	AA	 6.1	(3.0,	12.0)	 [115]	
MTRR	
c.66A>G	
AA	 3.5	(1.6,	7.4)	 [172]	 5.6	(3.0,	10.2)	 [162]	 	AA	 4.2	(1.8,	9.4)	 [120]	
AG	 5.6	(3.4,	9.1)	 [266]	 6.9	(4.3,	10.7)	 [247]	 	AG	 8.2	(5.1,	12.8)	 [196]	
GG	 6.4	(3.5,	11.4)	 [156]	 11.7	(7.5,	18.0)	 [245]	 	GG	 7.8	(4.2,	14.2)	 [115]	
1Percentage	 of	 cases	 (95%	 confidence	 interval).	 2Total	 sample	 size	 of	 the	 specific	 genotype.	 Chi	 square	 test,	 different	 frequencies	 between	
genotypes:	*p<0.05;	#p=0.055.	
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The	 observed	 genotype	 frequencies	 (34.0,	 48.6	 and	 17.4%,	 for	 CC,	 CT	 and	 TT,	
respectively)	 were	 similar	 to	 previous	 studies	 in	 Spain	 (Guillén	 et	 al.	 2001;	 García‐
Minguillán	et	al.	2014;	Bueno	et	al.	2016)	although	another	reported	a	lower	frequency	
(7.1%)	 of	 the	 variant	 homozygote	 genotype	 (Ubeda	 et	 al.	 2011).	 No	 apparent	
differences	 regarding	 ethnicity,	 age,	 health	 state	 and	 sampling	 date	 were	 observed	
between	 Ubeda	 et	 al.	 study	 and	 the	 RTBC	 or	 the	 other	 previous	 Spanish	 studies.	




(Botto	 and	 Yang	 2000),	 but	 not	 in	 other	 European	 countries	 (Harmon	 et	 al.	 1996;	
Molloy	et	al.	1997;	Geisel	et	al.	2001;	Castro	et	al.	2003;	Relton	et	al.	2005;	Devlin	et	al.	
2006;	 Fredriksen	 et	 al.	 2007;	 Stanislawska‐Sachadyn	 et	 al.	 2009;	 de	 Lau	 et	 al.	 2010;	
Pavlíková	et	al.	2012).	
Plasma/serum	 folate	 has	 been	 reported	 to	 be	 lower	 in	 MTHFR	 c.665C>T	 variant	
homozygote	 and/or	 heterozygotes	 in	 pregnancy	 studies	 in	 the	 absence	 of	 folic	 acid	
supplement	use	(Parle‐McDermott	et	al.	2006;	Barbosa	et	al.	2008a),	or	when	there	is	
little	folic	acid	use	(Molloy	et	al.	1997).	The	effect	of	the	polymorphism	on	plasma	folate	
was	 no	 longer	 observable	when	 folic	 acid	 supplements	were	 used	 in	 late	 pregnancy	
(Molloy	 et	 al.	 2002).	 In	 a	 Spanish	 study	 conducted	 in	 2000,	 when	 the	 folic	 acid	
supplement	intake	recommendation	to	prevent	NTD	was	beginning,	plasma	folate	was	
lower	 in	 CT	 than	 CC	 in	 the	 second	 and	 third	 trimester	 (Ubeda	 et	 al.	 2011).	 The	
recommendations	are	 to	use	 folic	 acid	 supplements	before	 the	 conception	and	 in	 the	
first	 trimester	 to	 prevent	 NTDs	 (Dirección	 General	 de	 Salud	 Pública	 (Ministerio	 de	
Sanidad	y	 Consumo	 ‐	Gobierno	de	España)	1998;	Dirección	General	 de	 Salud	Pública	
(Ministerio	de	Sanidad	y	Consumo	‐	Gobierno	de	España)	2001).	The	use	of	 folic	acid	
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supplements	during	 the	 second	and	 third	 trimester	may	have	been	 lower	 than	 in	 the	
first	 trimester	 in	Ubeda	et	al’s.	study.	We	have	previously	shown	that	coinciding	with	
the	 decrease	 in	 folic	 acid	 supplement	 use	 after	 the	 first	 trimester,	 plasma	 folate	 falls	
sharply	(although	RBC	folate	increases	during	supplementation	and	then	is	maintained	
more	or	less	stable	at	least	until	34	GW)	(Fernàndez‐Roig	et	al.	2013).	In	line	with	this,	
in	 Ubeda	 et	 al.	 first	 and	 second	 trimester	 serum	 folate	 were	 35.0	 and	 19.8nmol/L	
(Ubeda	et	al.	2011).	In	our	study	most	of	the	participants	took	folic	acid	supplements	in	
the	 first	 trimester,	 and	 half	 on	 them	 continued	 in	 the	 rest	 of	 pregnancy.	We	 did	 not	
observe	 the	 effect	 of	 the	 maternal	 polymorphism	 on	 plasma	 folate	 throughout	
pregnancy	 and	 in	 the	 cord,	 possibly	 due	 to	 the	 widespread	 use	 of	 supplements.	 In	
previous	 studies	 from	 the	 same	geographical	 region	with	a	non	pregnant	population,	
where	 vitamin	 supplement	 users	were	 excluded,	 and	with	 11.5nmol/L	 plasma	 folate	
mean;	lower	plasma	folate	was	associated	with	the	variant	allele	(García‐Minguillán	et	
al.	2014;	Bueno	et	al.	2016).	In	a	postfortification	Brazilian	pregnancy	study	where	half	
the	 sample	 were	 supplement	 users	 (multivitamin	 or	 folic	 acid	 alone),	 24.2nmol/L	
serum	folate	was	the	median	and	25%,	50%	and	25%	of	the	participants	in	first,	second	
and	third	trimester,	respectively;	 lower	serum	folate	was	observed	in	TT	participants	
(Barnabé	 et	 al.	 2015).	 But	 in	 South	 Korean	 pregnant	 women	 at	 24‐28	 GW,	 without	
medications	and	with	17.1nmol/L	 serum	 folate	mean;	 the	effect	on	 serum	 folate	was	
not	observable	(Kim	et	al.	2004).		
In	the	RTBC	plasma	folate	decreased	throughout	pregnancy,	with	similar	pattern	in	the	
three	MTHFR	 c.665C>T	 genotypes.	 Previously	 our	 group	 had	 reported	 this	 decrease	
pattern	 in	RTBC	participants	below	and	above	 the	plasma	 folate	median	 (Fernàndez‐
Roig	et	al.	2013).	As	detailed	in	Introduction	point	2.2,	 there	is	controversy	about	this	
plasma/serum	 folate	 change	 throughout	 pregnancy,	 although	 most	 studies	 found	 a	
decrease.	In	a	clinical	trial	of	folic	acid	supplement	intake	(400µg/d)	continued	in	the	
second	and	third	trimester,	the	intervention	group	had	similar	serum	folate	at	14	and	
36	 GW	 while	 in	 the	 placebo	 group	 serum	 folate	 decreased	 (McNulty	 et	 al.	 2013).	
McNulty	et	al.'s	study	where	folic	acid	 intake	compliance	was	controlled,	may	explain	
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assay	 for	 folate	 determination,	 a	 UK	 pregnancy	 study	 using	 a	 protein‐binding	 assay	
found	higher	RBC	 folate	 in	TT	participants	 (Relton	et	 al.	2005).	We	 found	 lower	RBC	
folate	by	the	microbiological	assay	in	TT	pregnant	women	at	mid‐late	pregnancy;	but	at	
15	GW	this	was	not	significant,	and	at	≤12	GW	it	was	borderline	significant.	RBC	folate	
indicates	 long	 term	 folate	 status	 (the	 previous	 120	 days	 or	 ≈17	 weeks)	 and	 plasma	
folate	 indicates	 recent	 folate	 intake.	 According	 to	 the	 questionnaires,	 in	 spite	 of	 the	
81%	 RTBC	 participants	 planning	 pregnancy,	 34%	 took	 folic	 acid	 supplements	
preconceptionally	 and	 92%	 in	 the	 first	 trimester.	 At	 the	 prenatal	 visit	 at	 ≤12	 GW	 a	





again.	 Our	 group	 previously	 found	 lower	 RBC	 folate	 in	 TT	 non‐pregnant	 population	
with	no	use	of	vitamin	supplements	(Bueno	et	al.	2016).	The	differences	between	both	
assays	 in	 the	 literature	 demonstrate	 that	 the	 SNP	affect	 the	 proportion	 of	RBC	 folate	
forms;	 and	 according	 to	 the	 microbiological	 assay,	 which	 is	 considered	 the	 most	
recommended,	the	SNP	also	lowers	the	RBC	total	folate	(Molloy	et	al.	1998;	Pfeiffer	et	
al.	2010).	Small	studies	analysing	RBC	from	USA	Caucasian	population	have	found:	
‐	More	THF	 and	5,10‐methyleneTHF,	 and	 less	 5‐methylTHF	 in	TT	 than	 in	 CC	women	
(Huang	et	al.	2008)	and	adults	(Summers	et	al.	2010).	
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‐	 Detectable	 amounts	 of	 formylTHF,	 and	 less	 5‐methylTHF	 in	 TT	 than	 in	 CC	women	
(Davis	et	al.	2005).	
The	 MTHFR	 variant	 enzyme	 is	 thermolabile	 and	 has	 lower	 activity	 than	 the	 normal	
enzyme	 (Frosst	 et	 al.	 1995;	 Daly	 et	 al.	 1999),	 maybe	 due	 to	 its	 higher	 homodimer	
dissociation	rate	with	the	subsequent	release	of	its	FAD	cofactor	(Yamada	et	al.	2001).	
An	 impairment	 in	 the	MTHFR	 irreversible	 reaction	 can	 increase	 5,10‐methyleneTHF	
which	 is	 poorly	 polyglutamated	 by	 the	 FPGS	 in	 comparison	 to	 other	 folate	 forms	
(Cichowicz	and	Shane	1987;	Chen	et	al.	1996).	Non‐polyglutamated	folate	would	not	be	
retained	 in	 RBC	 and	 would	 pass	 to	 the	 blood	 plasma,	 although	 we	 did	 not	 observe	
higher	plasma	folate,	and	indeed	other	studies	reported	lower	plasma	concentrations	in	
TT	 individuals	not	 taking	 folic	 acid	 supplements,	 as	previously	 commented.	DHF	and	
10‐formylTHF	are	assumed	to	be	the	starting	compounds	for	folate	catabolism	(Suh	et	
al.	2001),	and	both	can	be	formed	from	5,10‐methyleneTHF.	In	 line	with	this,	authors	
have	 suggested	 increased	 folate	 catabolism	 as	 the	 mechanism	 by	 which	 lower	 RBC	
folate	 is	 observed	 in	 TT	 individuals	 (Parle‐McDermott	 et	 al.	 2006),	 and	 this	 might	
explain	also	the	lower	plasma/serum	folate	associated	with	the	variant	allele	 in	some	
studies.	 Our	 finding	 of	 a	 RBC	 folate	 lowering	 effect	 with	 the	 variant	 homozygote	
genotype	 only	 reaching	 significance	 at	 mid‐late	 pregnancy,	 suggests	 that	 folic	 acid	
supplementation	 use	 pattern	 in	 the	 RTBC,	 and	 folate	 status	 (decrease	 in	 folate	




We	 observed	 a	 similar	 RBC	 folate	 pattern	 in	 the	 three	 genotypes	 in	 the	 RTBC:	 an	




UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 









in	 RBC	 folate	 throughout	 pregnancy	 (Cikot	 et	 al.	 2001;	 Takimoto	 et	 al.	 2007).	 In	 the	
aforementioned	 clinical	 trial	 of	 folic	 acid	 supplement	 intake	 continued	 in	 the	 second	
and	 third	 trimester,	 a	 RBC	 folate	 increase	 from	 14	 to	 36	 GW	 was	 found	 in	 the	
intervention	 group	 while	 in	 the	 placebo	 group	 RBC	 folate	 decreased	 (McNulty	 et	 al.	
2013).	We	suggest	 in	McNulty	et	al.'s	 trial	greater	 folic	acid	supplement	 intake	 in	 the	
second	 and	 third	 trimester	 (intervention	 group)	 not	 occurring	 in	 the	 RTBC	 could	
prevent	or	reverse	the	pregnancy	induced	RBC	folate	changes.	
Pregnancy	 studies,	 in	 the	 absence	 of	 folic	 acid	 supplementation,	 reported	 higher	
plasma/serum	 tHcy	 in	 TT	 participants	 in	 the	 first	 trimester	 (Parle‐McDermott	 et	 al.	
2006),	between	11‐25	GW	(Liang	et	al.	2014)	or	24‐28	GW	(Kim	et	al.	2004),	at	varying	
times	 of	 pregnancy	 (Barnabé	 et	 al.	 2015)	 and	 in	 variant	 allele	 carriers	 at	 labour	
(Lopreato	 et	 al.	 2008;	 Barbosa	 et	 al.	 2008a).	 Similar	 but	 non	 significant	 trends	were	
reported	 in	 two	 smaller	 studies	 including	 folic	 acid	 supplement	 users	 (Molloy	 et	 al.	
2002;	 Ubeda	 et	 al.	 2011).	We	 observed	 higher	 plasma	 tHcy	 in	 TT	 than	 in	 CC	 or	 CT	
participants	 throughout	 pregnancy;	 and	 higher	 cord	 plasma	 tHcy	 in	 TT	 than	 CC	
participants.	The	Irish	study	of	Molloy	et	al.	in	2002,	found	non	significant	higher	cord	
plasma	tHcy	with	maternal	TT	genotype	as	well	as	a	non	significant	effect	on	maternal	
plasma	 tHcy	 at	 labour	 (Molloy	 et	 al.	 2002).	 As	 we	 found	 an	 effect	 of	 the	 SNP	 on	
maternal	 tHcy,	 an	 effect	 on	 cord	 tHcy	 was	 expected	 given	 the	 foeto‐maternal	 tHcy	
correlations	 (Guerra‐Shinohara	 et	 al.	 2002;	 Murphy	 et	 al.	 2004;	 Molloy	 et	 al.	 2005;	
Obeid	 et	 al.	 2005;	 Wallace	 et	 al.	 2008),	 that	 maternal	 tHcy	 is	 the	 most	 important	
determinant	 of	 foetal	 tHcy	 (Molloy	 et	 al.	 2002),	 and	 the	 existence	 of	 tHcy	 transport	
systems	 in	 human	 placentas	 (Tsitsiou	 et	 al.	 2011).	 An	 impairment	 in	 the	 MTHFR	
reaction	 leads	 to	 lower	 5‐methylTHF	 and	 hence	 less	 folate‐dependent	 homocysteine	
remethylation.	 The	 MTHFR	 c.665C>T	 polymorphism	 is	 the	 most	 important	 genetic	
factor	that	determines	blood	tHcy,	as	meta	analysed	(van	Meurs	et	al.	2013).	According	
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RBC	 or	 plasma	 folate	 tertiles	 at	 these	 time	 points,	 showed	 that	 the	 differences	 in	
plasma	tHcy	among	the	genotypes	were	lost	in	the	highest	tertiles.	The	tHcy‐enhancing	
effect	of	 the	MTHFR	 variant	genotype	or	allele	has	been	reported	 to	be	 lost	 in	higher	





of	 multiple	 ethnicities	 at	 labour	 (Barbosa	 et	 al.	 2008a).	 Differences	 between	 both	








At	 15	 and	 24‐27	 GW	 plasma	 folate	 modulated	 the	 association	 between	 the	MTHFR	
c.665C>T	polymorphism	and	tHcy.	THcy	was	higher	in	TT	compared	to	CC	genotype	at	
24‐27	GW	 and	 in	 cord,	 only	 in	 the	 first	 plasma	 folate	 tertile.	 THcy	was	 higher	 in	 TT	
compared	to	CT	genotype	at	15,	24‐27	GW	and	in	cord	in	the	first	plasma	folate	tertile,	
and	 also	 in	 the	 second	 plasma	 folate	 tertile	 at	 15	 GW.	 At	 34	 GW,	 RBC	 folate	 did	 not	
modulate	 the	 effect	 of	 the	 SNP	 on	 tHcy,	 and	 plasma	 folate	 did	 with	 borderline	
significance.	At	 labour	no	modulation	by	plasma	 folate	was	observed;	 and	RBC	 folate	
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was	 not	 determined	 at	 this	 point.	 We	 speculate	 plasma	 folate	 must	 be	 a	 better	
determinant	 of	 the	 effect	 of	 the	 SNP	 than	 RBC	 at	 15	 and	 24‐27	 GW.	 We	 deem	 two	
factors	can	be	contributing	to	this	pattern	of	folate	interaction	from	15	GW	on.	The	first	
is	that	half	the	RTBC	participants	stopped	taking	folic	acid	supplements	after	the	first	
trimester.	 The	 second	 is	 that	 the	 tHcy	 change	 at	 late	 pregnancy	 compared	 to	 earlier	
stages	 is	 less	determined	by	 folate	 status.	 In	 the	RTBC	 study,	plasma	betaine	but	not	
folate	was	a	significant	predictor	of	the	change	in	tHcy	at	labour	in	participants	above	
the	 plasma	 folate	 median	 (Fernàndez‐Roig	 et	 al.	 2013).	 In	 participants	 below	 the	
plasma	folate	median,	plasma	folate	and	betaine	became	equally	strong	determinants	of	
the	 tHcy	change	at	 labour	(Fernàndez‐Roig	et	al.	2013).	As	RTBC	participants	started	




folate	 status	 were	 observed	 and	 we	 speculate	 this	 is	 due	 to	 reduced	 effect	 of	 folate	
status	 on	 tHcy	 at	 late	 pregnancy.	 However,	 the	 interpretation	 of	 the	 interaction	 by	
plasma	but	not	RBC	folate	at	24‐27	GW	on	SNP‐tHcy,	and	of	the	interaction	by	plasma	
folate	at	labour	on	SNP‐tHcy	in	cord;	is	unclear.	
According	 to	 most	 observational	 studies,	 tHcy	 follows	 a	 U‐shape	 pattern	 during	
pregnancy,	decreasing	from	early	to	mid	pregnancy	and	then	increasing	towards	labour	




We	 found	 no	 differences	 in	 the	 proportion	 of	 miscarriage	 cases	 among	 MTHFR	
c.665C>T	genotypes.	Hyperhomocysteinaemia	is	a	risk	factor	for	recurrent	miscarriage	
(Nelen	 et	 al.	 2000),	 and	 the	MTHFR	 c.665	 variant	 allele	 has	 a	 known	 homocysteine‐
enhancing	 effect.	 However,	 the	 maternal	 genotype	 has	 not	 been	 associated	 with	
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the	 Spanish	 population,	 even	 in	 the	 presence	 of	 low	 RBC	 folate	 (Creus	 et	 al.	 2013).	
Regarding	 sporadic	 miscarriage	 or	 unspecified	 type	 of	 miscarriage,	 no	 association	






No	differences	 in	 the	proportion	of	 IUGR	offspring	among	maternal	MTHFR	c.665C>T	
genotypes	were	found	either.	The	existing	studies	assessing	the	effect	of	the	maternal	
genotype	 on	 IUGR,	 which	 were	 in	 non	 fortified	 or	 non	 fully	 exposed	 to	 fortification	
populations,	 have	 found	 no	 association	 (Facco	 et	 al.	 2009).	 Moderately	 elevated	
maternal	 tHcy	(7.1µmol/L)	at	8	GW	was	associated	with	a	 threefold	 increased	risk	of	













the	mother	 to	 the	 foetus	 can	occur.	This	 is	 in	 line	with	 the	speculation	of	 lower	DNA	
synthesis	 in	 the	 presence	 of	 low	maternal	 folate	 status.	 However,	 given	 the	multiple	
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roles	 of	 homocysteine	 as	 a	 toxic	 agent	 (Introduction	 point	 2.1),	 an	 effector	 role	 of	
homocysteine	in	miscarriage	and	IUGR	risk	cannot	be	completely	ruled	out.	
The	proportion	of	IUGR	cases	were	different	according	to	MTHFR	c.665C>T	genotypes	
in	 the	 offspring.	 A	 lower	 number	 of	 TT	 neonates	 had	 IUGR	 (1.3%)	 compared	 to	 the	




Canada	 (November	 1998),	 in	 Infante‐Rivard	 et	 al.'s	 study	 the	 sample	 was	 partially	









be	 possible	 that	 the	 likely	 lower	 folate	 status	 of	 the	UK	 study	 (Glanville	 et	 al.	 2006)	
compared	 to	 the	 Canadian	 study	 (Infante‐Rivard	 et	 al.	 2002)	was	 the	 reason	 for	 the	
effect	 of	 the	 foetal	 SNP	 on	 IUGR	 not	 reaching	 significance	 in	 Glanville	 et	 al.	 No	
associations	 between	 the	 offspring	 genotype	 and	 birth	 weight	 were	 observed	 in	 a	
prefortification	Mexican	study	were	36%	of	the	participants	took	prenatal	supplements	
(Kordas	et	al.	2009).	Our	results	are	 in	 line	with	 the	studies	assessing	 IUGR	(Infante‐
Rivard	et	al.	2002;	Glanville	et	al.	2006).	As	our	group	has	reported	higher	risk	of	the	
neonate	being	 in	 the	 lower	birth	weight	 tertile	when	cord	plasma	tHcy	 is	moderately	
elevated	 (Murphy	 et	 al.	 2004),	 it	 could	 be	 expected	 that	 the	 variant	 allele	 would	
increase	 IUGR	 risk.	 But	 in	 spite	 of	 the	 homocysteine‐enhancing	 effect	 of	 the	MTHFR	
c.665C>T	polymorphism	in	pregnant	and	non	pregnant	populations,	this	effect	has	not	
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et	 al.	 2008;	 Plumptre	 et	 al.	 2015).	 In	 regards	 of	 the	 foetus	 survival	 speculation,	 a	
Spanish	 study	 found	 higher	 proportion	 of	 TT	 in	 aborted	 foetuses	 than	 in	 controls	
(Callejón	et	 al.	 2007);	but	no	association	 (Zetterberg	et	 al.	 2002)	or	 the	 contrary	has	
also	being	reported	(Isotalo	et	al.	2000;	Bae	et	al.	2007).	As	in	Callejon	et	al.	the	upper	
limit	 of	 gestational	 age	 of	 the	 miscarriage	 foetuses	 was	 earlier	 (10	 GW)	 than	 in	 the	
other	studies,	 it	 is	possible	 that	 the	abortions	due	to	 the	deleterious	effects	of	 the	TT	
genotype	 took	place	earlier.	A	high	number	of	embryo/foetal	 losses	can	also	occur	at	
pregnancy	 times	 where	 they	 cannot	 be	 identified,	 such	 as	 in	 embryo	 resorptions.	
Therefore,	in	addition	to	what	other	authors	have	proposed	as	the	mechanisms	of	the	









et	 al.	 2007)	 and	 China	 (Liang	 et	 al.	 2014).	 A	 slightly	 higher	 frequency	 of	 variant	
homozygotes	(14.5%)	was	reported	in	Italy	(Giusti	et	al.	2008).		
To	 the	 best	 of	 our	 knowledge,	 no	 study	 has	 investigated	 the	 maternal	 association	
between	 the	 BHMT	 c.716G>A	 polymorphism	 and	 plasma	 betaine	 or	 DMG	




(Fredriksen	et	 al.	 2007).	Our	 result	 is	not	 surprising	because	a	 stable	betaine	pool	 is	
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assumed	 to	be	maintained	even	when	 the	BHMT	pathway	 is	upregulated	 (Allen	et	 al.	
1993a;	 Dominguez‐Salas	 et	 al.	 2013),	 possibly	 to	 spare	 betaine	 for	 its	 principal	





RTBC	 (Fernàndez‐Roig	 et	 al.	 2013).	 In	vitro	and	 in	vivo	experiments	 of	 early	 embryo	
development	 in	mice	 suggest	 betaine	 is	 important	 at	 this	 stage,	 as	 an	 osmoprotector	
(Biggers	 et	 al.	 1993;	Dawson	and	Baltz	 1997;	Anas	 et	 al.	 2007)	 and	 also	 as	 a	methyl	
donor	(Lee	et	al.	2012).	Phosphatidylcholine	is	preferentially	produced/taken	up	by	the	
human	 foetus	 when	 it	 is	 derived	 from	 choline	 entering	 the	 PEMT	 pathway,	 where	
betaine	donates	methyl	groups	(Yan	et	al.	2013).	
Lower	 plasma	 DMG	 concentrations	 were	 found	 with	 variant	 allele	 increase	 in	
Norwegian	 cohorts	 of	 older	 adults	 (Fredriksen	 et	 al.	 2007)	 or	 stable	 angina	 pectoris	
patients	(Svingen	et	al.	2013).	Our	results	 in	pregnancy	are	 in	 line	with	them	at	most	
time	points	with	 lower	concentration	 in	GA	than	 in	GG	at	early	pregnancy,	and	 in	AA	
than	 in	 GG	 at	 late	 pregnancy	 and	 in	 the	 cord.	 In	 spite	 of	 the	 betaine	 pool	 not	 being	
affected	by	the	BHMT	c.716G>A	polymorphism,	the	DMG/betaine	ratio	did	not	mirror	
exactly	 the	 differences	 among	 genotypes	 reported	 for	 DMG.	 In	 some	 time	 points	 the	
differences	in	the	ratio	might	not	be	big	enough	to	be	statistically	detectable,	given	that	
the	ratio	depends	on	the	concentration	of	DMG	and	betaine,	and	only	the	former	was	
different	 among	 genotypes.	 Also,	 small	 differences	 among	 genotypes	 for	 betaine	 and	
DMG	 at	 the	 same	 time	 points	 and	 not	 reaching	 significance	 are	 possible.	 If	 these	
differences	are	 in	contrary	sense	for	betaine	and	DMG,	the	combination	of	both	could	
lead	to	significant	differences	in	the	DMG/betaine	ratio	
Plasma	DMG	had	 a	U‐shape	pattern	 throughout	pregnancy,	 as	described	 in	 the	RTBC	
(Fernàndez‐Roig	 et	 al.	 2013)	 and	 other	 studies	 (Velzing‐Aarts	 et	 al.	 2005;	Wu	 et	 al.	
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2013;	 Visentin	 et	 al.	 2015).	 In	 the	 case	 of	 the	 BHMT	 c.716AA	 genotype,	 the	 late	
pregnancy	 DMG	 increase	 started	 later	 than	 in	 GG	 and	 GA.	 The	 DMG/betaine	 ratio	
increased	 throughout	 pregnancy,	 but	 in	 AA	 no	 increase	 between	 15	 to	 34	 GW	 was	
observed.	 This	 is	 in	 agreement	 with	 human	 observational	 studies	 suggesting	
downregulation	of	the	BHMT	pathway	with	the	variant	enzyme	(Fredriksen	et	al.	2007;	







status	 category.	 This	 suggests	 a	 less	 active	 BHMT	 pathway	 in	 the	 presence	 of	 the	
variant	allele.	The	fact	that	at	mid‐late	pregnancy	where	folate	status	is	lower,	no	folate	
interaction	was	found	may	be	due	to	less	variation	in	folate	status	at	these	time	points.	
In	 the	 unstratified	 analysis	 lower	 DMG	 was	 observed	 in	 AA	 than	 in	 GG	 at	 late	
pregnancy,	 and	 in	 GA	 only	 in	 labour.	 These	 results	 point	 toward	 less	 BHMT	 activity	
with	the	variant	allele	in	the	extreme	ranges	of	plasma	folate	status	distribution	during	
gestation;	 i.e.	 in	 the	 high	 folate	 status	 category	 at	 early	 pregnancy,	 and	 at	 late	
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effect	 being	 stronger	 in	 the	 variant	 enzyme;	 and	 on	 the	 other	 hand	 low	 folate	 status	
leads	to	BHMT	activation,	with	a	weaker	effect	in	the	presence	of	the	variant	enzyme.	
Whether	 different	 folate	 forms	 can	 affect	 BHMT	 activity	 has	 not	 been	 studied,	 so	 a	










differences	 in	 the	 hepatic	 concentrations	 of	 the	 folate	 status	 groups	 cannot	 be	
discarded.	 Other	 compounds	 affected	 by	 folate	 status	may	 be	 unknown	 inhibitors	 of	
BHMT	with	 a	 potentially	 higher	 effect	 on	 the	 variant	 enzyme.	 It	 is	worth	noting	 that	
SAM	is	assumed	not	to	interact	directly	with	BHMT	according	to	experiments	with	the	
purified	enzyme	(Szegedi	et	al.	2008),	and	 the	 inhibition	 in	Finkelstein	et	al.	 rat	 liver	
extract	experiments	could	therefore	be	mediated	by	other	proteins	bound	to	BHMT	in	
vivo	 (Finkelstein	 et	 al.	 1972).	 According	 to	 in	 vitro	 experiments,	 SAM	 but	 not	
methionine	inhibits	BHMT	mRNA	expression	in	a	dose‐dependent	manner	(Castro	et	al.	
2002;	 Ou	 et	 al.	 2007).	 However,	 the	 harsh	 conditions	 of	 the	 assay	 in	 the	
aforementioned	 rat	 liver	 extract	 study	would	 likely	 prevent	 the	 cells	 from	 surviving	
and	 be	 transcriptionally/translationally	 active.	 Also,	 the	 BHMT	 c.716G>A	
polymorphism	 is	 non‐synonymous	 and	 no	 effect	 on	 protein	 expression	 has	 been	
reported	 (Li	 et	 al.	 2008;	 Feng	 et	 al.	 2011).	 Further	 knowledge	 of	 the	 yet	 unknown	
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contrary	 to	 previous	 human	 studies	 reporting	 less	 BHMT	 activity	 because	 DMG	
concentration	was	 lower	 in	 the	presence	of	 the	variant	allele	 (Fredriksen	et	al.	2007;	
Svingen	 et	 al.	 2013).	 In	 addition	 to	 the	 molecular	 environment	 according	 to	 folate	
status,	 other	 unknown	 factors	 related	 with	 gestational	 age	 may	 affect	 the	 variant	
enzyme	differently	to	the	normal	enzyme.	However,	this	might	be	a	chance	finding.	We	
carried	 out	 a	 stratified	 analysis	 of	 the	 sample	 in	 two	 plasma	 folate	 status	 categories	
(deficient/possibly	 deficient	 and	 normal/high)	 using	 WHO	 criteria	 in	 a	 recent	
publication	 (Colomina	 et	 al.	 2016),	 and	 we	 observed	 differences	 only	 in	 the	
normal/high	group	and	in	the	same	sense	as	the	results	of	this	thesis	(data	not	shown,	
and	Appendices).	
No	 differences	 in	 the	 frequency	 of	miscarriage	 or	 IUGR	 cases	were	 found	 among	 the	
three	 maternal	 BHMT	 c.716	 genotypes.	 A	 higher	 rate	 of	 embryo	 resorption	 was	
reported	 in	mouse	 experiments	where	 embryonic	BHMT	 transcription	was	 inhibited	
(Lee	et	al.	2012).	However,	there	is	controversy	in	human	and	in	vitro	studies	about	the	
implications	of	the	BHMT	c.716G>A	polymorphism	on	the	BHMT	pathway,	and	in	Lee	et	
al.'s	 study,	 inhibition	 of	 maternal	 BHMT	 expression	 was	 not	 investigated.	 We	 found	
lower	 cord	plasma	DMG	concentration	 in	AA	participants;	 and	 cord	plasma	DMG	has	
been	 reported	 to	 be	 a	 positive	 predictor	 of	 birth	weight	 (Hogeveen	 et	 al.	 2013).	 The	
lack	of	association	between	maternal	genotype	and	 IUGR	may	be	due	 to	birth	weight	
and	IUGR	risk	not	being	fully	comparable.	Also,	the	association	found	in	Hogeveen	et	al.	
does	 not	 indicate	 cause,	 and	 unknown	 factors	 could	 be	 affecting	 DMG	 concentration	
and	 birth	 weight	 independently.	 For	 example,	 as	 DMG	 through	 its	 full	 oxidation	 to	
glycine	in	the	mitochondria	contributes	to	glutathione	synthesis	in	pregnancy	(Friesen	
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No	association	was	 found	between	 IUGR	and	offspring	BHMT	c.716	genotypes.	 In	 the	
aforementioned	in	vitro	mouse	embryo	study,	the	posttransfer	growth	of	the	surviving	
embryos	 whose	 BHMT	 expression	 had	 been	 inhibited	 was	 the	 same	 than	 with	 no	
inhibition	(Lee	et	al.	2012).	Plasma	DMG	and	the	DMG/betaine	ratio	 increased	 in	 late	
pregnancy,	 as	 shown	 here	 and	 previously	 (Fernàndez‐Roig	 et	 al.	 2013),	 suggesting	
more	 importance	 of	 the	 BHMT	 pathway	 at	 that	 stage	 where	 the	 foetus	 has	 higher	
growth	 rate.	 BHMT	 activity	 and	 expression	 in	 foetal	 livers	 has	 been	 reported	 to	
increase	with	 gestational	 age	 in	 human	 (Gaull	 et	 al.	 1973;	 Feng	 et	 al.	 2011)	 and	 pig	
studies	 (Ganu	 et	 al.	 2013).	 However,	 the	 contribution	 of	 the	 foetal	 BHMT	 to	 1C	
metabolism	 is	unknown,	and	other	authors	have	 found	no	differences	 in	cord	plasma	
betaine	and	DMG	among	the	three	foetal	BHMT	c.716	genotypes	(Visentin	et	al.	2015).	
It	 seems	 the	 maternal	 BHMT	 c.716G>A	 polymorphism	 could	 be	 relevant	 to	 small	
changes	 in	birth	weight	not	 reaching	differences	 in	 IUGR	risk	 in	our	 study;	while	 the	




respectively.	 The	 genotype	 frequencies	 of	 the	 SLC19A1	 c.80G>A	 polymorphism	 in	
healthy	populations	 are	 highly	 variable	 in	 Europe	 (Chango	 et	 al.	 2000b;	 Relton	 et	 al.	
2005;	 Devlin	 et	 al.	 2006;	 Stanislawska‐Sachadyn	 et	 al.	 2009;	 de	 Lau	 et	 al.	 2010;	
Pavlíková	et	 al.	2012)	and	 in	 the	 rest	of	 the	world	 (Barbosa	et	 al.	2008b;	Liang	et	 al.	
2014),	but	usually	there	are	more	normal	homozygotes	than	variant	homozygotes	and	
the	 heterozygotes	 are	 the	most	 common.	 In	 a	 big	Norwegian	 study	 there	were	more	
normal	 homozygotes	 than	 heterozygotes	 though	 (Fredriksen	 et	 al.	 2007).	 To	 our	
knowledge,	we	have	found	the	highest	variant	homozygote	 frequency	(27.0%)	among	
other	studies	in	healthy	populations	(17.2‐24.1%).	
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2013),	 but	 the	 molecular	 implications	 of	 the	 SLC19A1	 c.80G>A	 polymorphism	 are	





kinetic	 parameters	 for	 5‐methylTHF	 (most	 prevalent	 folate	 form	 in	 the	 body)	 are	
unknown.	Moreover,	depending	on	cell	type	different	expression,	affinity	and	transport	





according	 to	 these	 results,	 the	 potential	 effect	 of	 the	 SNP	 is	 not	 strong	 enough	 to	
observe	 differences	 in	 plasma	 folate.	 Another	 possibility	 is	 that	 other	 folate	




mutants	 for	 the	 reduced	 folate	 carrier	 (Zhao	 et	 al.	 2001;	 Gelineau‐van	 Waes	 et	 al.	
2008),	 points	 to	 this	 transporter	 being	 important	 in	 folate	 uptake	 during	 the	
development	 of	RBCs.	As	with	 plasma	 folate,	most	 human	 studies	 have	 not	 found	 an	




2010).	 Two	 studies	 in	 healthy	 populations	 that	 used	microbiological	 assay	 reported	
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contrary	 results.	 In	 young	 Northern	 Irish	 adults	 including	 multivitamin	 supplement	
users	 (22.6%	of	 sample)	higher	RBC	 folate	was	observed	with	variant	 allele	 increase	









variant	 allele	 has	 no	 effect	 (Chango	 et	 al.	 2000b)	 or	 a	 lowering	 effect	 on	 RBC	 folate	
(Bueno	et	al.	2016).	However,	with	supplement	users	included	and	younger	individuals	
the	effect	is	 in	the	sense	of	enhancing	RBC	folate	(Stanislawska‐Sachadyn	et	al.	2009).	
On	 the	 contrary,	 taking	 into	 account	 folate	 status	 of	 these	 three	 studies	 do	 not	 shed	
light	 in	 the	comparison	of	 the	different	results.	Chango	et	al.'s	 study	plasma	and	RBC	
folate	medians	were	13.4	and	547nmol/L,	respectively.	Stanislawska‐Sachadyn	et	al.'s	
study	 plasma	 and	 RBC	 folate	 medians	 were	 12.8	 and	 644nmol/L,	 respectively.	 And	
Bueno	 et	 al.'s	 study	 plasma	 and	 RBC	 folate	 means	 were	 11.5	 and	 810nmol/L,	
respectively.	On	average,	the	RTBC	participants	were	young	and	folic	acid	supplement	
users,	but	as	 they	are	pregnant	 they	cannot	be	compared	 to	 the	Northern	 Irish	study	
(Stanislawska‐Sachadyn	et	al.	2009).	If	the	hypothesis	of	higher	RBC	folate	with	variant	
allele	 and	 supplement	 use	 was	 true,	 pregnancy‐associated	 unknown	 factors	 might	
hamper	 this	 effect	 in	 the	 RTBC.	 Also	 the	 genetic	 background	 may	 be	 relevant,	 as	
haplotypes	 including	 the	variant	 allele	 could	be	different	 in	Northern	 Ireland	 than	 in	
Spain.		
We	 found	 no	 differences	 in	 plasma	 tHcy	 among	 the	 SLC19A1	 c.80G>A	 genotypes	
throughout	 pregnancy	 and	 in	 the	 cord,	 which	 is	 in	 agreement	 with	 most	 studies	
(Introduction	point	3.3)	and	the	previous	results	on	plasma	and	RBC	folate.	The	absence	
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of	 interaction	 of	maternal	 folate	 status	 on	 polymorphism‐tHcy	 relationship	 is	 also	 in	
line	 with	 the	 literature	 (Devlin	 et	 al.	 2006).	 However,	 in	 the	 characteristic	 U‐shape	
pattern	 of	 tHcy	 throughout	 pregnancy,	 the	 increase	 in	 mid‐late	 pregnancy	 started	
earlier	 in	 the	 SLC19A1	 c.80GG	 genotype	 (normal	 homozygote).	 Given	 the	 lack	 of	
information	 regarding	 this	 polymorphism	 at	 the	 molecular	 level,	 the	 controversy	 in	
human	 studies,	 and	 that	 in	 Spanish	 non‐pregnant	 non‐supplemented	 population	 the	
variant	transporter	is	associated	with	apparently	less	folate	uptake	(Bueno	et	al.	2016);	
we	deem	this	as	a	likely	chance	finding.	
The	 proportion	 of	 miscarriage	 cases	 was	 borderline	 higher	 in	 participants	 with	 the	
SLC19A1	 c.80AA	 genotype.	 Previous	 studies	 have	 not	 found	 this	 association,	 but	 all	




in	 the	 effect	 of	 the	 variant	 transporter	 according	 to	 cell	 types	 has	 been	 described	
(Whetstine	et	al.	2001;	Baslund	et	al.	2008),	 it	can	be	speculated	whether	 the	variant	






As	 a	 final	 remark	 on	 SLC19A1,	 the	 effect	 of	 the	 addressed	 polymorphism	 is	 largely	
unknown	and	our	results	(with	the	exception	of	a	possible	effect	on	miscarriage	risk)	
support	the	idea	of	this	polymorphism	having	no	effect	or	a	slight	effect.	
UNIVERSITAT ROVIRA I VIRGILI 
PRENATAL ONE CARBON METABOLISM-GENE INTERACTIONS, PLACENTA TRACE ELEMENT CONTENT AND THEIR EFFECT 
ON PREGNANCY OUTCOMES 









respectively	 (with	 similar	 frequencies	 in	 RTBC	 offspring).	 Among	 healthy	 population	
studies,	the	heterozygote	genotype	is	the	most	common	genotype,	except	in	a	Chinese	
study,	 where	 also	 the	 lowest	 variant	 homozygote	 frequency	 (5.4%)	 was	 reported	
(Liang	et	al.	2014).	Normal	homozygotes	are	more	common	than	variant	homozygotes	
in	studies	 from	Northern	Ireland	(Gaughan	et	al.	2001),	Germany	(Geisel	et	al.	2001),	
Brazil	 (Barbosa	 et	 al.	 2008a)	 and	 China	 (Liang	 et	 al.	 2014);	 but	 not	 from	 Norway	
(Fredriksen	et	al.	2007)	and	the	USA	(Vaughn	et	al.	2004;	Yang	et	al.	2008).	
According	to	in	vitro	experiments,	the	variant	MTRR	has	less	affinity	for	MTR	resulting	
in	 lower	 formation	 of	 the	 MTRR‐MTR	 complex	 (Olteanu	 et	 al.	 2002;	 Wolthers	 and	
Scrutton	2007).	This	would	mean	that	after	the	MTR	cobalamin	cofactor	is	oxidised	to	
the	 inactive	 form	 cob(II)alamin,	 the	 variant	 MTRR	 would	 activate	 the	 cofactor	 at	 a	
lower	 rate	 than	 the	 normal	 enzyme,	 leading	 to	 impaired	 MTR	 reaction.	 Other	
implications	 leading	 to	 the	 same	 effect	 would	 be	 lower	 reduction	 of	 MTR‐bound	
aquacob(III)alamin	 to	 cob(II)alamin,	 lower	 conversion	 of	 free	 cob(II)alamin	 to	MTR‐
bound	 methylcob(III)alamin,	 as	 well	 as	 less	 stability	 of	 the	 MTR	 apoenzyme,	 in	 the	
variant	 compared	 to	 normal	MTRR	 (Yamada	 et	 al.	 2006).	 A	 hampered	MTR	 reaction	
would	 result	 in	 a	 higher	 proportion	 of	 5‐methylTHF	 that	 cannot	 be	 recycled	 back	 to	
other	 folate	 forms	 by	 enzymes	 other	 than	 MTR.	 As	 5‐methylTHF	 is	 poorly	
polyglutamated	by	the	FPGS	in	comparison	to	other	folate	forms	(Cichowicz	and	Shane	
1987;	Chen	et	al.	1996),	it	can	be	expected	that	folate	is	not	retained	in	cell.	According	
to	 this	 idea,	 in	 variant	 homozygotes	 higher	 plasma	 folate	 and	 lower	 RBC	 folate	
concentrations	are	expected.	
Plasma	folate	was	lower	in	AG	than	AA	(normal	homozygote)	participants	at	≤12	GW.	
In	 spite	 of	 the	 aforementioned	 molecular	 implications	 of	 the	 polymorphism,	 most	
human	 studies	 report	 no	 effect	 of	 the	 polymorphism	 on	 plasma/serum	 folate	
(Introduction	 point	 3.4).	 Our	 result	 in	 the	 heterozygote	 is	 counterintuitive	 because	
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MTRR	 is	 a	 monomer	 (Olteanu	 and	 Banerjee	 2001),	 so	 differences	 in	 the	 analyte	
concentrations	 among	 the	 three	 genotypes	 would	 be	 expected	 to	 follow	 a	 pattern	
where	the	heterozygote	has	 intermediate	concentrations	than	the	variant	and	normal	
homozygotes.	 However,	 there	 are	 reports	 of	 differences	 in	 plasma	 cobalamin	 in	




Most	 human	 studies	 also	 find	 no	 effect	 of	 the	 variant	 MTRR	 on	 RBC	 folate	
concentrations,	 and	 our	 result	 in	 the	 RTBC	 was	 in	 line	 with	 them.	 The	 longitudinal	
changes	in	RBC	folate	followed	the	pattern	of	an	increase	between	≤12	and	15	GW,	and	
a	decrease	from	15	GW	on,	but	with	the	concentrations	at	24‐27	or	34	GW	non	different	
to	 ≤12	 GW	 (data	 not	 shown).	 This	 RBC	 folate	 pattern	 was	 not	 different	 among	 the	
MTRR	c.66A>G	genotypes.	
Higher	plasma	tHcy	was	observed	in	variant	homozygotes	than	normal	homozygotes	at	
≤12	 and	 15	 GW,	 which	 is	 line	 with	 the	 commented	 putative	 metabolic	 outcomes	 of	
lower	affinity	of	variant	MTRR	for	MTR,	but	not	with	most	human	studies	that	find	no	
effect.	In	a	non‐pregnant	population	from	the	same	geographical	region	as	the	RTBC,	a	
trend	 towards	 higher	 plasma	 tHcy	 in	 variant	 allele	 carriers	was	 found	when	 plasma	
cobalamin	status	was	 low	(≤273pmol/L)	and	riboflavin	optimal	 (García‐Minguillán	et	
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at	 early	 pregnancy,	 and	 homogenously	 low	 compared	 to	 the	more	 variable	 values	 of	
early	 pregnancy.	 In	 line	 with	 this	 in	 a	 Spanish	 non	 pregnant	 population	 with	 no	
supplement	 use	 and	 11.5nmol/L	 plasma	 folate	 mean	 (possibly	 deficient),	 no	
independent	effect	of	the	MTRR	c.66A>G	polymorphism	on	tHcy	was	reported	(García‐
Minguillán	 et	 al.	 2014;	 Bueno	 et	 al.	 2016).	 We	 speculate	 that	 although	 the	 folate	
statuses	of	 the	 first	 tertiles	at	≤12	or	15	GW,	of	 the	mid‐late	pregnancy	period	and	of	




to	 higher	 SAM,	 SAM/SAH	 ratio	 and	 lower	 SAH	 concentrations	 resulting	 in	 the	
remediability	of	the	SNP	defect	in	the	enzyme.	There	is	some	evidence	that	folate	status	







enzymes	 were	 found	 (Villanueva	 and	 Halsted	 2004).	 Given	 that	 SAM	 is	 the	 methyl	
donor	 of	 the	 reaction	 catalysed	 by	MTRR	 (Foster	 et	 al.	 1964;	 Ludwig	 and	Matthews	
1997),	 it	 can	 be	 expected	 that	 higher	 SAM	 levels	 occurring	 with	 high	 folate	 status	
correct	to	a	certain	extent	a	defect	in	the	variant	MTRR.	Lower	SAH	concentration	could	
also	add	to	this	putative	correction	as	SAH	inhibits	many	methyltransferases	using	SAM	
(Clarke	 and	 Banfield	 2001),	 but	 whether	 SAH	 can	 inhibit	 MTRR	 has	 not	 been	
investigated	yet	to	the	best	of	our	knowledge.	
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According	 to	 the	 differences	 in	 affinity	 for	 MTR,	 the	MTRR	 c.66A>G	 polymorphism	
could	 imply	 impaired	 conversion	 of	 free	 or	MTR‐bound	 cob(II)alamin	 to	MTR‐bound	
methylcob(III)alamin,	 and	 of	 MTR‐bound	 aquacob(III)alamin	 to	 MTR‐bound	
cob(II)alamin.	 However,	 the	 conversion	 of	 free	 aquacob(III)alamin	 to	 free	






Nielsen	 et	 al.	 2012).	 The	 transport	 mediated	 by	 ABCC1	 involves	 the	 formation	 of	
glutathionyl‐cobalamin	 (Beedholm‐Ebsen	 et	 al.	 2010),	 suggesting	 this	 that	
methylcobalamin	 or	 adenosylcobalamin	 cannot	 be	 exported	 by	 this	 mechanism.	
However,	other	unknown	export	mechanisms	of	 free	cobalamin	are	assumed	to	exist,	




bound	 methylcob(III)alamin	 occurs	 with	 variant	 MTRR,	 leading	 to	 extracellular	
cobalamin	release	at	a	higher	rate	than	with	the	normal	MTRR.	We	indeed	found	higher	
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plasma	 cobalamin	 in	 variant	 homozygote	 participants	 than	 in	 normal	 homozygotes.	
However	this	was	only	found	at	24‐27	GW	and	could	be	a	chance	finding.	
Plasma	cobalamin	decreased	throughout	pregnancy	in	the	three	MTRR	c.66	genotypes.	




The	concentration	of	 these	analytes	 in	 cord	plasma	was	not	 affected	by	 the	maternal	




were	 no	 differences	 in	 the	 frequency	 of	miscarriage	 or	 IUGR	 cases	 among	 the	 three	
maternal	MTRR	 c.66A>G	 genotypes	 in	 the	 RTBC,	 and	 these	 results	 are	 in	 line	 with	
previous	human	studies	(Furness	et	al.	2008;	Kim	et	al.	2011).	Also	the	MTRR	deficient	
mutant	mice	offspring	of	Deng	et	al.	 had	 lower	birth	weight	 than	wild	 type	offspring	
(Deng	et	al.	2008).	We	found	no	association	either	between	IUGR	and	offspring	MTRR	
c.66A>G	genotypes,	which	agrees	with	a	previous	human	study	(Furness	et	al.	2008).	
The	MTRR	c.66A>G	polymorphism	effect	 is	probably	not	as	severe	as	 the	mutation	 in	
the	aforementioned	animal	study.	
5. Strengths	and	limitations	





analyte	 concentrations	 caused	 by	 temperature	 and	 time	 before	 separation	 of	 blood	
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cells.	 Pregnant	 women	 with	 chronic	 diseases	 and	 surgical	 interventions	 affecting	
nutritional	 status,	 and	 medical	 treatment	 known	 to	 affect	 1C	 metabolism	 were	 not	
included	in	the	RTBC.	
Plasma/serum	 creatinine	 is	 a	 marker	 of	 glomerular	 filtration	 rate	 which	 can	 affect	
plasma	 metabolites	 and	 nutrient	 concentrations,	 such	 as	 tHcy.	 As	 a	 result	 of	 the	
pregnancy	 induced	 hyperfiltration	 state,	 plasma/serum	 creatinine	 decreases	 during	
early	pregnancy	(de	Weerd	et	al.	2003;	Ogueh	et	al.	2011),	being	lower	at	10	GW	and	
remaining	 at	 this	 low	concentration	6	weeks	postpartum	 (Ogueh	et	 al.	 2011).	Rather	
than	 specifically	 adjusting	 for	 changes	 in	 renal	 function,	 haemodilution	 and	 albumin	
decline	 we	 adjusted	 the	 analyses	 by	 gestational	 age	 at	 the	 time	 of	 blood	 draw.	 This	
allowed	 us	 to	 reduce	 the	 number	 of	 covariables	 included	 in	 the	mutivariate	models.	
Further	 adjustment	 by	 plasma	 creatinine	 did	 not	 change	 the	 results	 or	 conclusions	
(data	not	shown).	
As	MTHFR	and	MTRR	have	riboflavin	cofactors,	plasma	riboflavin	or	riboflavin	status	
markers	 might	 affect	 the	 SNPs	 effects.	 In	 in	 vitro	 studies,	 the	 normal	 and	 variant	
MTHFR	 enzymes	 are	 protected	 against	 heat	 inactivation	 when	 incubated	 with	 FAD	
(Yamada	 et	 al.	 2001).	 In	 South	 Korean	 pregnant	 women	 at	 24‐28	 GW	 higher	 serum	
tHcy	in	MTHFR	variant	allele	carriers	was	only	found	below	serum	FAD	median	(Kim	et	
al.	2004).	We	have	previously	reported	in	the	non	pregnant	population	of	Catalonia	that	
the	 effect	 of	MTHFR	 c.665C>T	 polymorphism	 on	 homocysteine	 was	 increased	 with	
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in	 smokers	 while	 others	 did	 not	 find	 an	 effect,	 as	 discussed	 (Pagán	 et	 al.	 2001).	 In	
pregnant	 smokers	 plasma	 tHcy	was	 higher	 at	 18	 GW	 in	 a	 Norwegian	 study	 (Bjørke‐
Monsen	et	al.	2013)	and	at	11‐16	GW	in	a	Dutch	study	(Bergen	et	al.	2012).	However,	





Similarly,	 in	whole	blood/RBC	 folate	 a	 lowering	effect	 in	pregnant	 smokers	has	been	
found	in	more	studies	(Furness	et	al.	2012;	Vandevijvere	et	al.	2012;	Shen	et	al.	2016)	
than	the	studies	reporting	no	effect	(McDonald	et	al.	2002;	Prasodjo	et	al.	2014).	In	our	
analyses	 a	 further	 adjustment	 by	 smoking	 habit	 did	 not	 alter	 the	 results	 for	MTHFR,	
BHMT,	SLC19A1	and	MTRR	polymorphisms	(data	not	shown).	
The	 foetal	 genotypes	 of	 the	 addressed	 SNPs	 might	 be	 relevant	 for	 the	 cord	 plasma	
concentration	of	1C	analytes.	Foetal	MTHFR	c.665	genotype	was	reported	to	affect	cord	
plasma	 folate	 (Lopreato	 et	 al.	 2008;	 Plumptre	 et	 al.	 2015),	 RBC	 folate	 (Relton	 et	 al.	
2005;	 Plumptre	 et	 al.	 2015),	 but	 not	 tHcy	 (Molloy	 et	 al.	 2002;	 Lopreato	 et	 al.	 2008;	
Plumptre	 et	 al.	 2015).	 Cord	 plasma	 concentrations	 of	 betaine	 and	 DMG	 were	 not	
different	 among	 foetal	 genotypes	 of	 BHMT	 c.716G>A	 (Visentin	 et	 al.	 2015),	 as	 was	
reported	for	amniotic	fluid	tHcy	among	MTRR	c.66A>G	genotypes	(Brouns	et	al.	2008).	
Also,	the	foetal	SLC19A1	c.80G>A	polymorphism	did	not	affect	cord	RBC	folate	(Relton	
et	 al.	 2005),	 nor	 placenta	 plasma	 tHcy,	 serum	 folate	 or	 cobalamin	 (Lopreato	 et	 al.	
2008).	No	significant	 independent	effect	of	 the	 foetal	 genotypes	 for	 the	 four	SNPs	on	
cord	 plasma	 analytes	 concentration	was	 found,	 and	 adjusting	 by	 foetal	 genotype	 did	
not	change	the	results	observed	for	the	maternal	genotypes	(data	not	shown).	
Cobalamin	intake	has	not	been	taken	into	account	in	MTRR	c.66A>G	analyses	and	could	
have	 affected	 the	 results	 on	 plasma	 cobalamin	 concentration.	 We	 do	 not	 expect	 big	
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Many	 hypotheses	 arising	 from	 the	 results	 of	 this	 thesis	 involve	 SAM	 and	 SAH;	 and	
different	 folate	 forms	 in	 contrast	 to	 the	used	 "total"	 folate.	 These	 analytes	 are	highly	
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Values	 are	 1arithmetic	means	 or	 2percentages	 (95%	 confidence	 interval)	 [sample	 size];	 3based	 on	 total	
income,	occupation	and	education	level	of	both	parents.	
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	 Zinc	 Copper	 Selenium	 Iron	
Zinc	 ‐	 0.361**	 0.16*	 0.13	
Copper	 	 ‐	 0.28**	 0.03	




Zinc,	 copper,	 selenium	 and	 iron	 concentrations	 were	 compared	 between	 never	
smokers,	first	trimester	only	smokers	or	smokers	throughout	pregnancy	(Table	22).	
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1Sample	 size.	 2Trace	 element	 concentration	 geometric	 mean	 (95%	 confidence	 interval).	 T‐test:	 *p<0.05	
smokers	throughout	pregnancy	vs	non‐smokers.	
Placenta	selenium	concentration	was	higher	in	smokers	throughout	pregnancy	than	in	
non‐smokers.	 Limiting	 the	 results	 to	 first	 trimester	 smoking	 versus	 never	 smoking,	
both	copper	and	selenium	concentrations	were	higher	in	first	trimester	smokers	than	









positively	 correlated	 with	 placenta	 copper.	 Gestational	 age	 and	 maternal	 age	 were	
negatively	correlated	with	placenta	zinc.	Placenta	iron	was	not	correlated	with	any	of	
the	analysed	parameters.	
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	 [218]1	 [218] [209] [169] [204]	 [218] [209]
Zinc	 ‐0.272***	 ‐0.14*	 0.12	 0.08	 0.02	 ‐0.19**	 ‐0.03	
Copper	 ‐0.23***	 0.01	 0.09	 0.17*	 0.09	 0.01	 0.04	
Selenium	 ‐0.17**	 ‐0.06	 0.09	 0.08	 0.09	 ‐0.001	 ‐0.05	
Iron	 ‐0.03	 0.04	 ‐0.05	 ‐0.05	 ‐0.05	 0.04	 ‐0.10	
GW,	 gestational	weeks.	BMI,	 body	mass	 index.	 1Sample	 size	 varies	due	 to	missing	 information,	 blood	 sample	or	plasma	 cotinine	determination.	
2Spearman	correlation	coefficients.	Significant	correlations:	*p<0.05,	**p<0.01,	***p<0.001.	
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Trace	 element	 concentrations	 from	 placentas	 of	 male	 or	 female	 neonates	 were	
compared	 (Table	25).	 Placenta	 copper	 concentration	was	higher	 in	 female	neonates,	
although	 this	 did	 not	 reach	 significance	 (P=0.058).	 Zinc	 concentration	was	 higher	 in	






































In	 the	 second	and	 third	 trimester	of	 pregnancy	based	on	data	 from	200	participants,	
74.5%	 (95%	CI:	 68.0,	 80.0%)	 took	 supplements	 containing	 the	 aforementioned	 trace	
elements	and	77.9%	(95%	CI:	70.5,	83.8%)	of	these	took	iron	only.	The	patterns	of	use	
of	 supplements	 containing	 each	of	 the	 addressed	 trace	 elements	 are	 shown	 in	Table	
26.
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Users	 of	 supplements	 containing	 trace	 elements	 in	 the	 first	 trimester	 had	borderline	
lower	placenta	selenium	concentrations	than	non	users	(Table	28).	And	users	of	these	
supplements	 in	 the	 second	 and	 third	 trimesters	 had	 lower	 placenta	 copper	 and	
borderline	higher	iron	concentrations.	
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RDA,	 recommended	 dietary	 allowance	 (zinc:	 11mg/d,	 copper:	 1mg/d,	 selenium:	 60µg/d,	 iron:	 27mg/d);	 UL,	 tolerable	 upper	 intake	 level	 (zinc:	
40mg/d,	copper:	10mg/d,	selenium:	400µg/d,	iron:	45mg/d)	(Institute	of	Medicine	‐	Panel	on	Dietary	Antioxidant	and	Related	Compounds	2000;	
Institute	 of	 Medicine	 ‐	 Panel	 on	 Micronutrients	 2001).	 1Sample	 size.	 2Arithmetic	 mean	 intakes	 (95%	 confidence	 interval).	 3Percentage	 of	
participants	(95%	confidence	interval).	
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1Sample	 size.	 2Trace	 element	 concentration	 geometric	 mean	 (95%	 confidence	 interval).	 T‐test:	 *p<0.05,	 §p=0.056,	 #p=0.051	 user	 vs	 non‐user	
placenta.	
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element)	were	 studied	 as	 predictors	 of	 placenta	 trace	 element	 concentrations	 in	 the	
RTBC	by	multiple	 linear	 regression	models.	The	models	were	not	 significant	 for	 zinc,	
selenium	 and	 iron	 (data	 not	 shown).	 Placenta	 copper	 was	 positively	 predicted	 by	
gestational	age	and	maternal	BMI,	and	negatively	by	birth	weight	(Table	29).		
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placenta	 trace	 element	 concentrations	 (dependent	 variables)	was	 studied	 taking	 into	
account	plasma	folate	status	at	early	pregnancy,	and	plasma	tHcy,	betaine,	choline	and	
cobalamin	at	≤12	GW	and	at	labour	(independent	variables).	Multiple	linear	regression	
models	 were	 used	 and	 none	 was	 significant	 for	 zinc	 (adjusted	 R2	 from	 0.4	 to	 2.8),	
selenium	 (adjusted	 R2	 from	 1.4	 to	 3.7)	 and	 iron	 (adjusted	 R2	 =	 0)	 (data	 not	 shown).	
Plasma	 cobalamin	 at	 ≤12	GW	 and	 plasma	 tHcy	 at	 labour	were	 negative	 and	 positive	
predictors,	 respectively,	 of	 placenta	 copper	 concentration	 (Table	 30).	 None	 of	 the	
other	1C	metabolism	analytes	or	folate	categories	affected	placenta	copper.		
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	 Models	 	 	
Independent	variables	 Adjusted	R2	 F	[n]	 B	coefficient	(SE)	 p	value	
Plasma	cobalamin	at	≤12	GW	(pmol/L)1	 8.9	 3.0	[200]**	 ‐0.259	x	10‐3	(0.126	x	10‐3)	 <0.05	
Plasma	cobalamin	at	≤12	GW	(pmol/L)2	 9.1	 3.0	[200]**	 ‐0.270	x	10‐3	(0.125	x	10‐3)	 <0.05	
Plasma	tHcy	at	labour	(µmol/L)	 9.8	 4.0	[192]***	 0.016	(0.008)	 <0.05	
Plasma	tHcy	at	labour	(µmol/L)3	 9.2	 3.2	[192]**	 0.017	(0.008)	 <0.05	
Multiple	 linear	 regression	 analyses:	 dependent	 variable	 placenta	 copper	 concentration	 (ng/g	 ww).	 All	 models	 were	 adjusted	 for	 birth	 weight,	
gestational	age	at	 time	of	delivery,	pregnancy	smoking	patterns,	previous	pregnancies,	 total	copper	 intake,	 1low	or	high	early	pregnancy	plasma	
folate	 status	 (plasma	 folate	 tertile	 based	 categories)	 and	 plasma	 betaine	 at	 ≤12	GW,	 or	 2low	 or	 high	 early	 pregnancy	 plasma	 folate	 status	 and	
plasma	choline	at	≤12	GW,	or	3low	or	high	early	pregnancy	plasma	folate	status.	n,	sample	size	varies	due	to	missing	data	in	any	of	the	independent	
and	adjusting	variables.	SE,	standard	error.	GW,	gestational	weeks.	**pmodel<0.01,	***pmodel<0.001.	
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5.1. Placenta	 trace	 element	 concentrations	 in	 pregnancies	 with	 preterm	
deliveries	


































5.2. Placenta	 trace	 element	 concentrations	 in	 intrauterine	 growth	 restriction‐
affected	pregnancies		
Trace	 element	 concentrations	 from	 placentas	 of	 control	 or	 IUGR	 neonates	 were	
compared	(Table	32).	The	percentage	of	IUGR	neonates	in	the	sample	was	11.0%	(95%	
CI:	 7.2,	 16.4%).	 Placenta	 copper	 and	 selenium	 concentrations	 were	 higher	 in	 IUGR	
neonates.	
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1Sample	 size.	 2Trace	 element	 concentration	 geometric	mean	 (95%	 confidence	 interval).	 T‐test:	 *p<0.05,	
***p<0.001	IUGR	vs	control	neonate	placenta.	
The	effect	of	placental	copper	and	selenium	concentrations	on	IUGR	risk	were	studied	
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studies	using	 ICP‐MS	are	higher:	 11579ng/g	ww	 in	Bangladesh	 (Kippler	 et	 al.	 2010),	




placenta	 samples	 whose	 shortest	 dimension	 was	 0.5‐1cm,	 were	 thoroughly	 washed	
with	 deionised	 water	 to	 remove	 residual	 blood.	 Some	 of	 the	 other	 studies	 do	 not	
specify	whether	 they	 cleaned	 the	 samples	 (Liu	 et	 al.	 2013)	or	whether	washing	with	
water	or	 saline	was	 included	 in	 the	process	 (Osman	et	 al.	 2000;	Kippler	 et	 al.	 2010).	
The	median	placenta	 zinc,	 copper	 and	 selenium	concentrations,	most	 similar	 to	ours,	





samples	 that	 included	 the	 chorionic	 plate	 in	 addition	 to	 the	 chorionic	 villi.	 Studies	
comparing	 foetal	 side	 specimens	 including	 chorionic	 plate	 with	 maternal	 side	
specimens	 including	 decidua	 basalis	 have	 found	 differences	 in	 zinc,	 copper	 and	 iron	
concentrations	(Manci	and	Blackburn	1987;	Ronco	et	al.	2005;	De	Moraes	et	al.	2011),	
however	 similar	 studies	 comparing	 the	 chorionic	 villi	 with	 the	 chorionic	 plate	 are	
lacking.	There	is	no	consensus	on	placenta	specimens	collection	and	handling	(Iyengar	
and	Rapp	2001b),	making	comparisons	among	studies	hard.		
Placenta	 zinc	 concentration	 was	 positively	 correlated	 with	 those	 of	 copper	 and	
selenium.	The	association	with	copper	has	been	previously	reported	in	some	(Ward	et	
al.	1987;	Zadorozhnaja	et	al.	2000;	Odland	et	al.	2001),	but	not	other	studies	(Tsuchiya	
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reductases	 (Lu	 and	 Holmgren	 2014).	 The	 copper	 chaperone	 ATOX1	 has	 antioxidant	
properties	 resembling	 those	 of	 superoxide	 dismutases,	 although	 the	 mechanism	 is	
unknown	 (Hung	 et	 al.	 1998;	 Hatori	 and	 Lutsenko	 2013).	 Unlike	 in	 vitro	 results,	
metallothionein's	antioxidant	role	in	vivo	remains	controversial	(Chiaverini	and	De	Ley	
2010).	 Superoxide	 dismutase	 1,	 glutathione	 peroxidases	 (Wang	 and	 Walsh	 1996),	
superoxide	 dismutase	 3	 (Boggess	 et	 al.	 1998),	 thioredoxin	 reductases	 (Oblong	 et	 al.	
1993),	 the	 copper	 chaperone	 ATOX1	 (Gambling	 et	 al.	 2004),	 and	 metallothioneins	
(Waalkes	 et	 al.	 1984)	 expression	 and/or	 activity	 have	 been	 detected	 in	 placenta.	
Although	 with	 controversy	 in	 superoxide	 dismutases,	 the	 aforementioned	 proteins	
have	been	reported	to	be	upregulated	by	oxidative	stress	conditions	(Shull	et	al.	1991;	
Lu	et	al.	1993;	Stralin	and	Marklund	1994;	Dalton	et	al.	1994;	Lin	and	Culotta	1995;	Sun	
et	al.	1999;	Park	and	Rho	2002;	Moon	et	al.	2005).	 In	support	of	 this	hypothesis,	 the	
two	most	abundant	selenoproteins	in	placenta	are	glutathione	peroxidases	(Sonet	et	al.	
2016).		
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cadmium)	 in	 vivo	 (Stillman	 1995).	Metallothionein	 can	 detoxify	 cadmium	 directly	 by	
the	binding	of	the	toxic	metal	to	apometallothionein	or	replacing	zinc	atoms	(Pinter	et	
al.	2015).	Experiments	suggest	zinc	bound	to	metallothioneins	is	labile	and	serves	to	be	
effectively	 donated	 to	 maturing	 metalloproteins	 whereas	 cadmium	 is	 immobilised	
(Irvine	 et	 al.	 2016).	 However	 placental	 zinc	 retention	 has	 been	 suggested	 under	
cadmium	exposure.	Zinc,	copper,	cadmium,	nickel,	lead	and	arsenic	have	been	reported	
to	 upregulate	 metallothioneins	 via	 the	 metal‐transcription	 factor	 1	 (Heuchel	 et	 al.	
1994;	 He	 and	 Ma	 2009).	 Higher	 concentrations	 of	 zinc	 and	 copper	 due	 to	 higher	
metallothionein	levels	for	metal	detoxification	seems	plausible.	Selenium	has	also	been	
implied	 in	 metal	 detoxification,	 especially	 of	 mercury.	 It	 has	 been	 proposed	 that	
methylmercury	 toxicity	 (and	 its	 associated	 oxidative	 stress)	 is	 mainly	 due	 to	 the	
replacement	 of	 selenocysteines	 in	 selenoproteins,	 most	 of	 which	 are	 antioxidant	
(Arnold	 et	 al.	 1986).	 Methylmercury	 detoxification	 by	 selenium	 seems	 to	 rely	 on	
organic	 selenium	 for	 methylmercury	 excretion,	 inactivation	 or	 removal	 from	 some	
organs	(Li	et	al.	2012;	Yamashita	et	al.	2013b;	Yamashita	et	al.	2013a;	Li	et	al.	2014b;	
Wang	 et	 al.	 2017),	 and	 more	 selenium	 and	 seleno	 amino	 acids	 to	 compensate	 the	
selenium	deficiency	of	proteins	(Ralston	et	al.	2008;	Li	et	al.	2014b).	Redistribution	of	
selenium	 in	 blood	 and	 tissues	 in	 response	 to	 methylmercury	 has	 been	 reported	 in	
fishes	 (Huang	 et	 al.	 2014).	 Selenium	 is	 also	 involved	 in	 arsenic	 and	 cadmium	
detoxification,	especially	through	the	reduction	of	reactive	oxygen	species	generated	by	
these	 toxic	 metals	 (Zwolak	 and	 Zaporowska	 2012).	 Proteins	 with	 roles	 in	 oxidative	
stress	 and	 containing	 selenium	 have	 also	 been	 reported	 to	 be	 upregulated	 by	 zinc,	
copper	 or	 cadmium	 via	 the	 metal‐transcription	 factor	 1:	 selenoprotein	 H	 in	 human	
amniotic	 cells	 (Stoytcheva	et	 al.	2010)	and	selenoprotein	W	 in	 rat	glial	 and	myoblast	
cells	 (Amantana	 et	 al.	 2002).	 Although	 the	 protein	 expression	 of	 these	 two	
selenoproteins	 has	 not	 been	 studied	 in	 placenta,	 their	 mRNA	 expression	 has	 been	
reported	(Gu	et	al.	2000;	Dikiy	et	al.	2007;	Gilman	et	al.	2015).	Therefore,	we	suggest	
that	 the	 positive	 correlations	 between	 zinc,	 copper	 and	 selenium	may	 be	 due	 to	 the	
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involved,	 leading	 to	 differences	 in	 the	 defence	mechanisms	 related	with	 zinc,	 copper	
and	selenium.	
Plasma	 cotinine	 and	 smoking	 patterns	 during	 pregnancy	 were	 not	 associated	 with	
placenta	 zinc	 concentrations.	 Our	 results	 are	 in	 agreement	 with	 some	 studies	
(Zadorozhnaja	 et	 al.	 2000;	Kantola	 et	 al.	 2000;	Pereg	 et	 al.	 2001;	 Sorkun	et	 al.	 2007;	
Punshon	et	al.	2016),	but	other	studies	have	reported	higher	zinc	concentrations	in	the	
placentas	of	smokers	(Kuhnert	et	al.	1987b;	Ronco	et	al.	2005;	Stasenko	et	al.	2010).	All	




cord.	 Thiocyanate	 is	 considered	 a	 less	 specific	 marker	 of	 smoking	 than	 cotinine	
(Benowitz	1996),	but	our	results	differ	from	those	in	Ronco	et	al.	using	urine	cotinine.	
We	 speculate	 the	 intensity	 of	 smoking	 between	 our	 study	 and	 the	 studies	 reporting	
associations	might	be	different,	however	whether	intensity	of	smoking	affect	placental	









organ	 that	 were	washed.	 Smoking	 leading	 to	 increased	 zinc	 content	 of	 the	 placental	
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smoking	 reduces	 the	 zinc	 concentration	 in	 RBC	 of	 the	 foetus	 (Kuhnert	 et	 al.	 1987b;	
Kuhnert	et	 al.	1988a)	or	not	 (Aydogan	et	 al.	2013).	 It	 should	also	be	 considered	 that	
reported	maternal	whole	 blood	 zinc	 concentrations	 range	 from	 below	 two	 orders	 of	





Zinc	was	negatively	 correlated	with	 birth	weight	 and	 gestational	 age	 at	 delivery,	 but	
most	studies	have	not	found	an	association	with	birth	weight	(Kantola	et	al.	2000;	Díaz	
et	 al.	 2002;	 Odland	 et	 al.	 2004;	 Ozdemir	 et	 al.	 2009)	 or	 gestational	 age	 (Ward	 et	 al.	
1987;	Custódio	et	al.	2003;	Reddy	et	al.	2014).	Placenta	zinc	concentration	was	higher	
in	 those	 of	 female	 neonates	 than	 in	male	 neonates,	 but	 other	 studies	 have	 found	 the	
contrary	(Punshon	et	al.	2016)	or	no	association	(Osman	et	al.	2000;	Phuapradit	et	al.	
2000).	The	associations	with	gestational	age	and	sex	can	contribute	to	that	with	birth	
weight.	When	adjusting	 for	possible	 confounders	no	 association	with	birth	weight	or	
gestational	age	was	observed.	Placenta	zinc	was	not	associated	with	IUGR,	and	this	is	in	
agreement	with	previous	studies	(Malhotra	et	al.	1990;	Osada	et	al.	2002;	Zadrozna	et	
al.	 2009).	 We	 speculate	 that	 the	 possible	 effect	 of	 placenta	 zinc	 on	 birth	 weight	 is	
influenced	 by	 its	 association	 with	 neonate	 sex.	 Given	 that	 in	 human	 placentas	 X	
chromosome	 inactivation	 is	 random	 and	 the	 expression	 behaviour	 of	 the	 inactive	 X	
chromosome	can	be	heterogeneous	 (Moreira	de	Mello	et	al.	2010),	 if	 a	gene	affecting	
zinc	metabolism	or	its	regulation	is	located	in	the	X	chromosome,	the	effects	of	genetic	
variations	would	be	more	visible	 in	males.	A	GWAS	studying	 the	main	genetic	 factors	
associated	with	the	variance	in	RBC	zinc,	copper	and	selenium	found	only	in	the	case	of	
zinc,	 a	polymorphism	 in	a	gene	 in	 the	 chromosome	X,	 i.e.	NBDY	 g.56811695C>T.	The	
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controversy	 about	 whether	 an	 association	 between	 maternal	 age	 and	 placenta	 zinc	




has	 assessed	 this	 to	 our	 knowledge,	 and	 this	 is	 also	 true	 for	 the	 intake	 and	 placenta	
concentrations	 of	 the	 other	 addressed	 trace	 elements.	 Zinc	 supplementation	was	 not	
associated	with	maternal	blood	zinc	concentrations	 in	humans	(Caulfield	et	al.	2008),	





Without	 zinc	 status	 measurements	 of	 these	 participants	 we	 cannot	 assess	 whether	
their	zinc	status	was	low.	Zinc	intakes	not	meeting	the	zinc	RDA	in	pregnancy	(11mg/d)	
seem	common	in	populations	with	low	use	of	micronutrients	supplements.	Mean	total	
zinc	 intake	ranged	9.8‐11mg/d	 throughout	pregnancy	 in	a	Spanish	study	using	3‐day	
weighed	 food	 records	 (Carbone	 et	 al.	 1992)	 or	 a	 Greek	 study	 using	 food	 frequency	
questionnaires	(Petrakos	et	al.	2006).	In	pregnant	women	from	the	NHANES	III,	median	
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chronic	 folic	 acid	 affects	 zinc	 absorption	 and	 status,	 with	 slightly	 more	 evidence	
supporting	no	effect	than	a	negative	effect.	According	to	the	literature,	a	link	between	
choline	(as	acetylcholine)	and	placenta	zinc	could	exist.	1C	metabolism	could	affect	the	
regulation	 of	 zinc	 metabolism	 genes	 via	 methylation	 reactions,	 and	 indeed	 a	 foetal	
programming	effect	on	liver	and	kidney	zinc	concentrations	has	been	reported	in	rats	
(Król	 et	 al.	 2011).	 Zinc	 status	 could	 also	 affect	 1C	 metabolism	 because	 zinc	 is	 a	
component	 of	 BHMT	 (Millian	 and	 Garrow	 1998),	 the	 main	 intestinal	 glutamate	
hydrolase	folate	hydrolase	1	(Halsted	et	al.	1998),	DNA	methyltransferases	(Chuang	et	
al.	1996)	and	possibly	MTR	(Matthews	and	Goulding	1997).	The	 lower	polyglutamate	
than	monoglutamate	 folate	 absorption	 in	 humans	 after	 a	 zinc	 depletion	 intervention	
(Tamura	 et	 al.	 1978),	 suggests	 an	 effect	 on	 folate	 hydrolase	 1.	 Similar	 results	 were	
obtained	 in	 rats	 (Tamura	et	al.	1987;	Canton	et	al.	1989),	where	 the	other	 (non‐zinc‐
containing)	glutamate	hydrolase	gamma	glutamyl	hydrolase	is	responsible	for	removal	
of	 glutamates	 from	 folates	 in	 the	 intestine.	 Higher	 glutamate	 hydrolase	 activity	 was	
reported	 in	an	 in	vitro	 study	with	pig	pancreatic	 juice	when	higher	 concentrations	of	
zinc	 were	 present	 in	 the	 medium	 (Bhandari	 et	 al.	 1990).	 Studies	 in	 rats	 link	 zinc	
deficiency	with	 increases	 in	 hepatic	 homocysteine	 (Duerre	 and	Wallwork	 1986)	 and	
decreases	 in	plasma/serum	homocysteine	 (Hong	 et	 al.	 2000;	 Jing	 et	 al.	 2015).	 Lower	
(Tamura	et	al.	1987;	Hong	et	al.	2000)	or	non	different	(Jing	et	al.	2015)	plasma/serum	
folate	 in	 zinc	 deficient	 compared	 to	 pair	 fed	 control	 rats	 have	 been	 reported.	 Our	
results	 show	no	association	between	placenta	zinc	concentration	and	1C	metabolism.	
Zinc	deficiency	risk	in	Spain	is	low	(IZiNCG	2004),	and	in	the	RTBC	a	big	proportion	of	
folate	 intake	 is	 as	 folic	 acid	 supplements,	 where	 folate	 is	 monoglutamate.	 Thus,	 not	
observing	 and	 association	 between	 plasma	 folate	 and	 placenta	 zinc,	 potentially	
mediated	by	the	effect	of	zinc	deficiency	on	folate	absorption,	was	expected.	Moreover,	
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the	 same	way	with	 these	elements,	we	 speculate	 that	 the	positive	 association	among	
these	 trace	 elements	 can	 be	 due	 to	 all	 of	 them	 being	 involved	 in	 defence	 against	
oxidative	stress	and	metal	toxicity.	
In	 addition	 to	 a	positive	 correlation	between	placenta	 copper	 and	plasma	cotinine	at	
24‐27	 GW,	 we	 observed	 higher	 placenta	 copper	 concentration	 in	 first	 trimester	
smokers	compared	 to	non	smokers.	This	result	 is	contrary	 to	previous	studies	where	
smoking	status	was	assessed	as	self	 reported	by	 the	participants	(Zadorozhnaja	et	al.	
2000;	 Kantola	 et	 al.	 2000),	 but	 also	 taking	 into	 account	 urine	 cotinine	 at	 delivery	
(Ronco	et	al.	2005)	or	placenta	cadmium	(Stasenko	et	al.	2010).	Placenta	cadmium	has	
not	been	defined	yet	as	a	marker	of	smoking	during	pregnancy.	Some	studies	reported	
no	 associations	 between	 placenta	 cadmium	 and	 smoking	 (Fagher	 et	 al.	 1993;	
Zadorozhnaja	et	al.	2000;	Odland	et	al.	2001;	Terrones‐Saldivar	et	al.	2008).	However,	
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cadmium	 exposure	 such	 as	 diet	 and	 contamination	 might	 be	 involved.	 As	 exposed	
previously,	 residual	 blood	 was	 unlikely	 to	 affect	 the	 placental	 trace	 element	
determinations	 in	 the	 RTBC	 placentas	 due	 to	 the	 cleaning	 step	 in	 the	 sample	
preparation	procedure.	This	was	possibly	not	the	case	in	the	studies	reporting	no	effect	
of	 smoking	 on	 placenta	 copper	 because	 these	 studies	 either	 do	 not	 specify	 whether	
they	 cleaned	 the	 samples	 (Zadorozhnaja	 et	 al.	 2000;	 Kantola	 et	 al.	 2000)	 or	washed	
bigger	parts	of	the	organ	compared	to	the	RTBC	samples	(Ronco	et	al.	2005;	Stasenko	
et	 al.	 2010).	 A	 possibility	 is	 that	 smoking	 increases	 the	 concentration	 of	 placental	
copper	 but	 decreases	 that	 in	 the	 circulating	 blood,	 and	 thus	 these	 studies	 did	 not	
observe	 differences	 between	 smokers	 and	 non	 smokers.	 Studies	 in	women	 have	 not	
reported	 such	 smoking	 effect	 in	 blood	 copper,	 but	 absence	 of	 effect.	 Whole	 blood	
copper	 was	 not	 different	 between	 non	 pregnant	 smokers	 and	 non	 pregnant	 non	
smokers	(Benes	et	al.	2005).	No	effect	of	smoking	in	maternal	serum	(Mochizuki	et	al.	
1984;	Kantola	et	al.	2000)	and	cord	RBC	(Aydogan	et	al.	2013)	have	been	reported	in	
pregnancy	 studies.	We	speculate	whether	 the	 smoking	effect	on	placenta	 copper	was	
diluted	due	to	the	probably	higher	residual	blood	in	the	studies	not	reporting	an	effect	
(Zadorozhnaja	et	al.	2000;	Kantola	et	al.	2000;	Ronco	et	al.	2005;	Stasenko	et	al.	2010).	
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discrepancies.	 As	 we	 adjusted	 for	 other	 variables	 that	 can	 affect	 birth	 weight,	 we	
consider	our	approach	more	rigorous	and	propose	that	copper	may	be	retained	in	the	
placenta	 in	 response	 to	 adverse	 conditions	 that	 can	 limit	 foetal	 growth	 such	 as	
oxidative	 stress	 or	 metal	 toxicity.	 Unknown	 factors	 that	 may	 vary	 in	 the	 different	
populations	in	the	literature	may	affect	the	relationship	between	these	two	conditions	
and	placenta	copper.	
Gestational	 age	 at	 delivery	 was	 positively	 associated	 with	 placenta	 copper	 after	
adjusting	 for	 different	 confounders.	 Higher	 placenta	 copper	 has	 been	 reported	
previously	when	comparing	first	trimester	to	term	placentas	(Kantola	et	al.	2000),	but	




BMI	 and	 placenta	 copper	were	 positively	 associated	 after	 adjusting	 for	 birth	weight,	
gestational	age,	smoking	patterns,	maternal	age	and	copper	intake.	There	have	been	no	
previous	 reports	 on	 this	 to	 the	 best	 of	 our	 knowledge.	 Studies	 assessing	 BMI	 or	
categories	of	 it	 and	blood	copper	 in	non	pregnant	adults	 reported	controvert	 results.	
BMI	in	adults	and	plasma/serum	copper	have	been	reported	to	be	positively	associated	
(Tungtrongchitr	 et	 al.	 2003;	 Abiaka	 et	 al.	 2003;	 Ghayour‐Mobarhan	 et	 al.	 2009;	
Dabbaghmanesh	 et	 al.	 2011)	 or	 not	 associated	 (Chen	 et	 al.	 1997;	 Rotter	 et	 al.	 2015;	
Torkanlou	 et	 al.	 2016).	 BMI	 in	 adults	 was	 positively	 associated	 with	 whole	 blood	
copper	(Benes	et	al.	2005),	but	not	associated	with	RBC	copper	(Rükgauer	et	al.	2001;	
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associated	 (Arvanitidou	 et	 al.	 2007).	 Child	 BMI	 has	 been	 negatively	 associated	 with	
whole	blood	copper	(Blazewicz	et	al.	2013)	and	not	associated	with	RBC	copper	(Lima	
et	 al.	 2006).	Maternal	whole	blood	 copper	 concentrations	were	negatively	 associated	
with	BMI	at	an	unspecified	time	of	pregnancy	in	a	study	in	rural	India	(Mahanta	et	al.	
2012).	 In	 summary,	most	 studies	 in	 adults	 report	 positive	 associations	 between	BMI	
and	blood	copper	in	line	with	the	association	that	we	observed	in	RTBC	placentas.	BMI	
and	copper	status	might	be	related	through	oxidative	stress.	Plasma	malondialdehyde	




blood	 copper	 have	 found	 differences	 in	 RBC	 copper	 according	 to	 BMI.	We	 speculate	
whether	 higher	 levels	 of	 antioxidant	 copper	 proteins	 in	 plasma	 (such	 as	 superoxide	
dismutase	3)	or	placenta	occur	with	increasing	BMI,	but	such	hypothesis	has	not	been	
tested	 to	 the	best	of	our	knowledge	 in	humans.	 In	 leptin	mutant	obese	mouse	model	
higher	 superoxide	dismutase	3	protein	 levels	were	observed	 in	plasma,	 compared	 to	
the	wild	type	strain	(Nakao	et	al.	2000).	
Unlike	previous	reports	in	animal	studies	assessing	diets	ranging	from	copper	deficient	
to	 with	 twice	 the	 copper	 requirements	 (Masters	 et	 al.	 1983a;	 Ebesh	 et	 al.	 1999;	
Andersen	et	al.	2007;	Marques	et	al.	2016),	total	copper	intake	was	not	associated	with	
placental	 copper	 concentration	 in	 our	 study.	 Copper	 intake	 may	 not	 have	 varied	
sufficiently	among	the	participants	to	affect	placenta	copper	concentrations.	Moreover,	
adverse	conditions	such	as	oxidative	stress	and	metal	toxicity	may	be	more	important	
determinants	 of	 placenta	 copper	 concentrations	 and	mask	 the	 effect	 of	 the	 intake	on	
placenta	 copper.	We	 found	 lower	 copper	 concentrations	 in	 the	 placentas	 of	 users	 of	
multivitamin	 supplements	 containing	 trace	 elements	 during	 the	 second	 and	 third	
trimester.	About	78%	of	 these	users	at	 this	period	 took	supplements	 containing	only	
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iron	(and	 in	 the	 ferrous	state)	out	of	 the	 four	 trace	elements.	An	 interaction	between	
iron	and	 copper	 could	exist.	However,	placenta	 iron	and	 copper	were	not	 correlated,	
the	uptake	mechanisms	 in	 the	 intestine	and	placenta	are	different	 for	both	elements,	
and	placenta	copper	was	not	affected	by	total	copper	intake.	The	ferroxidase	enzymes,	
i.e.	hephaestin	in	the	enterocyte	basolateral	membrane,	ceruloplasmin	in	blood	plasma	





bloodstream,	 liver	and	 intestine	would	be	higher	 than	that	retained	by	zyklopen.	 In	a	
pregnant	 rat	 study	with	 diets	 from	 iron	 deficient	 to	 low	 (iron	 as	 7.5‐50mg/Kg	 diet),	
iron	 status	as	hepatic	 iron	was	negatively	 associated	with	placenta	 copper.	However,	
iron	status	was	also	negatively	associated	with	hepatic	and	serum	copper,	and	serum	
ceruloplasmin	and	zyklopen	activities	(Gambling	et	al.	2004).	A	possibility	not	studied	
to	 the	 best	 of	 our	 knowledge	 is	 whether	 iron	 status	 is	 positively	 associated	 with	
intestine	 copper	 and	 hephaestin.	 Also,	 studies	 using	 adequate	 and	 high	 iron	 intake	
could	shed	light	in	the	interaction	of	iron	and	copper.	
Plasma	cobalamin	at	≤12	GW	was	a	negative	predictor	of	placenta	copper	and	plasma	




components	 of	 1C	 metabolism	 associate	 with	 placenta	 copper	 at	 different	 stages	 of	
pregnancy	complicates	the	interpretation	of	this	result.	In	homocysteine	remethylation	
betaine	acquires	more	 importance	as	a	methyl	donor	 toward	 late	pregnancy,	and	 the	
folate	dependent	pathway	 is	 the	responsible	of	 the	remethylation	at	early	pregnancy.	
Plasma	tHcy	would	be	a	more	appropriate	marker	of	1C	metabolism	in	late	pregnancy	
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due	 to	 the	 importance	 of	 both	 pathways	 at	 this	 pregnancy	 stage;	 and	 cobalamin	 a	
marker	of	the	main	pathway	at	early	pregnancy,	i.e.	folate	dependent	remethylation.	
There	 has	 been	 relatively	 little	 research	 to	 date	 on	 associations	 between	 folate	 and	
copper	status.	A	possible	release	of	copper	 from	tissue	stores	to	blood	shortly	after	a	
pharmacological	dose	of	folic	acid	was	reported	in	mice	(Hamed	et	al.	2009),	and	lower	
renal	 copper	 concentrations	were	 reported	 in	 the	offspring	of	 rat	dams	 fed	 folic	 acid	
supplemented	diets	(Król	et	al.	2011).	In	the	cases	of	a	possible	association	between	1C	
metabolism	 and	 copper,	 copper	 could	 be	 the	 effector.	 The	 enzyme	
adenosylhomocysteinase,	which	is	present	in	human	placentas	(Hershfield	et	al.	1985),	
catalyses	 the	 reversible	 reaction	 adenosine	 +	 homocysteine	 ⇄	 SAH,	 that	 due	 to	 the	
efficient	 removal	of	homocysteine	and	adenosine	 in	 the	organism	 is	 in	 the	hydrolytic	
direction	 (Cantoni	 1985;	 Prigge	 and	 Chiang	 2001).	 Human	 recombinant	 placental	
adenosylhomocysteinase	has	been	reported	to	bind	copper	(Bethin	et	al.	1995b).	The	
relation	 of	 copper	 to	 nicotinamide	 adenine	 dinucleotide	 (NAD+)	 can	 regulate	
adenosylhomocysteinase	 activity	 according	 to	 in	 vitro	 studies.	 Copper	 acts	 as	 an	
inhibitor	 reducing	 the	 affinity	 of	 adenosylhomocysteinase	 for	 its	 NAD+	 cofactor,	
whereas	 higher	 concentrations	 on	 NAD+	 can	 prevent	 this	 inhibition.	 This	 has	 been	
proposed	 as	 a	 physiological	 adaptation	 to	 regulate	 adenosylhomocysteinase	 activity	
according	 to	 the	 redox	 status	 (Li	 et	 al.	 2007).	 If	 the	 reaction	 catalysed	 by	
adenosylhomocysteinase	 is	 impaired	by	copper,	 tHcy	would	decrease	and	SAH	would	
increase	(with	a	subsequent	inhibition	of	methyltransferases).	However,	adding	to	the	
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(HeLa)	 experiments,	 there	was	more	 release	of	 homocysteine	 to	 the	medium	 in	 cells	
with	64ng/ml	copper	in	the	medium	than	in	cells	with	control	medium	(Hultberg	et	al.	
1997).	In	a	cervical	dysplasia	case	control	study,	a	positive	correlation	between	plasma	
copper	 and	 tHcy	 was	 found	 in	 the	 whole	 sample,	 in	 the	 cases,	 and	 with	 borderline	
significance	 in	 controls	 (Thomson	 et	 al.	 2000).	 Similar	 results	 were	 obtained	 in	 a	
peripheral	vascular	disease	case	control	study	(Mansoor	et	al.	2000).	We	hypothesised	
higher	placenta	copper	concentrations	increase	adenosylhomocysteinase	expression	in	
this	 organ,	 leading	 to	 higher	 plasma	 tHcy	 concentrations	 at	 labour.	 The	 copper	
concentration	 in	 the	 placenta	 would	 affect	 the	 contribution	 of	 this	 organ	 to	 1C	
metabolism	at	labour,	and	that	would	be	the	reason	why	plasma	tHcy	at	≤12	GW	is	not	
a	predictor	of	placenta	copper,	but	 tHcy	at	 labour	 is.	As	 for	plasma	cobalamin	at	≤12	
GW,	we	 are	 not	 sure	 of	 a	 possible	 cause	 for	 the	 negative	 association	 between	 it	 and	




The	median	 placenta	 selenium	was	 82.2ng/g	ww.	Medians	 reported	 in	 other	 studies	
using	ICP‐MS	are	higher:	245.6ng/g	ww	in	Bangladesh	(Kippler	et	al.	2010),	189.5ng/g	
ww	 in	 Sweden	 (Osman	 et	 al.	 2000),	 229.5ng/g	 ww	 in	 China	 (Liu	 et	 al.	 2013)	 and	
173.3ng/g	ww	in	Japan	(Sakamoto	et	al.	2013).	As	previously	mentioned	in	the	case	of	
placenta	zinc	and	copper,	variations	in	reported	placenta	trace	element	concentrations	
between	 different	 studies	 may	 occur	 due	 to	 differences	 in	 sample	 collection	 and	
processing.	
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was	assessed	as	self	 reported	by	 the	participants	 (Kantola	et	 al.	2004;	Punshon	et	al.	
2016),	 except	 in	 one	 study	where	 in	 a	 subsample	 urine	 cotinine	was	 also	 taken	 into	
account	 (Osman	 et	 al.	 2000).	 These	 studies	 probably	 had	 higher	 content	 of	 residual	
blood	as	the	removal	procedure	was	not	specified	(Kantola	et	al.	2004;	Punshon	et	al.	
2016),	or	whether	washing	with	water	or	saline	was	included	in	the	process	(Osman	et	
al.	2000).	All	 the	RTBC	smokers	were	categorised	as	such	 taking	 into	account	plasma	
cotinine.	We	proposed	that	oxidative	stress	and	metal	toxicity,	such	as	from	cadmium,	
due	 to	 smoking,	 are	 associated	 with	 a	 placental	 selenium	 retention	 in	 smokers,	
especially	 in	 the	 aforementioned	 seleno	 proteins.	 The	 effect	 of	 smoking	 on	maternal	
and	cord	blood	selenium	ranges	 from	no	effect	 to	 lower	 concentrations	 (Introduction	
point	5.3),	 thus	 the	 likely	 higher	 residual	 blood	 in	 some	 of	 the	 previous	 studies	may	
mask	increases	in	placenta	selenium	concentration.	However,	the	association	between	
smoking	 and	 placenta	 selenium	 in	 the	 RTBC	must	 be	 taken	 cautiously	 as	 it	 was	 not	
observed	 after	 adjusting	 for	 confounders	 such	 as	 birth	 weight,	 gestational	 age,	
maternal	 age,	maternal	 BMI	 and	 selenium	 intake;	 or	was	 plasma	 cotinine	 correlated	
with	placenta	selenium.	
Placenta	 selenium	 was	 negatively	 correlated	 with	 birth	 weight,	 and	 higher	
concentrations	were	 found	 in	 placentas	 of	 IUGR	 than	 control	 neonates.	Most	 studies	
assessing	birth	weight	have	found	no	association,	including	a	study	from	Saudi	Arabia	
of	 250	 placentas	 with	 self	 reported	 non	 active	 smokers,	 and	 with	 the	 removal	 of	
residual	 blood	 with	 deionised	 water	 washes	 (Al‐Saleh	 et	 al.	 2015).	 Maternal	 whole	
blood	selenium	was	not	associated	with	birth	weight,	but	cord	selenium	was	positively	
associated	with	 birth	weight	 in	 non	 smokers	 (Kantola	 et	 al.	 2004).	 As	maternal	 and	
cord	whole	blood	selenium	concentrations	(Schramel	et	al.	1988;	Kosanovic	et	al.	2002;	
Kantola	et	al.	2004;	Al‐Saleh	et	al.	2004)	are	of	the	same	order	of	magnitude	as	those	of	
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the	 placenta;	 a	 possible	 dilution	 of	 the	 effect	 of	 smoking	 could	 have	 occurred	 in	 all	
these	 studies	 except	 Al‐Saleh	 et	 al.	 There	 is	 controversy	 about	 whether	 the	
concentrations	of	selenium	in	placentas	of	IUGR	neonates	are	lower	(Klapec	et	al.	2008)	
or	higher	 (Osada	et	 al.	2002;	Zadrozna	et	 al.	2009)	 than	 in	 controls.	Our	study	 is	 the	






Total	 selenium	 intake	 was	 not	 associated	 with	 placenta	 selenium.	 This	 is	 in	
disagreement	 with	 the	 only	 study	 to	 our	 knowledge	 addressing	 this,	 which	 found	
higher	concentrations	in	placentas	of	cattle	fed	with	selenium	supplemented	diets	(de	
Toledo	 and	 Perry	 1985).	 Selenium	 intake	 affects	 the	 concentrations	 in	 plasma.	 In	 a	
clinical	 trial	 in	UK	elderly	volunteers,	 after	 six	month	of	100µg/d	or	more	of	 organic	
selenium	 supplementation,	 higher	 plasma	 selenium	 concentrations	 were	 observed	
(Bekaert	et	al.	2008).	In	a	rat	study	with	deficient	to	low	selenium	diets	(2	to	119µg/Kg	
diet,	150µg/Kg	diet	is	the	required	selenium	for	maintenance/growth	in	rats),	plasma	
selenium	 was	 higher	 with	 higher	 selenium	 content	 in	 the	 diets	 (National	 Research	
Council	(US)	‐	Subcommittee	on	Laboratory	Animal	Nutrition	1995;	Uthus	et	al.	2002).	
We	suggest	 the	same	reasons	as	 for	zinc	and	copper	for	the	absence	of	association	 in	
the	 RTBC,	 including	 non	 extreme	 intakes	 of	 selenium,	 and	 placenta	 selenium	
concentrations	being	more	dependent	on	other	conditions	(oxidative	stress	and	metal	
toxicity).	
None	 of	 the	 analysed	 1C	 metabolism	 components	 was	 associated	 with	 placenta	
selenium.	Methyl	 groups	 derived	 from	 cobalamin	 dependent	 tHcy	 remethylation,	 but	
not	 from	 choline,	 seem	 to	 be	 involved	 in	 selenium	 detoxification	 (Introduction	point	
5.3).	The	absence	of	selenium	intakes	above	the	UL	plus	total	selenium	intake	not	being	
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a	predictor	 of	 placenta	 selenium	 in	 the	RTBC,	 suggest	 that	 selenium	detoxification	 is	
not	 a	 relevant	 contributor	 to	 the	 selenium	 content	 of	 this	 organ.	 Folic	 acid	
supplementation	impairs	selenomethionine	intestinal	absorption	in	rats	(Nogales	et	al.	
2011),	 and	 selenomethionine	 is	 the	 major	 form	 of	 dietary	 selenium	 (Institute	 of	
Medicine	 2000;	 Burk	 and	 Hill	 2015).	 In	 Nogales	 et	 al.	 the	 dams	 in	 which	 selenium	
intestinal	absorption	was	measured	in	their	pups,	were	fed	diets	containing	folic	acid	as	
2	or	8mg/Kg	diet	from	gestation	to	lactation,	that	is	200%	or	800%	the	requirements	
(National	 Research	 Council	 (US)	 ‐	 Subcommittee	 on	 Laboratory	 Animal	 Nutrition	
1995).	However,	in	the	RTBC	the	median	total	folate	intake	was	638	(95%	CI:	517,	839)	
µg/d	(Sole‐Navais	2016),	and	the	Spanish	recommended	dietary	intake	in	pregnancy	is	
500µg/d	 (Federación	 Española	 de	 Sociedades	 de	 Nutrición	 Alimentación	 y	 Dietética	
2010).	 In	 addition	 to	 the	 lack	 of	 association	 between	 selenium	 concentrations	 in	 the	
placenta	 and	 selenium	 total	 intake,	 the	 possible	 effect	 reported	 in	 rats	 is	 likely	 non	
observable	in	our	study	due	to	folate	intakes	being	less	extreme.		
In	 the	 aforementioned	 rat	 study,	 folic	 acid	 supplementation	 of	 8mg/Kg	 diet	 induced	
changes	 in	 the	 selenium	status	of	 several	 compartments	 in	 the	offspring	 (Ojeda	et	 al.	
2010;	 Nogales	 et	 al.	 2011).	 The	 dietary	 selenium	 content	 in	 this	 experiment	 was	
0.5mg/Kg	diet,	that	is	125%	the	requirements	of	reproducing	rats	(National	Research	
Council	 (US)	 ‐	Subcommittee	on	Laboratory	Animal	Nutrition	1995),	and	 in	 the	RTBC	
about	100µg/d	of	selenium,	that	is	167%	of	the	RDA	(Institute	of	Medicine	‐	Panel	on	
Dietary	Antioxidant	 and	Related	Compounds	2000).	 Thus,	 unlike	 folate,	 the	 intake	 of	
selenium	may	be	similar	in	both	studies.	In	the	RTBC,	at	moderate	folic	acid	intakes,	no	
changes	 in	 the	 selenium	 status	 of	 the	 placenta	 were	 observed	 according	 to	 plasma	
folate.	
Negative	associations	have	been	found	between	serum/plasma/whole	blood	selenium	
and	 plasma/serum	 tHcy	 in	 observational	 studies	 (Bates	 et	 al.	 2002;	 González	 et	 al.	
2004;	Klapcinska	 et	 al.	 2005;	Bélanger	 et	 al.	 2006).	However,	 selenium	deficient	 rats	
and	mice	have	 lower	plasma	 tHcy	 concentrations	 (Uthus	et	 al.	 2002;	Uthus	and	Ross	
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2007),	 and	 clinical	 trials	 of	 selenium	 supplementation	 failed	 to	 reduce	 plasma	 tHcy	
(Venn	 et	 al.	 2003;	 Bekaert	 et	 al.	 2008).	 In	 a	 genome‐wide	 meta	 analysis,	 genetic	
polymorphisms	located	close	to	genes	of	the	BHMT	or	transulphuration	pathway	were	
the	major	 determinants	 of	 toenail	 and	blood	 selenium	 concentrations	 (Cornelis	 et	 al.	
2015).	 The	 BHMT	 and	 transulphuration	 pathways	 are	 involved	 in	 the	 generation	 of	




would	 be	 retained	 in	 seleno	 proteins	 and	 tHcy	 found	 at	 lower	 levels	 because	 of	 the	
synthesis	 of	 glutathione.	However	 in	 animal	 studies,	 the	 induced	 selenium	deficiency	
brings	 lower	 seleno	protein	activities	as	 reported	 (Uthus	et	 al.	2002;	Uthus	and	Ross	
2007).	 The	 lower	 tHcy	 concentrations	 could	 reflect	 an	 effort	 to	 compensate	 this	 by	
higher	 glutathione	 synthesis.	 Indeed	 higher	 plasma	 glutathione	 concentrations	 have	
been	 found	 in	 selenium	 deficient	 rats,	 but	 not	 mice	 (Uthus	 and	 Ross	 2007).	 This	








in	 whole	 blood	 range	 from	 the	 same	 order	 of	 magnitude	 to	 two	 orders	 below	 the	
concentrations	of	the	placenta	(Tsuchiya	et	al.	1984;	Al‐Saleh	et	al.	2004).	Some	authors	
attribute	 the	 higher	 placenta	 iron	 concentrations	 in	 older	 studies	 to	 improper	 blood	
removal	(Iyengar	and	Rapp	2001a).	Our	 lower	 iron	concentrations	may	be	due	to	the	
specimen	being	more	thoroughly	cleaned	of	residual	blood.	
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placenta	 iron	 concentrations,	 so	 the	 finding	 of	 lower	 concentrations	 in	 participants	
with	 low	 compared	 to	 high	 socioeconomic	 level	 cannot	 be	 compared	 with	 previous	
studies.	 No	 differences	 in	 total	 and	 supplement	 iron	 intake	 existed	 between	 both	
socioeconomic	 levels	 (data	 not	 shown).	 The	 high	 socioeconomic	 level	 group	 had	
characteristics	 indicative	 of	 a	 healthier	 pregnancy:	 lower	 proportion	 of	 smokers	
throughout	 pregnancy,	 lower	 maternal	 BMI	 and	 higher	 proportion	 of	 preconception	
folic	acid	supplement	users	(data	not	shown).	However,	in	the	RTBC,	smoking	and	BMI	
were	not	associated	with	placenta	iron	concentrations,	and	as	will	be	commented,	iron	





In	 English	 pregnant	women,	 the	 use	 of	 iron	 supplements	 during	 pregnancy	was	 not	
associated	 with	 placenta	 iron	 (Ward	 et	 al.	 1987).	 We	 found	 borderline	 higher	 iron	




None	 of	 the	 analysed	 1C	metabolism	 components	was	 associated	with	 placenta	 iron.	
About	60%	of	the	total	iron	intake	in	the	RTBC	came	from	supplements.	The	iron	forms	
contained	 in	 these	 supplements	 are	 ferrous	 compound,	 none	 of	 which	 is	 haem	 iron.	
Folic	acid	simultaneous	to	non	haem	iron	does	not	independently	affect	iron	absorption	
(Buchanan	 1971;	 Campbell	 et	 al.	 1994),	 but	 folate	 deficient	 rabbits	 had	 higher	 non	
haem	 iron	 absorption	 compared	 to	 normal	 folate	 rabbits	 (Celada	 et	 al.	 1979).	 Our	
results	 cannot	 shed	 light	on	 this	because	placenta	 iron	was	not	affected	by	 total	 iron	
intake	 or	 intake	 from	 supplements	 when	 adjusting	 (data	 not	 shown).	 Other	
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The	 use	 of	 food	 frequency	 questionnaires	 to	 estimate	 the	 habitual	 intake	 of	 trace	
elements	 from	 food	 is	 imprecise	 for	 total	 intake	 estimations.	 Future	 analyses	 should	
include	 trace	 element	 determinations	 in	 blood	 to	 enable	 the	 study	 of	 interactions	




length	 and	 width	 of	 this	 organ.	 It	 is	 recommended	 to	 use	 multiple	 spots	 samples	
homogenised	 in	 a	 pooled	 sample	 (Iyengar	 and	 Rapp	 2001a),	 however	 this	 was	 not	







from	 these	 results.	 While	 measurements	 of	 oxidative	 stress	 and	 of	 trace	 element‐
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containing	 proteins	 involved	 in	 it	 are	 not	 available	 in	 the	 RTBC;	 toxic	 trace	 element	
concentrations	 were	 determined	 in	 the	 placentas.	 Due	 to	 the	 high	 degree	 of	
imputations	 because	 of	 a	 high	 proportion	 of	 placentas	 below	 the	 lower	 limits	 of	
detection,	and	some	cases	of	 implausible	recovery	percentages	(Material	and	methods	
point	 3.2	Table	 10),	 these	 other	 trace	 elements	 were	 not	 taken	 into	 account	 in	 the	
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Pregnancy	 is	a	physiological	state	 in	which	1C	metabolism	 is	extremely	 important,	as	
numerous	 studies	 have	 proven.	 Progress	 in	 knowledge	 in	 this	 field	 is	 of	 potential	
benefit	not	only	to	the	immediate	health	of	the	mother	and	her	neonate,	but	possibly	to	
the	ageing	process	of	the	neonate	by	foetal	programming	events.	In	addition,	given	that	
the	 placenta	 is	 responsible	 for	 the	 flux	 of	 nutrients	 and	waste	 products	 in	 the	 foeto‐
maternal	unit,	and	in	some	cases	act	as	a	barrier	or	accumulator	of	toxins,	the	processes	
occurring	 in	 this	 organ	 are	 expected	 to	 affect	 pregnancy	 outcome	 as	 well.	 However	
little	work	has	been	done	regarding	the	study	of	placental	trace	elements	such	as	zinc,	






and	related	metabolites	as	modulators	of	 the	effect	of	 these	polymorphisms	or	of	 the	
pathways	where	 these	 enzymes	 and	 transporter	 are	 located;	 but	 very	 few	 had	 been	
conducted	 in	 pregnancy,	 and	 virtually	 none	 in	 a	 longitudinal	 pregnancy	 study.	 The	
second	 part	 studied	 how	 maternal	 lifestyle	 factors	 and	 1C	 metabolism	 during	
pregnancy	 may	 affect	 the	 aforementioned	 four	 trace	 elements	 in	 the	 placenta	 and	




to	 date.	 This	 highlights	 the	 need	 to	 assess	 less	 conventional	 factors	 that	 are	 often	
overlooked	 or	 not	 investigated.	 In	 line	 with	 this,	 in	 the	 genetic	 chapter	 we	 have	
reported	 that	 folate	 status	 can	 modulate	 the	 effect	 of	 the	 BHMT	 c.716G>A	
polymorphism	on	DMG	and	DMG/betaine	ratio	at	early	pregnancy	(also	with	a	recent	
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publication,	 Appendices).	 Lower	 betaine	 to	 DMG	 conversion	 was	 found	 in	
heterozygotes	 compared	 to	 normal	 homozygotes	 at	 early	 pregnancy	 and	 only	 when	
folate	 status	 was	 high.	 At	 late	 pregnancy	 lower	 conversion	 was	 found	 in	 variant	
homozygotes	compared	to	normal	homozygotes,	and	this	was	not	modulated	by	folate	
status.	 In	 the	 trace	 element	 chapter,	 the	models	did	not	predict	 the	 variability	 in	 the	
concentrations	of	zinc,	selenium	and	iron	in	the	placenta,	and	in	the	case	of	copper	very	
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The	 frequency	 of	 heterozygotes	 and	 variant	 homozygotes	were:	 49%	and	 17%	







BHMT	 c.716	 variant	 allele	 carriers	 had	 lower	 plasma	 DMG	 concentrations	
throughout	pregnancy	compared	to	normal	homozygotes.	
Plasma	 and	 RBC	 folate	 and	 tHcy	 did	 not	 vary	 during	 pregnancy	with	 SLC19A1	
c.80G>A	genotype.	
Early	 pregnancy	 plasma	 tHcy	 was	 higher	 in	 MTRR	 c.66	 variant	 homozygotes	
compared	to	normal	homozygotes.	
‐	 Objective:	 To	 investigate	 whether	 folate	 status	 modulates	 the	 effect	 of	 the	 MTHFR	
c.665C>T,	 BHMT	 c.716G>A,	 SLC19A1	 c.80G>A,	 and	 MTRR	 c.66A>G	 maternal	
polymorphisms	 on	 1C	metabolism	 analytes	 other	 than	 plasma	 and	 RBC	 folate,	 in	 the	
RTBC.	
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Plasma	 folate	 status	 did	 not	 modify	 the	 relationship	 between	 the	 SLC19A1	
c.80G>A	polymorphism	and	plasma	tHcy	during	pregnancy.	







The	 maternal	 SLC19A1	 c.80	 variant	 homozygote	 genotype	 could	 be	 associated	
with	 miscarriage	 as	 this	 genotype	 had	 borderline	 higher	 proportion	 of	
miscarriage	cases	than	the	other	genotypes.	
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‐	 Objective:	 To	 report	 placenta	 zinc,	 copper,	 selenium	 and	 iron	 concentrations	 in	 the	
RTBC.	
The	median	concentrations	in	the	placenta	were	6809,	534	and	82.2ng/g	of	wet	







negatively	 associated	 with	 placenta	 copper.	 Elevated	 placenta	 copper	 was	
associated	with	IUGR	risk.	
High	socioeconomic	status	was	positively	associated	with	placenta	iron.	
Intakes	 of	 each	 trace	 element	 were	 not	 associated	 with	 their	 respective	
concentrations	in	placenta.	
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